Spike glycoprotein
UniProt P0DTC2 · gene S · Severe acute respiratory syndrome coronavirus 2 · 1273 residues
2468evidence items
0mapped to a state
0states
8techniques
7sources
0conflicts
Coverage grid
Mapped evidence per state and technique. Shaded rows rest on a single technique. Badge = best data level in the cell: raw (traces, images, FIDs: can be re-analysed), proc (maps, curves, tables, trajectories) or rep (values in the paper only).
| State | Basis | xray | cryoem | nmr_structure | nmr_shifts | saxs_sans | force_spectroscopy | af_prediction | md | Total |
|---|---|---|---|---|---|---|---|---|---|---|
| No states defined yet. | ||||||||||
Unmapped evidence: 2468 of 2468 items. Mappings come from curator assignments and curated rules; see About for how rules work.
Sources
| Source | Evidence | Mapped |
|---|---|---|
| AlphaFold DB | 1 | 0 |
| BMRB | 6 | 0 |
| DisProt | 25 | 0 |
| MDDB | 100 | 0 |
| RCSB PDB | 2294 | 0 |
| SASBDB | 6 | 0 |
| SMASH-BIO | 36 | 0 |
Structure
No state models are exported for this protein yet. Observed states export the representative PDB entry; inferred states need fitted models, not yet built.
States and transitions
No states defined.
| State | Basis | Parent | Description |
|---|
No transitions recorded in this version (no rate or free-energy evidence has been curated yet).
Evidence
One row per deposit or experiment. Filter by technique, environment or text. Unmapped evidence is listed too.
| Evidence | Technique | Observable | Conditions | Mapped to state |
|---|---|---|---|---|
| EV-PDB-11HL-1 RCSB PDB | cryoem | resolution: 2.8 Å | in vitro · ligands NAG SARS-CoV-2 spike S2 trimer stabilized in the early fusion intermediate conformation (E-FICs-v3) bound to the VN01H1 Fab (S2 local refinement) · E-FICs-v3 (chains A,B,C) | unmapped |
| EV-PDB-22HG-1 RCSB PDB | cryoem | resolution: 2.61 Å | in vitro · ligands NAG, ZN, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 BA.3.2.2(RE.2.2) RBD in complex with human ACE2 and monoclonal antibody S2H97 · Spike protein S1 (chains A) | unmapped |
| EV-PDB-6LZG-2 RCSB PDB | xray | resolution: 2.5 Å | in vitro · -173.15 °C · pH 6.5 · ligands NAG, ZN Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2 · Spike protein S1 (chains B) | unmapped |
| EV-PDB-6M0J-2 RCSB PDB | xray | resolution: 2.45 Å | in vitro · -173.15 °C · ligands CL, NAG, ZN Crystal structure of SARS-CoV-2 spike receptor-binding domain bound with ACE2 · Spike protein S1 (chains E) | unmapped |
| EV-PDB-6M17-3 RCSB PDB | cryoem | resolution: 2.9 Å | in vitro · ligands LEU, NAG, ZN, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose The 2019-nCoV RBD/ACE2-B0AT1 complex · Spike protein S1 (chains E,F) | unmapped |
| EV-PDB-6VW1-2 RCSB PDB | xray | resolution: 2.68 Å | in vitro · -173.15 °C · ligands CL, EDO, NAG, ZN, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Structure of SARS-CoV-2 chimeric receptor-binding domain complexed with its receptor human ACE2 · SARS-CoV-2 chimeric RBD (chains E,F) | unmapped |
| EV-PDB-6XF6-1 RCSB PDB | cryoem | resolution: 4 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of a biotinylated SARS-CoV-2 spike probe in the prefusion state (1 RBD up) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-6XLU-1 RCSB PDB | cryoem | resolution: 2.4 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Structure of SARS-CoV-2 spike at pH 4.0 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-6XM0-1 RCSB PDB | cryoem | resolution: 2.7 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Consensus structure of SARS-CoV-2 spike at pH 5.5 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-6XKQ-1 RCSB PDB | xray | resolution: 2.55 Å | in vitro · -173.15 °C · ligands NAG Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody CV07-250 · Spike protein S1 (chains A) | unmapped |
| EV-PDB-6XKP-1 RCSB PDB | xray | resolution: 2.72 Å | in vitro · -173.15 °C · ligands NAG, SO4 Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody CV07-270 · Spike protein S1 (chains A,B) | unmapped |
| EV-PDB-6XKL-1 RCSB PDB | cryoem | resolution: 3.21 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 HexaPro S One RBD up · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-6XF5-1 RCSB PDB | cryoem | resolution: 3.45 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of a biotinylated SARS-CoV-2 spike probe in the prefusion state (RBDs down) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-6XEY-1 RCSB PDB | cryoem | resolution: 3.25 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of the SARS-CoV-2 spike glycoprotein bound to Fab 2-4 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-6XE1-3 RCSB PDB | xray | resolution: 2.75 Å | in vitro · -173.15 °C · pH 7 · ligands NAG Structure of SARS-CoV-2 spike protein receptor binding domain in complex with a potent neutralizing antibody, CV30 Fab · Spike protein S1 (chains E) | unmapped |
| EV-PDB-6XDG-1 RCSB PDB | cryoem | resolution: 3.9 Å | in vitro · ligands branched: alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Complex of SARS-CoV-2 receptor binding domain with the Fab fragments of two neutralizing antibodies · Spike protein S1 (chains E) | unmapped |
| EV-PDB-6XCN-1 RCSB PDB | cryoem | resolution: 3.66 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Structure of the SARS-CoV-2 spike glycoprotein in complex with the C105 neutralizing antibody Fab fragment (state 2) · Spike glycoprotein (chains A,C,E) | unmapped |
| EV-PDB-6XCM-1 RCSB PDB | cryoem | resolution: 3.42 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Structure of the SARS-CoV-2 spike glycoprotein in complex with the C105 neutralizing antibody Fab fragment (state 1) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-6XC7-1 RCSB PDB | xray | resolution: 2.883 Å | in vitro · -173.15 °C · ligands branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Crystal structure of SARS-CoV-2 receptor binding domain in complex with antibodies CC12.3 and CR3022 · Spike protein S1 (chains A) | unmapped |
| EV-PDB-6XC4-1 RCSB PDB | xray | resolution: 2.341 Å | in vitro · -173.15 °C · ligands NAG Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody CC12.3 · Spike protein S1 (chains A,Z) | unmapped |
| EV-PDB-6XC3-5 RCSB PDB | xray | resolution: 2.698 Å | in vitro · -173.15 °C · ligands branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Crystal structure of SARS-CoV-2 receptor binding domain in complex with antibodies CC12.1 and CR3022 · Spike protein S1 (chains C) | unmapped |
| EV-PDB-6XC2-1 RCSB PDB | xray | resolution: 3.112 Å | in vitro · -173.15 °C · ligands NAG Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody CC12.1 · Spike protein S1 (chains A,Z) | unmapped |
| EV-PDB-6X79-1 RCSB PDB | cryoem | resolution: 2.9 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Prefusion SARS-CoV-2 S ectodomain trimer covalently stabilized in the closed conformation · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-6X6P-1 RCSB PDB | cryoem | resolution: 3.22 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Characterization of the SARS-CoV-2 S Protein: Biophysical, Biochemical, Structural, and Antigenic Analysis · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-6X45-1 RCSB PDB | xray | resolution: 2.2 Å | in vitro · -173.15 °C · pH 7.8 SARS-CoV2 spike glycoprotein N-terminal heptad repeat domain + SARS-CoV2(QEYKKEKE) · Spike protein S2' (chains D,E,F) | unmapped |
| EV-PDB-6X2C-1 RCSB PDB | cryoem | resolution: 3.2 Å | in vitro SARS-CoV-2 u1S2q All Down RBD State Spike Protein Trimer · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-6X2B-1 RCSB PDB | cryoem | resolution: 3.6 Å | in vitro SARS-CoV-2 u1S2q 2-RBD Up Spike Protein Trimer · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-6X2A-1 RCSB PDB | cryoem | resolution: 3.3 Å | in vitro SARS-CoV-2 u1S2q 1-RBD Up Spike Protein Trimer · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-6X29-1 RCSB PDB | cryoem | resolution: 2.7 Å | in vitro SARS-CoV-2 rS2d Down State Spike Protein Trimer · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-6WPT-1 RCSB PDB | cryoem | resolution: 3.7 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose Structure of the SARS-CoV-2 spike glycoprotein in complex with the S309 neutralizing antibody Fab fragment (open state) · spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-6WPS-1 RCSB PDB | cryoem | resolution: 3.1 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose Structure of the SARS-CoV-2 spike glycoprotein in complex with the S309 neutralizing antibody Fab fragment · spike glycoprotein (chains A,B,E) | unmapped |
| EV-PDB-6W41-3 RCSB PDB | xray | resolution: 3.084 Å | in vitro · -173.15 °C · ligands GOL, NAG, SO4 Crystal structure of SARS-CoV-2 receptor binding domain in complex with human antibody CR3022 · Spike protein S1 (chains C) | unmapped |
| EV-PDB-6VYB-1 RCSB PDB | cryoem | resolution: 3.2 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 spike ectodomain structure (open state) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-6VXX-1 RCSB PDB | cryoem | resolution: 2.8 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Structure of the SARS-CoV-2 spike glycoprotein (closed state) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-6VSB-1 RCSB PDB | cryoem | resolution: 3.46 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Prefusion 2019-nCoV spike glycoprotein with a single receptor-binding domain up · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-6M1V-1 RCSB PDB | xray | resolution: 1.5 Å | in vitro · -173.15 °C · pH 6.5 Crystal structure of post fusion core of 2019-nCoV S2 subunit · Spike protein S2,Spike protein S2 (chains A) | unmapped |
| EV-PDB-6LXT-1 RCSB PDB | xray | resolution: 2.9 Å | in vitro · -173.15 °C · pH 6 · ligands PG4, ZN Structure of post fusion core of 2019-nCoV S2 subunit · Spike protein S2, Spike protein S2 (chains A,B,C,D,E,F) | unmapped |
| EV-PDB-6LVN-1 RCSB PDB | xray | resolution: 2.47 Å | in vitro · -173.15 °C Structure of the 2019-nCoV HR2 Domain · Spike protein S2' (chains A,B,C,D) | unmapped |
| EV-PDB-45ID-3 RCSB PDB | xray | resolution: 3.54 Å | in vitro · -173.15 °C Complex structure of THZ-939 Fab bound to SARS-CoV-2 WT RBD · Spike protein S1 (chains A) | unmapped |
| EV-PDB-36AZ-3 RCSB PDB | cryoem | resolution: 3.9 Å | in vitro · ligands NAG Structure of BA.1-S-RBD/2130WT/2196-S93Y · Spike protein (chains A) | unmapped |
| EV-PDB-28IL-3 RCSB PDB | xray | resolution: 3.1 Å | in vitro · -173.15 °C P1-15 T-cell Receptor bound to HLA A*2402-NF9 pMHC complex · Spike protein S1 (chains C,H) | unmapped |
| EV-PDB-27KF-2 RCSB PDB | cryoem | resolution: 3.4 Å | in vitro Cryo-EM structure of Tundra swan ACE2 complexed with SARS-CoV-2 RBD · Spike protein S1 (chains B) | unmapped |
| EV-PDB-27KE-2 RCSB PDB | cryoem | resolution: 3.3 Å | in vitro Cryo-EM structure of Black swan ACE2 complexed with SARS-CoV-2 RBD · Spike protein S1 (chains B) | unmapped |
| EV-PDB-26DA-1 RCSB PDB | cryoem | resolution: 2.88 Å | in vitro Cryo-EM structure of spike protein within graphene reservoir sandwich · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-22OV-1 RCSB PDB | cryoem | resolution: 2.37 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 BA.3.2.2(RE.2.2) spike protein · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-22HP-1 RCSB PDB | cryoem | resolution: 3.19 Å | in vitro · ligands NAG SARS-CoV-2 BA.3.2.2(RE.2.2) RBD in complex with monoclonal antibodies S2K146 and L4.65 · Spike protein S1 (chains A) | unmapped |
| EV-PDB-11HW-1 RCSB PDB | cryoem | resolution: 2.8 Å | in vitro · ligands NAG SARS-CoV-2 spike S2 trimer stabilized in the early fusion intermediate conformation (E-FICs-v3) bound to C77G12 (Fab local refinement) · E-FICs-v3 (chains A,B,G) | unmapped |
| EV-PDB-11HN-1 RCSB PDB | cryoem | resolution: 2.7 Å | in vitro · ligands NAG SARS-CoV-2 spike S2 trimer stabilized in the early fusion intermediate conformation (E-FICs-v3) bound to C77G12 (S2 local refinement) · Spike protein S2 (chains A,B,C) | unmapped |
| EV-PDB-11HK-1 RCSB PDB | cryoem | resolution: 2.7 Å | in vitro · ligands NAG SARS-CoV-2 spike S2 trimer stabilized in the early fusion intermediate conformation (E-FICs-v3) bound to the VN01H1 Fab (Fab local refinement) · E-FICS-v3 (chains A,D,G) | unmapped |
| EV-PDB-10MU-3 RCSB PDB | cryoem | resolution: 3.16 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 S2 in complex with polyclonal Fab_Donor2 · Spike protein S2 (chains C,D,E) | unmapped |
| EV-PDB-6XM5-1 RCSB PDB | cryoem | resolution: 3.1 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Structure of SARS-CoV-2 spike at pH 5.5, all RBDs down · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-6Z43-1 RCSB PDB | cryoem | resolution: 3.3 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM Structure of SARS-CoV-2 Spike : H11-D4 Nanobody Complex · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-6ZB5-1 RCSB PDB | cryoem | resolution: 2.85 Å | in vitro · ligands EIC, NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS CoV-2 Spike protein, Closed conformation, C3 symmetry · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-6ZDH-1 RCSB PDB | cryoem | resolution: 3.7 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 Spike glycoprotein in complex with a neutralizing antibody EY6A Fab · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-6ZGI-1 RCSB PDB | cryoem | resolution: 2.9 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Furin Cleaved Spike Protein of SARS-CoV-2 in Closed Conformation · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-6ZHD-1 RCSB PDB | cryoem | resolution: 3.7 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose H11-H4 bound to Spike · Spike glycoprotein,Fibritin (chains A,B,C) | unmapped |
| EV-PDB-6ZOX-1 RCSB PDB | cryoem | resolution: 3 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Structure of Disulphide-stabilized SARS-CoV-2 Spike Protein Trimer (x2 disulphide-bond mutant, G413C, V987C, single Arg S1/S2 cleavage site) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-6ZP1-1 RCSB PDB | cryoem | resolution: 3.3 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Structure of SARS-CoV-2 Spike Protein Trimer (K986P, V987P, single Arg S1/S2 cleavage site) in Closed State · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-6ZP7-1 RCSB PDB | cryoem | resolution: 3.3 Å | in vitro · ligands DMS, MAN, NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-6)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 spike in prefusion state (flexibility analysis, 1-up open conformation) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7A29-1 RCSB PDB | cryoem | resolution: 2.94 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of the SARS-CoV-2 spike protein bound to neutralizing sybodies (Sb23) 2-up conformation · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7A95-1 RCSB PDB | cryoem | resolution: 4.3 Å | in vitro SARS-CoV-2 Spike Glycoprotein with 1 ACE2 Bound and 1 RBD Erect in Clockwise Direction · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7A94-1 RCSB PDB | cryoem | resolution: 3.9 Å | in vitro · ligands NAG, ZN SARS-CoV-2 Spike Glycoprotein with 1 ACE2 Bound · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7A93-1 RCSB PDB | cryoem | resolution: 5.9 Å | in vitro SARS-CoV-2 Spike Glycoprotein with 2 RBDs Erect · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7A92-2 RCSB PDB | cryoem | resolution: 4.2 Å | in vitro · ligands NAG, ZN, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Dissociated S1 domain of SARS-CoV-2 Spike bound to ACE2 (Unmasked Refinement) · Spike glycoprotein (chains A) | unmapped |
| EV-PDB-7A91-2 RCSB PDB | cryoem | resolution: 3.6 Å | in vitro · ligands NAG, ZN, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Dissociated S1 domain of SARS-CoV-2 Spike bound to ACE2 (Non-Uniform Refinement) · Spike glycoprotein (chains A) | unmapped |
| EV-PDB-7A5S-3 RCSB PDB | cryoem | resolution: 3.9 Å | in vitro · ligands branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Complex of SARS-CoV-2 spike and CR3022 Fab (Homogeneous Refinement) · Spike glycoprotein (chains A,B) | unmapped |
| EV-PDB-7A5R-3 RCSB PDB | cryoem | resolution: 3.7 Å | in vitro · ligands branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Complex of SARS-CoV-2 spike and CR3022 Fab (Non-Uniform Refinement) · Spike glycoprotein (chains A,B) | unmapped |
| EV-PDB-7A4N-1 RCSB PDB | cryoem | resolution: 2.75 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of a prefusion stabilized SARS-CoV-2 Spike (D614N, R682S, R685G, A892P, A942P and V987P)(S-closed trimer) · Spike glycoprotein,Fibritin (chains A,B,C) | unmapped |
| EV-PDB-7A25-1 RCSB PDB | cryoem | resolution: 3.06 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of the SARS-CoV-2 spike protein bound to neutralizing sybodies (Sb23) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-6ZXN-1 RCSB PDB | cryoem | resolution: 2.93 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of the SARS-CoV-2 spike protein bound to neutralizing nanobodies (Ty1) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-6ZWV-1 RCSB PDB | cryoem | resolution: 3.5 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 Spike Proteins on intact virions: 3 Closed RBDs · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-6ZP5-1 RCSB PDB | cryoem | resolution: 3.1 Å | in vitro · ligands DMS, MAN, NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-6)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 spike in prefusion state (flexibility analysis, 1-up closed conformation) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-6ZP2-1 RCSB PDB | cryoem | resolution: 3.1 Å | in vitro · ligands BLA, EIC, NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Structure of SARS-CoV-2 Spike Protein Trimer (K986P, V987P, single Arg S1/S2 cleavage site) in Locked State · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-6ZP0-1 RCSB PDB | cryoem | resolution: 3 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Structure of SARS-CoV-2 Spike Protein Trimer (single Arg S1/S2 cleavage site) in Closed State · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-6ZOZ-1 RCSB PDB | cryoem | resolution: 3.5 Å | in vitro · ligands BLA, NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Structure of Disulphide-stabilized SARS-CoV-2 Spike Protein Trimer (x1 disulphide-bond mutant, S383C, D985C, K986P, V987P, single Arg S1/S2 cleavage site) in Locked State · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-6ZOY-1 RCSB PDB | cryoem | resolution: 3.1 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Structure of Disulphide-stabilized SARS-CoV-2 Spike Protein Trimer (x1 disulphide-bond mutant, S383C, D985C, K986P, V987P, single Arg S1/S2 cleavage site) in Closed State · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-6ZOW-1 RCSB PDB | cryoem | resolution: 3 Å | in vitro · ligands DMS, MAN, NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-6)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 spike in prefusion state · Spike glycoprotein (chains A,B,C,a) | unmapped |
| EV-PDB-6ZLR-1 RCSB PDB | xray | resolution: 3.1 Å | in vitro · -173.15 °C · pH 7.7 · ligands NAG Soaking competent crystal form of the SARS-CoV-2 Receptor Binding Domain (RBD):CR3022 complex. · Spike glycoprotein (chains AAA,DDD,EEE) | unmapped |
| EV-PDB-6ZH9-3 RCSB PDB | xray | resolution: 3.31 Å | in vitro · -173.15 °C Ternary complex CR3022 H11-H4 and RBD (SARS-CoV-2) · Spike glycoprotein (chains EEE) | unmapped |
| EV-PDB-6ZGH-1 RCSB PDB | cryoem | resolution: 6.8 Å | in vitro Furin Cleaved Spike Protein of SARS-CoV-2 in Intermediate Conformation · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-6ZGG-1 RCSB PDB | cryoem | resolution: 3.8 Å | in vitro Furin Cleaved Spike Protein of SARS-CoV-2 with One RBD Erect · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-6ZGE-1 RCSB PDB | cryoem | resolution: 2.6 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Uncleavable Spike Protein of SARS-CoV-2 in Closed Conformation · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-6ZFO-1 RCSB PDB | cryoem | resolution: 4.4 Å | in vitro · ligands NAG Association of two complexes of largely structurally disordered Spike ectodomain with bound EY6A Fab · Spike protein S1 (chains A,E) | unmapped |
| EV-PDB-6ZER-1 RCSB PDB | xray | resolution: 3.8 Å | in vitro · -173.15 °C · ligands NAG, PO4 Crystal structure of receptor binding domain of SARS-CoV-2 Spike glycoprotein in complex with EY6A Fab · Spike protein S1 (chains A,D,E) | unmapped |
| EV-PDB-6ZDG-1 RCSB PDB | cryoem | resolution: 4.7 Å | in vitro · ligands NAG Association of three complexes of largely structurally disordered Spike ectodomain with bound EY6A Fab · Spike protein S1 (chains A,D,E) | unmapped |
| EV-PDB-6ZCZ-1 RCSB PDB | xray | resolution: 2.65 Å | in vitro · -173.15 °C · ligands CL, MG, NAG Crystal structure of receptor binding domain of SARS-CoV-2 Spike glycoprotein in ternary complex with EY6A Fab and a nanobody. · Spike protein S1 (chains E) | unmapped |
| EV-PDB-6ZBP-1 RCSB PDB | xray | resolution: 1.85 Å | in vitro · -173.15 °C · ligands NAG, SO4 H11-H4 complex with SARS-CoV-2 · Spike glycoprotein (chains EEE) | unmapped |
| EV-PDB-6ZB4-1 RCSB PDB | cryoem | resolution: 3.03 Å | in vitro · ligands EIC, NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS CoV-2 Spike protein, Closed conformation, C1 symmetry · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-6Z97-1 RCSB PDB | cryoem | resolution: 3.4 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Structure of the prefusion SARS-CoV-2 spike glycoprotein · Spike glycoprotein,Fibritin (chains A,B,C) | unmapped |
| EV-PDB-6Z2M-1 RCSB PDB | xray | resolution: 2.71 Å | in vitro · -173.15 °C · ligands NAG H11-D4, SARS-CoV-2 RBD, CR3022 ternary complex · Spike glycoprotein (chains A,E) | unmapped |
| EV-PDB-6YZ7-1 RCSB PDB | xray | resolution: 3.3 Å | in vitro · -173.15 °C · ligands NAG H11-D4, SARS-CoV-2 RBD, CR3022 ternary complex · Spike glycoprotein (chains AAA,EEE) | unmapped |
| EV-PDB-6YZ5-1 RCSB PDB | xray | resolution: 1.8 Å | in vitro · -173.15 °C · ligands ACT, EDO, NAG H11-D4 complex with SARS-CoV-2 RBD · Spike glycoprotein (chains E) | unmapped |
| EV-PDB-6YOR-1 RCSB PDB | cryoem | resolution: 3.3 Å | in vitro Structure of the SARS-CoV-2 spike S1 protein in complex with CR3022 Fab · Spike glycoprotein (chains A,E) | unmapped |
| EV-PDB-6YM0-1 RCSB PDB | xray | resolution: 4.36 Å | in vitro · -173.15 °C · pH 8 Crystal structure of the SARS-CoV-2 receptor binding domain in complex with CR3022 Fab (crystal form 1) · Spike glycoprotein (chains E) | unmapped |
| EV-PDB-6YLA-1 RCSB PDB | xray | resolution: 2.42 Å | in vitro · -173.15 °C · ligands 1PE, DMS, MLI, NAG, PG0 Crystal structure of the SARS-CoV-2 receptor binding domain in complex with CR3022 Fab · Spike glycoprotein (chains A,E) | unmapped |
| EV-PDB-6XS6-1 RCSB PDB | cryoem | resolution: 3.7 Å | in vitro SARS-CoV-2 Spike D614G variant, minus RBD · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-6XRA-1 RCSB PDB | cryoem | resolution: 3 Å | in vitro · ligands MAN, NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-3)-alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Distinct conformational states of SARS-CoV-2 spike protein · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-6XR8-1 RCSB PDB | cryoem | resolution: 2.9 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-3)-alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Distinct conformational states of SARS-CoV-2 spike protein · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-6XM4-1 RCSB PDB | cryoem | resolution: 2.9 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Structure of SARS-CoV-2 spike at pH 5.5, single RBD up, conformation 2 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-6XM3-1 RCSB PDB | cryoem | resolution: 2.9 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Structure of SARS-CoV-2 spike at pH 5.5, single RBD up, conformation 1 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7A96-1 RCSB PDB | cryoem | resolution: 4.8 Å | in vitro SARS-CoV-2 Spike Glycoprotein with 1 ACE2 Bound and 1 RBD Erect in Anticlockwise Direction · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7A97-1 RCSB PDB | cryoem | resolution: 4.4 Å | in vitro SARS-CoV-2 Spike Glycoprotein with 2 ACE2 Bound · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7A98-1 RCSB PDB | cryoem | resolution: 5.4 Å | in vitro SARS-CoV-2 Spike Glycoprotein with 3 ACE2 Bound · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7BH9-2 RCSB PDB | cryoem | resolution: 2.9 Å | in vitro · ligands NAG, ZN SARS-CoV-2 RBD-62 in complex with ACE2 peptidase domain · Spike protein S1 (chains E) | unmapped |
| EV-PDB-7BNN-1 RCSB PDB | cryoem | resolution: 3.5 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose Open conformation of D614G SARS-CoV-2 spike with 1 Erect RBD · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7BNO-1 RCSB PDB | cryoem | resolution: 4.2 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Open conformation of D614G SARS-CoV-2 spike with 2 Erect RBDs · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7BYR-1 RCSB PDB | cryoem | resolution: 3.84 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose BD23-Fab in complex with the S ectodomain trimer · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7BZ5-1 RCSB PDB | xray | resolution: 1.84 Å | in vitro · -173.15 °C · pH 6 · ligands NAG Structure of COVID-19 virus spike receptor-binding domain complexed with a neutralizing antibody · Spike protein S1 (chains A) | unmapped |
| EV-PDB-7C8J-2 RCSB PDB | xray | resolution: 3.18 Å | in vitro · -173.15 °C · ligands ZN Structural basis for cross-species recognition of COVID-19 virus spike receptor binding domain to bat ACE2 · SARS-CoV-2 Receptor binding domain (chains B) | unmapped |
| EV-PDB-7C8V-2 RCSB PDB | xray | resolution: 2.15 Å | in vitro · -173.15 °C · ligands GOL, NAG Structure of sybody SR4 in complex with the SARS-CoV-2 S Receptor Binding domain (RBD) · Spike protein S1 (chains B) | unmapped |
| EV-PDB-7CHH-1 RCSB PDB | cryoem | resolution: 3.49 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of the SARS-CoV-2 S-6P in complex with BD-368-2 Fabs · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7CHF-3 RCSB PDB | xray | resolution: 2.674 Å | in vitro · -193.15 °C Crystal structure of the SARS-CoV-2 RBD in complex with BD-604 Fab and BD-368-2 Fab · Spike protein S1 (chains R) | unmapped |
| EV-PDB-7CHE-3 RCSB PDB | xray | resolution: 3.416 Å | in vitro · -193.15 °C Crystal structure of the SARS-CoV-2 RBD in complex with BD-236 Fab and BD-368-2 Fab · Spike protein S1 (chains R) | unmapped |
| EV-PDB-7CHC-3 RCSB PDB | xray | resolution: 2.71 Å | in vitro · -193.15 °C Crystal structure of the SARS-CoV-2 S RBD in complex with BD-629 Fab and BD-368-2 Fab · Spike protein S1 (chains R) | unmapped |
| EV-PDB-7CHB-3 RCSB PDB | xray | resolution: 2.4 Å | in vitro · -193.15 °C · ligands branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Crystal structure of the SARS-CoV-2 RBD in complex with BD-236 Fab · Spike protein S1 (chains R) | unmapped |
| EV-PDB-7CH5-3 RCSB PDB | xray | resolution: 2.7 Å | in vitro · -193.15 °C Crystal structure of the SARS-CoV-2 S RBD in complex with BD-629 Fab · Spike protein S1 (chains R) | unmapped |
| EV-PDB-7CH4-3 RCSB PDB | xray | resolution: 3.15 Å | in vitro · -193.15 °C Crystal structure of the SARS-CoV-2 S RBD in complex with BD-604 Fab · Spike protein S1 (chains R) | unmapped |
| EV-PDB-7CDJ-1 RCSB PDB | xray | resolution: 3.396 Å | in vitro · -173.15 °C · ligands NAG Crystal structure of SARS-CoV-2 antibody P2C-1A3 with RBD · Spike protein S1 (chains E) | unmapped |
| EV-PDB-7CDI-1 RCSB PDB | xray | resolution: 2.96 Å | in vitro · -173.15 °C · ligands NAG Crystal structure of SARS-CoV-2 antibody P2C-1F11 with RBD · Spike protein S1 (chains E) | unmapped |
| EV-PDB-7CAN-2 RCSB PDB | xray | resolution: 2.94 Å | in vitro · -173.15 °C · ligands GOL, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose Structure of sybody MR17-K99Y in complex with the SARS-CoV-2 S Receptor-binding domain (RBD) · Spike protein S1 (chains B) | unmapped |
| EV-PDB-7CAK-1 RCSB PDB | cryoem | resolution: 3.58 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 S trimer with three RBD in the open state and complexed with three H014 Fab · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7CAI-1 RCSB PDB | cryoem | resolution: 3.49 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 S trimer with two RBDs in the open state and complexed with two H014 Fab · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7CAH-3 RCSB PDB | cryoem | resolution: 3.9 Å | in vitro The interface of H014 Fab binds to SARS-CoV-2 S · Spike protein S1 (chains A) | unmapped |
| EV-PDB-7CAC-1 RCSB PDB | cryoem | resolution: 3.55 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 S trimer with one RBD in the open state and complexed with one H014 Fab. · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7CAB-1 RCSB PDB | cryoem | resolution: 3.52 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Structural basis for neutralization of SARS-CoV-2 and SARS-CoV by a potent therapeutic antibody · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7C8W-2 RCSB PDB | xray | resolution: 2.77 Å | in vitro · -173.15 °C · ligands GOL, branched: alpha-L-fucopyranose-(1-3)-[2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)][alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose Structure of sybody MR17 in complex with the SARS-CoV-2 S receptor-binding domain (RBD) · Spike protein S1 (chains B) | unmapped |
| EV-PDB-7C8D-2 RCSB PDB | cryoem | resolution: 3 Å | in vitro · ligands ZN Cryo-EM structure of cat ACE2 and SARS-CoV-2 RBD · Spike protein S1 (chains B) | unmapped |
| EV-PDB-7C53-1 RCSB PDB | xray | resolution: 2.278 Å | in vitro · -173.15 °C · ligands CA Crystal Structure of SARS-CoV-2 HR1 motif in complex with pan-CoVs inhibitor EK1 · Spike protein S2',pan-CoVs inhibitor EK1 (chains A,B,C,D,E,F) | unmapped |
| EV-PDB-7C2L-1 RCSB PDB | cryoem | resolution: 3.1 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose S protein of SARS-CoV-2 in complex bound with 4A8 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7C01-1 RCSB PDB | xray | resolution: 2.88 Å | in vitro · -173.15 °C · ligands NAG Molecular basis for a potent human neutralizing antibody targeting SARS-CoV-2 RBD · Spike protein S1 (chains A,B) | unmapped |
| EV-PDB-7BWJ-1 RCSB PDB | xray | resolution: 2.85 Å | in vitro · -173.15 °C · ligands NAG crystal structure of SARS-CoV-2 antibody with RBD · Spike protein S1 (chains E) | unmapped |
| EV-PDB-7BNV-1 RCSB PDB | xray | resolution: 2.35 Å | in vitro · -173.15 °C · ligands NAG Crystal Structure of the SARS-CoV-2 Receptor Binding Domain in Complex with Antibody ION-300 · Surface glycoprotein (chains A) | unmapped |
| EV-PDB-7BNM-1 RCSB PDB | cryoem | resolution: 3.6 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Closed conformation of D614G SARS-CoV-2 spike protein · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7BEP-1 RCSB PDB | xray | resolution: 2.61 Å | in vitro · -173.15 °C · pH 6.5 · ligands CL, GLU, GLY, GOL, IMD, PEG, PG4, PGE, branched: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose Crystal structure of the receptor binding domain of SARS-CoV-2 Spike glycoprotein in a ternary complex with COVOX-384 and S309 Fabs · Spike glycoprotein (chains C,E) | unmapped |
| EV-PDB-7BEO-1 RCSB PDB | xray | resolution: 3.19 Å | in vitro · -173.15 °C · pH 5.5 · ligands ACT, CL, GOL, NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose Crystal structure of the receptor binding domain of SARS-CoV-2 Spike glycoprotein in a ternary complex with COVOX-253H55L and COVOX-75 Fabs · Spike glycoprotein (chains R,X) | unmapped |
| EV-PDB-7BEN-1 RCSB PDB | xray | resolution: 2.5 Å | in vitro · -173.15 °C · pH 6.5 · ligands BR, GOL, IMD, IOD, PEG, PG6, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose Crystal structure of the receptor binding domain of SARS-CoV-2 Spike glycoprotein in a ternary complex with COVOX-253 and COVOX-75 Fabs · Spike glycoprotein (chains C,E) | unmapped |
| EV-PDB-7BEM-3 RCSB PDB | xray | resolution: 2.52 Å | in vitro · -173.15 °C · ligands CL, GOL, PO4, PRO, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose Crystal structure of the receptor binding domain of SARS-CoV-2 Spike glycoprotein in complex with COVOX-269 scFv · Spike glycoprotein (chains E) | unmapped |
| EV-PDB-7BEL-1 RCSB PDB | xray | resolution: 2.53 Å | in vitro · -173.15 °C · pH 8 · ligands ACT, GOL, NAG, branched: alpha-D-mannopyranose-(1-3)-alpha-D-mannopyranose-(1-6)-[alpha-D-mannopyranose-(1-3)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Crystal structure of the receptor binding domain of SARS-CoV-2 Spike glycoprotein in a ternary complex with COVOX-88 and COVOX-45 Fabs · Spike glycoprotein (chains R,X) | unmapped |
| EV-PDB-7BEK-3 RCSB PDB | xray | resolution: 2.04 Å | in vitro · -173.15 °C · pH 7.6 · ligands CL, GOL, PEG, SO4, TRS, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose Crystal structure of the receptor binding domain of SARS-CoV-2 Spike glycoprotein in complex with COVOX-158 Fab (crystal form 2) · Spike glycoprotein (chains E) | unmapped |
| EV-PDB-7BEJ-3 RCSB PDB | xray | resolution: 2.42 Å | in vitro · -173.15 °C · pH 7 · ligands FMT, GOL, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose Crystal structure of the receptor binding domain of SARS-CoV-2 Spike glycoprotein in complex with COVOX-158 Fab (crystal form 1) · Spike glycoprotein (chains E) | unmapped |
| EV-PDB-7BEI-3 RCSB PDB | xray | resolution: 2.3 Å | in vitro · -173.15 °C · pH 6.5 · ligands CL, NO3, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose Crystal structure of the receptor binding domain of SARS-CoV-2 Spike glycoprotein in complex with COVOX-150 Fab · Spike glycoprotein (chains E) | unmapped |
| EV-PDB-7BEH-1 RCSB PDB | xray | resolution: 2.3 Å | in vitro · -173.15 °C · ligands GOL, TRS, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose Crystal structure of the receptor binding domain of SARS-CoV-2 Spike glycoprotein in complex with COVOX-316 Fab · Spike glycoprotein (chains E) | unmapped |
| EV-PDB-7B62-1 RCSB PDB | xray | resolution: 1.82 Å | in vitro · -173.15 °C · pH 8 · ligands 1PE, BLA, NAG, PEG, PG4, PGE Crystal structure of SARS-CoV-2 spike protein N-terminal domain in complex with biliverdin · Spike glycoprotein (chains A) | unmapped |
| EV-PDB-7B3O-1 RCSB PDB | xray | resolution: 2 Å | in vitro · -173.15 °C · ligands branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Crystal structure of the SARS-CoV-2 RBD in complex with STE90-C11 Fab · Spike protein S1 (chains E) | unmapped |
| EV-PDB-7B18-1 RCSB PDB | cryoem | resolution: 2.62 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-spike bound to two neutralising nanobodies · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7B17-1 RCSB PDB | cryoem | resolution: 4.01 Å | in vitro · ligands NAG SARS-CoV-spike RBD bound to two neutralising nanobodies. · Spike protein S1 (chains A) | unmapped |
| EV-PDB-7B14-1 RCSB PDB | cryoem | resolution: 3.79 Å | in vitro · ligands NAG Nanobody E bound to Spike-RBD in a localized reconstruction · Spike protein S1 (chains A) | unmapped |
| EV-PDB-7B0B-3 RCSB PDB | xray | resolution: 2.98 Å | in vitro · -173.15 °C · ligands branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Fab HbnC3t1p1_C6 bound to SARS-CoV-2 RBD · Surface glycoprotein (chains F) | unmapped |
| EV-PDB-7AKD-1 RCSB PDB | cryoem | resolution: 4 Å | in vitro · ligands FUC, MAN, NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(3-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-3)-alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-6)-alpha-D-mannopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose Structure of the SARS-CoV-2 spike glycoprotein in complex with the 47D11 neutralizing antibody Fab fragment · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7AD1-1 RCSB PDB | cryoem | resolution: 2.92 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of a prefusion stabilized SARS-CoV-2 Spike (D614N, R682S, R685G, A892P, A942P and V987P)(One up trimer) · Spike glycoprotein,Envelope glycoprotein,Spike glycoprotein,Envelope glycoprotein,SARS-CoV-2 S protein (chains A,B,C) | unmapped |
| EV-PDB-7DCX-2 RCSB PDB | cryoem | resolution: 5.9 Å | in vitro S-3C1-F3a structure, two RBDs are up and one RBD is down, each RBD binds with a 3C1 fab. · Spike glycoprotein (chains C,D,K) | unmapped |
| EV-PDB-7DDN-1 RCSB PDB | cryoem | resolution: 6.3 Å | in vitro SARS-Cov2 S protein at open state · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7DF3-1 RCSB PDB | cryoem | resolution: 2.7 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 S trimer, S-closed · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7DEU-1 RCSB PDB | xray | resolution: 2.1 Å | in vitro · -173.15 °C · ligands NAG Crystal structure of SARS-CoV-2 RBD in complex with a neutralizing antibody scFv · Spike protein S1 (chains A) | unmapped |
| EV-PDB-7DET-1 RCSB PDB | xray | resolution: 2.2 Å | in vitro · -173.15 °C · ligands NAG Crystal structure of SARS-CoV-2 RBD in complex with a neutralizing antibody scFv · Spike protein S1 (chains A,C) | unmapped |
| EV-PDB-7DEO-2 RCSB PDB | xray | resolution: 2.5 Å | in vitro · -173.15 °C · ligands CA, NAG Crystal structure of SARS-CoV-2 RBD in complex with a neutralizing antibody scFv · Spike protein S1 (chains B,D) | unmapped |
| EV-PDB-7DDO-2 RCSB PDB | cryoem | resolution: 3.4 Å | in vitro · ligands NAG, ZN Cryo-EM structure of human ACE2 and GD/1/2019 RBD · Spike protein S1 (chains C) | unmapped |
| EV-PDB-7DDD-1 RCSB PDB | cryoem | resolution: 3 Å | in vitro SARS-Cov2 S protein at close state · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7DD8-3 RCSB PDB | cryoem | resolution: 7.5 Å | in vitro S-3C1-F1 structure, one RBD is up and two RBDs are down, the up RBD binds with a 3C1 fab · Spike glycoprotein (chains C,D,E) | unmapped |
| EV-PDB-7DD2-1 RCSB PDB | cryoem | resolution: 5.6 Å | in vitro S-3C1-F2 structure, two RBDs are up and one RBD is down, the two up RBD bind with a 3C1 fab. · Spike glycoprotein (chains C,D,K) | unmapped |
| EV-PDB-7DCC-2 RCSB PDB | cryoem | resolution: 4.3 Å | in vitro S-3C1-F3b structure, all the three RBDs are in the up conformation and each of them associates with a 3C1 Fab · Spike glycoprotein (chains E,I,K) | unmapped |
| EV-PDB-7D6I-1 RCSB PDB | xray | resolution: 3.41 Å | in vitro · -173.15 °C · pH 6.5 · ligands branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose A neutralizing MAb targeting receptor-binding-domain of SARS-CoV-2 · Spike protein S1 (chains A) | unmapped |
| EV-PDB-7D4G-1 RCSB PDB | cryoem | resolution: 3.9 Å | in vitro A proof of concept for neutralizing antibody-guided vaccine design against SARS-CoV-2 · Spike glycoprotein S1 (chains B) | unmapped |
| EV-PDB-7D30-2 RCSB PDB | xray | resolution: 2.1 Å | in vitro · -173.15 °C · pH 4.5 · ligands 1PE, ACT, BU2, CD, GOL, branched: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-3)][alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose Structure of sybody MR17-SR31 fusion in complex with the SARS-CoV-2 S Receptor Binding domain (RBD) · Spike protein S1 (chains B) | unmapped |
| EV-PDB-7D2Z-2 RCSB PDB | xray | resolution: 1.97 Å | in vitro · -173.15 °C · ligands ACT, FMT, GOL, branched: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-3)][alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose Structure of sybody SR31 in complex with the SARS-CoV-2 S Receptor Binding domain (RBD) · Spike protein S1 (chains B) | unmapped |
| EV-PDB-7D0D-1 RCSB PDB | cryoem | resolution: 3.8 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose S protein of SARS-CoV-2 in complex bound with P5A-3C12_2B · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7D0C-1 RCSB PDB | cryoem | resolution: 3.4 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose S protein of SARS-CoV-2 in complex bound with P5A-3A1 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7D0B-1 RCSB PDB | cryoem | resolution: 3.9 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose S protein of SARS-CoV-2 in complex bound with P5A-3C12_1B · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7D03-1 RCSB PDB | cryoem | resolution: 3.2 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose S protein of SARS-CoV-2 in complex bound with FabP5A-2G7 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7D00-1 RCSB PDB | cryoem | resolution: 3 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose S protein of SARS-CoV-2 in complex bound with FabP5A-1B8 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7CZZ-1 RCSB PDB | cryoem | resolution: 3.2 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose S protein of SARS-CoV-2 in complex bound with P5A-2F11_3B · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7CZY-1 RCSB PDB | cryoem | resolution: 3.3 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose S protein of SARS-CoV-2 in complex bound with P5A-2F11_2B · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7CZX-1 RCSB PDB | cryoem | resolution: 2.8 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose S protein of SARS-CoV-2 in complex bound with P5A-1B9 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7CZW-1 RCSB PDB | cryoem | resolution: 2.8 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose S protein of SARS-CoV-2 in complex bound with P5A-2G7 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7CZV-1 RCSB PDB | cryoem | resolution: 3.3 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose S protein of SARS-CoV-2 in complex bound with P5A-1B6_3B · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7CZU-1 RCSB PDB | cryoem | resolution: 3.4 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose S protein of SARS-CoV-2 in complex bound with P5A-1B6_2B · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7CZT-1 RCSB PDB | cryoem | resolution: 2.7 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose S protein of SARS-CoV-2 in complex bound with P5A-2G9 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7CZS-1 RCSB PDB | cryoem | resolution: 3.6 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose S protein of SARS-CoV-2 in complex bound with P5A-1B8_3B · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7CZR-1 RCSB PDB | cryoem | resolution: 3.5 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose S protein of SARS-CoV-2 in complex bound with P5A-1B8_2B · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7CZQ-1 RCSB PDB | cryoem | resolution: 2.8 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose S protein of SARS-CoV-2 in complex bound with P2B-1A10 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7CZP-1 RCSB PDB | cryoem | resolution: 3 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose S protein of SARS-CoV-2 in complex bound with P2B-1A1 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7CYV-2 RCSB PDB | xray | resolution: 3.13 Å | in vitro · -173.15 °C · pH 5.5 · ligands branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-3)][alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose Crystal structure of FD20, a neutralizing single-chain variable fragment (scFv) in complex with SARS-CoV-2 Spike receptor-binding domain (RBD) · Spike protein S1 (chains B) | unmapped |
| EV-PDB-7CYP-1 RCSB PDB | cryoem | resolution: 3.5 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Complex of SARS-CoV-2 spike trimer with its neutralizing antibody HB27 · SARS-CoV-2 Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7CYH-1 RCSB PDB | cryoem | resolution: 3.9 Å | in vitro Binding interface of SARS-CoV-2 RBD and its neutralizing antibody HB27 · Spike glycoprotein (chains A) | unmapped |
| EV-PDB-7CWU-3 RCSB PDB | cryoem | resolution: 3.5 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 spike proteins trimer in complex with P17 and FC05 Fabs cocktail · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7CWT-1 RCSB PDB | cryoem | resolution: 3.7 Å | in vitro · ligands NAG SARS-CoV-2 Spike protein in complex with hb27 and fc05 Fab cocktail · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7CWS-5 RCSB PDB | cryoem | resolution: 3.4 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 Spike Proteins Trimer in Complex with FC05 and H014 Fabs Cocktail · Spike glycoprotein (chains O,Q,R) | unmapped |
| EV-PDB-7CWO-1 RCSB PDB | cryoem | resolution: 3.9 Å | in vitro SARS-CoV-2 spike protein RBD and P17 fab complex · Spike glycoprotein (chains A) | unmapped |
| EV-PDB-7CWN-1 RCSB PDB | cryoem | resolution: 3.2 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose P17-H014 Fab cocktail in complex with SARS-CoV-2 spike protein · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7CWM-1 RCSB PDB | cryoem | resolution: 3.6 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Complex of SARS-CoV-2 spike protein and Fab P17 with one RBD in open state and two RBD in closed state · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7CWL-1 RCSB PDB | cryoem | resolution: 3.8 Å | in vitro · ligands NAG SARS-CoV-2 spike protein and P17 fab complex with one RBD in close state · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7CT5-1 RCSB PDB | cryoem | resolution: 4 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose S protein of SARS-CoV-2 in complex bound with T-ACE2 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7COT-1 RCSB PDB | xray | resolution: 2.16 Å | in vitro · -173.15 °C Structure of post fusion core of SARS-CoV-2 S2 subunit · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7CN9-1 RCSB PDB | cryoem | resolution: 4.7 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 Spike ectodomain · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7CN4-1 RCSB PDB | cryoem | resolution: 2.93 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of bat RaTG13 spike glycoprotein · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7CM4-1 RCSB PDB | xray | resolution: 2.71 Å | in vitro · -173.15 °C · pH 8 · ligands EDO, NI, branched: alpha-D-mannopyranose-(1-6)-alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose Crystal Structure of COVID-19 virus spike receptor-binding domain complexed with a neutralizing antibody CT-P59 · Spike glycoprotein (chains A) | unmapped |
| EV-PDB-7CJF-3 RCSB PDB | xray | resolution: 2.108 Å | in vitro · -173.15 °C · ligands NAG Crystal structure of SARS-CoV-2 RBD in complex with a neutralizing antibody Fab · Spike protein S1 (chains C) | unmapped |
| EV-PDB-7CHS-1 RCSB PDB | xray | resolution: 2.401 Å | in vitro · -173.15 °C · ligands NAG Crystal structure of SARS-CoV-2 antibody P22A-1D1 with RBD · Spike protein S1 (chains E) | unmapped |
| EV-PDB-7CHP-1 RCSB PDB | xray | resolution: 2.357 Å | in vitro · -173.15 °C · ligands NAG Crystal structure of SARS-CoV-2 antibody P5A-3C8 with RBD · Spike protein S1 (chains E) | unmapped |
| EV-PDB-7CHO-1 RCSB PDB | xray | resolution: 2.561 Å | in vitro · -173.15 °C · ligands NAG Crystal structure of SARS-CoV-2 antibody P5A-1D2 with RBD · Spike protein S1 (chains A,E) | unmapped |
| EV-PDB-7DF4-2 RCSB PDB | cryoem | resolution: 3.8 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 S-ACE2 complex · Spike glycoprotein (chains B,C,D) | unmapped |
| EV-PDB-7DHX-2 RCSB PDB | xray | resolution: 2.3 Å | in vitro · -173.15 °C · ligands NAG, ZN Crystal structure of SARS-CoV-2 RBD binding to pangolin ACE2 · Spike glycoprotein (chains B) | unmapped |
| EV-PDB-7DJZ-3 RCSB PDB | xray | resolution: 2.397 Å | in vitro · -173.15 °C · pH 5.6 · ligands CIT, NAG Crystal structure of SARS-CoV-2 Spike RBD in complex with MW01 Fab · Spike protein S1 (chains C) | unmapped |
| EV-PDB-7DK0-3 RCSB PDB | xray | resolution: 3.199 Å | in vitro · -173.15 °C · ligands NAG Crystal structure of SARS-CoV-2 Spike RBD in complex with MW05 Fab · Spike protein S1 (chains C) | unmapped |
| EV-PDB-7DK2-3 RCSB PDB | xray | resolution: 3 Å | in vitro · -173.15 °C · pH 6.5 · ligands NAG Crystal structure of SARS-CoV-2 Spike RBD in complex with MW07 Fab · Spike protein S1 (chains C,F,I,L) | unmapped |
| EV-PDB-7DK3-1 RCSB PDB | cryoem | resolution: 6 Å | in vitro SARS-CoV-2 S trimer, S-open · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7DK4-3 RCSB PDB | cryoem | resolution: 3.8 Å | in vitro S-2H2-F3a structure, two RBDs are up and one RBD is down, each RBD binds with a 2H2 Fab. · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7DK5-1 RCSB PDB | cryoem | resolution: 13.5 Å | in vitro S-2H2-F1 structure, one RBD is up and two RBDs are down, only up RBD binds with a 2H2 Fab · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7DK6-1 RCSB PDB | cryoem | resolution: 4.3 Å | in vitro S-2H2-F2 structure, two RBDs are up and one RBD is down, each up RBD binds with a 2H2 Fab. · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7DK7-3 RCSB PDB | cryoem | resolution: 9.7 Å | in vitro S-2H2-F3b structure, three RBDs are up and each RBD binds with a 2H2 Fab. · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7DMU-2 RCSB PDB | xray | resolution: 3.2 Å | in vitro · -173.15 °C · ligands NAG, SO4, ZN, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-3)-alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Structure of SARS-CoV-2 spike receptor-binding domain complexed with high affinity ACE2 mutant 3N39 · Spike protein S1 (chains B,D) | unmapped |
| EV-PDB-7DPM-3 RCSB PDB | xray | resolution: 3.304 Å | in vitro · -173.15 °C · pH 3.5 · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose Crystal structure of SARS-CoV-2 Spike RBD in complex with MW06 Fab · Spike protein S1 (chains C,F,I,L) | unmapped |
| EV-PDB-7DQA-2 RCSB PDB | cryoem | resolution: 2.8 Å | in vitro · ligands CL, NAG, ZN Cryo-EM structure of SARS-CoV2 RBD-ACE2 complex · Spike glycoprotein (chains C) | unmapped |
| EV-PDB-7DWX-3 RCSB PDB | cryoem | resolution: 8.3 Å | in vitro · ligands LEU, NAG, ZN, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Conformation 1 of S-ACE2-B0AT1 ternary complex · Spike glycoprotein (chains E,F,G,H,I,J) | unmapped |
| EV-PDB-7DWY-1 RCSB PDB | cryoem | resolution: 2.7 Å | in vitro · ligands EIC, NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose S protein of SARS-CoV-2 in the locked conformation · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7DWZ-1 RCSB PDB | cryoem | resolution: 3.3 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose S protein of SARS-CoV-2 in the active conformation · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7DX0-1 RCSB PDB | cryoem | resolution: 3.2 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Trypsin-digested S protein of SARS-CoV-2 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7DX1-1 RCSB PDB | cryoem | resolution: 3.1 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose S protein of SARS-CoV-2 D614G mutant · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7DX2-1 RCSB PDB | cryoem | resolution: 3.3 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Trypsin-digested S protein of SARS-CoV-2 D614G mutant · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7DX4-2 RCSB PDB | cryoem | resolution: 3.6 Å | in vitro · ligands NAG The structure of FC08 Fab-hA.CE2-RBD complex · Spike protein S1 (chains E) | unmapped |
| EV-PDB-7DX5-1 RCSB PDB | cryoem | resolution: 3.3 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose S protein of SARS-CoV-2 bound with PD of ACE2 in the conformation 2 (1 up RBD and 1 PD bound) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7DX6-1 RCSB PDB | cryoem | resolution: 3 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose S protein of SARS-CoV-2 bound with PD of ACE2 in the conformation 3 (2 up RBD and 1 PD bound) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7DX7-1 RCSB PDB | cryoem | resolution: 3.4 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Trypsin-digested S protein of SARS-CoV-2 bound with PD of ACE2 in the conformation 1 (1 up RBD and 1 PD bound) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7DX8-1 RCSB PDB | cryoem | resolution: 2.9 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Trypsin-digested S protein of SARS-CoV-2 bound with PD of ACE2 in the conformation 2 (2 up RBD and 2 PD bound) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7DZW-1 RCSB PDB | cryoem | resolution: 3.45 Å | in vitro Apo spike protein from SARS-CoV2 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7DZX-1 RCSB PDB | cryoem | resolution: 3.53 Å | in vitro Spike protein from SARS-CoV2 with Fab fragment of enhancing antibody 8D2 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7DZY-1 RCSB PDB | cryoem | resolution: 3.6 Å | in vitro Spike protein from SARS-CoV2 with Fab fragment of enhancing antibody 2490 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7E23-1 RCSB PDB | cryoem | resolution: 3.3 Å | in vitro · ligands NAG SARS-CoV-2 spike in complex with the CA521 neutralizing antibody Fab (focused refinement on Fab-RBD) · Spike protein S1 (chains A) | unmapped |
| EV-PDB-7E3B-1 RCSB PDB | cryoem | resolution: 4.2 Å | in vitro · ligands NAG SARS-Cov-2 spike in complex with the Ab5 neutralizing antibody (focused refinement on Fab-RBD) · Spike protein S1 (chains A) | unmapped |
| EV-PDB-7E3C-1 RCSB PDB | cryoem | resolution: 4.2 Å | in vitro · ligands NAG SARS-CoV-2 spike in complex with the Ab1 neutralizing antibody (focused refinement on Fab-RBD) · Spike protein S1 (chains A) | unmapped |
| EV-PDB-7E3J-2 RCSB PDB | xray | resolution: 2.99 Å | in vitro · -173.15 °C · pH 8 · ligands NAG, ZN Crystal structure of SARS-CoV-2 RBD binding to dog ACE2 · Spike protein S1 (chains B) | unmapped |
| EV-PDB-7E3K-1 RCSB PDB | cryoem | resolution: 3.9 Å | in vitro · ligands NAG Ultrapotent SARS-CoV-2 neutralizing antibodies with protective efficacy against newly emerged mutational variants · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7E3O-3 RCSB PDB | xray | resolution: 2.51 Å | in vitro · -173.15 °C Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody nCoV617 · Spike protein S1 (chains R) | unmapped |
| EV-PDB-7E5O-3 RCSB PDB | xray | resolution: 2.8 Å | in vitro · -173.15 °C · ligands branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Crystal structure of SARS-CoV-2 RBD in complex with antibody NT-193 · Spike protein S1 (chains A) | unmapped |
| EV-PDB-7E5R-3 RCSB PDB | cryoem | resolution: 3.6 Å | in vitro · ligands branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 S trimer with three-antibody cocktail complex · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7E5S-1 RCSB PDB | cryoem | resolution: 3.6 Å | in vitro · ligands branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 S trimer with four-antibody cocktail complex · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7E5Y-1 RCSB PDB | xray | resolution: 3.59 Å | in vitro · -173.15 °C Molecular basis for neutralizing antibody 2B11 targeting SARS-CoV-2 RBD · Spike protein S1 (chains A,R) | unmapped |
| EV-PDB-7E7B-1 RCSB PDB | cryoem | resolution: 2.6 Å | in vitro · ligands ELA, NAG, VCG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of the SARS-CoV-2 furin site mutant S-Trimer from a subunit vaccine candidate · Spike glycoprotein,Collagen alpha-1(I) chain (chains A,B,C) | unmapped |
| EV-PDB-7E7D-1 RCSB PDB | cryoem | resolution: 3.2 Å | in vitro · ligands ELA, NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of the SARS-CoV-2 wild-type S-Trimer from a subunit vaccine candidate · Spike glycoprotein,Collagen alpha-1(I) chain (chains A,B,C) | unmapped |
| EV-PDB-7E7X-1 RCSB PDB | xray | resolution: 2.78 Å | in vitro · -193.15 °C SARS-CoV-2 Spike Protein N terminal domain in Complex with N11 Fab · Spike protein S1 (chains A,B) | unmapped |
| EV-PDB-7E86-1 RCSB PDB | xray | resolution: 2.9 Å | in vitro · -173.15 °C Crystal structure of the SARS-CoV-2 S RBD in complex with BD-508 Fab · Spike protein S1 (chains C) | unmapped |
| EV-PDB-7E88-3 RCSB PDB | xray | resolution: 3.14 Å | in vitro · -173.15 °C Crystal structure of the SARS-CoV-2 S RBD in complex with BD-515 Fab · Spike protein S1 (chains C,F,I,L) | unmapped |
| EV-PDB-7E8F-8 RCSB PDB | cryoem | resolution: 3.18 Å | in vitro SARS-CoV-2 NTD in complex with N9 Fab · Spike protein S1 (chains R) | unmapped |
| EV-PDB-7E8F-1 RCSB PDB | cryoem | resolution: 3.18 Å | in vitro SARS-CoV-2 NTD in complex with N9 Fab · Spike protein S1 (chains A) | unmapped |
| EV-PDB-7E8M-1 RCSB PDB | xray | resolution: 2.09 Å | in vitro · -173.15 °C · ligands NAG Crystal structure of SARS-CoV-2 antibody P2C-1F11 with mutated RBD · Spike protein S1 (chains E) | unmapped |
| EV-PDB-7E8C-1 RCSB PDB | cryoem | resolution: 3.16 Å | in vitro SARS-CoV-2 S-6P in complex with 9 Fabs · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7E7Y-3 RCSB PDB | xray | resolution: 2.41 Å | in vitro · -173.15 °C Crystal structure of the SARS-CoV-2 S RBD in complex with BD-623 Fab · Spike protein S1 (chains E,R) | unmapped |
| EV-PDB-7E3L-1 RCSB PDB | cryoem | resolution: 3.6 Å | in vitro · ligands NAG Ultrapotent SARS-CoV-2 neutralizing antibodies with protective efficacy against newly emerged mutational variants · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7E39-1 RCSB PDB | cryoem | resolution: 3.7 Å | in vitro · ligands NAG SARS-CoV-2 spike in complex with the Ab4 neutralizing antibody (State 3) · Spike protein S1 (chains A) | unmapped |
| EV-PDB-7DX9-1 RCSB PDB | cryoem | resolution: 3.6 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Trypsin-digested S protein of SARS-CoV-2 bound with PD of ACE2 in the conformation 3 (3 up RBD and 2 PD bound) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7DX3-1 RCSB PDB | cryoem | resolution: 3.5 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose S protein of SARS-CoV-2 bound with PD of ACE2 in the conformation 1 (1 up RBD and no PD bound) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7EB3-1 RCSB PDB | cryoem | resolution: 3.6 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 Spike D614G variant, one RBD-up conformation 3 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7EB4-1 RCSB PDB | cryoem | resolution: 3.5 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 Spike D614G variant, two RBD-up conformation 1 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7EJ5-1 RCSB PDB | cryoem | resolution: 3.5 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 spike in complex with a neutralizing antibody RBD-chAb-45 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7F5G-1 RCSB PDB | xray | resolution: 1.75 Å | in vitro · -173.15 °C · ligands ACT, GOL, branched: alpha-L-fucopyranose-(1-3)-[2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)][alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose The crystal structure of RBD-Nanobody complex, DL4 (SA4) · Spike glycoprotein (chains A,C) | unmapped |
| EV-PDB-7F5R-2 RCSB PDB | xray | resolution: 3.01 Å | in vitro · -173.15 °C · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-beta-D-glucopyranose Crystal structure of SARS-CoV-2 Y453F-RBD bound to mink ACE2 · Spike protein S1 (chains C,E,F) | unmapped |
| EV-PDB-7F5H-1 RCSB PDB | xray | resolution: 3 Å | in vitro · -173.15 °C · ligands GOL, PO4, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose The crystal structure of RBD-Nanobody complex, DL28 (SC4) · SARS-CoV-2 Spike Receptor-Binding Domain (RBD) (chains A,B) | unmapped |
| EV-PDB-7F4W-3 RCSB PDB | xray | resolution: 2.9 Å | in vitro · -173.15 °C · pH 8.1 Complex structure of HLA2402 with recognizing SARS-CoV-2 epitope pep4 · SARS-CoV-2 T-cell Epitope pep4 (chains E,F) | unmapped |
| EV-PDB-7F46-1 RCSB PDB | cryoem | resolution: 4.79 Å | in vitro · ligands NAG Cryo-EM structure of the SARS-CoV-2 S-6P in complex with 35B5 Fab (state1, local refinement of the RBD, NTD and 35B5 Fab) · Spike glycoprotein (chains B,C) | unmapped |
| EV-PDB-7F3Q-1 RCSB PDB | cryoem | resolution: 3.3 Å | in vitro · ligands MES, NAG SARS-CoV-2 RBD in complex with A5-10 Fab and A34-2 Fab · Spike glycoprotein (chains A) | unmapped |
| EV-PDB-7F15-1 RCSB PDB | xray | resolution: 2.65 Å | in vitro · -173.15 °C · ligands NAG A SARS-CoV-2 neutralizing antibody · Spike protein S1 (chains A) | unmapped |
| EV-PDB-7F12-1 RCSB PDB | xray | resolution: 3.15 Å | in vitro · -173.15 °C · ligands NAG A SARS-CoV-2 neutralizing antibody · Spike protein S1 (chains A) | unmapped |
| EV-PDB-7F0X-1 RCSB PDB | xray | resolution: 2.8 Å | in vitro · -173.15 °C A SARS-CoV-2 neutralizing antibody · Spike protein S1 (chains A) | unmapped |
| EV-PDB-7EZV-1 RCSB PDB | cryoem | resolution: 3.3 Å | in vitro local CryoEM structure of the SARS-CoV-2 S6PV2 in complex with BD-812 Fab and BD-836 Fab · Spike glycoprotein (chains A) | unmapped |
| EV-PDB-7EYA-4 RCSB PDB | cryoem | resolution: 3.77 Å | in vitro · ligands branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Local CryoEM structure of the SARS-CoV-2 S6PV2 in complex with BD-804 Fab · Spike glycoprotein (chains N) | unmapped |
| EV-PDB-7EYA-1 RCSB PDB | cryoem | resolution: 3.77 Å | in vitro · ligands branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Local CryoEM structure of the SARS-CoV-2 S6PV2 in complex with BD-804 Fab · Spike glycoprotein (chains R) | unmapped |
| EV-PDB-7EY5-1 RCSB PDB | cryoem | resolution: 3.4 Å | in vitro Local CryoEM structure of the SARS-CoV-2 S6PV2 in complex with BD-771 Fab and BD-821 Fab · Spike glycoprotein (chains A) | unmapped |
| EV-PDB-7EY4-4 RCSB PDB | cryoem | resolution: 3.69 Å | in vitro · ligands branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Local CryoEM of the SARS-CoV-2 S6PV2 in complex with BD-667 · Spike glycoprotein (chains N) | unmapped |
| EV-PDB-7EY4-3 RCSB PDB | cryoem | resolution: 3.69 Å | in vitro · ligands branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Local CryoEM of the SARS-CoV-2 S6PV2 in complex with BD-667 · Spike glycoprotein (chains R) | unmapped |
| EV-PDB-7EY0-4 RCSB PDB | cryoem | resolution: 3.2 Å | in vitro Local CryoEM structure of the SARS-CoV-2 S6PV2 in complex with BD-813 Fab and BD-744 Fab · Spike glycoprotein (chains N,R) | unmapped |
| EV-PDB-7EU2-3 RCSB PDB | xray | resolution: 2.8 Å | in vitro · -173.15 °C · pH 9 Complex structure of HLA0201 with recognizing SARS-CoV-2 epitope S1 · SARS-CoV-2 T-cell Epitope S1 (chains C,F) | unmapped |
| EV-PDB-7EPX-1 RCSB PDB | cryoem | resolution: 3 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose S protein of SARS-CoV-2 in complex with GW01 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7ENG-3 RCSB PDB | cryoem | resolution: 3.59 Å | in vitro · ligands branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of the SARS-CoV-2 S-6P in complex with Fab30 (local refinement of the RBD and Fab30) · Spike glycoprotein (chains B) | unmapped |
| EV-PDB-7ENF-1 RCSB PDB | cryoem | resolution: 2.76 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of the SARS-CoV-2 S-6P in complex with Fab30 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7EKH-2 RCSB PDB | xray | resolution: 2.4 Å | in vitro · -173.15 °C · pH 6.5 · ligands NAG, ZN Structure of SARS-CoV-2 spike receptor-binding domain Y453F mutation complexed with human ACE2 · Spike protein S1 (chains B) | unmapped |
| EV-PDB-7EKG-2 RCSB PDB | xray | resolution: 2.63 Å | in vitro · -173.15 °C · pH 6.5 · ligands NAG, ZN, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Structure of SARS-CoV-2 Beta variant spike receptor-binding domain complexed with human ACE2 · Spike protein S1 (chains B) | unmapped |
| EV-PDB-7EKF-2 RCSB PDB | xray | resolution: 2.85 Å | in vitro · -173.15 °C · pH 6.5 · ligands NAG, ZN, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Structure of SARS-CoV-2 Alpha variant spike receptor-binding domain complexed with human ACE2 · Spike protein S1 (chains B) | unmapped |
| EV-PDB-7EKE-2 RCSB PDB | xray | resolution: 2.7 Å | in vitro · -173.15 °C · pH 6.5 · ligands NAG, ZN Structure of SARS-CoV-2 spike receptor-binding domain F486L mutation complexed with human ACE2 · Spike protein S1 (chains B) | unmapped |
| EV-PDB-7EKC-2 RCSB PDB | xray | resolution: 2.8 Å | in vitro · -173.15 °C · pH 6.5 · ligands NAG, ZN, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Structure of SARS-CoV-2 Gamma variant spike receptor-binding domain complexed with human ACE2 · Spike protein S1 (chains B) | unmapped |
| EV-PDB-7EK6-2 RCSB PDB | xray | resolution: 1.243 Å | in vitro · 22.85 °C · pH 5.6 Structure of viral peptides IPB19/N52 · Spike protein S2 (chains B) | unmapped |
| EV-PDB-7EK6-1 RCSB PDB | xray | resolution: 1.243 Å | in vitro · 22.85 °C · pH 5.6 Structure of viral peptides IPB19/N52 · Spike protein S2 (chains A) | unmapped |
| EV-PDB-7EK0-1 RCSB PDB | xray | resolution: 2.7 Å | in vitro · -173.15 °C Complex Structure of antibody BD-503 and RBD-N501Y of COVID-19 · Spike protein S1 (chains R) | unmapped |
| EV-PDB-7EJZ-1 RCSB PDB | xray | resolution: 3.63 Å | in vitro · -173.15 °C · ligands NAG Complex Structure of antibody BD-503 and RBD-S477N of COVID-19 · Spike protein S1 (chains R) | unmapped |
| EV-PDB-7EJY-1 RCSB PDB | xray | resolution: 3.04 Å | in vitro · -173.15 °C · ligands NAG Complex Structure of antibody BD-503 and RBD of COVID-19 · Spike protein S1 (chains R) | unmapped |
| EV-PDB-7EJL-3 RCSB PDB | xray | resolution: 1.89 Å | in vitro · -173.15 °C · pH 8.2 Complex Structure of HLA-A*2402 with the Peptide from HCoV(CoV-2) spike protein · 9-mer peptide from the HCoV spike protein (chains C) | unmapped |
| EV-PDB-7EJ4-1 RCSB PDB | cryoem | resolution: 3.6 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 spike in complex with a neutralizing antibody RBD-chAb-25 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7EH5-1 RCSB PDB | cryoem | resolution: 4 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 S-D614G variant in complex with neutralizing antibodies, RBD-chAb15 and RBD-chAb45 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7EFR-2 RCSB PDB | xray | resolution: 2.494 Å | in vitro · -173.15 °C · pH 7.5 · ligands NAG Structure of SARS-CoV-2 spike receptor-binding domain in complex with high affinity ACE2 mutant (T27W,N330Y) · Spike glycoprotein (chains B) | unmapped |
| EV-PDB-7EFP-2 RCSB PDB | xray | resolution: 2.698 Å | in vitro · -173.15 °C · pH 6.5 · ligands NAG Structure of SARS-CoV-2 spike receptor-binding domain in complex with high affinity ACE2 mutant (S19W,N330Y) · Spike glycoprotein (chains B) | unmapped |
| EV-PDB-7EDJ-1 RCSB PDB | cryoem | resolution: 3.3 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 S-UK variant (B.1.1.7) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7EDI-1 RCSB PDB | cryoem | resolution: 3.3 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 S-UK variant (B.1.1.7), two RBD-up conformation · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7EDH-1 RCSB PDB | cryoem | resolution: 3.6 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 S-UK variant (B.1.1.7), one RBD-up conformation 3 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7EDG-1 RCSB PDB | cryoem | resolution: 3.2 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 S-UK variant (B.1.1.7), one RBD-up conformation 2 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7EDF-1 RCSB PDB | cryoem | resolution: 3.2 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 S-UK variant (B.1.1.7), one RBD-up conformation 1 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7EB5-1 RCSB PDB | cryoem | resolution: 3.4 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 Spike D614G variant, two RBD-up conformation 2 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7EB0-1 RCSB PDB | cryoem | resolution: 3.6 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 Spike D614G variant, one RBD-up conformation 2 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7EAZ-1 RCSB PDB | cryoem | resolution: 3.5 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 Spike D614G variant, one RBD-up conformation 1 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7EAN-1 RCSB PDB | xray | resolution: 1.91 Å | in vitro · -173.15 °C · ligands NAG immune complex of SARS-CoV-2 RBD and cross-neutralizing antibody 6D6 · Spike protein S1 (chains A) | unmapped |
| EV-PDB-7EAM-1 RCSB PDB | xray | resolution: 1.4 Å | in vitro · -173.15 °C · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose immune complex of SARS-CoV-2 RBD and cross-neutralizing antibody 7D6 · Spike protein S1 (chains A,B) | unmapped |
| EV-PDB-7E9T-1 RCSB PDB | cryoem | resolution: 10.9 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Nanometer resolution in situ structure of SARS-CoV-2 post-fusion spike · Spike protein S2 (chains A,B,C) | unmapped |
| EV-PDB-7E9Q-1 RCSB PDB | cryoem | resolution: 3.65 Å | in vitro · ligands NAG Cryo-EM structure of the SARS-CoV-2 S-6P in complex with 35B5 Fab(1 out RBD, state3) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7E9P-1 RCSB PDB | cryoem | resolution: 3.69 Å | in vitro · ligands NAG Cryo-EM structure of the SARS-CoV-2 S-6P in complex with 35B5 Fab(state2, local refinement of the RBD and 35B5 Fab) · Spike glycoprotein (chains B) | unmapped |
| EV-PDB-7E9O-1 RCSB PDB | cryoem | resolution: 3.41 Å | in vitro · ligands NAG Cryo-EM structure of the SARS-CoV-2 S-6P in complex with 35B5 Fab(3 up RBDs, state2) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7E9N-1 RCSB PDB | cryoem | resolution: 3.69 Å | in vitro · ligands NAG Cryo-EM structure of the SARS-CoV-2 S-6P in complex with 35B5 Fab(1 down RBD, state1) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7JWY-1 RCSB PDB | cryoem | resolution: 2.5 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Structure of SARS-CoV-2 spike at pH 4.5 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7JWB-2 RCSB PDB | cryoem | resolution: 3.2 Å | in vitro SARS CoV2 Spike ectodomain with engineered trimerized VH binder · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7JW0-1 RCSB PDB | cryoem | resolution: 4.3 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 spike in complex with the S304 neutralizing antibody Fab fragment · Spike glycoprotein (chains A,B,E) | unmapped |
| EV-PDB-7JVC-1 RCSB PDB | cryoem | resolution: 3.3 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 spike in complex with the S2A4 neutralizing antibody Fab fragment · Spike glycoprotein (chains A,B,E) | unmapped |
| EV-PDB-7JVB-1 RCSB PDB | xray | resolution: 3.287 Å | in vitro · -193.15 °C · pH 6.5 · ligands CAC Crystal structure of the SARS-CoV-2 spike receptor-binding domain (RBD) with nanobody Nb20 · Spike protein S1 (chains A,B) | unmapped |
| EV-PDB-7JVA-3 RCSB PDB | cryoem | resolution: 3.6 Å | in vitro · ligands branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 spike in complex with the S2A4 neutralizing antibody Fab fragment (local refinement of the receptor-binding domain and Fab variable domains) · Spike glycoprotein (chains A) | unmapped |
| EV-PDB-7JV6-1 RCSB PDB | cryoem | resolution: 3 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 spike in complex with the S2H13 neutralizing antibody (closed conformation) · Spike glycoprotein (chains A,B,E) | unmapped |
| EV-PDB-7JV4-1 RCSB PDB | cryoem | resolution: 3.4 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 spike in complex with the S2H13 neutralizing antibody (one RBD open) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7JV2-3 RCSB PDB | cryoem | resolution: 3.5 Å | in vitro SARS-CoV-2 spike in complex with the S2H13 neutralizing antibody Fab fragment (local refinement of the receptor-binding motif and Fab variable domains) · Spike glycoprotein (chains A) | unmapped |
| EV-PDB-7JMW-1 RCSB PDB | xray | resolution: 2.89 Å | in vitro · -173.15 °C · pH 6.9 · ligands branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Crystal structure of SARS-CoV-2 spike protein receptor-binding domain in complex with cross-neutralizing antibody COVA1-16 Fab · Spike protein S1 (chains A) | unmapped |
| EV-PDB-7JMP-1 RCSB PDB | xray | resolution: 1.712 Å | in vitro · -173.15 °C · ligands NAG Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody COVA2-39 · Spike protein S1 (chains A) | unmapped |
| EV-PDB-7JMO-1 RCSB PDB | xray | resolution: 2.359 Å | in vitro · -173.15 °C · ligands NAG Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody COVA2-04 · Spike protein S1 (chains A) | unmapped |
| EV-PDB-7JJJ-1 RCSB PDB | cryoem | resolution: 4.5 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose Structure of SARS-CoV-2 3Q-2P full-length dimers of spike trimers · Spike glycoprotein (chains A,B,C,D,E,F) | unmapped |
| EV-PDB-7JJI-1 RCSB PDB | cryoem | resolution: 3.6 Å | in vitro · ligands EIC, NAG, VCG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Structure of SARS-CoV-2 3Q-2P full-length prefusion spike trimer (C3 symmetry) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7JJC-2 RCSB PDB | xray | resolution: 2.36 Å | in vitro · -173.15 °C · pH 5 · ligands GOL, PEG Crystal structure of neuropilin-1 b1 domain in complex with SARS-CoV-2 S1 C-end rule (CendR) peptide · Spike protein S1 (chains E,F,G,H) | unmapped |
| EV-PDB-7FJS-2 RCSB PDB | xray | resolution: 2.9 Å | in vitro · -173.15 °C · ligands NAG Crystal structure of T6 Fab bound to theSARS-CoV-2 RBD of B.1.351 · Spike protein S1 (chains B,E) | unmapped |
| EV-PDB-7FJO-3 RCSB PDB | cryoem | resolution: 3.34 Å | in vitro · ligands NAG Cryo-EM structure of South African (B.1.351) SARS-CoV-2 spike glycoprotein in complex with three T6 Fab · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7FJN-1 RCSB PDB | cryoem | resolution: 3.25 Å | in vitro · ligands NAG Cryo-EM structure of South African (B.1.351) SARS-CoV-2 spike glycoprotein in complex with two T6 Fab · Spike glycoprotein,Envelope glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7FJC-3 RCSB PDB | xray | resolution: 2.96 Å | in vitro · -173.15 °C · ligands branched: alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-beta-D-glucopyranose Crystal structure of SARS-CoV-2 Beta RBD complexed with P36-5D2 Fab · Spike protein S1 (chains E) | unmapped |
| EV-PDB-7FH0-1 RCSB PDB | xray | resolution: 3.2 Å | in vitro · -173.15 °C · pH 7.5 · ligands GOL, NAG, PEG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Crystallographic structure of two neutralizing nanobodies in complex with SARS-CoV-2 spike receptor-binding Domain (RBD) · Spike protein S1,Spike protein S1 (chains A) | unmapped |
| EV-PDB-7FG7-1 RCSB PDB | cryoem | resolution: 6.9 Å | in vitro Cryo-EM structure of S protein trimer of SARS-CoV2 · Spike glycoprotein (chains A) | unmapped |
| EV-PDB-7FG3-1 RCSB PDB | cryoem | resolution: 3.9 Å | in vitro Major cryo-EM structure of S protein trimer of SARS-CoV2 with K-874, composite map · Spike glycoprotein (chains A) | unmapped |
| EV-PDB-7FG2-1 RCSB PDB | cryoem | resolution: 4.4 Å | in vitro Minor cryo-EM structure of S protein trimer of SARS-CoV2 with K-874A VHH, composite map · Spike glycoprotein (chains A) | unmapped |
| EV-PDB-7FET-1 RCSB PDB | cryoem | resolution: 3.7 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 B.1.1.7 Spike Glycoprotein trimer · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7FEM-1 RCSB PDB | cryoem | resolution: 4.1 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 B.1.1.7 S-ACE2 complex · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7FDK-2 RCSB PDB | cryoem | resolution: 3.69 Å | in vitro · ligands NAG SARS-COV-2 Spike RBDMACSp36 binding to mACE2 · Spike protein S1 (chains E) | unmapped |
| EV-PDB-7FDI-2 RCSB PDB | cryoem | resolution: 3.12 Å | in vitro · ligands NAG SARS-COV-2 Spike RBDMACSp36 binding to hACE2 · Spike protein S1 (chains E) | unmapped |
| EV-PDB-7FDH-2 RCSB PDB | cryoem | resolution: 3.72 Å | in vitro · ligands NAG SARS-COV-2 Spike RBDMACSp25 binding to hACE2 · Spike protein S1 (chains E) | unmapped |
| EV-PDB-7FDG-2 RCSB PDB | cryoem | resolution: 3.69 Å | in vitro · ligands NAG SARS-COV-2 Spike RBDMACSp6 binding to hACE2 · Spike protein S1 (chains E) | unmapped |
| EV-PDB-7FCQ-1 RCSB PDB | xray | resolution: 1.89 Å | in vitro · -173.15 °C · pH 5.6 · ligands GOL, NAG Crystallographic structure of neutralizing antibody P14-44 in complex with SARS-CoV-2 spike receptor-binding Domain (RBD) · Spike protein S1 (chains A) | unmapped |
| EV-PDB-7FCP-1 RCSB PDB | xray | resolution: 2.4 Å | in vitro · -173.15 °C · pH 7 · ligands GOL, NAG, TRS Crystallographic structure of two neutralizing antibodies in complex with SARS-CoV-2 spike receptor-binding Domain (RBD) · Spike protein S1 (chains A) | unmapped |
| EV-PDB-7FCE-1 RCSB PDB | cryoem | resolution: 3.1 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Structure of the SARS-CoV-2 A372T spike glycoprotein (closed) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7FCD-1 RCSB PDB | cryoem | resolution: 3.9 Å | in vitro · ligands NAG Structure of the SARS-CoV-2 A372T spike glycoprotein (open) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7FC5-1 RCSB PDB | xray | resolution: 2.894 Å | in vitro · -173.15 °C · ligands NAG Crystal structure of SARS-CoV-2 RBD and horse ACE2 · Spike protein S1 (chains E) | unmapped |
| EV-PDB-7FBK-1 RCSB PDB | xray | resolution: 1.9 Å | in vitro · -173.15 °C · pH 7.5 · ligands branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose Crystal structure of SARS-CoV-2 receptor binding domain N501Y mutant in complex with neutralizing nanobody 20G6 · Spike protein S1 (chains A,B) | unmapped |
| EV-PDB-7FBJ-1 RCSB PDB | xray | resolution: 2.85 Å | in vitro · -173.15 °C · pH 7.5 · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing nanobody 17F6 · Spike protein S1 (chains A,C,E,G,I,K,M,O) | unmapped |
| EV-PDB-7FB4-1 RCSB PDB | cryoem | resolution: 3.4 Å | in vitro SARS-CoV-2 spike protein in two-RBD weak state after CTSL-treatment · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7FB3-1 RCSB PDB | cryoem | resolution: 3.1 Å | in vitro SARS-CoV-2 spike protein in one-RBD weak state after CTSL-treatment · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7FB1-1 RCSB PDB | cryoem | resolution: 3.7 Å | in vitro SARS-CoV-2 spike protein in one-RBD open state · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7FB0-1 RCSB PDB | cryoem | resolution: 3.4 Å | in vitro SARS-CoV-2 spike protein in closed state · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7FAU-1 RCSB PDB | xray | resolution: 2.08 Å | in vitro · -176 °C · ligands ZN Structure Determination of the NB1B11-RBD Complex · Spike protein S1 (chains A,C) | unmapped |
| EV-PDB-7FAT-1 RCSB PDB | xray | resolution: 1.99 Å | in vitro · -176 °C · ligands branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Structure Determination of the RBD-NB1A7 · Spike protein S1 (chains A) | unmapped |
| EV-PDB-7FAF-1 RCSB PDB | cryoem | resolution: 3.69 Å | in vitro S protein of SARS-CoV-2 in complex bound with P36-5D2 (state1) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7FAE-1 RCSB PDB | cryoem | resolution: 3.65 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose S protein of SARS-CoV-2 in complex bound with P36-5D2(state2) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7F7H-3 RCSB PDB | xray | resolution: 3.19 Å | in vitro · -173.15 °C SARS-CoV-2 S protein RBD in complex with A8-1 Fab · Spike glycoprotein S1 (chains E,F) | unmapped |
| EV-PDB-7F7E-3 RCSB PDB | xray | resolution: 2.49 Å | in vitro · -173.15 °C · ligands NAG SARS-CoV-2 S protein RBD in complex with A5-10 Fab · Spike protein S1 (chains E) | unmapped |
| EV-PDB-7F6Z-1 RCSB PDB | xray | resolution: 3 Å | in vitro · -173.15 °C · ligands branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Complex Structure of antibody BD-503 and RBD-501Y.V2 of COVID-19 · Spike protein S1 (chains R) | unmapped |
| EV-PDB-7F6Y-1 RCSB PDB | xray | resolution: 3 Å | in vitro · -173.15 °C · ligands NAG Complex Structure of antibody BD-503 and RBD-E484K of COVID-19 · Spike protein S1 (chains R) | unmapped |
| EV-PDB-7F63-1 RCSB PDB | cryoem | resolution: 3.9 Å | in vitro Cryo-EM structure of SARS-CoV-2 spike in complex with a neutralizing antibody chAb-45 (Focused refinement of S-RBD and chAb-45 region) · Spike glycoprotein (chains A) | unmapped |
| EV-PDB-7F62-1 RCSB PDB | cryoem | resolution: 3.6 Å | in vitro Cryo-EM structure of SARS-CoV-2 spike in complex with a neutralizing antibody chAb-25 (Focused refinement of S-RBD and chAb-25 region) · Spike glycoprotein (chains A) | unmapped |
| EV-PDB-7JX3-7 RCSB PDB | xray | resolution: 2.65 Å | in vitro · -173.15 °C · ligands NAG Mapping neutralizing and immunodominant sites on the SARS-CoV-2 spike receptor-binding domain by structure-guided high-resolution serology · Spike protein S1 (chains R) | unmapped |
| EV-PDB-7JZM-2 RCSB PDB | cryoem | resolution: 3.5 Å | in vitro · ligands branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 spike in complex with LCB3 (local refinement of the RBD and LCB3) · Spike glycoprotein (chains B) | unmapped |
| EV-PDB-7JZN-1 RCSB PDB | cryoem | resolution: 3.1 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 spike in complex with LCB3 (2RBDs open) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7K43-1 RCSB PDB | cryoem | resolution: 2.6 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 spike in complex with the S2M11 neutralizing antibody Fab fragment · Spike glycoprotein (chains A,B,E) | unmapped |
| EV-PDB-7K45-3 RCSB PDB | cryoem | resolution: 3.7 Å | in vitro · ligands branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 spike in complex with the S2E12 neutralizing antibody Fab fragment (local refinement of the RBD and Fab variable domains) · Spike glycoprotein (chains B) | unmapped |
| EV-PDB-7K4N-1 RCSB PDB | cryoem | resolution: 3.3 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 spike in complex with the S2E12 neutralizing antibody Fab fragment · Spike glycoprotein (chains A,B,E) | unmapped |
| EV-PDB-7K8M-3 RCSB PDB | xray | resolution: 3.2 Å | in vitro · -173.15 °C · ligands NAG Structure of the SARS-CoV-2 receptor binding domain in complex with the human neutralizing antibody Fab fragment, C102 · Spike glycoprotein (chains E) | unmapped |
| EV-PDB-7K8T-1 RCSB PDB | cryoem | resolution: 3.4 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragment, C002 (State 2) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7K8U-1 RCSB PDB | cryoem | resolution: 3.8 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragment, C104 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7K8V-1 RCSB PDB | cryoem | resolution: 3.8 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C110 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7K8X-1 RCSB PDB | cryoem | resolution: 3.9 Å | in vitro · ligands NAG Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C121 (State 1) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7K8Y-1 RCSB PDB | cryoem | resolution: 4.4 Å | in vitro · ligands NAG Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C121 (State 2) · Spike glycoprotein (chains B,D,E) | unmapped |
| EV-PDB-7K8Z-1 RCSB PDB | cryoem | resolution: 3.5 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C135 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7K90-1 RCSB PDB | cryoem | resolution: 3.24 Å | in vitro · ligands NAG Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragment, C144 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7K9H-1 RCSB PDB | cryoem | resolution: 3.2 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 Spike in complex with neutralizing Fab 2B04 (one up, two down conformation) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7K9I-1 RCSB PDB | cryoem | resolution: 3.3 Å | in vitro · ligands NAG SARS-CoV-2 Spike RBD in complex with neutralizing Fab 2B04 (local refinement) · Spike protein S1 (chains A) | unmapped |
| EV-PDB-7K9J-1 RCSB PDB | cryoem | resolution: 3 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 Spike in complex with neutralizing Fab 2H04 (three down conformation) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7K9Z-5 RCSB PDB | xray | resolution: 2.95 Å | in vitro · -173.15 °C · ligands NAG Crystal structure of SARS-CoV-2 receptor binding domain in complex with the Fab fragments of neutralizing antibodies 298 and 52 · Spike protein S1 (chains E) | unmapped |
| EV-PDB-7KDH-1 RCSB PDB | cryoem | resolution: 3.33 Å | in vitro · ligands NAG SARS-CoV-2 RBD up Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7KDI-1 RCSB PDB | cryoem | resolution: 3.26 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 D614G 3 RBD down Spike Protein Trimer fully cleaved by furin without the P986-P987 stabilizing mutations (S-RRAR-D614G) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7KDJ-1 RCSB PDB | cryoem | resolution: 3.49 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 D614G 1-RBD-up Spike Protein Trimer fully cleaved by furin without the P986-P987 stabilizing mutations (S-RRAR-D614G) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7KDK-1 RCSB PDB | cryoem | resolution: 2.8 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 D614G 3 RBD down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7KDL-1 RCSB PDB | cryoem | resolution: 2.96 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 D614G 1-RBD up Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7KE4-1 RCSB PDB | cryoem | resolution: 3.21 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 D614G 3 RBD down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G Sub-class) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7KE6-1 RCSB PDB | cryoem | resolution: 3.1 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 D614G 3 RBD down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G sub-classification) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7KE7-1 RCSB PDB | cryoem | resolution: 3.32 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 D614G 3-RBD-down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G Sub-Classification) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7KE8-1 RCSB PDB | cryoem | resolution: 3.26 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 D614G 3 RBD down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G sub-classification) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7KE9-1 RCSB PDB | cryoem | resolution: 3.08 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 D614G 1-RBD-up Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G sub-classification) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7KEA-1 RCSB PDB | cryoem | resolution: 3.33 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 D614G 1-RBD-up Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G sub classification) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7KEB-1 RCSB PDB | cryoem | resolution: 3.48 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 D614G 1RBD up Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G sub-classification) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7KEC-1 RCSB PDB | cryoem | resolution: 3.84 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 D614G 1-RBD-up Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G Sub-Classification) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7KFW-1 RCSB PDB | xray | resolution: 2.792 Å | in vitro · -193.15 °C · pH 7.5 · ligands NAG Structural basis for a germline-biased antibody response to SARS-CoV-2 (RBD:C1A-B3 Fab) · Spike glycoprotein (chains A,B,E) | unmapped |
| EV-PDB-7KFY-1 RCSB PDB | xray | resolution: 2.157 Å | in vitro · -193.15 °C · pH 4.5 · ligands NAG Structural basis for a germline-biased antibody response to SARS-CoV-2 (RBD:C1A-F10 Fab) · Spike glycoprotein (chains A) | unmapped |
| EV-PDB-7KGJ-1 RCSB PDB | xray | resolution: 2.3 Å | in vitro · -173.15 °C · pH 7 Crystal structure of synthetic nanobody (Sb45) complexes with SARS-CoV-2 receptor binding domain · Spike glycoprotein (chains A) | unmapped |
| EV-PDB-7KGK-1 RCSB PDB | xray | resolution: 2.6 Å | in vitro · -173.15 °C · pH 7 Crystal structure of synthetic nanobody (Sb16) complexes with SARS-CoV-2 receptor binding domain · Spike protein S1 (chains A) | unmapped |
| EV-PDB-7KJ2-1 RCSB PDB | cryoem | resolution: 3.6 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 Spike Glycoprotein with one ACE2 Bound · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7KJ3-1 RCSB PDB | cryoem | resolution: 3.7 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 Spike Glycoprotein with two ACE2 Bound · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7KJ4-1 RCSB PDB | cryoem | resolution: 3.4 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 Spike Glycoprotein with three ACE2 Bound · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7KJ5-1 RCSB PDB | cryoem | resolution: 3.6 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 Spike Glycoprotein, prefusion with one RBD up conformation · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7KKK-1 RCSB PDB | cryoem | resolution: 3.03 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 Spike in complex with neutralizing nanobody Nb6 · Spike glycoprotein (chains A,C,E) | unmapped |
| EV-PDB-7KL9-1 RCSB PDB | cryoem | resolution: 4.1 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Structure of the SARS-CoV-2 S 6P trimer in complex with the ACE2 protein decoy, CTC-445.2 (State 4) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7KKL-1 RCSB PDB | cryoem | resolution: 2.85 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 Spike in complex with neutralizing nanobody mNb6 · Spike glycoprotein (chains A,C,D) | unmapped |
| EV-PDB-7KFX-1 RCSB PDB | xray | resolution: 2.226 Å | in vitro · -193.15 °C · pH 7.6 · ligands NAG Structural basis for a germline-biased antibody response to SARS-CoV-2 (RBD:C1A-C2 Fab) · Spike glycoprotein (chains A) | unmapped |
| EV-PDB-7KFV-1 RCSB PDB | xray | resolution: 2.102 Å | in vitro · -193.15 °C · pH 8.5 · ligands NAG Structural basis for a germline-biased antibody response to SARS-CoV-2 (RBD:C1A-B12 Fab) · Spike glycoprotein (chains A,B,E) | unmapped |
| EV-PDB-7KDG-1 RCSB PDB | cryoem | resolution: 3.01 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 RBD down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7K9K-1 RCSB PDB | cryoem | resolution: 3.14 Å | in vitro · ligands branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 Spike RBD in complex with neutralizing Fab 2H04 (local refinement) · Spike protein S1 (chains A) | unmapped |
| EV-PDB-7K8W-1 RCSB PDB | cryoem | resolution: 3.6 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C119 · Spike glycoprotein (chains A,B,G) | unmapped |
| EV-PDB-7K8S-1 RCSB PDB | cryoem | resolution: 3.4 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C002 (state 1) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7JZU-2 RCSB PDB | cryoem | resolution: 3.1 Å | in vitro · ligands branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 spike in complex with LCB1 (local refinement of the RBD and LCB1) · Spike glycoprotein (chains B) | unmapped |
| EV-PDB-7JZL-1 RCSB PDB | cryoem | resolution: 2.7 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 spike in complex with LCB1 (2RBDs open) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7KML-1 RCSB PDB | cryoem | resolution: 3.8 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose cryo-EM structure of SARS-CoV-2 spike in complex with Fab 15033-7, three RBDs bound · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7KNE-1 RCSB PDB | cryoem | resolution: 3.85 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of single ACE2-bound SARS-CoV-2 trimer spike at pH 5.5 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7L0N-6 RCSB PDB | xray | resolution: 2.78 Å | in vitro · -173.15 °C · pH 8.5 · ligands CL, NA, NAG, PG4, PG5, PGE, SO4, ZN, branched: alpha-D-mannopyranose-(1-6)-alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity · Spike protein S1 (chains R,S) | unmapped |
| EV-PDB-7L2C-1 RCSB PDB | xray | resolution: 3.65 Å | in vitro · -173.15 °C · pH 6.5 · ligands ACT, CA, CAC, NAG, PGE, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Crystallographic structure of neutralizing antibody 2-51 in complex with SARS-CoV-2 spike N-terminal domain (NTD) · Spike glycoprotein (chains A,B) | unmapped |
| EV-PDB-7L2F-1 RCSB PDB | cryoem | resolution: 3.9 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of NTD-directed neutralizing antibody 5-24 in complex with prefusion SARS-CoV-2 spike glycoprotein · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7LAA-1 RCSB PDB | cryoem | resolution: 3.42 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Structure of SARS-CoV-2 S protein in complex with Receptor Binding Domain antibody DH1041 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7L7K-1 RCSB PDB | cryoem | resolution: 3.29 Å | in vitro Cryo-EM structure of protein encoded by vaccine candidate BNT162b2 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7L7F-2 RCSB PDB | cryoem | resolution: 3.24 Å | in vitro Cryo-EM structure of human ACE2 receptor bound to protein encoded by vaccine candidate BNT162b1 · Spike glycoprotein, Envelope glycoprotein fusion (chains E,F) | unmapped |
| EV-PDB-7L7E-5 RCSB PDB | xray | resolution: 3 Å | in vitro · -173.15 °C · ligands NAG, PO4 Crystal structure of SARS-CoV-2 spike RBD in complex with human monoclonal antibodies AZD8895 and AZD1061 · Spike protein S1 (chains G,K,S,b) | unmapped |
| EV-PDB-7L7D-3 RCSB PDB | xray | resolution: 2.5 Å | in vitro · -173.15 °C · ligands GOL, NAG Crystal structure of SARS-CoV-2 spike RBD in complex with human monoclonal antibody AZD8895 · Spike protein S1 (chains E) | unmapped |
| EV-PDB-7L5B-1 RCSB PDB | xray | resolution: 3.18 Å | in vitro · -173.15 °C · pH 7.5 Crystallographic structure of neutralizing antibody 2-15 in complex with SARS-CoV-2 spike receptor-binding Domain (RBD). · Spike protein S1 (chains A) | unmapped |
| EV-PDB-7L58-1 RCSB PDB | cryoem | resolution: 5.07 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of the SARS-CoV-2 spike glycoprotein bound to Fab H4 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7L57-1 RCSB PDB | cryoem | resolution: 5.87 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of the SARS-CoV-2 spike glycoprotein bound to Fab 2-15 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7L56-1 RCSB PDB | cryoem | resolution: 3.6 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-galactopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-3)-alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-galactopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)-alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-galactopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-2)-alpha-D-mannopyranose-(1-6)-[alpha-D-mannopyranose-(1-6)-alpha-D-mannopyranose-(1-3)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of the SARS-CoV-2 spike glycoprotein bound to Fab 2-43 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7L4Z-1 RCSB PDB | xray | resolution: 3.96 Å | in vitro · -173.15 °C · ligands NAG Structure of SARS-CoV-2 spike RBD in complex with cyclic peptide · Spike protein S1 (chains A,B,C,D,E) | unmapped |
| EV-PDB-7L3N-1 RCSB PDB | cryoem | resolution: 3.27 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV 2 Spike Protein bound to LY-CoV555 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7L2E-1 RCSB PDB | cryoem | resolution: 2.97 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of NTD-directed neutralizing antibody 4-18 in complex with prefusion SARS-CoV-2 spike glycoprotein · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7L2D-1 RCSB PDB | cryoem | resolution: 3.55 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of NTD-directed neutralizing antibody 1-87 in complex with prefusion SARS-CoV-2 spike glycoprotein · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7L09-1 RCSB PDB | cryoem | resolution: 3.1 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-6)-[beta-D-mannopyranose-(1-3)]alpha-D-mannopyranose-(1-6)-[beta-D-mannopyranose-(1-3)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-3)-[beta-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 2P S ectodomain bound domain-swapped antibody 2G12 from masked 3D refinement · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7L06-1 RCSB PDB | cryoem | resolution: 3.3 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-6)-[beta-D-mannopyranose-(1-3)]alpha-D-mannopyranose-(1-6)-[beta-D-mannopyranose-(1-3)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-3)-[beta-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 2P S ectodomain bound to two copies of domain-swapped antibody 2G12 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7L02-1 RCSB PDB | cryoem | resolution: 3.2 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-6)-[beta-D-mannopyranose-(1-3)]alpha-D-mannopyranose-(1-6)-[beta-D-mannopyranose-(1-3)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-3)-[beta-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 2P S ectodomain bound to one copy of domain-swapped antibody 2G12 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7KZB-3 RCSB PDB | xray | resolution: 2.83 Å | in vitro · -173.15 °C · ligands CL, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose Potent SARS-CoV-2 binding and neutralization through maturation of iconic SARS-CoV-1antibodies · Spike glycoprotein (chains C) | unmapped |
| EV-PDB-7KXK-1 RCSB PDB | cryoem | resolution: 5 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 spike protein in complex with Fab 15033-7, 2-"up"-1-"down" conformation · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7KXJ-1 RCSB PDB | cryoem | resolution: 6.4 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 spike protein in complex with Fab 15033-7, 3-"up", asymmetric · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7KSG-1 RCSB PDB | cryoem | resolution: 3.33 Å | in vitro · ligands NAG SARS-CoV-2 spike in complex with nanobodies E · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7KS9-3 RCSB PDB | cryoem | resolution: 4.75 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of prefusion SARS-CoV-2 spike glycoprotein in complex with 910-30 Fab · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7KRS-1 RCSB PDB | cryoem | resolution: 3.2 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Structural impact on SARS-CoV-2 spike protein by D614G substitution · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7KRR-1 RCSB PDB | cryoem | resolution: 3.5 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Structural impact on SARS-CoV-2 spike protein by D614G substitution · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7KRQ-1 RCSB PDB | cryoem | resolution: 3.4 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Structural impact on SARS-CoV-2 spike protein by D614G substitution · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7KQE-3 RCSB PDB | cryoem | resolution: 2.88 Å | in vitro SARS-CoV-2 spike glycoprotein:Fab 3D11 complex · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7KQB-1 RCSB PDB | cryoem | resolution: 2.42 Å | in vitro · ligands NAG SARS-CoV-2 spike glycoprotein:Fab 5A6 complex I · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7KNI-1 RCSB PDB | cryoem | resolution: 3.91 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of Triple ACE2-bound SARS-CoV-2 Trimer Spike at pH 5.5 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7KNH-1 RCSB PDB | cryoem | resolution: 3.74 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM Structure of Double ACE2-Bound SARS-CoV-2 Trimer Spike at pH 5.5 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7KNB-1 RCSB PDB | cryoem | resolution: 3.93 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of single ACE2-bound SARS-CoV-2 trimer spike at pH 7.4 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7KN7-1 RCSB PDB | xray | resolution: 2.73 Å | in vitro · -173.15 °C · ligands NAG Crystal structure of SARS-CoV-2 receptor binding domain complexed with nanobody VHH W and antibody Fab CC12.3 · Spike protein S1 (chains A) | unmapped |
| EV-PDB-7KN6-1 RCSB PDB | xray | resolution: 2.55 Å | in vitro · -173.15 °C · ligands NAG Crystal structure of SARS-CoV-2 receptor binding domain complexed with nanobody VHH V and antibody Fab CC12.3 · Spike protein S1 (chains A) | unmapped |
| EV-PDB-7KN5-1 RCSB PDB | xray | resolution: 1.87 Å | in vitro · -173.15 °C · ligands EDO, NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Crystal structure of SARS-CoV-2 receptor binding domain complexed with nanobodies VHH E and U · Spike protein S1 (chains A,B) | unmapped |
| EV-PDB-7KN4-1 RCSB PDB | xray | resolution: 2.7 Å | in vitro · -173.15 °C · pH 5.6 · ligands NAG Crystal structure of SARS-CoV-2 spike protein receptor-binding domain complexed with a pre-pandemic antibody S-E6 Fab · Spike protein S1 (chains A,B) | unmapped |
| EV-PDB-7KN3-1 RCSB PDB | xray | resolution: 2.251 Å | in vitro · -173.15 °C · pH 6.6 · ligands EDO, NAG, PGE, SO4 Crystal structure of SARS-CoV-2 spike protein receptor-binding domain complexed with a pre-pandemic antibody S-B8 Fab · Spike protein S1 (chains A,B) | unmapped |
| EV-PDB-7KMZ-1 RCSB PDB | cryoem | resolution: 3.62 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of double ACE2-bound SARS-CoV-2 trimer Spike at pH 7.4 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7KMS-2 RCSB PDB | cryoem | resolution: 3.64 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of triple ACE2-bound SARS-CoV-2 trimer spike at pH 7.4 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7KMK-1 RCSB PDB | cryoem | resolution: 4.2 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose cryo-EM structure of SARS-CoV-2 spike in complex with Fab 15033-7, two RBDs bound · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7KMI-3 RCSB PDB | xray | resolution: 1.73 Å | in vitro · -173.15 °C · pH 5.8 · ligands GOL, NAG LY-CoV481 neutralizing antibody against SARS-CoV-2 · Spike protein S1 (chains C) | unmapped |
| EV-PDB-7KMH-3 RCSB PDB | xray | resolution: 1.72 Å | in vitro · -173.15 °C · pH 7.7 · ligands GOL, NAG, PRO LY-CoV488 neutralizing antibody against SARS-CoV-2 · Spike protein S1 (chains C) | unmapped |
| EV-PDB-7KMG-3 RCSB PDB | xray | resolution: 2.16 Å | in vitro · -173.15 °C · pH 4.6 · ligands GOL LY-CoV555 neutralizing antibody against SARS-CoV-2 · Spike protein S1 (chains C,F) | unmapped |
| EV-PDB-7KMB-2 RCSB PDB | cryoem | resolution: 3.39 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose ACE2-RBD Focused Refinement Using Symmetry Expansion of Applied C3 for Triple ACE2-bound SARS-CoV-2 Trimer Spike at pH 7.4 · Spike glycoprotein (chains G) | unmapped |
| EV-PDB-7KM5-1 RCSB PDB | xray | resolution: 3.19 Å | in vitro · -173.15 °C · ligands CL, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Crystal structure of SARS-CoV-2 RBD complexed with Nanosota-1 · Spike protein S1 (chains A,B) | unmapped |
| EV-PDB-7KLW-1 RCSB PDB | xray | resolution: 2.6 Å | in vitro · -173.15 °C · pH 6 Crystal structure of synthetic nanobody (Sb45+Sb68) complexes with SARS-CoV-2 receptor binding domain · Spike protein S1 (chains A) | unmapped |
| EV-PDB-7KLH-3 RCSB PDB | xray | resolution: 3 Å | in vitro · -173.15 °C · pH 7 · ligands NAG SARS-CoV-2 RBD in complex with Fab 15033-7 · Spike glycoprotein (chains A,B) | unmapped |
| EV-PDB-7KLG-3 RCSB PDB | xray | resolution: 3.2 Å | in vitro · -173.15 °C · pH 7 · ligands NAG SARS-CoV-2 RBD in complex with Fab 15033 · Spike glycoprotein (chains A,B) | unmapped |
| EV-PDB-7LAB-3 RCSB PDB | cryoem | resolution: 2.97 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Structure of SARS-CoV-2 S protein in complex with N-terminal domain antibody DH1052 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7LC8-1 RCSB PDB | nmr_structure | structure | in vitro · 29.85 °C · pH 6.8 SARS-CoV-2 spike Protein TM domain · Spike protein S2' (chains A,B,C) | unmapped |
| EV-PDB-7LCN-1 RCSB PDB | cryoem | resolution: 3.35 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Structure of SARS-CoV-2 S protein in complex with N-terminal domain antibody DH1050.1 · Spike glycoprotein (chains A,C,K) | unmapped |
| EV-PDB-7LD1-1 RCSB PDB | cryoem | resolution: 3.4 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Structure of SARS-CoV-2 S protein in complex with Receptor Binding Domain antibody DH1047 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7LDJ-1 RCSB PDB | xray | resolution: 2.36 Å | in vitro · -173.15 °C · pH 6 · ligands MAN, NAG, PG4, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-alpha-D-mannopyranose-(1-6)-alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[beta-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[beta-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 receptor binding domain in complex with WNb-2 · Spike glycoprotein (chains A,B,C,D) | unmapped |
| EV-PDB-7LJR-1 RCSB PDB | cryoem | resolution: 3.66 Å | in vitro SARS-CoV-2 Spike Protein Trimer bound to DH1043 fab · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7LM8-1 RCSB PDB | xray | resolution: 1.936 Å | in vitro · -173.15 °C · pH 4 · ligands EDO, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose Crystal structure of SARS-CoV-2 spike protein receptor-binding domain in complex with two cross-neutralizing antibodies CV38-142 and COVA1-16 Fabs isolated from COVID-19 patients · Spike protein S1 (chains A) | unmapped |
| EV-PDB-7LO4-2 RCSB PDB | xray | resolution: 2.465 Å | in vitro · -173.15 °C · pH 7 · ligands EDO, NAG, ZN, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 spike receptor-binding domain with a G485R mutation in complex with human ACE2 · Spike protein S1 (chains B) | unmapped |
| EV-PDB-7LOP-3 RCSB PDB | xray | resolution: 2.246 Å | in vitro · -173.15 °C · pH 4.8 · ligands NAG Crystal structure of SARS-CoV-2 receptor binding domain in complex with antibodies CV05-163 and CR3022 · Spike protein S1 (chains A,Z) | unmapped |
| EV-PDB-7LQV-1 RCSB PDB | cryoem | resolution: 3.25 Å | in vitro · ligands NAG Cryo-EM structure of NTD-directed neutralizing antibody 4-8 Fab in complex with SARS-CoV-2 S2P spike · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7LQW-3 RCSB PDB | cryoem | resolution: 4.47 Å | in vitro · ligands NAG Cryo-EM structure of NTD-directed neutralizing antibody 2-17 Fab in complex with SARS-CoV-2 S2P spike · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7LRT-3 RCSB PDB | cryoem | resolution: 3.54 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 spike in complex with neutralizing antibody A23-58.1 that targets the receptor-binding domain · SARS-CoV-2 spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7LWK-1 RCSB PDB | cryoem | resolution: 2.92 Å | in vitro · ligands NAG Mink Cluster 5-associated SARS-CoV-2 spike protein (S-GSAS-D614G-delFV) in the 3-RBD down conformation · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7LWM-1 RCSB PDB | cryoem | resolution: 2.83 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Mink Cluster 5-associated SARS-CoV-2 spike protein (S-GSAS-D614G-delFV) in the 1-RBD up conformation · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7LWN-1 RCSB PDB | cryoem | resolution: 2.94 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Mink Cluster 5-associated SARS-CoV-2 spike protein (S-GSAS-D614G-delFV) in the 1-RBD up conformation · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7LWO-1 RCSB PDB | cryoem | resolution: 2.85 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Mink Cluster 5-associated SARS-CoV-2 spike protein (S-GSAS-D614G-delFV) in the 1-RBD up conformation · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7LWP-1 RCSB PDB | cryoem | resolution: 3.01 Å | in vitro · ligands NAG Mink Cluster 5-associated SARS-CoV-2 spike protein (S-GSAS-D614G-delFV) in the 2-RBD up conformation · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7LWQ-1 RCSB PDB | cryoem | resolution: 3.44 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Mink Cluster 5-associated SARS-CoV-2 spike protein(S-GSAS-D614G-delFV) missing the S1 subunit and SD2 subdomain of one protomer · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7LWT-1 RCSB PDB | cryoem | resolution: 3.19 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose UK (B.1.1.7) SARS-CoV-2 spike protein variant (S-GSAS-B.1.1.7) in the 1-RBD-up conformation · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7LWV-1 RCSB PDB | cryoem | resolution: 3.12 Å | in vitro · ligands NAG UK (B.1.1.7) SARS-CoV-2 spike protein variant (S-GSAS-B.1.1.7) in the 1-RBD-up conformation · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7LWW-1 RCSB PDB | cryoem | resolution: 3 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Triple mutant (K417N-E484K-N501Y) SARS-CoV-2 spike protein in the 1-RBD-up conformation (S-GSAS-D614G-K417N-E484K-N501Y) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7LX5-1 RCSB PDB | cryoem | resolution: 3.44 Å | in vitro The SARS-CoV-2 spike protein receptor binding domain bound to neutralizing nanobodies WNb 2 and WNb 10 · Spike glycoprotein (chains B) | unmapped |
| EV-PDB-7LXW-3 RCSB PDB | cryoem | resolution: 2.8 Å | in vitro · ligands branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 S/S2M11/S2X333 Local Refinement · Spike glycoprotein (chains A) | unmapped |
| EV-PDB-7LXX-3 RCSB PDB | cryoem | resolution: 3 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 S/S2M11/S2L28 Local Refinement · Spike glycoprotein (chains A) | unmapped |
| EV-PDB-7LXY-1 RCSB PDB | cryoem | resolution: 2.2 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 S/S2M11/S2X333 Global Refinement · Spike glycoprotein (chains A,B,J) | unmapped |
| EV-PDB-7LXZ-1 RCSB PDB | cryoem | resolution: 2.6 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 S/S2M11/S2L28 Global Refinement · Spike glycoprotein (chains A,B,K) | unmapped |
| EV-PDB-7LY0-1 RCSB PDB | cryoem | resolution: 2.6 Å | in vitro · ligands NAG, branched: alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 S/S2M11/S2M28 Local Refinement · Spike glycoprotein (chains A) | unmapped |
| EV-PDB-7LY3-1 RCSB PDB | xray | resolution: 3 Å | in vitro · -173.15 °C · pH 4.75 · ligands NAG, SO4, UNX, XYL, branched: alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose Crystal structure of SARS-CoV-2 S NTD bound to S2M28 Fab · Spike protein S1 (chains A,B) | unmapped |
| EV-PDB-7M0J-1 RCSB PDB | cryoem | resolution: 3.52 Å | in vitro SARS-CoV-2 u1S2q All Down RBD State Spike Protein Trimer - asymmetric refinement · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7M3I-3 RCSB PDB | xray | resolution: 2.8 Å | in vitro · -173.15 °C · pH 7.5 · ligands NAG Structure of SARS-CoV-2 spike protein receptor binding domain in complex with a neutralizing antibody, CV2-75 Fab · Spike protein S1 (chains C,R) | unmapped |
| EV-PDB-7M42-3 RCSB PDB | cryoem | resolution: 3.3 Å | in vitro · ligands branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Complex of SARS-CoV-2 receptor binding domain with the Fab fragments of neutralizing antibodies REGN10985 and REGN10989 · Spike protein S1 (chains E) | unmapped |
| EV-PDB-7M6D-3 RCSB PDB | xray | resolution: 3.1 Å | in vitro · -173.15 °C · pH 5 · ligands branched: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose Structure of the SARS-CoV-2 RBD in complex with neutralizing antibodies BG4-25 and CR3022 · Spike protein S1 (chains C) | unmapped |
| EV-PDB-7M53-1 RCSB PDB | xray | resolution: 1.4 Å | in vitro · -193.15 °C · ligands GOL B6 Fab fragment bound to the SARS-CoV/SARS-CoV-2 spike stem helix peptide · Spike glycoprotein stem helix peptide (chains A) | unmapped |
| EV-PDB-7LYQ-1 RCSB PDB | cryoem | resolution: 3.34 Å | in vitro · ligands NAG South African (B.1.351) SARS-CoV-2 spike protein variant (S-GSAS-B.1.351) in the 1-RBD-up conformation · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7LYP-1 RCSB PDB | cryoem | resolution: 4.05 Å | in vitro · ligands NAG South African (B.1.351) SARS-CoV-2 spike protein variant (S-GSAS-B.1.351) in the 1-RBD-up conformation · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7LYO-1 RCSB PDB | cryoem | resolution: 3.32 Å | in vitro · ligands NAG South African (B.1.351) SARS-CoV-2 spike protein variant (S-GSAS-B.1.351) in the 1-RBD-up conformation · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7LYN-1 RCSB PDB | cryoem | resolution: 3.32 Å | in vitro · ligands NAG South African (B.1.351) SARS-CoV-2 spike protein variant (S-GSAS-B.1.351) in the 1-RBD-up conformation · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7LYM-1 RCSB PDB | cryoem | resolution: 3.57 Å | in vitro · ligands NAG South African (B.1.351) SARS-CoV-2 spike protein variant (S-GSAS-B.1.351) in the RBD-down conformation · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7LYL-1 RCSB PDB | cryoem | resolution: 3.72 Å | in vitro · ligands NAG South African (B.1.351) SARS-CoV-2 spike protein variant (S-GSAS-B.1.351) in the RBD-down conformation · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7LYK-1 RCSB PDB | cryoem | resolution: 3.65 Å | in vitro · ligands NAG South African (B.1.351) SARS-CoV-2 spike protein variant (S-GSAS-B.1.351) in the 2-RBD-up conformation · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7LY2-1 RCSB PDB | cryoem | resolution: 2.5 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 S/S2M11/S2M28 Global Refinement · Spike glycoprotein (chains A,B,J) | unmapped |
| EV-PDB-7LWU-1 RCSB PDB | cryoem | resolution: 3.22 Å | in vitro · ligands NAG UK (B.1.1.7) SARS-CoV-2 spike protein variant (S-GSAS-B.1.1.7) in the 1-RBD-up conformation · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7LWS-1 RCSB PDB | cryoem | resolution: 3.22 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose UK (B.1.1.7) SARS-CoV-2 S-GSAS-D614G variant spike protein in the 3-RBD-down conformation · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7LWL-1 RCSB PDB | cryoem | resolution: 2.84 Å | in vitro · ligands NAG Mink Cluster 5-associated SARS-CoV-2 spike protein (S-GSAS-D614G-delFV) in the 3-RBD down conformation · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7LWJ-1 RCSB PDB | cryoem | resolution: 3.24 Å | in vitro · ligands NAG Mink Cluster 5-associated SARS-CoV-2 spike protein (S-GSAS-D614G-delFV) in the 3-RBD down conformation · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7LWI-1 RCSB PDB | cryoem | resolution: 3.07 Å | in vitro · ligands NAG Mink Cluster 5-associated SARS-CoV-2 spike protein (S-GSAS-D614G-delFV) in the 3-RBD down conformation · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7LSS-1 RCSB PDB | cryoem | resolution: 3.72 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of the SARS-CoV-2 spike glycoprotein bound to Fab 2-7 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7LS9-1 RCSB PDB | cryoem | resolution: 3.42 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of neutralizing antibody 1-57 in complex with prefusion SARS-CoV-2 spike glycoprotein · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7LRS-1 RCSB PDB | cryoem | resolution: 3.89 Å | in vitro · ligands branched: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 spike in complex with neutralizing antibody A23-58.1 that targets the receptor-binding domain · Spike glycoprotein (chains C) | unmapped |
| EV-PDB-7LQ7-1 RCSB PDB | xray | resolution: 3.4 Å | in vitro · -173.15 °C · ligands NAG Crystal structure of SARS-CoV-2 receptor binding domain in complex with antibodies CV503 and COVA1-16 · Spike protein S1 (chains A,B,E) | unmapped |
| EV-PDB-7M6F-1 RCSB PDB | cryoem | resolution: 3.9 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragment, BG1-22 · Spike glycoprotein (chains A,B,E) | unmapped |
| EV-PDB-7M6H-1 RCSB PDB | cryoem | resolution: 4 Å | in vitro · ligands NAG Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, BG7-20 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7M6I-1 RCSB PDB | cryoem | resolution: 4 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, BG1-24 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7M71-1 RCSB PDB | cryoem | resolution: 2.66 Å | in vitro · ligands NAG SARS-CoV-2 Spike:5A6 Fab complex I focused refinement · Spike glycoprotein (chains A,B) | unmapped |
| EV-PDB-7M7B-1 RCSB PDB | cryoem | resolution: 2.95 Å | in vitro · ligands NAG SARS-CoV-2 Spike:Fab 3D11 complex focused refinement · Spike glycoprotein (chains A) | unmapped |
| EV-PDB-7M7W-5 RCSB PDB | xray | resolution: 2.65 Å | in vitro · -173.15 °C · ligands NAG Antibodies to the SARS-CoV-2 receptor-binding domain that maximize breadth and resistance to viral escape · Spike protein S1 (chains R,S) | unmapped |
| EV-PDB-7M8J-1 RCSB PDB | cryoem | resolution: 3.48 Å | in vitro SARS-CoV-2 S-NTD + Fab CM25 · Spike protein S1 (chains A) | unmapped |
| EV-PDB-7M8S-3 RCSB PDB | xray | resolution: 2.35 Å | in vitro · -173.15 °C · pH 5.6 · ligands GOL Crystal Structure of HLA-A*02:01 in complex with KLNDLCFTNV, an 10-mer epitope from SARS-CoV-2 Spike (S386-395) · Spike protein S1 peptide (chains C,F) | unmapped |
| EV-PDB-7M8T-3 RCSB PDB | xray | resolution: 1.5 Å | in vitro · -173.15 °C · pH 6.5 · ligands CA, CL, GOL, NA, SO4 Crystal Structure of HLA-A*11:01 in complex with NSASFSTFK, an 9-mer epitope from SARS-CoV-2 spike (S370-378) · Spike protein S1 peptide (chains C) | unmapped |
| EV-PDB-7M8U-3 RCSB PDB | xray | resolution: 1.45 Å | in vitro · -173.15 °C · pH 6.5 · ligands NA, PO4 Crystal Structure of HLA-B*35:01 in complex with IPFAMQMAY, an 9-mer epitope from SARS-CoV-2 spike (S896-904) · Spike protein S2 peptide (chains C) | unmapped |
| EV-PDB-7MDW-2 RCSB PDB | cryoem | resolution: 3.58 Å | in vitro · ligands NAG CryoEM structure of SARS-CoV-2 RBD in complex with nanobodies Nb21 and Nb105 · Spike protein S1 (chains R) | unmapped |
| EV-PDB-7ME7-1 RCSB PDB | cryoem | resolution: 3.73 Å | in vitro CryoEM structure of SARS-CoV-2 RBD in complex with nanobodies Nb17 and Nb105 · Spike protein S1 (chains R) | unmapped |
| EV-PDB-7MF1-1 RCSB PDB | xray | resolution: 2.092 Å | in vitro · -173.15 °C · pH 7.5 · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody 47D1 · Spike protein S1 (chains A) | unmapped |
| EV-PDB-7MFU-1 RCSB PDB | xray | resolution: 1.7 Å | in vitro · -173.15 °C · pH 7.5 · ligands EDO, GOL Crystal structure of synthetic nanobody (Sb14+Sb68) complexes with SARS-CoV-2 receptor binding domain · Spike protein S1 (chains A,D) | unmapped |
| EV-PDB-7MJG-1 RCSB PDB | cryoem | resolution: 2.81 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of the SARS-CoV-2 N501Y mutant spike protein ectodomain · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7MJH-1 RCSB PDB | cryoem | resolution: 2.66 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of the SARS-CoV-2 N501Y mutant spike protein ectodomain bound to VH ab8 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7MJI-1 RCSB PDB | cryoem | resolution: 2.81 Å | in vitro · ligands NAG Cryo-EM structure of the SARS-CoV-2 N501Y mutant spike protein ectodomain bound to VH ab8 (focused refinement of RBD and VH ab8) · Spike glycoprotein (chains B) | unmapped |
| EV-PDB-7MJK-1 RCSB PDB | cryoem | resolution: 2.73 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of the SARS-CoV-2 N501Y mutant spike protein ectodomain bound to Fab ab1 (class 2) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7MJL-1 RCSB PDB | cryoem | resolution: 2.95 Å | in vitro · ligands NAG Cryo-EM structure of the SARS-CoV-2 N501Y mutant spike protein ectodomain bound to Fab ab1 (focused refinement of RBD and Fab ab1) · Spike glycoprotein (chains A) | unmapped |
| EV-PDB-7MJM-1 RCSB PDB | cryoem | resolution: 2.83 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of the SARS-CoV-2 N501Y mutant spike protein ectodomain bound to human ACE2 ectodomain · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7MJN-1 RCSB PDB | cryoem | resolution: 3.29 Å | in vitro · ligands NAG Cryo-EM structure of the SARS-CoV-2 N501Y mutant spike protein ectodomain bound to human ACE2 ectodomain (focused refinement of RBD and ACE2) · Spike glycoprotein (chains B) | unmapped |
| EV-PDB-7MKB-3 RCSB PDB | xray | resolution: 1.9 Å | in vitro · -173.15 °C · pH 5.5 · ligands GOL Human leukocyte antigen A*0201 in complex with SARS-CoV-2 epitope YLQPRTFLL · Spike protein S1 (chains C) | unmapped |
| EV-PDB-7MKM-1 RCSB PDB | cryoem | resolution: 3.16 Å | in vitro · ligands NAG SARS-CoV-2 Spike RBD in complex with neutralizing Fab SARS2-38 (local refinement) · Spike protein S1 (chains A) | unmapped |
| EV-PDB-7MLZ-1 RCSB PDB | cryoem | resolution: 3.71 Å | in vitro · ligands branched: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 spike in complex with neutralizing antibody B1-182.1 that targets the receptor-binding domain · Spike protein S1 (chains A) | unmapped |
| EV-PDB-7MM0-3 RCSB PDB | cryoem | resolution: 3.15 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 spike in complex with neutralizing antibody B1-182.1 that targets the receptor-binding domain · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7MMO-3 RCSB PDB | xray | resolution: 2.427 Å | in vitro · -173.15 °C · ligands NAG LY-CoV1404 neutralizing antibody against SARS-CoV-2 · Spike protein S1 (chains C,F) | unmapped |
| EV-PDB-7MSQ-1 RCSB PDB | xray | resolution: 2.29 Å | in vitro · -173.15 °C · pH 6.9 · ligands CL, GOL, SCN, branched: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose Complex between the Fab arm of AB-3467 and the SARS-CoV-2 receptor binding domain (RBD) · Spike protein S1 (chains A,B) | unmapped |
| EV-PDB-7MTC-1 RCSB PDB | cryoem | resolution: 2.6 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Structure of freshly purified SARS-CoV-2 S2P spike at pH 7.4 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7MTD-1 RCSB PDB | cryoem | resolution: 3.5 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Structure of aged SARS-CoV-2 S2P spike at pH 7.4 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7MTE-1 RCSB PDB | cryoem | resolution: 3.2 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Structure of SARS-CoV-2 S2P spike at pH 7.4 refolded by low-pH treatment · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7MW2-1 RCSB PDB | cryoem | resolution: 2.97 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Structure of the SARS-CoV-2 Spike trimer with all RBDs down in complex with the Fab fragment of human neutralizing antibody clone 6 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7MW3-3 RCSB PDB | cryoem | resolution: 3.15 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-3)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Structure of the SARS-CoV-2 Spike trimer with two RBDs down in complex with the Fab fragment of human neutralizing antibody clone 6 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7MW4-1 RCSB PDB | cryoem | resolution: 3.42 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-3)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Structure of the SARS-CoV-2 Spike trimer with one RBD down in complex with the Fab fragment of human neutralizing antibody clone 6 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7MW5-3 RCSB PDB | cryoem | resolution: 3.42 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Structure of the SARS-CoV-2 Spike trimer with one RBD down in complex with the Fab fragment of human neutralizing antibody clone 2 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7MXP-1 RCSB PDB | cryoem | resolution: 4.46 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[2-acetamido-2-deoxy-beta-D-glucopyranose-(1-2)][beta-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of NTD-directed neutralizing antibody LP5 Fab in complex with SARS-CoV-2 S2P spike · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7MY2-1 RCSB PDB | cryoem | resolution: 2.65 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose CryoEM structure of neutralizing nanobody Nb30 in complex with SARS-CoV2 spike · Spike glycoprotein (chains B,C,E) | unmapped |
| EV-PDB-7MY3-1 RCSB PDB | cryoem | resolution: 2.9 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose CryoEM structure of neutralizing nanobody Nb12 in complex with SARS-CoV2 spike · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7MY8-1 RCSB PDB | nmr_structure | structure | in vitro · 31.85 °C · pH 5 Fusion Peptide of SARS-CoV-2 Spike Rearranges into a Wedge Inserted in Bilayered Micelles · Spike protein S2 (chains A) | unmapped |
| EV-PDB-7MZF-1 RCSB PDB | xray | resolution: 2.493 Å | in vitro · -173.15 °C · pH 8.5 · ligands CL, GOL, SO4, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 receptor binding domain bound to Fab PDI 37 · Spike protein S1 (chains A) | unmapped |
| EV-PDB-7MZG-3 RCSB PDB | xray | resolution: 2 Å | in vitro · -173.15 °C · pH 6.2 · ligands GOL, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 receptor binding domain bound to Fab PDI 42 · Spike protein S1 (chains A) | unmapped |
| EV-PDB-7MZH-1 RCSB PDB | xray | resolution: 2.1 Å | in vitro · -173.15 °C · ligands branched: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 receptor binding domain bound to Fab WCSL 119 · Spike protein S1 (chains A,E) | unmapped |
| EV-PDB-7MZI-3 RCSB PDB | xray | resolution: 1.85 Å | in vitro · -173.15 °C · pH 5.5 · ligands GOL, PG4, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 receptor binding domain bound to Fab WCSL 129 · Spike protein S1 (chains A) | unmapped |
| EV-PDB-7MZJ-3 RCSB PDB | xray | resolution: 2.4 Å | in vitro · -173.15 °C · pH 4.5 · ligands GOL, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 receptor binding domain bound to Fab WCSL 129 and Fab PDI 93 · Spike protein S1 (chains A,B) | unmapped |
| EV-PDB-7MW6-1 RCSB PDB | cryoem | resolution: 3.22 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-3)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Structure of the SARS-CoV-2 Spike trimer with three RBDs up in complex with the Fab fragment of human neutralizing antibody clone 2 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7MKL-1 RCSB PDB | cryoem | resolution: 3.2 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 Spike in complex with neutralizing Fab SARS2-38 (three down conformation) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7MJJ-1 RCSB PDB | cryoem | resolution: 3.32 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of the SARS-CoV-2 N501Y mutant spike protein ectodomain bound to Fab ab1 (class 1) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7MEJ-2 RCSB PDB | cryoem | resolution: 3.55 Å | in vitro CryoEM structure of SARS-CoV-2 RBD in complex with nanobodies Nb21 and Nb36 · Spike protein S1 (chains R) | unmapped |
| EV-PDB-7M8K-1 RCSB PDB | cryoem | resolution: 3.8 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of Brazil (P.1) SARS-CoV-2 spike glycoprotein variant in the prefusion state (1 RBD up) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7M6G-1 RCSB PDB | cryoem | resolution: 3.7 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragment, BG7-15 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7M6E-1 RCSB PDB | cryoem | resolution: 3.3 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragment, BG10-19 · Spike glycoprotein (chains A,B,E) | unmapped |
| EV-PDB-7MZK-2 RCSB PDB | xray | resolution: 2.25 Å | in vitro · -173.15 °C · pH 5.5 · ligands CIT, GOL, MPD, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 receptor binding domain bound to Fab WCSL 129 and Fab PDI 96 · Spike protein S1 (chains A,B) | unmapped |
| EV-PDB-7MZL-1 RCSB PDB | xray | resolution: 3.7 Å | in vitro · -173.15 °C · ligands branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 receptor binding domain bound to Fab PDI 210 · Spike protein S1 (chains A) | unmapped |
| EV-PDB-7MZM-3 RCSB PDB | xray | resolution: 2.3 Å | in vitro · -173.15 °C · pH 5.6 · ligands IPA, branched: alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 receptor binding domain bound to Fab PDI 215 · Spike protein S1 (chains A) | unmapped |
| EV-PDB-7MZN-1 RCSB PDB | xray | resolution: 3.1 Å | in vitro · -173.15 °C · ligands SO4, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 receptor binding domain bound to Fab PDI 231 · Spike protein S1 (chains A) | unmapped |
| EV-PDB-7N0G-1 RCSB PDB | cryoem | resolution: 3.02 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose CryoEm structure of SARS-CoV-2 spike protein (S-6P, 1-up) in complex with sybodies (Sb45) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7N0H-1 RCSB PDB | cryoem | resolution: 3.34 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose CryoEM structure of SARS-CoV-2 spike protein (S-6P, 2-up) in complex with sybodies (Sb45) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7N1A-3 RCSB PDB | xray | resolution: 2.065 Å | in vitro · -173.15 °C · pH 7 · ligands PG4 SARS-CoV-2 YLQ peptide binds to HLA-A2 · Spike protein S1 (chains C,F) | unmapped |
| EV-PDB-7N1B-3 RCSB PDB | xray | resolution: 2.81 Å | in vitro · -173.15 °C · pH 6.5 SARS-CoV-2 RLQ peptide binds to HLA-A2 · Spike protein S2 (chains C,F) | unmapped |
| EV-PDB-7N1E-3 RCSB PDB | xray | resolution: 2.3 Å | in vitro · -173.15 °C · pH 6 SARS-CoV-2 RLQ peptide-specific TCR pRLQ3 binds to RLQ-HLA-A2 · Spike protein S2 (chains C) | unmapped |
| EV-PDB-7N1Q-1 RCSB PDB | cryoem | resolution: 2.9 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7N1V-1 RCSB PDB | cryoem | resolution: 3.21 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7N1Y-1 RCSB PDB | cryoem | resolution: 4.3 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7N3I-1 RCSB PDB | xray | resolution: 2.03 Å | in vitro · -173.15 °C · ligands NAG Crystal structure of the SARS-CoV-2 receptor binding domain in complex with the human neutralizing antibody Fab fragment C098 · Spike protein S1 (chains C) | unmapped |
| EV-PDB-7N4I-3 RCSB PDB | xray | resolution: 2.284 Å | in vitro · -173.15 °C · pH 5 · ligands GOL, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing human antibody WRAIR-2057. · Spike protein S1 (chains C) | unmapped |
| EV-PDB-7N4J-1 RCSB PDB | xray | resolution: 2.207 Å | in vitro · -173.15 °C · pH 8.5 · ligands branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing human antibody WRAIR-2173. · Spike protein S1 (chains A) | unmapped |
| EV-PDB-7N4L-1 RCSB PDB | xray | resolution: 3.601 Å | in vitro · -173.15 °C · pH 8.5 Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing human antibody WRAIR-2125. · Spike protein S1 (chains A) | unmapped |
| EV-PDB-7N5H-1 RCSB PDB | cryoem | resolution: 3.24 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of broadly neutralizing antibody 2-36 in complex with prefusion SARS-CoV-2 spike glycoprotein · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7N62-1 RCSB PDB | cryoem | resolution: 4 Å | in vitro · ligands NAG SARS-CoV-2 Spike (2P) in complex with C12C9 Fab (NTD local reconstruction) · Spike glycoprotein (chains A) | unmapped |
| EV-PDB-7N64-1 RCSB PDB | cryoem | resolution: 4.2 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 Spike (2P) in complex with G32R7 Fab (RBD and NTD local reconstruction) · Spike glycoprotein (chains A,B) | unmapped |
| EV-PDB-7N6D-3 RCSB PDB | xray | resolution: 2.3 Å | in vitro · -173.15 °C · ligands EDO HLA peptide complex · Spike protein S1 (chains C,G,K,O) | unmapped |
| EV-PDB-7N6E-3 RCSB PDB | xray | resolution: 3.2 Å | in vitro · -173.15 °C · pH 8 TCR peptide HLA-A2 complex · Spike protein S1 (chains C,F) | unmapped |
| EV-PDB-7N8I-3 RCSB PDB | cryoem | resolution: 3 Å | in vitro · ligands NAG SARS-CoV-2 S (B.1.429 / epsilon variant) + S2M11 + S2L20 (Local Refinement of the NTD/S2L20) · Spike glycoprotein (chains A) | unmapped |
| EV-PDB-7N9A-2 RCSB PDB | cryoem | resolution: 3.5 Å | in vitro Potent neutralizing nanobodies resist convergent circulating variants of SARS-CoV-2 by targeting novel and conserved epitopes-CovS RBD with NB21 · Spike protein S1 (chains E) | unmapped |
| EV-PDB-7N9B-1 RCSB PDB | cryoem | resolution: 3.8 Å | in vitro Potent neutralizing nanobodies resist convergent circulating variants of SARS-CoV-2 by targeting novel and conserved epitopes-CovS with NB21 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7N9E-2 RCSB PDB | cryoem | resolution: 3.52 Å | in vitro Potent neutralizing nanobodies resist convergent circulating variants of SARS-CoV-2 by targeting novel and conserved epitopes-CovS with NB34 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7N9T-1 RCSB PDB | cryoem | resolution: 3.18 Å | in vitro CryoEM structure of SARS-CoV-2 Spike in complex with Nb17 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7ND3-1 RCSB PDB | cryoem | resolution: 3.7 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose EM structure of SARS-CoV-2 Spike glycoprotein in complex with COVOX-40 Fab · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7ND5-1 RCSB PDB | cryoem | resolution: 3.4 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose EM structure of SARS-CoV-2 Spike glycoprotein in complex with COVOX-150 Fab · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7ND6-1 RCSB PDB | cryoem | resolution: 7.3 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose EM structure of SARS-CoV-2 Spike glycoprotein in complex with COVOX-40 Fab · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7ND7-1 RCSB PDB | cryoem | resolution: 3.6 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose EM structure of SARS-CoV-2 Spike glycoprotein in complex with COVOX-316 Fab · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7ND8-1 RCSB PDB | cryoem | resolution: 3.5 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose EM structure of SARS-CoV-2 Spike glycoprotein in complex with COVOX-384 Fab · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7ND9-1 RCSB PDB | cryoem | resolution: 2.8 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose EM structure of SARS-CoV-2 Spike glycoprotein (one RBD up) in complex with COVOX-253H55L Fab · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7NDA-1 RCSB PDB | cryoem | resolution: 3.3 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose EM structure of SARS-CoV-2 Spike glycoprotein (all RBD down) in complex with COVOX-253H55L Fab · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7NDB-1 RCSB PDB | cryoem | resolution: 4.6 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose EM structure of SARS-CoV-2 Spike glycoprotein in complex with COVOX-253H165L Fab · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7NDC-1 RCSB PDB | cryoem | resolution: 4.1 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose EM structure of SARS-CoV-2 Spike glycoprotein (all RBD down) in complex with COVOX-159 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7NDD-1 RCSB PDB | cryoem | resolution: 4.2 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose EM structure of SARS-CoV-2 Spike glycoprotein (one RBD up) in complex with COVOX-159 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7NEG-3 RCSB PDB | xray | resolution: 2.19 Å | in vitro · -173.15 °C · pH 6 · ligands GOL, SO4, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose Crystal structure of the N501Y mutant receptor binding domain of SARS-CoV-2 Spike glycoprotein in complex with COVOX-269 Fab · Surface glycoprotein (chains E) | unmapped |
| EV-PDB-7NEH-3 RCSB PDB | xray | resolution: 1.77 Å | in vitro · -173.15 °C · pH 7.5 · ligands CL, EDO, NO3, PEG, SO4, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose Crystal structure of the receptor binding domain of SARS-CoV-2 Spike glycoprotein in complex with COVOX-269 Fab · Spike glycoprotein (chains E) | unmapped |
| EV-PDB-7NKT-1 RCSB PDB | xray | resolution: 2.3 Å | in vitro · -173.15 °C · pH 5 · ligands NAG, PEG, PO4 RBD domain of SARS-CoV2 in complex with neutralizing nanobody NM1226 · Spike protein S1 (chains AAA) | unmapped |
| EV-PDB-7NLL-1 RCSB PDB | cryoem | resolution: 2.89 Å | in vitro · ligands NAG SARS-CoV-2 Spike RBD (dimer) in complex with two Fu2 nanobodies · Spike protein S1 (chains B,D) | unmapped |
| EV-PDB-7ND4-1 RCSB PDB | cryoem | resolution: 3.6 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose EM structure of SARS-CoV-2 Spike glycoprotein in complex with COVOX-88 Fab · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7NAB-3 RCSB PDB | xray | resolution: 2.15 Å | in vitro · -173.15 °C · pH 5.6 · ligands CIT, NA Crystal structure of human neutralizing mAb CV3-25 binding to SARS-CoV-2 S MPER peptide 1140-1165 · Spike protein S2 (chains C,D) | unmapped |
| EV-PDB-7N9C-1 RCSB PDB | cryoem | resolution: 3.71 Å | in vitro Potent neutralizing nanobodies resist convergent circulating variants of SARS-CoV-2 by targeting novel and conserved epitopes-CovS with NB95 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7N8H-1 RCSB PDB | cryoem | resolution: 2.3 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 S (B.1.429 / epsilon variant) + S2M11 + S2L20 Global Refinement · Spike glycoprotein (chains A,F,K) | unmapped |
| EV-PDB-7N4M-2 RCSB PDB | xray | resolution: 3.79 Å | in vitro · -173.15 °C · pH 4.6 · ligands branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing human antibody WRAIR-2151. · Spike protein S1 (chains A) | unmapped |
| EV-PDB-7N1X-1 RCSB PDB | cryoem | resolution: 4 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7N1W-1 RCSB PDB | cryoem | resolution: 3.33 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7N1U-1 RCSB PDB | cryoem | resolution: 3.14 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7N1T-1 RCSB PDB | cryoem | resolution: 3.11 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7N1F-5 RCSB PDB | xray | resolution: 2.393 Å | in vitro · -173.15 °C · pH 5 SARS-CoV-2 YLQ peptide-specific TCR pYLQ7 binds to YLQ-HLA-A2 · Spike protein S1 (chains C) | unmapped |
| EV-PDB-7NP1-1 RCSB PDB | xray | resolution: 2.8 Å | in vitro · -173.15 °C · pH 7.5 · ligands NAG, branched: alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-beta-D-glucopyranose Crystal Structure of the SARS-CoV-2 Receptor Binding Domain in Complex with Antibody ION-360 · Spike protein S1 (chains A,B,C,D) | unmapped |
| EV-PDB-7NS6-2 RCSB PDB | cryoem | resolution: 3.18 Å | in vitro · ligands NAG, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 Spike (dimers) in complex with six Fu2 nanobodies · Spike glycoprotein,Fibritin (chains I,J,K,L,M,N) | unmapped |
| EV-PDB-7NT9-1 RCSB PDB | cryoem | resolution: 3.36 Å | in vitro · ligands BLA, NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Trimeric SARS-CoV-2 spike ectodomain in complex with biliverdin (closed conformation) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7NX6-3 RCSB PDB | xray | resolution: 2.25 Å | in vitro · -173.15 °C · ligands CL, GOL, NAG, SO4 Crystal structure of the receptor binding domain of SARS-CoV-2 Spike glycoprotein in complex with COVOX-222 and EY6A Fabs · Spike protein S1 (chains E) | unmapped |
| EV-PDB-7NX7-3 RCSB PDB | xray | resolution: 2.3 Å | in vitro · -173.15 °C · ligands CIT, CL, GOL, NAG, SO4 Crystal structure of the K417N mutant receptor binding domain of SARS-CoV-2 Spike glycoprotein in complex with COVOX-222 and EY6A Fabs · Spike protein S1 (chains E) | unmapped |
| EV-PDB-7NX8-3 RCSB PDB | xray | resolution: 1.95 Å | in vitro · -173.15 °C · ligands CIT, CL, GOL, NAG, PEG, SO4 Crystal structure of the K417T mutant receptor binding domain of SARS-CoV-2 Spike glycoprotein in complex with COVOX-222 and EY6A Fabs · Spike protein S1 (chains E) | unmapped |
| EV-PDB-7NX9-3 RCSB PDB | xray | resolution: 2.4 Å | in vitro · -173.15 °C · ligands CL, GOL, NAG, PEG, SO4 Crystal structure of the N501Y mutant receptor binding domain of SARS-CoV-2 Spike glycoprotein in complex with COVOX-222 and EY6A Fabs · Spike protein S1 (chains E) | unmapped |
| EV-PDB-7NXA-3 RCSB PDB | xray | resolution: 2.5 Å | in vitro · -173.15 °C · ligands GOL, NAG, PEG, SO4 Crystal structure of the receptor binding domain of SARS-CoV-2 B.1.351 variant Spike glycoprotein in complex with COVOX-222 and EY6A Fabs · Spike protein S1 (chains E) | unmapped |
| EV-PDB-7NXB-3 RCSB PDB | xray | resolution: 2.67 Å | in vitro · -173.15 °C · ligands GOL, NAG, PEG, SO4 Crystal structure of the receptor binding domain of SARS-CoV-2 P.1 variant Spike glycoprotein in complex with COVOX-222 and EY6A Fabs · Spike protein S1 (chains E) | unmapped |
| EV-PDB-7OAN-1 RCSB PDB | cryoem | resolution: 3 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Nanobody C5 bound to Spike · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7OAO-1 RCSB PDB | xray | resolution: 1.5 Å | in vitro · -173.15 °C · ligands ACT, NAG Nanobody C5 bound to RBD · Spike protein S1 (chains EEE) | unmapped |
| EV-PDB-7OAP-2 RCSB PDB | xray | resolution: 1.901 Å | in vitro · -173.15 °C · ligands CIT, CL, NAG Nanobody H3 AND C1 bound to RBD · Spike protein S1 (chains EEE) | unmapped |
| EV-PDB-7OAQ-2 RCSB PDB | xray | resolution: 1.55 Å | in vitro · -173.15 °C · ligands CIT, CL, NAG Nanobody H3 AND C1 bound to RBD with Kent mutation · Spike protein S1 (chains EEE) | unmapped |
| EV-PDB-7OAU-1 RCSB PDB | xray | resolution: 1.65 Å | in vitro · -173.15 °C · ligands GOL, NAG Nanobody C5 bound to Kent variant RBD (N501Y) · Spike protein S1 (chains AAA,EEE) | unmapped |
| EV-PDB-7OAY-1 RCSB PDB | xray | resolution: 2.34 Å | in vitro · -173.15 °C · ligands NAG Nanobody F2 bound to RBD · Spike protein S1 (chains AAA,CCC,EEE,GGG,III,KKK) | unmapped |
| EV-PDB-7OLZ-3 RCSB PDB | xray | resolution: 1.75 Å | in vitro · -173.15 °C · pH 7.5 · ligands DMX, SO4 Crystal structure of the SARS-CoV-2 RBD with neutralizing-VHHs Re5D06 and Re9F06 · Spike protein S1 (chains A) | unmapped |
| EV-PDB-7OR9-1 RCSB PDB | xray | resolution: 2.34 Å | in vitro · -173.15 °C · ligands CL, GOL, PG4, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose Crystal structure of the receptor binding domain of SARS-CoV-2 Spike glycoprotein in complex with COVOX-222 and COVOX-278 Fabs · Spike protein S1 (chains E) | unmapped |
| EV-PDB-7ORA-1 RCSB PDB | xray | resolution: 2.6 Å | in vitro · -173.15 °C · ligands CL, GOL, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-beta-D-glucopyranose Crystal structure of the T478K mutant receptor binding domain of SARS-CoV-2 Spike glycoprotein in complex with COVOX-45 and COVOX-253 Fabs · Spike protein S1 (chains C,R) | unmapped |
| EV-PDB-7P19-2 RCSB PDB | xray | resolution: 3.24 Å | in vitro · -173.15 °C · ligands CL, EDO, NAG, ZN Crystal structure of SARS-CoV-2 RBD Q498Y complexed with human ACE2 · Spike protein S1 (chains C,E) | unmapped |
| EV-PDB-7P3E-3 RCSB PDB | xray | resolution: 2 Å | in vitro · -173.15 °C · pH 7.5 · ligands IOD, PEG MHC I A02 Allele presenting YLQLRTFLL · TYR-LEU-GLN-LEU-ARG-THR-PHE-LEU-LEU (chains C,F) | unmapped |
| EV-PDB-7P5G-1 RCSB PDB | nmr_structure | structure | in vitro · 24.85 °C · pH 2.5 NMR structure of a peptide deriving from SARS-CoV-2 S RBD 482-506 fragment in HFIP/H2O · Spike glycoprotein (chains A) | unmapped |
| EV-PDB-7P77-1 RCSB PDB | cryoem | resolution: 2.98 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(5-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 spike protein in complex with sybody#15 and sybody#68 in a 3up conformation · Spike glycoprotein (chains B,C,E) | unmapped |
| EV-PDB-7P78-1 RCSB PDB | cryoem | resolution: 3.32 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(5-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 spike protein in complex with sybody#15 and sybody#68 in a 1up/1up-out/1down conformation · Spike glycoprotein (chains A,C,E) | unmapped |
| EV-PDB-7P79-1 RCSB PDB | cryoem | resolution: 4 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(5-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 spike protein in complex with sybodyb#15 in a 1up/1up-out/1down conformation. · Spike glycoprotein (chains A,C,E) | unmapped |
| EV-PDB-7P7A-1 RCSB PDB | cryoem | resolution: 4.76 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(5-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 spike protein in complex with sybody#68 in a 2up/1flexible conformation · Spike glycoprotein (chains B,C,E) | unmapped |
| EV-PDB-7P7B-1 RCSB PDB | cryoem | resolution: 3.13 Å | in vitro SARS-CoV-2 spike protein in complex with sybody no68 in a 1up/2down conformation · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7PBE-3 RCSB PDB | xray | resolution: 3 Å | in vitro · -173.15 °C · pH 8.5 · ligands PEG, SO4 Emergence of immune escape at dominant SARS-CoV-2 killer T-cell epitope · Spike protein S1 (chains C,H) | unmapped |
| EV-PDB-7PHG-1 RCSB PDB | cryoem | resolution: 4.3 Å | in vitro MaP OF P5C3RBD Interface · Surface glycoprotein (chains A) | unmapped |
| EV-PDB-7PKI-2 RCSB PDB | xray | resolution: 2.94234 Å | in vitro · -193.15 °C · pH 8.5 · ligands CL, GOL, NAG, PEG, SO4, TRS, ZN, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Crystal structure of human ACE2 bound to the spike receptor-binding domain from a cave bat sarbecovirus closely related to SARS-CoV-2. · BANAL 236 coronavirus spike receptor-binding domain (chains E) | unmapped |
| EV-PDB-7PQY-1 RCSB PDB | xray | resolution: 3 Å | in vitro · -173.15 °C · ligands branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose Crystal structure of the receptor binding domain of SARS-CoV-2 Spike glycoprotein in complex with FI-3A Fab · Spike protein S1 (chains A,E) | unmapped |
| EV-PDB-7PR0-1 RCSB PDB | xray | resolution: 2.92 Å | in vitro · -173.15 °C · ligands CL, GOL, NAG, NO3, SO4 Crystal structure of the receptor binding domain of SARS-CoV-2 Spike glycoprotein in complex with FD-5D Fab · Spike protein S1 (chains A,D,E) | unmapped |
| EV-PDB-7PRY-5 RCSB PDB | xray | resolution: 3.1 Å | in vitro · -173.15 °C · ligands branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose Crystal structure of the receptor binding domain of SARS-CoV-2 beta variant spike glycoprotein in complex with COVOX-45 and beta-6 Fabs · Spike protein S1 (chains E,I) | unmapped |
| EV-PDB-7PRZ-2 RCSB PDB | xray | resolution: 3.2 Å | in vitro · -173.15 °C · ligands SO4, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-beta-D-glucopyranose Crystal structure of the receptor binding domain of SARS-CoV-2 beta variant spike glycoprotein in complex with beta-22 Fabs · Spike protein S1 (chains E) | unmapped |
| EV-PDB-7PS0-1 RCSB PDB | xray | resolution: 2.92 Å | in vitro · -173.15 °C · ligands NAG, SO4 Crystal structure of the receptor binding domain of SARS-CoV-2 beta variant spike glycoprotein in complex with beta-24 Fabs · Spike protein S1 (chains A,E) | unmapped |
| EV-PDB-7PS1-1 RCSB PDB | xray | resolution: 2.4 Å | in vitro · -173.15 °C · ligands CL, GOL, IOD, NAG, PEG Crystal structure of the receptor binding domain of SARS-CoV-2 beta variant spike glycoprotein in complex with Beta-27 Fab · Spike protein S1 (chains E) | unmapped |
| EV-PDB-7PS2-2 RCSB PDB | xray | resolution: 2.99 Å | in vitro · -173.15 °C · ligands GOL, PEG, SO4, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose Crystal structure of the receptor binding domain of SARS-CoV-2 beta variant spike glycoprotein in complex with Beta-29 and Beta-53 Fabs · Spike protein S1 (chains G) | unmapped |
| EV-PDB-7PS4-1 RCSB PDB | xray | resolution: 1.94 Å | in vitro · -173.15 °C · ligands CL, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Crystal structure of the receptor binding domain of SARS-CoV-2 beta variant spike glycoprotein in complex with Beta-38 · Spike protein S1 (chains A,E) | unmapped |
| EV-PDB-7PS5-3 RCSB PDB | xray | resolution: 3.14 Å | in vitro · -173.15 °C · ligands branched: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(1-3)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose Crystal structure of the receptor binding domain of SARS-CoV-2 beta variant spike glycoprotein in complex with Beta-47 Fab · Spike protein S1 (chains E) | unmapped |
| EV-PDB-7PQZ-1 RCSB PDB | xray | resolution: 3.2 Å | in vitro · -173.15 °C · ligands PO4, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Crystal structure of the receptor binding domain of SARS-CoV-2 Spike glycoprotein in complex with FI-3A and FD-11A Fabs · Spike protein S1 (chains E) | unmapped |
| EV-PDB-7P5S-1 RCSB PDB | nmr_structure | structure | in vitro · 24.85 °C · pH 2.5 NMR structure of a peptide deriving from SARS-CoV-2 Lineages P.1 and B.1.351 S RBD 482-506 fragment in HFIP/H2O · Spike glycoprotein (chains A) | unmapped |
| EV-PDB-7P5Q-1 RCSB PDB | nmr_structure | structure | in vitro · 24.85 °C · pH 2.5 NMR structure of a peptide deriving from SARS-CoV-2 Lineage B.1.1.7 S RBD 482-506 fragment in HFIP/H2O · Spike glycoprotein (chains A) | unmapped |
| EV-PDB-7P40-1 RCSB PDB | cryoem | resolution: 3.5 Å | in vitro P5C3 is a potent fab neutralizer · Spike glycoprotein (chains A,E,G) | unmapped |
| EV-PDB-7P3D-3 RCSB PDB | xray | resolution: 1.67 Å | in vitro · -173.15 °C · ligands ACT, CA, EDO MHC I A02 Allele presenting YLQPRTFLL · Spike glycoprotein (chains C) | unmapped |
| EV-PDB-7OWX-1 RCSB PDB | xray | resolution: 1.929 Å | in vitro · -173.15 °C · pH 8 · ligands EDO, ZN Structure of coiled-coil tetramer from SARS-CoV-2 spike stalk region · Spike protein S2 (chains A,B,C,D) | unmapped |
| EV-PDB-7ORB-1 RCSB PDB | xray | resolution: 2.5 Å | in vitro · -173.15 °C · ligands BTB, CL, GOL, PEG, PO4, TRS, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose Crystal structure of the L452R mutant receptor binding domain of SARS-CoV-2 Spike glycoprotein in complex with COVOX-75 and COVOX-253 Fabs · Spike protein S1 (chains R,X) | unmapped |
| EV-PDB-7ODL-1 RCSB PDB | cryoem | resolution: 3.03 Å | in vitro · ligands EIC, NAG SARS CoV-2 Spike protein, Bristol UK Deletion variant, Closed conformation, C1 symmetry · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7OD3-1 RCSB PDB | cryoem | resolution: 2.8 Å | in vitro · ligands EIC, NAG SARS CoV-2 Spike protein, Bristol UK Deletion variant, Closed conformation, C3 symmetry · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7NXC-2 RCSB PDB | xray | resolution: 3.14 Å | in vitro · -173.15 °C · pH 7 · ligands NAG Crystal structure of the receptor binding domain of SARS-CoV-2 P.1 variant Spike glycoprotein in complex with ACE2 · Spike protein S1 (chains B) | unmapped |
| EV-PDB-7NTC-1 RCSB PDB | cryoem | resolution: 3.6 Å | in vitro · ligands BLA, NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Trimeric SARS-CoV-2 spike ectodomain bound to P008_056 Fab · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7NTA-1 RCSB PDB | cryoem | resolution: 3.5 Å | in vitro · ligands BLA, NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Trimeric SARS-CoV-2 spike ectodomain in complex with biliverdin (one RBD erect) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7R4Q-1 RCSB PDB | cryoem | resolution: 3.6 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose The SARS-CoV-2 spike in complex with the 1.29 neutralizing nanobody · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7R8L-3 RCSB PDB | xray | resolution: 2.6 Å | in vitro · -173.15 °C · ligands branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose Structure of the SARS-CoV-2 RBD in complex with neutralizing antibody C099 and CR3022 · Spike protein S1 (chains E) | unmapped |
| EV-PDB-7R7N-2 RCSB PDB | cryoem | resolution: 3.95 Å | in vitro · ligands branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 spike in complex with the S2D106 neutralizing antibody Fab fragment (local refinement of the RBD and S2D106) · Spike glycoprotein (chains E) | unmapped |
| EV-PDB-7R6X-3 RCSB PDB | xray | resolution: 2.95 Å | in vitro · -173.15 °C · ligands CL, NAG SARS-CoV-2 spike receptor-binding domain (RBD) in complex with S2E12 Fab, S309 Fab, and S304 Fab · Spike protein S1 (chains R) | unmapped |
| EV-PDB-7R6W-5 RCSB PDB | xray | resolution: 1.83 Å | in vitro · -173.15 °C · ligands CL, GOL, POL, SO4, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 spike receptor-binding domain (RBD) in complex with S2X35 Fab and S309 Fab · Spike protein S1 (chains R) | unmapped |
| EV-PDB-7R4R-1 RCSB PDB | cryoem | resolution: 3.9 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose The SARS-CoV-2 spike in complex with the 1.10 neutralizing nanobody · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7R4I-1 RCSB PDB | cryoem | resolution: 3.2 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose The SARS-CoV-2 spike in complex with the 2.15 neutralizing nanobody · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7R40-1 RCSB PDB | cryoem | resolution: 2.9 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Structure of the SARS-CoV-2 spike glycoprotein in complex with the 87G7 antibody Fab fragment · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7R1B-1 RCSB PDB | cryoem | resolution: 2.8 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Mink Variant SARS-CoV-2 Spike with 1 Erect RBD · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7R1A-1 RCSB PDB | cryoem | resolution: 3.9 Å | in vitro · ligands NAG, ZN, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Furin Cleaved Alpha Variant SARS-CoV-2 Spike in complex with 3 ACE2 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7R19-1 RCSB PDB | cryoem | resolution: 3.3 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Mink Variant SARS-CoV-2 Spike with 2 Erect RBDs · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7R18-1 RCSB PDB | cryoem | resolution: 3 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose Mink Variant SARS-CoV-2 Spike in Closed conformation · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7R17-1 RCSB PDB | cryoem | resolution: 3.7 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Beta Variant SARS-CoV-2 Spike with 2 Erect RBDs · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7R16-1 RCSB PDB | cryoem | resolution: 3.5 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Beta Variant SARS-CoV-2 Spike with 1 Erect RBD · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7R15-1 RCSB PDB | cryoem | resolution: 4.1 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Alpha Variant SARS-CoV-2 Spike with 2 Erect RBDs · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7R14-1 RCSB PDB | cryoem | resolution: 3.4 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose Alpha Variant SARS-CoV-2 Spike with 1 Erect RBD · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7R13-1 RCSB PDB | cryoem | resolution: 3.6 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Alpha Variant SARS-CoV-2 Spike in Closed conformation · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7R12-2 RCSB PDB | cryoem | resolution: 3.3 Å | in vitro · ligands NAG, ZN Dissociated S1 domain of Mink Variant SARS-CoV-2 Spike bound to ACE2 (Non-Uniform Refinement) · Spike glycoprotein (chains A) | unmapped |
| EV-PDB-7R11-2 RCSB PDB | cryoem | resolution: 3.5 Å | in vitro · ligands NAG, ZN Dissociated S1 domain of Beta Variant SARS-CoV-2 Spike bound to ACE2 (Non-Uniform Refinement) · Spike glycoprotein (chains A) | unmapped |
| EV-PDB-7R10-2 RCSB PDB | cryoem | resolution: 4 Å | in vitro · ligands NAG, ZN Dissociated S1 domain of Alpha Variant SARS-CoV-2 Spike bound to ACE2 · Spike glycoprotein (chains A) | unmapped |
| EV-PDB-7R0Z-2 RCSB PDB | cryoem | resolution: 3.5 Å | in vitro · ligands NAG, ZN Dissociated S1 domain of Alpha Variant SARS-CoV-2 Spike bound to ACE2 (Non-Uniform Refinement) · Spike glycoprotein (chains A) | unmapped |
| EV-PDB-7QUS-1 RCSB PDB | cryoem | resolution: 2.39 Å | in vitro · ligands EIC, NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-L-fucopyranose-(1-3)-[2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)][alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 Spike, C3 symmetry · Spike glycoprotein,Fibritin (chains A,B,C) | unmapped |
| EV-PDB-7QTI-5 RCSB PDB | cryoem | resolution: 3.04 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 S Omicron Spike B.1.1.529 - 3-P2G3 and 1-P5C3 Fabs (Global) · Spike glycoprotein,Envelope glycoprotein (chains A,D,K) | unmapped |
| EV-PDB-7QO9-1 RCSB PDB | cryoem | resolution: 3.88 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 S Omicron Spike B.1.1.529 - RBD and NTD (Local) · Spike glycoprotein,SARS-CoV-2 S Omicron Spike B.1.1.529 (chains A,B) | unmapped |
| EV-PDB-7QO7-1 RCSB PDB | cryoem | resolution: 3.02 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 S Omicron Spike B.1.1.529 · Surface glycoprotein,Fibritin,SARS-CoV-2 S Omicron Spike B.1.1.529 (chains A,B,C) | unmapped |
| EV-PDB-7QNY-3 RCSB PDB | xray | resolution: 2.84 Å | in vitro · -173.15 °C · ligands GOL, NA, NAG The receptor binding domain of SARS-CoV-2 spike glycoprotein in complex with COVOX-58 and COVOX-158 Fabs · Surface glycoprotein (chains E) | unmapped |
| EV-PDB-7QNX-5 RCSB PDB | xray | resolution: 2.92 Å | in vitro · -173.15 °C · ligands branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose The receptor binding domain of SARS-CoV-2 spike glycoprotein in complex with Beta-55 and EY6A Fabs · Surface glycoprotein (chains E) | unmapped |
| EV-PDB-7QNW-3 RCSB PDB | xray | resolution: 2.4 Å | in vitro · -173.15 °C · ligands ACT, CL, GOL, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose The receptor binding domain of SARS-CoV-2 Omicron variant spike glycoprotein in complex with Beta-55 and EY6A Fabs · Surface glycoprotein (chains E) | unmapped |
| EV-PDB-7QF1-1 RCSB PDB | xray | resolution: 2.8 Å | in vitro · -193.15 °C · ligands NAG, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Crystal structure of the SARS-CoV-2 RBD in complex with the human antibody CV2.6264 · Spike protein S1 (chains A,F) | unmapped |
| EV-PDB-7QF0-1 RCSB PDB | xray | resolution: 2.3 Å | in vitro · -196.15 °C · pH 7 · ligands CL, NA, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Crystal structure of the SARS-CoV-2 RBD in complex with the human antibody CV2.2325 · Spike protein S1 (chains A) | unmapped |
| EV-PDB-7QEZ-1 RCSB PDB | xray | resolution: 2.89 Å | in vitro · -196.15 °C · pH 8 · ligands NAG, SO4 Crystal structure of the SARS-CoV-2 RBD in complex with the ultrapotent antibody CV2.1169 and CR3022 · Spike protein S1 (chains A) | unmapped |
| EV-PDB-7QDH-1 RCSB PDB | cryoem | resolution: 4.2 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 S protein S:D614G mutant 1-up · Spike glycoprotein,Fibritin (chains A,B,C) | unmapped |
| EV-PDB-7QDG-1 RCSB PDB | cryoem | resolution: 3.4 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-alpha-D-glucopyranose, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 S protein S:A222V + S:D614G mutant 1-up · Spike glycoprotein,Fibritin (chains A,B,C) | unmapped |
| EV-PDB-7Q9P-1 RCSB PDB | cryoem | resolution: 4.5 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Beta-06 fab in complex with SARS-CoV-2 beta-Spike glycoprotein · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7Q9M-1 RCSB PDB | cryoem | resolution: 3.7 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Beta-53 fab in complex with SARS-CoV-2 beta-Spike glycoprotein · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7Q9K-1 RCSB PDB | cryoem | resolution: 4.5 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Beta-32 fab in complex with SARS-CoV-2 beta-Spike glycoprotein · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7Q9J-1 RCSB PDB | cryoem | resolution: 4 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Beta-26 fab in complex with SARS-CoV-2 beta-Spike glycoprotein · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7Q9I-1 RCSB PDB | cryoem | resolution: 4.9 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Beta-43 fab in complex with SARS-CoV-2 beta-Spike glycoprotein · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7Q9G-1 RCSB PDB | cryoem | resolution: 3.3 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose COVOX-222 fab in complex with SARS-CoV-2 beta-Spike glycoprotein · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7Q9F-1 RCSB PDB | cryoem | resolution: 3.6 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose Beta-50 fab in complex with SARS-CoV-2 beta-Spike glycoprotein · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7Q6E-1 RCSB PDB | cryoem | resolution: 2.7 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose Beta049 fab in complex with SARS-CoV2 beta-Spike glycoprotein, The Beta mAb response underscores the antigenic distance to other SARS-CoV-2 variants · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7Q3R-1 RCSB PDB | xray | resolution: 1.92 Å | in vitro · -173.15 °C · pH 4.5 · ligands CL, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Crystal structure of SARS-CoV-2 RBD in complex with the neutralizing nanobodies VHH-F04 and VHH-G09 · Spike glycoprotein (chains A) | unmapped |
| EV-PDB-7Q3Q-2 RCSB PDB | xray | resolution: 2.3 Å | in vitro · -173.15 °C · pH 8.5 · ligands CL, GOL, SO4, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Crystal structure of SARS-CoV-2 RBD in complex with the neutralizing nanobody VHH-12 · Spike glycoprotein (chains A) | unmapped |
| EV-PDB-7Q1Z-1 RCSB PDB | cryoem | resolution: 3.4 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Structure of formaldehyde cross-linked SARS-CoV-2 S glycoprotein · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7Q0I-3 RCSB PDB | xray | resolution: 2.39 Å | in vitro · -173.15 °C · ligands CL, GOL, NAG, PEG, PG4, PO4, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(4-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-beta-D-glucopyranose Crystal structure of the N-terminal domain of SARS-CoV-2 beta variant spike glycoprotein in complex with Beta-43 · Spike protein S1 (chains C,D) | unmapped |
| EV-PDB-7Q0H-5 RCSB PDB | xray | resolution: 3.65 Å | in vitro · -173.15 °C · ligands branched: alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose Crystal structure of the receptor binding domain of SARS-CoV-2 beta variant spike glycoprotein in complex with Beta-50 and Beta-54 · Spike protein S1 (chains E) | unmapped |
| EV-PDB-7Q0G-1 RCSB PDB | xray | resolution: 1.82 Å | in vitro · -173.15 °C · ligands CL, GOL, K, TAR, branched: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose Crystal structure of the receptor binding domain of SARS-CoV-2 beta variant spike glycoprotein in complex with Beta-49 and FI-3A Fabs · Spike protein S1 (chains E) | unmapped |
| EV-PDB-7Q0A-1 RCSB PDB | cryoem | resolution: 4.8 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 Spike ectodomain with Fab FI3A · Spike glycoprotein,Spike ectodomain,Spike protein S2' (chains A,B,C) | unmapped |
| EV-PDB-7PS7-1 RCSB PDB | xray | resolution: 3.9 Å | in vitro · -173.15 °C Crystal structure of the receptor binding domain of SARS-CoV-2 beta variant spike glycoprotein in complex with Beta-40 Fab · Spike protein S1 (chains E,R) | unmapped |
| EV-PDB-7PS6-3 RCSB PDB | xray | resolution: 2.26 Å | in vitro · -173.15 °C · ligands CL, GOL, PEG, PG0, branched: alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-beta-D-glucopyranose Crystal structure of the receptor binding domain of SARS-CoV-2 beta variant spike glycoprotein in complex with Beta-44 and Beta-54 Fabs · Spike protein S1 (chains E) | unmapped |
| EV-PDB-7RQ6-1 RCSB PDB | cryoem | resolution: 4.18 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 spike in complex with non-neutralizing NTD-directed CV3-13 Fab isolated from convalescent individual · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7S0B-3 RCSB PDB | xray | resolution: 2.9 Å | in vitro · -173.15 °C · ligands NAG Structure of the SARS-CoV-2 RBD in complex with neutralizing antibody N-612-056 · Spike protein S1 (chains E,F) | unmapped |
| EV-PDB-7S4S-1 RCSB PDB | xray | resolution: 2.05 Å | in vitro · -173.15 °C · pH 6 · ligands ACT, NAG, SO4 Crystal Structure of SARS-CoV-2 S receptor-binding domain (RBD) in complex CoV11 Fab · Spike protein S1 (chains A) | unmapped |
| EV-PDB-7SBO-1 RCSB PDB | cryoem | resolution: 4.3 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose One RBD-up 2 of pre-fusion SARS-CoV-2 Delta variant spike protein · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7SBL-1 RCSB PDB | cryoem | resolution: 3.4 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose One RBD-up 1 of pre-fusion SARS-CoV-2 Delta variant spike protein · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7SBK-1 RCSB PDB | cryoem | resolution: 3.1 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Closed state of pre-fusion SARS-CoV-2 Delta variant spike protein · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7SA2-3 RCSB PDB | xray | resolution: 1.85 Å | in vitro · -173.15 °C · ligands CD, NA SARS-CoV-2 spike-derived peptide S1060-1068 (VVFLHVTYV) presented by HLA-A*02:01 · Spike protein S2' peptide VVFLHVTYV (chains C) | unmapped |
| EV-PDB-7S83-2 RCSB PDB | xray | resolution: 2.52 Å | in vitro · -173.15 °C · ligands GOL, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Crystal structure of SARS CoV-2 Spike Receptor Binding Domain in complex with shark neutralizing VNARs ShAb01 and ShAb02 · Spike protein S1 (chains C) | unmapped |
| EV-PDB-7S6L-1 RCSB PDB | cryoem | resolution: 4 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose J08 fragment antigen binding in complex with SARS-CoV-2-6P-Mut7 S protein (conformation 3) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7S6K-1 RCSB PDB | cryoem | resolution: 3.4 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose J08 fragment antigen binding in complex with SARS-CoV-2-6P-Mut2 S protein (conformation 2) · Spike glycoprotein (chains A,B,E) | unmapped |
| EV-PDB-7S6J-1 RCSB PDB | cryoem | resolution: 3.4 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose J08 fragment antigen binding in complex with SARS-CoV-2-6P-Mut2 S protein (conformation 1) · Spike glycoprotein (chains A,B,E) | unmapped |
| EV-PDB-7S6I-1 RCSB PDB | cryoem | resolution: 3.2 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2-6P-Mut2 S protein · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7S5R-1 RCSB PDB | xray | resolution: 2.45 Å | in vitro · -173.15 °C · pH 9 · ligands EDO, NAG, SO4 Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibodies CV07-287 and COVA1-16 · Spike protein S1 (chains A) | unmapped |
| EV-PDB-7S5Q-1 RCSB PDB | xray | resolution: 2.88 Å | in vitro · -173.15 °C · pH 4 · ligands EDO, NAG, SO4 Crystal structure of SARS-CoV-2 B.1.351 variant receptor binding domain in complex with neutralizing antibodies CS44 and COVA1-16 · Spike protein S1 (chains A) | unmapped |
| EV-PDB-7S5P-1 RCSB PDB | xray | resolution: 2.86 Å | in vitro · -173.15 °C · pH 9 · ligands EDO, NAG, SO4 Crystal structure of SARS-CoV-2 B.1.351 variant receptor binding domain in complex with neutralizing antibody CS23 · Spike protein S1 (chains A) | unmapped |
| EV-PDB-7S3N-1 RCSB PDB | xray | resolution: 1.9 Å | in vitro · -193.15 °C SARS-CoV-2 S stem helix peptide bound to Fab22 · Spike glycoprotein (chains A) | unmapped |
| EV-PDB-7S0E-1 RCSB PDB | cryoem | resolution: 4.9 Å | in vitro Structure of the SARS-CoV-2 S1 subunit in complex with antibody N-612-004 · Spike glycoprotein (chains A) | unmapped |
| EV-PDB-7S0D-1 RCSB PDB | cryoem | resolution: 3.5 Å | in vitro Structure of the SARS-CoV-2 S 6P trimer in complex with neutralizing antibody N-612-014 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7S0C-1 RCSB PDB | cryoem | resolution: 3.25 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Structure of the SARS-CoV-2 S 6P trimer in complex with neutralizing antibody N-612-017 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7RZV-2 RCSB PDB | cryoem | resolution: 2.11 Å | in vitro Cryo-EM structure of the SARS-CoV-2 HR1HR2 fusion core complex with V1176F mutation · Spike protein S2' (chains D,E,F) | unmapped |
| EV-PDB-7RZV-1 RCSB PDB | cryoem | resolution: 2.11 Å | in vitro Cryo-EM structure of the SARS-CoV-2 HR1HR2 fusion core complex with V1176F mutation · SARS-CoV-2 HR1 linked to a scaffold,Spike protein S2' (chains A,B,C) | unmapped |
| EV-PDB-7RZU-2 RCSB PDB | cryoem | resolution: 2.3 Å | in vitro Cryo-EM structure of the SARS-CoV-2 HR1HR2 fusion core complex with A942S mutation · Spike protein S2' (chains D,E,F) | unmapped |
| EV-PDB-7RZU-1 RCSB PDB | cryoem | resolution: 2.3 Å | in vitro Cryo-EM structure of the SARS-CoV-2 HR1HR2 fusion core complex with A942S mutation · SARS-CoV-2 HR1 A942S linked to a scaffold,Spike protein S2' (chains A,B,C) | unmapped |
| EV-PDB-7RZT-2 RCSB PDB | cryoem | resolution: 2.35 Å | in vitro Cryo-EM structure of the SARS-CoV-2 HR1HR2 fusion core complex with S940F mutation · Spike protein S2' (chains D,E,F) | unmapped |
| EV-PDB-7RZT-1 RCSB PDB | cryoem | resolution: 2.35 Å | in vitro Cryo-EM structure of the SARS-CoV-2 HR1HR2 fusion core complex with S940F mutation · SARS-CoV-2 HR1 S940F linked to a scaffold,Spike protein S2' (chains A,B,C) | unmapped |
| EV-PDB-7RZS-2 RCSB PDB | cryoem | resolution: 2.52 Å | in vitro Cryo-EM structure of the SARS-CoV-2 HR1HR2 fusion core complex with L938F mutation · Spike protein S2' (chains D,E,F) | unmapped |
| EV-PDB-7RZS-1 RCSB PDB | cryoem | resolution: 2.52 Å | in vitro Cryo-EM structure of the SARS-CoV-2 HR1HR2 fusion core complex with L938F mutation · SARS-CoV-2 HR1 L938F linked to a scaffold,Spike protein S2' (chains A,B,C) | unmapped |
| EV-PDB-7RZR-2 RCSB PDB | cryoem | resolution: 2.27 Å | in vitro Cryo-EM structure of the SARS-CoV-2 HR1HR2 fusion core complex with D936Y mutation · Spike protein S2' (chains D,E,F) | unmapped |
| EV-PDB-7RZR-1 RCSB PDB | cryoem | resolution: 2.27 Å | in vitro Cryo-EM structure of the SARS-CoV-2 HR1HR2 fusion core complex with D936Y mutation · SARS-CoV-2 HR1 D936Y linked to a scaffold,Spike protein S2' (chains A,B,C) | unmapped |
| EV-PDB-7RZQ-2 RCSB PDB | cryoem | resolution: 2.09 Å | in vitro Cryo-EM structure of the SARS-CoV-2 HR1HR2 fusion core complex · Spike protein S2' (chains D,E,F) | unmapped |
| EV-PDB-7RZQ-1 RCSB PDB | cryoem | resolution: 2.09 Å | in vitro Cryo-EM structure of the SARS-CoV-2 HR1HR2 fusion core complex · SARS-CoV-2 HR1 linked to a scaffold,Spike protein S2' (chains A,B,C) | unmapped |
| EV-PDB-7RXD-5 RCSB PDB | cryoem | resolution: 3.6 Å | in vitro · ligands branched: alpha-D-glucopyranose-(1-4)-alpha-D-glucopyranose CryoEM structure of RBD domain of COVID-19 in complex with Legobody · Spike protein S1 (chains R) | unmapped |
| EV-PDB-7RW2-1 RCSB PDB | cryoem | resolution: 3.5 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of NTD-directed neutralizing antibody 5-7 in complex with prefusion SARS-CoV-2 spike glycoprotein · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7RU8-3 RCSB PDB | cryoem | resolution: 3.8 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose CC6.30 fragment antigen binding in complex with SARS-CoV-2-6P-Mut7 S protein (RBD/Fv local refinement) · Spike glycoprotein (chains C) | unmapped |
| EV-PDB-7RU5-1 RCSB PDB | cryoem | resolution: 3.6 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose CC6.30 fragment antigen binding in complex with SARS-CoV-2-6P-Mut7 S protein (non-uniform refinement) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7RU4-3 RCSB PDB | cryoem | resolution: 3.3 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose CC6.33 IgG in complex with SARS-CoV-2-6P-Mut7 S protein (RBD/Fv local refinement) · Spike glycoprotein (chains A) | unmapped |
| EV-PDB-7RU3-3 RCSB PDB | cryoem | resolution: 3.3 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose CC6.33 IgG in complex with SARS-CoV-2-6P-Mut7 S protein (non-uniform refinement) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7RU2-1 RCSB PDB | cryoem | resolution: 3 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2-6P-Mut7 S protein (asymmetric) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7RU1-1 RCSB PDB | cryoem | resolution: 2.8 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2-6P-Mut7 S protein (C3 symmetry) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7RTR-3 RCSB PDB | xray | resolution: 2.6 Å | in vitro · -173.15 °C · ligands NA YLQ-SG3 TCR in complex with SARS-CoV-2 Spike-derived peptide S269-277 (YLQPRTFLL) presented by HLA-A*02:01 · Spike protein S1 (chains C) | unmapped |
| EV-PDB-7RTD-3 RCSB PDB | xray | resolution: 2.05 Å | in vitro · -173.15 °C SARS-CoV-2 Spike-derived peptide S269-277 (YLQPRTFLL) presented by HLA-A*02:01 · Spike protein S1 (chains C) | unmapped |
| EV-PDB-7RR0-1 RCSB PDB | cryoem | resolution: 3.12 Å | in vitro · ligands NAG SARS-CoV-2 receptor binding domain bound to Fab PDI 222 · Spike protein S1 (chains A) | unmapped |
| EV-PDB-7RPV-2 RCSB PDB | xray | resolution: 3.54 Å | in vitro · -173.15 °C · pH 6.5 · ligands NAG, ZN Crystal structure of affinity-enhancing and catalytically inactive ACE2 in complex with SARS-CoV-2 RBD · Spike protein S1 (chains E,F,G,H) | unmapped |
| EV-PDB-7RNJ-3 RCSB PDB | xray | resolution: 2.67 Å | in vitro · -173.15 °C · ligands SO4 S2P6 Fab fragment bound to the SARS-CoV/SARS-CoV-2 spike stem helix peptide · Spike glycoprotein stem helix peptide (chains B) | unmapped |
| EV-PDB-7RKV-1 RCSB PDB | cryoem | resolution: 3.45 Å | in vitro · ligands NAG Structure of the SARS-CoV-2 S 6P trimer in complex with neutralizing antibody C118 (State 1) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7RKU-1 RCSB PDB | xray | resolution: 3.2 Å | in vitro · -173.15 °C · ligands NAG, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Structure of the SARS-CoV-2 receptor binding domain in complex with the human neutralizing antibody Fab fragment, C022 · Spike protein S1 (chains A,B,C,D) | unmapped |
| EV-PDB-7RBY-1 RCSB PDB | xray | resolution: 2.82 Å | in vitro · -173.15 °C · pH 7.5 · ligands MG, NAG Crystal structure of Nanobody nb112 and SARS-CoV-2 RBD · Spike protein S1 (chains A,C) | unmapped |
| EV-PDB-7RBV-3 RCSB PDB | cryoem | resolution: 3.6 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-3)-alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-4)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 Spike in complex with PVI.V6-14 Fab · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7RBU-1 RCSB PDB | cryoem | resolution: 3.7 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 Spike in complex with PVI.V6-14 Fab · Spike protein S1 (chains B) | unmapped |
| EV-PDB-7RAQ-3 RCSB PDB | xray | resolution: 1.74 Å | in vitro · -173.15 °C · ligands GOL, SO4 Crystal structure of CV3-25 Fab bound to SARS-CoV-2 spike stem helix peptide · spike stem helix peptide (chains P) | unmapped |
| EV-PDB-7RAL-3 RCSB PDB | cryoem | resolution: 3.7 Å | in vitro · ligands NAG SARS-CoV-2 S bound to S2X259 Fab (local refinement of the RBD/S2X259 variable domains) · Spike glycoprotein (chains B) | unmapped |
| EV-PDB-7RA8-1 RCSB PDB | cryoem | resolution: 3.1 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 S glycoprotein in complex with S2X259 Fab · Spike glycoprotein (chains A,B,E) | unmapped |
| EV-PDB-7R95-1 RCSB PDB | nmr_structure | structure | in vitro · 34.85 °C · pH 6 Membrane bound structure of HR1 domain of SARS-CoV-2 spike protein · Spike protein S2 (chains A) | unmapped |
| EV-PDB-7R8O-1 RCSB PDB | cryoem | resolution: 3.5 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose Structure of the SARS-CoV-2 S 6P trimer in complex with neutralizing antibody C548 · Spike glycoprotein (chains A,B,E) | unmapped |
| EV-PDB-7R8N-1 RCSB PDB | cryoem | resolution: 3.55 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Structure of the SARS-CoV-2 S 6P trimer in complex with neutralizing antibody C051 · Spike glycoprotein (chains A,B,E) | unmapped |
| EV-PDB-7R8M-1 RCSB PDB | cryoem | resolution: 3.4 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose Structure of the SARS-CoV-2 S 6P trimer in complex with neutralizing antibody C032 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7SBU-1 RCSB PDB | xray | resolution: 2.53 Å | in vitro · -173.15 °C · pH 7.5 · ligands GOL, NAG Crystal structure of SARS-CoV-2 spike protein receptor-binding domain in complex with a highly potent antibody J08 Fab · Spike protein S1 (chains A) | unmapped |
| EV-PDB-7SN3-1 RCSB PDB | cryoem | resolution: 3.1 Å | in vitro · ligands NAG, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Structure of human SARS-CoV-2 spike glycoprotein trimer bound by neutralizing antibody C1C-A3 Fab (variable region) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7SWN-1 RCSB PDB | cryoem | resolution: 4.3 Å | in vitro G32A4 Fab in complex with SARS-CoV-2 Spike 6P (RBD local reconstruction) · Spike protein S1 (chains A) | unmapped |
| EV-PDB-7SWO-1 RCSB PDB | cryoem | resolution: 4.1 Å | in vitro C98C7 Fab in complex with SARS-CoV-2 Spike 6P (RBD local reconstruction) · Spike protein S1 (chains A) | unmapped |
| EV-PDB-7SXU-1 RCSB PDB | cryoem | resolution: 3 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of the SARS-CoV-2 D614G,N501Y,E484K mutant spike protein ectodomain · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7SY0-1 RCSB PDB | cryoem | resolution: 3 Å | in vitro · ligands NAG Cryo-EM structure of the SARS-CoV-2 D614G,L452R mutant spike protein ectodomain bound to human ACE2 ectodomain (focused refinement of RBD and ACE2) · Spike glycoprotein (chains B) | unmapped |
| EV-PDB-7SY6-1 RCSB PDB | cryoem | resolution: 2.81 Å | in vitro · ligands NAG Cryo-EM structure of the SARS-CoV-2 D614G,N501Y,E484K,K417N mutant spike protein ectodomain bound to human ACE2 ectodomain (focused refinement of RBD and ACE2) · Spike glycoprotein (chains B) | unmapped |
| EV-PDB-7T01-1 RCSB PDB | cryoem | resolution: 2.69 Å | in vitro SARS-CoV-2 S-RBD + Fab 54042-4 · Spike protein S1 (chains A) | unmapped |
| EV-PDB-7SY8-1 RCSB PDB | cryoem | resolution: 3.14 Å | in vitro · ligands NAG Cryo-EM structure of the SARS-CoV-2 D614G,N501Y,E484K,K417T mutant spike protein ectodomain bound to human ACE2 ectodomain (focused refinement of RBD and ACE2) · Spike glycoprotein (chains B) | unmapped |
| EV-PDB-7SY7-1 RCSB PDB | cryoem | resolution: 2.81 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of the SARS-CoV-2 D614G,N501Y,E484K,K417T mutant spike protein ectodomain bound to human ACE2 ectodomain (global refinement) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7SY5-1 RCSB PDB | cryoem | resolution: 2.59 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of the SARS-CoV-2 D614G,N501Y,E484K,K417N mutant spike protein ectodomain bound to human ACE2 ectodomain (global refinement) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7SY4-1 RCSB PDB | cryoem | resolution: 3.35 Å | in vitro · ligands NAG Cryo-EM structure of the SARS-CoV-2 D614G,N501Y,E484K mutant spike protein ectodomain bound to human ACE2 ectodomain (focused refinement of RBD and ACE2) · Spike glycoprotein (chains B) | unmapped |
| EV-PDB-7SY3-1 RCSB PDB | cryoem | resolution: 2.95 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of the SARS-CoV-2 D614G,N501Y,E484K mutant spike protein ectodomain bound to human ACE2 ectodomain (global refinement) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7SY2-1 RCSB PDB | cryoem | resolution: 3.11 Å | in vitro · ligands NAG Cryo-EM structure of the SARS-CoV-2 D614G,N501Y mutant spike protein ectodomain bound to human ACE2 ectodomain (focused refinement of RBD and ACE2) · Spike glycoprotein (chains B) | unmapped |
| EV-PDB-7SY1-1 RCSB PDB | cryoem | resolution: 2.83 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of the SARS-CoV-2 D614G,N501Y mutant spike protein ectodomain bound to human ACE2 ectodomain (global refinement) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7SXZ-1 RCSB PDB | cryoem | resolution: 2.61 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of the SARS-CoV-2 D614G,L452R mutant spike protein ectodomain bound to human ACE2 ectodomain (global refinement) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7SXY-1 RCSB PDB | cryoem | resolution: 2.79 Å | in vitro · ligands NAG Cryo-EM structure of the SARS-CoV-2 D614G mutant spike protein ectodomain bound to human ACE2 ectodomain (focused refinement of RBD and ACE2) · Spike glycoprotein (chains B) | unmapped |
| EV-PDB-7SXX-1 RCSB PDB | cryoem | resolution: 2.66 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of the SARS-CoV-2 D614G mutant spike protein ectodomain bound to human ACE2 ectodomain (global refinement) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7SXW-1 RCSB PDB | cryoem | resolution: 2.85 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of the SARS-CoV-2 D614G,N501Y,E484K,K417T mutant spike protein ectodomain · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7SXV-1 RCSB PDB | cryoem | resolution: 2.79 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of the SARS-CoV-2 D614G,N501Y,E484K,K417N mutant spike protein ectodomain · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7SXT-1 RCSB PDB | cryoem | resolution: 2.31 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of the SARS-CoV-2 D614G,N501Y mutant spike protein ectodomain · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7SXS-1 RCSB PDB | cryoem | resolution: 2.64 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of the SARS-CoV-2 D614G,L452R mutant spike protein ectodomain · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7SXR-1 RCSB PDB | cryoem | resolution: 3 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of the SARS-CoV-2 D614G mutant spike protein ectodomain · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7SWX-1 RCSB PDB | cryoem | resolution: 3.13 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 Spike in complex with neutralizing Fab SARS2-57 (three down conformation) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7SWW-1 RCSB PDB | cryoem | resolution: 3.13 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 Spike NTD in complex with neutralizing Fab SARS2-57 (local refinement) · Spike protein S1 (chains A) | unmapped |
| EV-PDB-7SWP-1 RCSB PDB | cryoem | resolution: 3.8 Å | in vitro G32Q4 Fab in complex with SARS-CoV-2 Spike 6P (RBD local reconstruction) · Spike protein S1 (chains A) | unmapped |
| EV-PDB-7SPP-1 RCSB PDB | xray | resolution: 1.96 Å | in vitro · -173.15 °C · ligands CL, EDO, NAG Crystal structure of the SARS-CoV-2 receptor binding domain in complex with VNAR 2C02 · Spike protein S1 (chains A) | unmapped |
| EV-PDB-7SPO-1 RCSB PDB | xray | resolution: 1.92 Å | in vitro · -173.15 °C · ligands EDO, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose Crystal structure of the SARS-CoV-2 receptor binding domain in complex with VNAR 3B4 · Spike protein S1 (chains A,B) | unmapped |
| EV-PDB-7SOF-3 RCSB PDB | cryoem | resolution: 3.6 Å | in vitro · ligands NAG, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 S NTD B.1.617.1 kappa variant S2X303 Local Refinement · Spike glycoprotein (chains A) | unmapped |
| EV-PDB-7SOE-1 RCSB PDB | cryoem | resolution: 2.8 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 S B.1.617.1 kappa variant + S2X303 Global Refinement · Spike glycoprotein (chains A,C,F) | unmapped |
| EV-PDB-7SOD-3 RCSB PDB | cryoem | resolution: 3.2 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 S NTD B.1.617.1 kappa variant S2L20 Local Refinement · Spike glycoprotein (chains A) | unmapped |
| EV-PDB-7SOC-1 RCSB PDB | cryoem | resolution: 3.3 Å | in vitro · ligands NAG, branched: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 S RBD B.1.617.1 kappa variant S309 Local Refinement · Spike glycoprotein (chains A) | unmapped |
| EV-PDB-7SOB-1 RCSB PDB | cryoem | resolution: 2.4 Å | in vitro · ligands NAG SARS-CoV-2 S B.1.617.1 kappa variant + S309 + S2L20 Global Refinement · Spike glycoprotein (chains A,D,K) | unmapped |
| EV-PDB-7SOA-3 RCSB PDB | cryoem | resolution: 3.1 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 S NTD B.1.617.2 delta variant + S2L20 Local Refinement · Spike glycoprotein (chains A) | unmapped |
| EV-PDB-7SO9-1 RCSB PDB | cryoem | resolution: 2.4 Å | in vitro · ligands NAG, branched: alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 S B.1.617.2 delta variant + S2M11 + S2L20 Global Refinement · Spike glycoprotein (chains A,F,K) | unmapped |
| EV-PDB-7SN2-1 RCSB PDB | cryoem | resolution: 4.3 Å | in vitro · ligands branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[2-acetamido-2-deoxy-beta-D-glucopyranose-(1-2)-alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Structure of human SARS-CoV-2 neutralizing antibody C1C-A3 Fab · Spike glycoprotein (chains A) | unmapped |
| EV-PDB-7SN0-2 RCSB PDB | xray | resolution: 3.08 Å | in vitro · -193.15 °C · pH 8.5 · ligands CL, NAG, ZN, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-galactopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-2)-[beta-D-galactopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)]alpha-D-mannopyranose-(1-3)-[2-acetamido-2-deoxy-beta-D-glucopyranose-(1-2)-alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-galactopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[2-acetamido-2-deoxy-beta-D-glucopyranose-(1-2)]alpha-D-mannopyranose-(1-3)-[2-acetamido-2-deoxy-beta-D-glucopyranose-(1-2)-alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-galactopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[2-acetamido-2-deoxy-beta-D-glucopyranose-(1-2)]alpha-D-mannopyranose-(1-3)-[beta-D-galactopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Crystal structure of spike protein receptor binding domain of escape mutant SARS-CoV-2 from immunocompromised patient (d146*) in complex with human receptor ACE2 · Surface glycoprotein (chains C,D) | unmapped |
| EV-PDB-7SL5-3 RCSB PDB | xray | resolution: 2.5 Å | in vitro · -193.15 °C Crystal Structure of VP12E7 Fab in complex with SARS-CoV-2 S fusion peptide · PRO-SER-LYS-ARG-SER-PHE-ILE-GLU-ASP-LEU-LEU-PHE-ASN (chains C,F,I,L) | unmapped |
| EV-PDB-7SKZ-1 RCSB PDB | xray | resolution: 1.86 Å | in vitro · -193.15 °C Crystal Structure of VN01H1 Fab in complex with SARS-CoV-2 S fusion peptide · PRO-SER-LYS-ARG-SER-PHE-ILE-GLU-ASP-LEU-LEU-PHE-ASN (chains A) | unmapped |
| EV-PDB-7SJS-3 RCSB PDB | xray | resolution: 1.612 Å | in vitro · -173.15 °C · pH 4.26 · ligands ACT, GOL, SO4 Crystal structure of SARS-CoV-2 spike stem helix peptide in complex with neutralizing antibody CC40.8 · stem helix peptide of Spike protein S2' (chains C) | unmapped |
| EV-PDB-7SJ0-1 RCSB PDB | cryoem | resolution: 3.36 Å | in vitro · ligands NAG Antibody A7V3 bound to N-terminal domain of the spike · Spike glycoprotein (chains A) | unmapped |
| EV-PDB-7SIS-3 RCSB PDB | xray | resolution: 1.9 Å | in vitro · -173.15 °C · ligands ACT, CD, ZN SARS-CoV-2 Spike-derived peptide S976-984 (VLNDILSRL) presented by HLA-A*02:01 · Spike protein S2' peptide VLNDILSRL (chains C) | unmapped |
| EV-PDB-7SI2-3 RCSB PDB | xray | resolution: 3.2 Å | in vitro · -173.15 °C · ligands branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Crystal structure of neutralizing antibody 10-28 in complex with SARS-CoV-2 spike receptor binding domain (RBD) · Spike protein S1 (chains A,B,C) | unmapped |
| EV-PDB-7SD5-1 RCSB PDB | xray | resolution: 1.53 Å | in vitro · -173.15 °C · pH 5.5 · ligands branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Crystallographic structure of neutralizing antibody 10-40 in complex with SARS-CoV-2 spike receptor binding domain · Spike protein S1 (chains A) | unmapped |
| EV-PDB-7SC1-1 RCSB PDB | cryoem | resolution: 3.2 Å | in vitro · ligands NAG Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragment, R40-1G8 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7SBT-1 RCSB PDB | cryoem | resolution: 4.4 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose One RBD-up 2 of pre-fusion SARS-CoV-2 Gamma variant spike protein · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7SBS-1 RCSB PDB | cryoem | resolution: 3.8 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose One RBD-up 1 of pre-fusion SARS-CoV-2 Gamma variant spike protein · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7SBR-1 RCSB PDB | cryoem | resolution: 4.3 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose One RBD-up 2 of pre-fusion SARS-CoV-2 Kappa variant spike protein · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7SBQ-1 RCSB PDB | cryoem | resolution: 3.7 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose One RBD-up 1 of pre-fusion SARS-CoV-2 Kappa variant spike protein · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7SBP-1 RCSB PDB | cryoem | resolution: 3.1 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Closed state of pre-fusion SARS-CoV-2 Kappa variant spike protein · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7T3M-1 RCSB PDB | cryoem | resolution: 3 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 S (Spike Glycoprotein) D614G with Three (3) RBDs Up, Bound to Antibody 2-7 scFv, composite map · Spike glycoprotein (chains A,C,G) | unmapped |
| EV-PDB-7T5O-1 RCSB PDB | cryoem | resolution: 3.39 Å | in vitro VFLIP Spike Trimer with GAR03 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7T67-1 RCSB PDB | cryoem | resolution: 3 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 S (Spike Glycoprotein) D614G with One(1) RBD Up · Spike glycoprotein (chains A,C,G) | unmapped |
| EV-PDB-7T72-3 RCSB PDB | xray | resolution: 3.177 Å | in vitro · -173.15 °C · ligands NAG Epitope-based selection of SARS-CoV-2 neutralizing antibodies from convalescent patients · Spike protein S1 (chains A) | unmapped |
| EV-PDB-7T7B-1 RCSB PDB | xray | resolution: 2.59 Å | in vitro · -173.15 °C · pH 4.6 · ligands branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose Crystal structure of SARS-CoV-2 spike protein receptor-binding domain in complex with a cross-neutralizing antibody ADI-62113 Fab · Spike protein S1 (chains A) | unmapped |
| EV-PDB-7T9J-1 RCSB PDB | cryoem | resolution: 2.79 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of the SARS-CoV-2 Omicron spike protein · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7T9K-1 RCSB PDB | cryoem | resolution: 2.45 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 Omicron spike protein in complex with human ACE2 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7T9L-1 RCSB PDB | cryoem | resolution: 2.66 Å | in vitro · ligands NAG Cryo-EM structure of SARS-CoV-2 Omicron spike protein in complex with human ACE2 (focused refinement of RBD and ACE2) · Spike glycoprotein (chains A) | unmapped |
| EV-PDB-7TAS-3 RCSB PDB | cryoem | resolution: 3.2 Å | in vitro · ligands branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 spike in complex with the S2K146 neutralizing antibody Fab fragment (local refinement of the RBD and S2K146) · Spike glycoprotein (chains E) | unmapped |
| EV-PDB-7TAT-1 RCSB PDB | cryoem | resolution: 3.2 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 spike in complex with the S2K146 neutralizing antibody Fab fragment (two receptor-binding domains open) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7TB4-1 RCSB PDB | cryoem | resolution: 3.29 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of the spike of SARS-CoV-2 Omicron variant of concern · Surface glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7TB8-1 RCSB PDB | cryoem | resolution: 2.83 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-3)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 spike in complex with antibodies B1-182.1 and A19-61.1 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7TBF-1 RCSB PDB | cryoem | resolution: 3.1 Å | in vitro · ligands branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Locally refined region of SARS-CoV-2 spike in complex with antibodies B1-182.1 and A19-61.1 · Spike glycoprotein (chains A) | unmapped |
| EV-PDB-7TC9-1 RCSB PDB | cryoem | resolution: 5.08 Å | in vitro · ligands NAG Locally refined region of SARS-CoV-2 spike in complex with antibody A19-46.1 · Spike protein S1 (chains B) | unmapped |
| EV-PDB-7TCA-1 RCSB PDB | cryoem | resolution: 3.85 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 Omicron spike in complex with antibody A19-46.1 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7TCC-1 RCSB PDB | cryoem | resolution: 3.86 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 Omicron spike in complex with antibodies A19-46.1 and B1-182.1 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7TE1-3 RCSB PDB | xray | resolution: 3.5 Å | in vitro · -173.15 °C · pH 7 SARS-CoV-2 Receptor Binding Domain in Complex with Ab17 · Spike protein S1 (chains D,E) | unmapped |
| EV-PDB-7TEX-1 RCSB PDB | cryoem | resolution: 3.27 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 Delta (B.1.617.2) spike protein in complex with human ACE2 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7TEZ-1 RCSB PDB | cryoem | resolution: 3.27 Å | in vitro · ligands NAG Cryo-EM structure of SARS-CoV-2 Kappa (B.1.617.1) spike protein in complex with human ACE2 (focused refinement of RBD and ACE2) · Spike glycoprotein (chains B) | unmapped |
| EV-PDB-7TF1-1 RCSB PDB | cryoem | resolution: 3.57 Å | in vitro · ligands NAG Cryo-EM structure of SARS-CoV-2 Kappa (B.1.617.1) Q484I spike protein (focused refinement of RBD) · Spike glycoprotein (chains A,B,C,D,E,F) | unmapped |
| EV-PDB-7TF2-1 RCSB PDB | cryoem | resolution: 3.62 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 Kappa (B.1.617.1) Q484I spike protein · Spike glycoprotein (chains A,B,C,D,E,F) | unmapped |
| EV-PDB-7TF4-1 RCSB PDB | cryoem | resolution: 3.01 Å | in vitro · ligands NAG Cryo-EM structure of SARS-CoV-2 Kappa (B.1.617.1) spike protein (focused refinement of RBD) · Spike glycoprotein (chains A,B,C,D,E,F) | unmapped |
| EV-PDB-7TF5-1 RCSB PDB | cryoem | resolution: 3.16 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 Kappa (B.1.617.1) spike protein · Spike glycoprotein (chains A,B,C,D,E,F) | unmapped |
| EV-PDB-7TGW-1 RCSB PDB | cryoem | resolution: 3 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Omicron spike at 3.0 A (open form) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7TGX-1 RCSB PDB | cryoem | resolution: 3.2 Å | in vitro · ligands MAN, NAG, branched: alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Prototypic SARS-CoV-2 G614 spike (open form) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7TGY-1 RCSB PDB | cryoem | resolution: 3 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Prototypic SARS-CoV-2 G614 spike (closed form) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7THE-1 RCSB PDB | cryoem | resolution: 3.87 Å | in vitro · ligands NAG Structure of RBD directed antibody DH1042 in complex with SARS-CoV-2 spike: Local refinement of RBD-Fab interface · Spike protein S1 (chains A) | unmapped |
| EV-PDB-7THK-1 RCSB PDB | cryoem | resolution: 3.11 Å | in vitro · ligands NAG Cryo-EM structure of prefusion SARS-CoV-2 spike omicron B.1.1.529 variant · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7THT-1 RCSB PDB | cryoem | resolution: 3.42 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose CryoEM structure of SARS-CoV-2 S protein in complex with Receptor Binding Domain antibody DH1042 · Spike glycoprotein (chains C,S,V) | unmapped |
| EV-PDB-7TIK-2 RCSB PDB | cryoem | resolution: 2.4 Å | in vitro Structure of the SARS-CoV-2 Omicron spike post-fusion bundle · Spike protein S2' (chains D,E,F) | unmapped |
| EV-PDB-7TIK-1 RCSB PDB | cryoem | resolution: 2.4 Å | in vitro Structure of the SARS-CoV-2 Omicron spike post-fusion bundle · Ferritin, Dps family protein and Spike protein S2' chimera (chains A,B,C) | unmapped |
| EV-PDB-7TL1-1 RCSB PDB | cryoem | resolution: 3.5 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 Omicron 3-RBD down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-Omicron) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7TLD-1 RCSB PDB | cryoem | resolution: 2.89 Å | in vitro Down-state locked, S2 stabilized rS2d-HexaPro SARS-CoV-2 spike ectodomain in the RBD-down conformation, State 2 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7TLT-3 RCSB PDB | xray | resolution: 2.3 Å | in vitro · -173.15 °C · ligands MG, NA, SO4 SARS-CoV-2 Spike-derived peptide S489-497 (YFPLQSYGF) presented by HLA-A*29:02 · Spike protein S1 peptide (chains E,F) | unmapped |
| EV-PDB-7TLY-3 RCSB PDB | cryoem | resolution: 3 Å | in vitro · ligands branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 S B.1.1.529 Omicron variant (RBD + S309 Local Refinement) · Spike glycoprotein (chains I) | unmapped |
| EV-PDB-7TLZ-3 RCSB PDB | cryoem | resolution: 3.3 Å | in vitro · ligands NAG SARS-CoV-2 S NTD B.1.1.529 Omicron variant + S309 Local Refinement · Spike glycoprotein (chains J) | unmapped |
| EV-PDB-7TM0-1 RCSB PDB | cryoem | resolution: 3.1 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 S B.1.1.529 Omicron variant + S309 + S2L20 Global Refinement · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7TN0-6 RCSB PDB | xray | resolution: 2.85 Å | in vitro · -173.15 °C · ligands CL, EDO, NAG, ZN SARS-CoV-2 Omicron RBD in complex with human ACE2 and S304 Fab and S309 Fab · Spike protein S1 (chains I,S) | unmapped |
| EV-PDB-7TNW-1 RCSB PDB | cryoem | resolution: 3.1 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Structural and functional impact by SARS-CoV-2 Omicron spike mutations · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7TLC-1 RCSB PDB | cryoem | resolution: 2.83 Å | in vitro Down-state locked, S2 stabilized rS2d-HexaPro SARS-CoV-2 spike ectodomain in the RBD-down conformation, State 1 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7TLB-1 RCSB PDB | cryoem | resolution: 3.06 Å | in vitro Down-state locked rS2d SARS-CoV-2 spike ectodomain in the RBD-down conformation, State 2 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7TLA-1 RCSB PDB | cryoem | resolution: 3.13 Å | in vitro Down-state locked rS2d SARS-CoV-2 spike ectodomain in the RBD-down conformation, State 1 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7TL9-1 RCSB PDB | cryoem | resolution: 3.5 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 Omicron 1-RBD up Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-Omicron) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7TGE-1 RCSB PDB | cryoem | resolution: 3.68 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 Omicron 1-RBD down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-Omicron) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7TF8-1 RCSB PDB | cryoem | resolution: 3.36 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 Omicron 3-RBD down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-Omicron) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7TF3-1 RCSB PDB | cryoem | resolution: 2.25 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 Kappa (B.1.617.1) Q484A spike protein · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7TF0-1 RCSB PDB | cryoem | resolution: 3.02 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 Kappa (B.1.617.1) spike protein in complex with human ACE2 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7TEY-1 RCSB PDB | cryoem | resolution: 2.25 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 Delta (B.1.617.2) spike protein · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7TEW-1 RCSB PDB | cryoem | resolution: 3.52 Å | in vitro · ligands NAG Cryo-EM structure of SARS-CoV-2 Delta (B.1.617.2) spike protein in complex with human ACE2 (focused refinement of RBD and ACE2) · Spike glycoprotein (chains B) | unmapped |
| EV-PDB-7TEI-1 RCSB PDB | cryoem | resolution: 3.4 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 Omicron 1-RBD up Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-Omicron) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7TCQ-3 RCSB PDB | xray | resolution: 2.02 Å | in vitro · -173.15 °C · ligands PEG, SO4 Crystal structure of SARS-CoV-2 neutralizing antibody WS6 in complex with spike S2 peptide · Pegylated spike S2 peptide (chains C,D) | unmapped |
| EV-PDB-7TO4-1 RCSB PDB | cryoem | resolution: 3.4 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Structural and functional impact by SARS-CoV-2 Omicron spike mutations · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7TOU-1 RCSB PDB | cryoem | resolution: 3.24 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 3-RBD-down conformation; consensus state D1 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7TOV-1 RCSB PDB | cryoem | resolution: 3.16 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 1-RBD-up conformation; consensus state D2 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7TOW-3 RCSB PDB | xray | resolution: 2.15 Å | in vitro · -173.15 °C · ligands CA, PO4 Antibody DH1058 Fab fragment bound to SARS-CoV-2 fusion peptide · Spike protein S2 (chains D,E) | unmapped |
| EV-PDB-7TOX-1 RCSB PDB | cryoem | resolution: 3.62 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 3-RBD-down conformation; Subclassification D5 state · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7TOY-1 RCSB PDB | cryoem | resolution: 3.53 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 3-RBD-down conformation; Subclassification D6 state · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7TOZ-1 RCSB PDB | cryoem | resolution: 4.07 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 3-RBD-down conformation; Subclassification D7 state · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7TP0-1 RCSB PDB | cryoem | resolution: 3.57 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 3-RBD-down conformation; Subclassification D8 state · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7TP1-1 RCSB PDB | cryoem | resolution: 3.81 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 3-RBD-down conformation; Subclassification D9 state · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7TP2-1 RCSB PDB | cryoem | resolution: 3.72 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 3-RBD-down conformation; Subclassification D10 state · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7TP3-1 RCSB PDB | xray | resolution: 2.33 Å | in vitro · -173.15 °C · ligands CAC Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody K288.2 · Spike protein S1 (chains Z) | unmapped |
| EV-PDB-7TP4-1 RCSB PDB | xray | resolution: 1.95 Å | in vitro · -173.15 °C · ligands EDO, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody K398.22 · Spike protein S1 (chains Z) | unmapped |
| EV-PDB-7TP7-1 RCSB PDB | cryoem | resolution: 3.48 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 1-RBD-up conformation; Subclassification D11 state · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7TP8-1 RCSB PDB | cryoem | resolution: 3.4 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 1-RBD-up conformation; Subclassification D12 state · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7TP9-1 RCSB PDB | cryoem | resolution: 3.48 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 1-RBD-up conformation; Subclassification D13 state · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7TPA-1 RCSB PDB | cryoem | resolution: 3.6 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 1-RBD-up conformation; Subclassification D14 state · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7TPC-1 RCSB PDB | cryoem | resolution: 3.91 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 1-RBD-up conformation; Subclassification D15 state · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7TPE-1 RCSB PDB | cryoem | resolution: 4 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 1-RBD-up conformation; Subclassification D16 state · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7TPF-1 RCSB PDB | cryoem | resolution: 3.4 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 1-RBD-up conformation; Subclassification D17 state · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7TPH-1 RCSB PDB | cryoem | resolution: 3.58 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 2-RBD-up conformation - D3 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7TPI-1 RCSB PDB | cryoem | resolution: 2.3 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 E406W mutant Spike ectodomain · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7TPK-1 RCSB PDB | cryoem | resolution: 3.4 Å | in vitro · ligands NAG SARS-CoV-2 E406W mutant RBD - Local Refinement · Spike protein S1 (chains E) | unmapped |
| EV-PDB-7TPL-1 RCSB PDB | cryoem | resolution: 3.87 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the M1 conformation, D4 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7TPR-1 RCSB PDB | cryoem | resolution: 2.39 Å | in vitro Camel nanobodies 7A3 and 8A2 broadly neutralize SARS-CoV-2 variants · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7TZ0-1 RCSB PDB | cryoem | resolution: 4.17 Å | in vitro Cryo-EM structure of SARS-CoV-2 spike in complex with FSR22, an anti-SARS-CoV-2 DARPin (Local refinement of FSR22 and RBD) · Spike glycoprotein (chains A) | unmapped |
| EV-PDB-7U0D-1 RCSB PDB | cryoem | resolution: 4.8 Å | in vitro · ligands NAG Local refinement of cryo-EM structure of the interface of the Omicron RBD in complex with antibodies B-182.1 and A19-46.1 · Surface glycoprotein (chains B) | unmapped |
| EV-PDB-7U0P-1 RCSB PDB | cryoem | resolution: 3.76 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-Cov2 S protein structure in complex with neutralizing monoclonal antibody 002-S21F2 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7U0Q-1 RCSB PDB | cryoem | resolution: 3.86 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-Cov2 S protein structure in complex with neutralizing monoclonal antibody 002-02 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7U0X-1 RCSB PDB | cryoem | resolution: 3.82 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-Cov2 S protein structure in complex with neutralizing monoclonal antibody 002-13 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7U1R-3 RCSB PDB | xray | resolution: 1.8 Å | in vitro · -173.15 °C · ligands ACT, CD, CL, NA, ZN SARS-CoV-2 Spike-derived peptide S1185-1193 K1191N mutant (RLNEVANNL) presented by HLA-A*02:01 · Spike protein S2' peptide (chains C) | unmapped |
| EV-PDB-7U2D-1 RCSB PDB | xray | resolution: 2.76 Å | in vitro · -173.15 °C · pH 4.16 · ligands CIT, NAG, SO4 Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody ADG20 · Spike protein S1 (chains A) | unmapped |
| EV-PDB-7U2E-1 RCSB PDB | xray | resolution: 2.85 Å | in vitro · -173.15 °C · pH 3.8 · ligands NAG, SO4 Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody ADI-55688 · Spike protein S1 (chains A) | unmapped |
| EV-PDB-7U8E-1 RCSB PDB | xray | resolution: 2.29 Å | in vitro · -173.15 °C · pH 4.6 · ligands CL, GOL, NAG Crystal structure of antibody Ab246 in complex with SARS-CoV-2 receptor binding domain · Spike protein S1 (chains A) | unmapped |
| EV-PDB-7U9O-1 RCSB PDB | cryoem | resolution: 3.4 Å | in vitro · ligands NAG SARS-CoV-2 spike trimer RBD in complex with Fab NE12 · Spike glycoprotein (chains A,B) | unmapped |
| EV-PDB-7U9P-1 RCSB PDB | cryoem | resolution: 3.5 Å | in vitro · ligands NAG SARS-CoV-2 spike trimer RBD in complex with Fab NA8 · Spike glycoprotein (chains A,B) | unmapped |
| EV-PDB-7UAP-1 RCSB PDB | cryoem | resolution: 2.8 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Structure of the SARS-CoV-2 S 6P trimer in complex with the neutralizing antibody Fab fragment, C1520 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7UAQ-1 RCSB PDB | cryoem | resolution: 3.1 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Structure of the SARS-CoV-2 NTD in complex with C1520, local refinement · Spike glycoprotein (chains A) | unmapped |
| EV-PDB-7UAR-1 RCSB PDB | cryoem | resolution: 3.5 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose Structure of the SARS-CoV-2 S 6P trimer in complex with the neutralizing antibody Fab fragment, C1717 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7UB0-1 RCSB PDB | cryoem | resolution: 3.31 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 Omicron-BA.2 3-RBD down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-Omicron-BA.2) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7UB5-1 RCSB PDB | cryoem | resolution: 3.35 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 Omicron-BA.2 3-RBD down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-Omicron-BA.2) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7UB6-1 RCSB PDB | cryoem | resolution: 3.52 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 Omicron-BA.2 3-RBD down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-Omicron-BA.2) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7UFK-2 RCSB PDB | xray | resolution: 2.38 Å | in vitro · -173.15 °C · ligands CL, EDO, NA, NAG, ZN, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Crystal structure of chimeric omicron RBD (strain BA.2) complexed with human ACE2 · Spike protein S1 (chains E,F) | unmapped |
| EV-PDB-7UFL-2 RCSB PDB | xray | resolution: 2.84 Å | in vitro · -173.15 °C · ligands CL, EDO, NAG, ZN, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Crystal structure of chimeric omicron RBD (strain BA.2) complexed with chimeric mouse ACE2 · Spike protein S1 (chains E,F) | unmapped |
| EV-PDB-7UHB-1 RCSB PDB | cryoem | resolution: 3 Å | in vitro · ligands branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 spike in complex with AHB2-2GS-SB175 (local refinement of the RBD and AHB2) · Spike glycoprotein (chains C) | unmapped |
| EV-PDB-7UHC-1 RCSB PDB | cryoem | resolution: 3.1 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 spike in complex with AHB2-2GS-SB175 · Spike glycoprotein (chains A,B,D) | unmapped |
| EV-PDB-7UKL-2 RCSB PDB | cryoem | resolution: 3.09 Å | in vitro · ligands NAG Cryo-EM structure of Antibody 12-16 in complex with prefusion SARS-CoV-2 Spike glycoprotein · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7UKM-1 RCSB PDB | cryoem | resolution: 3.03 Å | in vitro · ligands NAG Cryo-EM structure of Antibody 12-19 in complex with prefusion SARS-CoV-2 Spike glycoprotein · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7UL0-1 RCSB PDB | xray | resolution: 2.49 Å | in vitro · -193.15 °C · pH 7 · ligands NA, NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Crystal structure of SARS-CoV-2 RBD in complex with the ridge-binding nAb EH8 isolated from a nonvaccinated pediatric patient · Spike protein S1 (chains A) | unmapped |
| EV-PDB-7UL1-1 RCSB PDB | xray | resolution: 2.65 Å | in vitro · -193.15 °C · pH 5 · ligands NAG Crystal structure of SARS-CoV-2 RBD in complex with the neutralizing IGHV3-53-encoded antibody EH3 isolated from a nonvaccinated pediatric patient · Spike protein S1 (chains A) | unmapped |
| EV-PDB-7TYZ-1 RCSB PDB | cryoem | resolution: 3.51 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 spike in complex with FSR22, an anti-SARS-CoV-2 DARPin · Spike glycoprotein (chains A,C,E) | unmapped |
| EV-PDB-7UM2-3 RCSB PDB | xray | resolution: 1.63 Å | in vitro · -173.15 °C · ligands CD, NA, ZN SARS-CoV-2 Spike-derived peptide S417-425 K417T mutant (TIADYNYKL) presented by HLA-A*02:01 · SARS-CoV-2 Spike-derived peptide S417-425 K417T mutant (TIADYNYKL) (chains C) | unmapped |
| EV-PDB-7UOW-1 RCSB PDB | cryoem | resolution: 4.4 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-Cov2 S protein structure in complex with neutralizing monoclonal antibody 034_32 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7UPL-1 RCSB PDB | cryoem | resolution: 4.1 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-Cov2 Omicron varient S protein structure in complex with neutralizing monoclonal antibody 002-S21F2 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7UPW-1 RCSB PDB | cryoem | resolution: 2.7 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Three RBD-down state of SARS-CoV-2 D614G spike in complex with the SP1-77 neutralizing antibody Fab fragment · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7UPX-1 RCSB PDB | cryoem | resolution: 3.2 Å | in vitro · ligands branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose Three RBD-down state of SARS-CoV-2 D614G spike in complex with the SP1-77 neutralizing antibody Fab fragment (local refinement of the RBD and Fab variable domains) · Spike glycoprotein (chains A) | unmapped |
| EV-PDB-7UPY-1 RCSB PDB | cryoem | resolution: 3.1 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose An antibody from single human VH-rearranging mouse neutralizes all SARS-CoV-2 variants through BA.5 by inhibiting membrane fusion · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7UR1-3 RCSB PDB | xray | resolution: 2.17 Å | in vitro · -173.15 °C SARS-CoV-2 Spike-derived peptide S1215-1224 (YIWLGFIAGL) presented by HLA-A*02:01 · SARS-CoV-2 Spike-derived peptide S1215-1224 (YIWLGFIAGL) (chains C) | unmapped |
| EV-PDB-7URQ-1 RCSB PDB | xray | resolution: 2.05 Å | in vitro · -173.15 °C · pH 5.5 · ligands CIT, NAG Crystal Structure of SARS-CoV-2 S delta variant receptor-binding domain (RBD) in complex CoV11 Fab crystal form 1 · Spike protein S1 (chains A) | unmapped |
| EV-PDB-7URS-1 RCSB PDB | xray | resolution: 2.4 Å | in vitro · -173.15 °C · pH 6.5 · ligands MPD, NAG, PO4 Crystal Structure of SARS-CoV-2 S delta variant receptor-binding domain (RBD) in complex CoV11 Fab crystal form 2 · Spike protein S1 (chains A) | unmapped |
| EV-PDB-7UZ4-1 RCSB PDB | cryoem | resolution: 3.1 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Structure of the SARS-CoV-2 S 6P trimer in complex with the mouse antibody Fab fragment, M8a-3 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7UZ5-1 RCSB PDB | cryoem | resolution: 3.2 Å | in vitro · ligands NAG Structure of the SARS-CoV-2 S 6P trimer in complex with the mouse antibody Fab fragment, M8a-6 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7UZ6-1 RCSB PDB | cryoem | resolution: 2.8 Å | in vitro · ligands NAG Structure of the SARS-CoV-2 S 6P trimer in complex with the mouse antibody Fab fragment, M8a-28 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7UZ7-1 RCSB PDB | cryoem | resolution: 2.9 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Structure of the SARS-CoV-2 S 6P trimer in complex with the mouse antibody Fab fragment, M8a-31 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7UZ8-1 RCSB PDB | cryoem | resolution: 3.1 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Structure of the SARS-CoV-2 Omicron BA.1 S 6P trimer in complex with the mouse antibody Fab fragment, M8a-31 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7UZ9-1 RCSB PDB | cryoem | resolution: 3.5 Å | in vitro · ligands NAG Structure of the SARS-CoV-2 S 6P trimer in complex with the mouse antibody Fab fragment, M8a-34 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7UZA-1 RCSB PDB | cryoem | resolution: 3.1 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Structure of the SARS-CoV-2 S 6P trimer in complex with the mouse antibody Fab fragment, HSW-1 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7UZB-1 RCSB PDB | cryoem | resolution: 4.1 Å | in vitro · ligands NAG Structure of the SARS-CoV-2 S S1 doamin in complex with the mouse antibody Fab fragment, HSW-2 · Spike glycoprotein (chains A) | unmapped |
| EV-PDB-7UZC-1 RCSB PDB | xray | resolution: 2.2 Å | in vitro · -173.15 °C · ligands branched: alpha-D-mannopyranose-(1-3)-alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Structure of the SARS-CoV-2 RBD in complex with the mouse antibody Fab fragment, M8a-34 · Spike protein S1 (chains A,B) | unmapped |
| EV-PDB-7UZD-1 RCSB PDB | xray | resolution: 3 Å | in vitro · -173.15 °C · ligands branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Structure of the SARS-CoV-2 RBD in complex with the mouse antibody Fab fragment, HSW-2 · Spike protein S1 (chains A) | unmapped |
| EV-PDB-7V20-1 RCSB PDB | cryoem | resolution: 2.86 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose CryoEM structure of del68-76/del679-688 prefusion-stabilized spike · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7V22-1 RCSB PDB | cryoem | resolution: 3.38 Å | in vitro Local CryoEM structure del68-76/del679-688 prefusion-stabilized spike · Spike glycoprotein (chains A) | unmapped |
| EV-PDB-7V23-1 RCSB PDB | cryoem | resolution: 2.96 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose CryoEM structure of del68-76/del679-688 prefusion-stabilized spike in complex with the Fab of N12-9 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7V24-3 RCSB PDB | cryoem | resolution: 3.29 Å | in vitro Local CryoEM structure of del68-76/del679-688 prefusion-stabilized spike in complex with the Fab of N12-9 · Spike glycoprotein (chains A) | unmapped |
| EV-PDB-7V26-1 RCSB PDB | cryoem | resolution: 3.85 Å | in vitro · ligands NAG XG005-bound SARS-CoV-2 S · Spike glycoprotein (chains A,C,E) | unmapped |
| EV-PDB-7V27-1 RCSB PDB | cryoem | resolution: 4.18 Å | in vitro · ligands NAG RBD/XG005 local refinement · Spike protein S1 (chains C) | unmapped |
| EV-PDB-7V2A-1 RCSB PDB | cryoem | resolution: 3.4 Å | in vitro · ligands NAG SARS-CoV-2 Spike trimer in complex with XG014 Fab · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7V76-1 RCSB PDB | cryoem | resolution: 3.2 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 S-Beta variant (B.1.351), uncleavable form, one RBD-up conformation · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7V77-1 RCSB PDB | cryoem | resolution: 3.3 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 S-Beta variant (B.1.351), uncleavable form, two RBD-up conformation · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7V78-1 RCSB PDB | cryoem | resolution: 3.4 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 S-Gamma variant (P.1), one RBD-up conformation 1 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7V7A-1 RCSB PDB | cryoem | resolution: 3.4 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 S-Gamma variant (P.1), two RBD-up conformation · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7V7D-1 RCSB PDB | cryoem | resolution: 3 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 S-Kappa variant (B.1.617.1), all RBD-down conformation · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7V7E-1 RCSB PDB | cryoem | resolution: 2.9 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 S-Kappa variant (B.1.617.1), one RBD-up conformation 1 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7V7F-1 RCSB PDB | cryoem | resolution: 2.9 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 S-Kappa variant (B.1.617.1), one RBD-up conformation 2 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7V7G-1 RCSB PDB | cryoem | resolution: 3.1 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 S-Kappa variant (B.1.617.1), two RBD-up conformation · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7V7H-1 RCSB PDB | cryoem | resolution: 3.2 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 S-Kappa variant (B.1.617.1), dimer of S trimer conformation 1 · Spike glycoprotein (chains A,B,C,D,E,F) | unmapped |
| EV-PDB-7V7I-1 RCSB PDB | cryoem | resolution: 3.3 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 S-Kappa variant (B.1.617.1), dimer of S trimer conformation 2 · Spike glycoprotein (chains A,B,C,D,E,F) | unmapped |
| EV-PDB-7V7J-1 RCSB PDB | cryoem | resolution: 3.4 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 S-Kappa variant (B.1.617.1), dimer of S trimer conformation 3 · Spike glycoprotein (chains A,B,C,D,E,F) | unmapped |
| EV-PDB-7V7N-1 RCSB PDB | cryoem | resolution: 2.9 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2), all RBD-down conformation · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7V7O-1 RCSB PDB | cryoem | resolution: 2.9 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2), one RBD-up conformation 1 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7V7P-1 RCSB PDB | cryoem | resolution: 2.9 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2), one RBD-up conformation 2 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7V7Q-1 RCSB PDB | cryoem | resolution: 2.8 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2), one RBD-up conformation 3 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7V7R-1 RCSB PDB | cryoem | resolution: 2.9 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2), one RBD-up conformation 4 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7V7S-1 RCSB PDB | cryoem | resolution: 3 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2), one RBD-up conformation 5 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7V7T-1 RCSB PDB | cryoem | resolution: 3 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2), two RBD-up conformation 1 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7V7U-1 RCSB PDB | cryoem | resolution: 3 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2), two RBD-up conformation 2 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7V7V-1 RCSB PDB | cryoem | resolution: 3.1 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2), two RBD-up conformation 3 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7V7Z-1 RCSB PDB | cryoem | resolution: 3.1 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 S-Beta variant (B.1.351) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, three ACE2-bound form · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7V80-1 RCSB PDB | cryoem | resolution: 3.9 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Local refinement of SARS-CoV-2 S-Beta variant (B.1.351) RBD and Angiotensin-converting enzyme 2 (ACE2) ectodomain · Spike glycoprotein (chains A) | unmapped |
| EV-PDB-7V81-1 RCSB PDB | cryoem | resolution: 3.2 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 S-Gamma variant (P.1) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, two ACE2-bound form · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7V79-1 RCSB PDB | cryoem | resolution: 3.3 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 S-Gamma variant (P.1), one RBD-up conformation 2 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7V82-1 RCSB PDB | cryoem | resolution: 2.8 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 S-Gamma variant (P.1) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, three ACE2-bound form conformation 1 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7V83-1 RCSB PDB | cryoem | resolution: 2.8 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 S-Gamma variant (P.1) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, three ACE2-bound form conformation 2 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7V84-1 RCSB PDB | cryoem | resolution: 3 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Local refinement of SARS-CoV-2 S-Gamma variant (P.1) RBD and Angiotensin-converting enzyme 2 (ACE2) ectodomain · Spike glycoprotein (chains A) | unmapped |
| EV-PDB-7V85-1 RCSB PDB | cryoem | resolution: 3.3 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 S-Kappa variant (B.1.617.1) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, two ACE2-bound form · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7V86-1 RCSB PDB | cryoem | resolution: 2.8 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 S-Kappa variant (B.1.617.1) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, three ACE2-bound form · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7V87-1 RCSB PDB | cryoem | resolution: 3.3 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Local refinement of SARS-CoV-2 S-Kappa variant (B.1.617.1) RBD and Angiotensin-converting enzyme 2 (ACE2) ectodomain · Spike glycoprotein (chains A) | unmapped |
| EV-PDB-7V89-1 RCSB PDB | cryoem | resolution: 2.8 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, three ACE2-bound form conformation 1 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7V8A-1 RCSB PDB | cryoem | resolution: 2.7 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, three ACE2-bound form conformation 2 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7V8B-1 RCSB PDB | cryoem | resolution: 3.2 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Local refinement of SARS-CoV-2 S-Delta variant (B.1.617.2) RBD and Angiotensin-converting enzyme 2 (ACE2) ectodomain · Spike glycoprotein (chains A) | unmapped |
| EV-PDB-7V8C-1 RCSB PDB | cryoem | resolution: 3.4 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 S-Beta variant (B.1.351), Cleavable form, one RBD-up conformation · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7VHH-1 RCSB PDB | cryoem | resolution: 3.8 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Delta variant of SARS-CoV-2 Spike protein · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7VHJ-1 RCSB PDB | cryoem | resolution: 4.2 Å | in vitro Furin Site deletion of SARS-CoV-2 spike · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7VHK-1 RCSB PDB | cryoem | resolution: 3.6 Å | in vitro S1-S2 deletion S-2P trimer(3 down) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7VHL-1 RCSB PDB | cryoem | resolution: 3.9 Å | in vitro Double deletion S-2P trimer(1 Up) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7VHM-1 RCSB PDB | cryoem | resolution: 3.2 Å | in vitro Double deletion S-2P trimer(3 down) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7VHN-1 RCSB PDB | cryoem | resolution: 3.8 Å | in vitro · ligands NAG Spike of SARS-CoV-2 spike protein(1 up) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7VMU-2 RCSB PDB | xray | resolution: 2.89 Å | in vitro · -173.15 °C Crystal Structure of SARS-CoV Spike Receptor-Binding Domain Complexed with Neutralizing Antibody · Spike protein S1 (chains B) | unmapped |
| EV-PDB-7VNB-2 RCSB PDB | xray | resolution: 2.27 Å | in vitro · -173.15 °C · ligands NAG Crystal structure of the SARS-CoV-2 RBD in complex with a human single domain antibody n3113 · Spike protein S1 (chains B) | unmapped |
| EV-PDB-7VNC-1 RCSB PDB | cryoem | resolution: 3.7 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Structure of the SARS-CoV-2 spike glycoprotein in complex with a human single domain antibody n3113 (UDD-state, state 1) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7VND-1 RCSB PDB | cryoem | resolution: 3.6 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Structure of the SARS-CoV-2 spike glycoprotein in complex with a human single domain antibody n3113 (UUD-state, state 2) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7VOA-2 RCSB PDB | xray | resolution: 1.8 Å | in vitro · -83.15 °C · pH 5.5 · ligands NAG Crystal structure of SARS-CoV-2 RBD in complex with aRBD5 · Spike glycoprotein (chains B) | unmapped |
| EV-PDB-7VQ0-1 RCSB PDB | cryoem | resolution: 3.03 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of the SARS-CoV-2 spike protein (2-up RBD) bound to neutralizing nanobodies P86 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7VRW-1 RCSB PDB | cryoem | resolution: 3.6 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose VAS5 Spike (3 RBD down) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7VX5-2 RCSB PDB | cryoem | resolution: 3.8 Å | in vitro · ligands NAG, ZN ACE2-RBD in SARS-CoV-2 Kappa variant S-ACE2 complex · Spike glycoprotein (chains E) | unmapped |
| EV-PDB-7VX9-1 RCSB PDB | cryoem | resolution: 4 Å | in vitro SARS-CoV-2 Kappa variant spike protein in complex wth ACE2, state C1 · Spike glycoprotein (chains A,B,D) | unmapped |
| EV-PDB-7VXE-1 RCSB PDB | cryoem | resolution: 3.2 Å | in vitro SARS-CoV-2 Kappa variant spike protein in open state · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7VXK-1 RCSB PDB | cryoem | resolution: 3.7 Å | in vitro SARS-CoV-2 spike protein in complex with ACE2, Beta variant, C2A state · Spike glycoprotein (chains A,B,D) | unmapped |
| EV-PDB-7VYR-3 RCSB PDB | xray | resolution: 2.2 Å | in vitro · -173.15 °C Crystal structure of SARS-CoV-2 Spike RBD in complex with the D27 neutralizing antibody Fab fragment · Spike protein S1 (chains C,R) | unmapped |
| EV-PDB-7VZT-1 RCSB PDB | xray | resolution: 3.41 Å | in vitro · -173.15 °C · ligands branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose A human neutralizing antibody targeting SARS-CoV-2 RBD · Spike protein S1 (chains A) | unmapped |
| EV-PDB-7W6U-2 RCSB PDB | xray | resolution: 2.56 Å | in vitro · -173.15 °C · ligands NAG, ZN Structure of SARS-CoV-2 spike receptor-binding domain complexed with its receptor equine ACE2 · Spike protein S1 (chains B) | unmapped |
| EV-PDB-7W94-1 RCSB PDB | cryoem | resolution: 3.4 Å | in vitro Transition state of SARS-CoV-2 Delta variant spike protein · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7W98-1 RCSB PDB | cryoem | resolution: 3.6 Å | in vitro SARS-CoV-2 Delta S-ACE2-C1 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7W9B-1 RCSB PDB | cryoem | resolution: 3.4 Å | in vitro SARS-CoV-2 Delta S-ACE2-C2b · Spike glycoprotein (chains B,C,D) | unmapped |
| EV-PDB-7W9C-1 RCSB PDB | cryoem | resolution: 3.2 Å | in vitro SARS-CoV-2 Delta S-ACE2-C3 · Spike glycoprotein (chains B,C,D) | unmapped |
| EV-PDB-7W99-1 RCSB PDB | cryoem | resolution: 3.4 Å | in vitro SARS-CoV-2 Delta S-ACE2-C2a · Spike glycoprotein (chains A,C,D) | unmapped |
| EV-PDB-7W92-1 RCSB PDB | cryoem | resolution: 3.1 Å | in vitro Open state of SARS-CoV-2 Delta variant spike protein · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7W8S-2 RCSB PDB | cryoem | resolution: 2.85 Å | in vitro · ligands ZN, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Structure of SARS-CoV-2 spike receptor-binding domain Y453F mutation complexed with American mink ACE2 · Spike protein S1 (chains B) | unmapped |
| EV-PDB-7W1S-1 RCSB PDB | xray | resolution: 1.997 Å | in vitro · -173.15 °C Crystal structure of SARS-CoV-2 spike receptor-binding domain in complex with neutralizing nanobody Nb-007 · Spike protein S1 (chains A) | unmapped |
| EV-PDB-7VXM-1 RCSB PDB | cryoem | resolution: 3.6 Å | in vitro SARS-CoV-2 spike protein in complex with ACE2, Beta variant, C3 state · Spike glycoprotein (chains A,B,D) | unmapped |
| EV-PDB-7VXI-1 RCSB PDB | cryoem | resolution: 3.4 Å | in vitro SARS-CoV-2 Kappa variant spike protein in transition state · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7VXF-1 RCSB PDB | cryoem | resolution: 3.6 Å | in vitro SARS-CoV-2 spike protein in complex with ACE2, Beta variant, C2B state · Spike glycoprotein (chains A,B,D) | unmapped |
| EV-PDB-7VXD-1 RCSB PDB | cryoem | resolution: 4 Å | in vitro SARS-CoV-2 spike protein in complex with ACE2, Beta variant, C1 state · Spike glycoprotein (chains A,B,D) | unmapped |
| EV-PDB-7VXC-1 RCSB PDB | cryoem | resolution: 3.9 Å | in vitro SARS-CoV-2 Kappa variant spike protein in C3 state · Spike glycoprotein (chains A,B,D) | unmapped |
| EV-PDB-7VXB-1 RCSB PDB | cryoem | resolution: 3.9 Å | in vitro SARS-CoV-2 Kappa variant spike protein in C2b state · Spike glycoprotein (chains A,B,D) | unmapped |
| EV-PDB-7VXA-1 RCSB PDB | cryoem | resolution: 3.9 Å | in vitro SARS-CoV-2 Kappa variant spike protein in complex with ACE2, state C2a · Spike glycoprotein (chains A,B,D) | unmapped |
| EV-PDB-7VX4-2 RCSB PDB | cryoem | resolution: 3.9 Å | in vitro · ligands NAG, ZN ACE2-RBD in SARS-CoV-2 Beta variant S-ACE2 complex · Spike glycoprotein (chains E) | unmapped |
| EV-PDB-7VX1-1 RCSB PDB | cryoem | resolution: 3.5 Å | in vitro SARS-CoV-2 Beta variant spike protein in open state · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7VRV-1 RCSB PDB | cryoem | resolution: 4.2 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose VAS5 Spike (1 RBD up) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7VNE-1 RCSB PDB | cryoem | resolution: 3.5 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Structure of the SARS-CoV-2 spike glycoprotein in complex with a human single domain antibody n3113.1 (UUU-state) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7V88-1 RCSB PDB | cryoem | resolution: 3.3 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, two ACE2-bound form · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7W9E-1 RCSB PDB | cryoem | resolution: 3.1 Å | in vitro SARS-CoV-2 Delta S-8D3 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7W9F-3 RCSB PDB | cryoem | resolution: 3.6 Å | in vitro SARS-CoV-2 Delta S-RBD-8D3 · Spike protein S1 (chains E) | unmapped |
| EV-PDB-7W9I-2 RCSB PDB | cryoem | resolution: 3.4 Å | in vitro SARS-CoV-2 Delta S-RBD-ACE2 · Spike protein S1 (chains E) | unmapped |
| EV-PDB-7WA1-2 RCSB PDB | cryoem | resolution: 2.9 Å | in vitro · ligands ZN Structure of SARS-CoV-2 spike receptor-binding domain F486L mutation complexed with American mink ACE2 · Spike protein S1 (chains B) | unmapped |
| EV-PDB-7WB5-3 RCSB PDB | cryoem | resolution: 3.7 Å | in vitro · ligands branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose local structure of hu33 and spike · Surface glycoprotein (chains R) | unmapped |
| EV-PDB-7WBH-1 RCSB PDB | cryoem | resolution: 3.7 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose overall structure of hu33 and spike · Spike glycoprotein (chains A) | unmapped |
| EV-PDB-7WBH-2 RCSB PDB | cryoem | resolution: 3.7 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose overall structure of hu33 and spike · Spike glycoprotein (chains B,C) | unmapped |
| EV-PDB-7WBL-2 RCSB PDB | cryoem | resolution: 3.4 Å | in vitro · ligands NAG, ZN Cryo-EM structure of human ACE2 complexed with SARS-CoV-2 Omicron RBD · Spike protein S1 (chains B) | unmapped |
| EV-PDB-7WBP-2 RCSB PDB | xray | resolution: 3 Å | in vitro · -173.15 °C · pH 6.5 · ligands NAG, ZN, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Crystal structure of the receptor binding domain of SARS-CoV-2 Omicron variant spike glycoprotein in complex with its receptor human ACE2 · Spike protein S1 (chains B) | unmapped |
| EV-PDB-7WBQ-2 RCSB PDB | xray | resolution: 3.34 Å | in vitro · -173.15 °C · pH 6.5 · ligands NAG, ZN, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-beta-D-glucopyranose Crystal structure of the receptor binding domain of SARS-CoV-2 Delta variant spike glycoprotein in complex with its receptor human ACE2 · Spike protein S1 (chains B,D) | unmapped |
| EV-PDB-7WBZ-1 RCSB PDB | xray | resolution: 2.42 Å | in vitro · -173.15 °C · ligands NAG Crystal structure of the SARS-Cov-2 RBD in complex with Fab 2303 · Spike protein S1 (chains A) | unmapped |
| EV-PDB-7WCD-1 RCSB PDB | cryoem | resolution: 3.3 Å | in vitro · ligands NAG Cryo EM structure of SARS-CoV-2 spike in complex with TAU-2212 mAbs in conformation 4 · Spike glycoprotein (chains C,H,J) | unmapped |
| EV-PDB-7WCH-1 RCSB PDB | cryoem | resolution: 3.19 Å | in vitro CryoEM structure of the SARS-CoV-2 S6P(B.1.617.2) in complex with SWA9 Fab · Surface glycoprotein (chains A,B,G) | unmapped |
| EV-PDB-7WCK-3 RCSB PDB | cryoem | resolution: 3.49 Å | in vitro Local CryoEM structure of the SARS-CoV-2 S6P(B.1.617.2) in complex with SWA9 Fab · Surface glycoprotein (chains R) | unmapped |
| EV-PDB-7WCP-1 RCSB PDB | cryoem | resolution: 3.01 Å | in vitro CryoEM structure of the SARS-CoV-2 S6P(B.1.617.2) in complex with SWC11 Fab · Surface glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7WCR-1 RCSB PDB | cryoem | resolution: 3.5 Å | in vitro RBD-1 of SARS-CoV-2 Beta spike in complex with S5D2 Fab · Spike glycoprotein (chains A) | unmapped |
| EV-PDB-7WCU-3 RCSB PDB | cryoem | resolution: 3.09 Å | in vitro Local CryoEM structure of the SARS-CoV-2 S6P(B.1.617.2) in complex with SWC11 Fab · Surface glycoprotein (chains R) | unmapped |
| EV-PDB-7WCZ-1 RCSB PDB | cryoem | resolution: 3.5 Å | in vitro SARS-CoV-2 Beta spike in complex with one S5D2 Fab · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7WD0-1 RCSB PDB | cryoem | resolution: 3.3 Å | in vitro SARS-CoV-2 Beta spike in complex with two S5D2 Fabs · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7WD1-1 RCSB PDB | xray | resolution: 2.5 Å | in vitro · 17.85 °C · ligands branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-beta-D-glucopyranose Crystal structure of R14 bound to SARS-CoV-2 RBD · Spike protein S1 (chains A,B) | unmapped |
| EV-PDB-7WD2-1 RCSB PDB | xray | resolution: 2.69 Å | in vitro · 17.85 °C · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-beta-D-glucopyranose Crystal structure of S43 bound to SARS-CoV-2 RBD · Spike protein S1 (chains A,B) | unmapped |
| EV-PDB-7WD7-1 RCSB PDB | cryoem | resolution: 3.5 Å | in vitro SARS-CoV-2 Beta spike in complex with three S5D2 Fabs · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7WD8-1 RCSB PDB | cryoem | resolution: 4.3 Å | in vitro SARS-CoV-2 Beta spike SD1 in complex with S3H3 Fab · Spike glycoprotein (chains A,B) | unmapped |
| EV-PDB-7WD9-1 RCSB PDB | cryoem | resolution: 3.7 Å | in vitro SARS-CoV-2 Beta spike in complex with three S3H3 Fabs · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7WDF-1 RCSB PDB | cryoem | resolution: 3.9 Å | in vitro SARS-CoV-2 Beta spike in complex with two S3H3 Fabs · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7WE7-3 RCSB PDB | cryoem | resolution: 3.8 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 Omicron variant spike protein in complex with Fab XGv282 · Spike glycoprotein (chains D,E,G) | unmapped |
| EV-PDB-7WE8-1 RCSB PDB | cryoem | resolution: 3.5 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 Omicron variant spike protein in complex with Fab XGv265 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7WE9-1 RCSB PDB | cryoem | resolution: 3.6 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 Omicron variant spike protein in complex with Fab XGv289 · Spike glycoprotein (chains A,B,F) | unmapped |
| EV-PDB-7WEA-1 RCSB PDB | cryoem | resolution: 3.3 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 Omicron variant spike protein in complex with two XGv347 binding to one close state RBD and one open state RBD · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7WEC-3 RCSB PDB | cryoem | resolution: 3.3 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 Omicron variant spike protein with three XGv347 Fabs binding to three closed state RBDs · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7WED-1 RCSB PDB | cryoem | resolution: 3.5 Å | in vitro SARS-CoV-2 Omicron variant spike RBD in complex with Fab XGv347 · Spike protein S1 (chains E) | unmapped |
| EV-PDB-7WEE-1 RCSB PDB | cryoem | resolution: 4 Å | in vitro SARS-CoV-2 Omicron variant spike RBD in complex with Fab XGv265 · Spike glycoprotein (chains E) | unmapped |
| EV-PDB-7WEF-2 RCSB PDB | cryoem | resolution: 3.8 Å | in vitro SARS-CoV-2 Omicron variant spike RBD in complex with Fab XGv289 · Spike protein S1 (chains E) | unmapped |
| EV-PDB-7WEV-1 RCSB PDB | cryoem | resolution: 3.6 Å | in vitro SARS-COV-2 BETA VARIANT SPIKE PROTEIN IN TRANSITION STATE · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7WG6-1 RCSB PDB | cryoem | resolution: 3.4 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Neutral Omicron Spike Trimer · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7WG7-1 RCSB PDB | cryoem | resolution: 4 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Acidic Omicron Spike Trimer · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7WG8-1 RCSB PDB | cryoem | resolution: 3.9 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Delta Spike Trimer(3 RBD Down) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7WG9-1 RCSB PDB | cryoem | resolution: 3.5 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Delta Spike Trimer(1 RBD Up) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7WGB-1 RCSB PDB | cryoem | resolution: 3.5 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Neutral Omicron Spike Trimer in complex with ACE2 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7WGV-1 RCSB PDB | cryoem | resolution: 3.2 Å | in vitro · ligands BLR, EIC, NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 spike glycoprotein trimer in closed state · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7WGX-1 RCSB PDB | cryoem | resolution: 3.5 Å | in vitro · ligands BLR, NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 spike glycoprotein trimer in closed state after treatment with Cathepsin L · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7WGY-1 RCSB PDB | cryoem | resolution: 4 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 spike glycoprotein trimer in Intermediate state · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7WGZ-1 RCSB PDB | cryoem | resolution: 4.5 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 spike glycoprotein trimer in open state · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7WHB-1 RCSB PDB | cryoem | resolution: 2.67 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 spike in complex with the ZB8 neutralizing antibody Fab (3U) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7WHD-1 RCSB PDB | cryoem | resolution: 2.65 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 spike in complex with the ZB8 neutralizing antibody Fab (2u1d) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7WHH-2 RCSB PDB | xray | resolution: 2.6 Å | in vitro · -173.15 °C · ligands CL, NAG, ZN, branched: alpha-L-fucopyranose-(1-3)-[2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)]2-acetamido-2-deoxy-beta-D-glucopyranose Crystal structure of SARS-CoV-2 omicron RBD and human ACE2 · Spike glycoprotein (chains E) | unmapped |
| EV-PDB-7WHI-1 RCSB PDB | cryoem | resolution: 2.93 Å | in vitro · ligands NAG The state 2 complex structure of Omicron spike with Bn03 (2-up RBD, 4 nanobodies) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7WHJ-1 RCSB PDB | cryoem | resolution: 3.27 Å | in vitro · ligands NAG The state 1 complex structure of Omicron spike with Bn03 (1-up RBD, 3 nanobodies) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7WH8-3 RCSB PDB | cryoem | resolution: 3.11 Å | in vitro SARS-CoV-2 spike in complex with the ZB8 neutralizing antibody Fab (focused refinement on Fab-RBD) · Spike glycoprotein (chains C) | unmapped |
| EV-PDB-7WGC-2 RCSB PDB | cryoem | resolution: 3.6 Å | in vitro · ligands NAG Neutral Omicron Spike Trimer in complex with ACE2. · Spike glycoprotein (chains C) | unmapped |
| EV-PDB-7WEB-3 RCSB PDB | cryoem | resolution: 3.7 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 Omicron variant spike protein with two XGv347 binding to two open state RBDs · Spike glycoprotein (chains B,C,D) | unmapped |
| EV-PDB-7WPF-1 RCSB PDB | cryoem | resolution: 2.92 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 Omicron Variant S Trimer complexed with three JMB2002 Fab · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7WPH-1 RCSB PDB | xray | resolution: 2.89 Å | in vitro · -193.15 °C · ligands NAG SARS-CoV2 RBD bound to Fab06 · Spike protein S1 (chains A,B) | unmapped |
| EV-PDB-7WPE-1 RCSB PDB | cryoem | resolution: 2.69 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 Omicron Variant S Trimer complexed with two JMB2002 Fab · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7WPD-1 RCSB PDB | cryoem | resolution: 3.18 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 Omicron Variant S Trimer complexed with one JMB2002 Fab · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7WPC-1 RCSB PDB | cryoem | resolution: 2.57 Å | in vitro · ligands CL, NAG, ZN, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose The second RBD of SARS-CoV-2 Omicron Variant in complexed with RBD-ACE2 · Spike glycoprotein (chains A,B) | unmapped |
| EV-PDB-7WPB-1 RCSB PDB | cryoem | resolution: 2.79 Å | in vitro · ligands CL, NAG, ZN SARS-CoV-2 Omicron Variant RBD complexed with ACE2 · Spike glycoprotein (chains A) | unmapped |
| EV-PDB-7WPA-1 RCSB PDB | cryoem | resolution: 2.77 Å | in vitro · ligands CL, NAG, ZN, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 Omicron Variant SPIKE trimer complexed with ACE2 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7WP9-1 RCSB PDB | cryoem | resolution: 2.56 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 Omicron Variant SPIKE trimer, all RBDs down · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7WP8-4 RCSB PDB | cryoem | resolution: 3.88 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 recombinant spike protein STFK1628x in complex with three neutralizing antibodies · Spike glycoprotein (chains F) | unmapped |
| EV-PDB-7WP6-4 RCSB PDB | cryoem | resolution: 3.81 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 recombinant spike protein STFK in complex with three neutralizing antibodies · Spike protein S1 (chains F) | unmapped |
| EV-PDB-7WP5-3 RCSB PDB | cryoem | resolution: 3.9 Å | in vitro · ligands branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 Omicron S6P trimer in complex with neutralizing antibody VacW-209 (local refinement) · Spikeprotein S1 (chains F) | unmapped |
| EV-PDB-7WP2-3 RCSB PDB | cryoem | resolution: 3.52 Å | in vitro · ligands branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 C.1.2 S6P trimer in complex with neutralizing antibody VacW-209 (local refinement) · Spike protein S1 (chains F) | unmapped |
| EV-PDB-7WP1-3 RCSB PDB | cryoem | resolution: 3.77 Å | in vitro · ligands branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 Mu S6P trimer in complex with neutralizing antibody VacW-209 (local refinement) · Spike protein S1 (chains F) | unmapped |
| EV-PDB-7WP0-3 RCSB PDB | cryoem | resolution: 3.71 Å | in vitro · ligands NAG Cryo-EM structure of SARS-CoV-2 Delta S6P trimer in complex with neutralizing antibody VacW-209 (local refinement) · Spike protein S1 (chains F) | unmapped |
| EV-PDB-7WOW-1 RCSB PDB | cryoem | resolution: 6.11 Å | in vitro The state 6 of Omicron Spike with bispecific antibody FD01 · Spike glycoprotein (chains A,B,C,J,K,L) | unmapped |
| EV-PDB-7WOV-1 RCSB PDB | cryoem | resolution: 3.87 Å | in vitro · ligands NAG The state 5 of Omicron Spike with bispecific antibody FD01 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7WOU-1 RCSB PDB | cryoem | resolution: 3.47 Å | in vitro · ligands NAG The state 4 of Omicron Spike with bispecific antibody FD01 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7WOS-1 RCSB PDB | cryoem | resolution: 3.91 Å | in vitro · ligands NAG The state 3 of Omicron Spike with bispecific antibody FD01 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7WOR-1 RCSB PDB | cryoem | resolution: 3.7 Å | in vitro · ligands NAG The state 2 of Omicron Spike with bispecific antibody FD01 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7WOQ-1 RCSB PDB | cryoem | resolution: 3.47 Å | in vitro · ligands NAG The state 1 of Omicron Spike with bispecific antibody FD01 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7WOP-1 RCSB PDB | cryoem | resolution: 3.51 Å | in vitro The local refined map of Omicron spike with bispecific antibody FD01 · Spike protein S1 (chains A) | unmapped |
| EV-PDB-7WON-1 RCSB PDB | cryoem | resolution: 3.9 Å | in vitro · ligands branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 S2P trimer in complex with neutralizing antibody VacW-209 (local refinement) · Spike protein S1 (chains F) | unmapped |
| EV-PDB-7WOG-1 RCSB PDB | cryoem | resolution: 4.06 Å | in vitro SARS-CoV-2 Omicron S monomer complexed with 553-49 · Spike protein S1 (chains C) | unmapped |
| EV-PDB-7WOC-1 RCSB PDB | cryoem | resolution: 3.35 Å | in vitro · ligands NAG Locally refined region of SARS-CoV-2 Spike in complex with IgG 553-60 · Spike protein S1 (chains C) | unmapped |
| EV-PDB-7WOB-1 RCSB PDB | cryoem | resolution: 3.25 Å | in vitro · ligands NAG SARS-CoV-2 Spike in complex with IgG 553-60 (2-up trimer) · Spike glycoprotein (chains A,C,E) | unmapped |
| EV-PDB-7WOA-1 RCSB PDB | cryoem | resolution: 3.25 Å | in vitro · ligands NAG SARS-CoV-2 Spike in complex with IgG 553-60 (1-up trimer) · Spike glycoprotein (chains A,C,E) | unmapped |
| EV-PDB-7WO7-3 RCSB PDB | cryoem | resolution: 3.8 Å | in vitro · ligands NAG Locally refined region of SARS-CoV-2 Spike in complex with IgG 553-15 · Spike protein S1 (chains C) | unmapped |
| EV-PDB-7WO5-1 RCSB PDB | cryoem | resolution: 3.45 Å | in vitro · ligands NAG SARS-CoV-2 Spike in complex with IgG 553-15 (S-553-15 trimer) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7WO4-1 RCSB PDB | cryoem | resolution: 4.47 Å | in vitro · ligands NAG SARS-CoV-2 Spike in complex with IgG 553-15 (S-553-15 dimer trimer ) · Spike glycoprotein (chains A,B,C,J,K,L) | unmapped |
| EV-PDB-7WNM-2 RCSB PDB | xray | resolution: 2.7 Å | in vitro · -173.15 °C · pH 6 · ligands NAG, ZN Structure of SARS-CoV-2 Gamma variant receptor-binding domain complexed with high affinity human ACE2 mutant (T27F,R273Q) · Spike protein S1 (chains A) | unmapped |
| EV-PDB-7WNB-1 RCSB PDB | xray | resolution: 2.18 Å | in vitro · -173.15 °C · ligands SO4, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Crystal structure of SARS-CoV-2 spike receptor-binding domain (RBD) in complex with NCV2SG48 Fab · Spike protein S1 (chains R) | unmapped |
| EV-PDB-7WN2-1 RCSB PDB | xray | resolution: 2.35 Å | in vitro · -173.15 °C · ligands NAG, SO4 Crystal structure of SARS-CoV-2 spike receptor-binding domain (RBD) in complex with NCV2SG53 Fab · Spike protein S1 (chains A,R) | unmapped |
| EV-PDB-7WM0-1 RCSB PDB | cryoem | resolution: 3.35 Å | in vitro · ligands NAG Cryo-EM structure of the Omicron RBD in complex with 35B5 Fab( local refinement of the RBD and 35B5 Fab) · Spike glycoprotein (chains B) | unmapped |
| EV-PDB-7WLZ-1 RCSB PDB | cryoem | resolution: 2.98 Å | in vitro · ligands NAG Cryo-EM structure of the Omicron S in complex with 35B5 Fab(1 down-, 1 up- and 1 invisible RBDs) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7WLY-1 RCSB PDB | cryoem | resolution: 3.4 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of the Omicron S in complex with 35B5 Fab(1 down- and 2 up RBDs) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7WLC-1 RCSB PDB | cryoem | resolution: 4 Å | in vitro SARS-CoV-2 Omicron variant spike RBD in complex with Fab XGv282 · Spike protein S1 (chains E) | unmapped |
| EV-PDB-7WKA-1 RCSB PDB | cryoem | resolution: 3.64 Å | in vitro SARS-CoV-2 Omicron closed state spike protein in complex with S3H3 Fab · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7WK9-1 RCSB PDB | cryoem | resolution: 3.48 Å | in vitro SARS-CoV-2 Omicron open state spike protein in complex with S3H3 Fab · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7WK8-3 RCSB PDB | cryoem | resolution: 3.61 Å | in vitro SARS-CoV-2 Omicron spike protein SD1 in complex with S3H3 Fab · Spike glycoprotein (chains A,B) | unmapped |
| EV-PDB-7WK6-1 RCSB PDB | cryoem | resolution: 3.67 Å | in vitro Cryo-EM structure of SARS-CoV-2 Omicron spike protein with human ACE2 (focus refinement on RBD-1/ACE2) · Spike glycoprotein (chains E) | unmapped |
| EV-PDB-7WK5-2 RCSB PDB | cryoem | resolution: 3.66 Å | in vitro Cryo-EM structure of Omicron S-ACE2, C2 state · Spike glycoprotein (chains B,C,D) | unmapped |
| EV-PDB-7WK4-2 RCSB PDB | cryoem | resolution: 3.69 Å | in vitro Cryo-EM structure of SARS-CoV-2 Omicron spike protein with ACE2, C1 state · Spike glycoprotein (chains B,C,D) | unmapped |
| EV-PDB-7WK3-1 RCSB PDB | cryoem | resolution: 3.4 Å | in vitro SARS-CoV-2 Omicron S-open · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7WK2-1 RCSB PDB | cryoem | resolution: 3.1 Å | in vitro SARS-CoV-2 Omicron S-close · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7WK0-3 RCSB PDB | cryoem | resolution: 3.32 Å | in vitro · ligands NAG Local refine of Omicron spike bitrimer with 6m6 antibody · Spike protein S1 (chains C,F) | unmapped |
| EV-PDB-7WJZ-1 RCSB PDB | cryoem | resolution: 3.34 Å | in vitro · ligands NAG Omicron Spike bitrimer with 6m6 antibody · Spike glycoprotein (chains B,I,J,K,L,M) | unmapped |
| EV-PDB-7WJY-1 RCSB PDB | cryoem | resolution: 3.24 Å | in vitro · ligands NAG Omicron spike trimer with 6m6 antibody · Spike glycoprotein (chains A,D,G) | unmapped |
| EV-PDB-7WI0-1 RCSB PDB | cryoem | resolution: 3.82 Å | in vitro · ligands NAG SARS-CoV-2 Omicron variant spike in complex with three human neutralizing antibodies · Spike protein S1 (chains A) | unmapped |
| EV-PDB-7WHZ-1 RCSB PDB | cryoem | resolution: 3.42 Å | in vitro · ligands NAG SARS-CoV-2 spike protein in complex with three human neutralizing antibodies · Spike protein S1 (chains A) | unmapped |
| EV-PDB-7WHK-1 RCSB PDB | cryoem | resolution: 3.01 Å | in vitro · ligands NAG The state 3 complex structure of Omicron spike with Bn03 (2-up RBD, 5 nanobodies) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7WQV-1 RCSB PDB | xray | resolution: 2.8 Å | in vitro · -173.15 °C · ligands CA, CL, MPD, NAG, branched: alpha-L-fucopyranose-(1-3)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-beta-D-glucopyranose Crystal structure of a neutralizing monoclonal antibody (Ab08) in complex with SARS-CoV-2 receptor-binding domain (RBD) · Spike protein S1 (chains A,C,E,G,I,K,M,O) | unmapped |
| EV-PDB-7WRH-1 RCSB PDB | cryoem | resolution: 2.66 Å | in vitro · ligands NAG, ZN, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 Omicron BA.1 spike protein in complex with mouse ACE2 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7WRI-2 RCSB PDB | cryoem | resolution: 3.03 Å | in vitro · ligands NAG, ZN Cryo-EM structure of SARS-CoV-2 Omicron spike receptor-binding domain in complex with mouse ACE2 · Spike glycoprotein (chains B) | unmapped |
| EV-PDB-7WRJ-1 RCSB PDB | cryoem | resolution: 4.08 Å | in vitro · ligands branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Local CryoEM structure of the SARS-CoV-2 S6P(B.1.1.529) in complex with BD55-4637 Fab · Spike protein S1 (chains R) | unmapped |
| EV-PDB-7WRL-3 RCSB PDB | cryoem | resolution: 3.51 Å | in vitro Local structure of BD55-1239 Fab and SARS-COV2 Omicron RBD complex · Spike protein S1 (chains R) | unmapped |
| EV-PDB-7WRO-3 RCSB PDB | cryoem | resolution: 3.4 Å | in vitro Local structure of BD55-3372 and delta spike · Spike protein S1 (chains R) | unmapped |
| EV-PDB-7WRY-1 RCSB PDB | cryoem | resolution: 3.28 Å | in vitro · ligands branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Local structure of BD55-3546 Fab and SARS-COV2 Delta RBD complex · Spike protein S1 (chains R) | unmapped |
| EV-PDB-7WRZ-3 RCSB PDB | cryoem | resolution: 3.26 Å | in vitro · ligands branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Local resolution of BD55-5840 Fab and SARS-COV2 Omicron RBD · Spike protein S1 (chains R) | unmapped |
| EV-PDB-7WS0-1 RCSB PDB | cryoem | resolution: 3.2 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7WS1-1 RCSB PDB | cryoem | resolution: 3.4 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7WS2-2 RCSB PDB | cryoem | resolution: 3.3 Å | in vitro Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development · Spike protein S1 (chains A) | unmapped |
| EV-PDB-7WS3-1 RCSB PDB | cryoem | resolution: 3.6 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7WS4-1 RCSB PDB | cryoem | resolution: 3.7 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Ultrapotent SARS-CoV-2 neutralizing antibodies with protective efficacy against newly emerged mutational variants · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7WS5-1 RCSB PDB | cryoem | resolution: 3.7 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7WS6-1 RCSB PDB | cryoem | resolution: 3.8 Å | in vitro Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development · Spike protein S1 (chains C) | unmapped |
| EV-PDB-7WS7-1 RCSB PDB | cryoem | resolution: 3.4 Å | in vitro · ligands branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development · Spike protein S1 (chains B) | unmapped |
| EV-PDB-7WS8-1 RCSB PDB | cryoem | resolution: 3 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7WS9-1 RCSB PDB | cryoem | resolution: 2.9 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7WSA-1 RCSB PDB | cryoem | resolution: 3 Å | in vitro · ligands NAG Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development · Spike protein S1 (chains A) | unmapped |
| EV-PDB-7WSC-1 RCSB PDB | cryoem | resolution: 3.78 Å | in vitro · ligands branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Local structure of BD55-3500 and omicron RBD complex · Spike protein S1 (chains R) | unmapped |
| EV-PDB-7WSE-2 RCSB PDB | cryoem | resolution: 2.93 Å | in vitro · ligands ZN Cryo-EM structure of SARS-CoV-2 spike receptor-binding domain complexed with its receptor minke whale ACE2 · Spike protein S1 (chains B) | unmapped |
| EV-PDB-7WSK-2 RCSB PDB | xray | resolution: 3.3 Å | in vitro · -173.15 °C · ligands NAG, ZN, branched: alpha-D-mannopyranose-(1-3)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Crystal structure of SARS-CoV-2 Omicron spike receptor-binding domain in complex with civet ACE2 · Spike protein S1 (chains B) | unmapped |
| EV-PDB-7WT7-1 RCSB PDB | cryoem | resolution: 3.4 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 Omicron variant spike in complex with Fab 9A8 (State 1) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7WT8-1 RCSB PDB | cryoem | resolution: 3.6 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 Omicron variant spike in complex with Fab 9A8 (State 2) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7WT9-2 RCSB PDB | cryoem | resolution: 4.3 Å | in vitro SARS-CoV-2 Omicron variant spike RBD in complex with Fab 9A8 · Spike glycoprotein (chains E) | unmapped |
| EV-PDB-7WTG-1 RCSB PDB | cryoem | resolution: 3.8 Å | in vitro SARS-CoV-2 Omicron variant spike RBD in complex with Fab XGv051 · Spike protein S1 (chains E) | unmapped |
| EV-PDB-7WTH-1 RCSB PDB | cryoem | resolution: 4.3 Å | in vitro SARS-CoV-2 Omicron variant spike RBD in complex with Fab XGv264 · Spike protein S1 (chains E) | unmapped |
| EV-PDB-7WTI-1 RCSB PDB | cryoem | resolution: 3.8 Å | in vitro · ligands NAG SARS-CoV-2 Omicron variant spike in complex with Fab XGv264 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7WTJ-3 RCSB PDB | cryoem | resolution: 4.2 Å | in vitro SARS-CoV-2 Omicron variant spike RBD in complex with Fab XGv286 · Spike protein S1 (chains E) | unmapped |
| EV-PDB-7WTK-1 RCSB PDB | cryoem | resolution: 3.6 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 Omicron variant spike in complex with Fab XGv286 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7WUE-1 RCSB PDB | xray | resolution: 3.2 Å | in vitro · -173.15 °C · pH 4.6 · ligands branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose Crystal structure of SARS-CoV-2 Receptor Binding Domain in complex with the monoclonal antibody m31A7 · Spike protein S1 (chains A,B) | unmapped |
| EV-PDB-7WUH-1 RCSB PDB | cryoem | resolution: 4.7 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-2)-[alpha-D-mannopyranose-(1-6)]alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-6)-alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 Spike in complex with Fab of m31A7 · Spike glycoprotein (chains A,C,E) | unmapped |
| EV-PDB-7WVL-3 RCSB PDB | xray | resolution: 3 Å | in vitro · -173.15 °C · pH 5.5 Structure of P4A2 Fab in complex with Spike-RBD from SARS-CoV-2 · Spike protein S1 (chains F) | unmapped |
| EV-PDB-7WVN-1 RCSB PDB | cryoem | resolution: 3.4 Å | in vitro SARS-CoV-2 Omicron S-open · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7WVO-1 RCSB PDB | cryoem | resolution: 3.41 Å | in vitro SARS-CoV-2 Omicron S-open-2 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7WVP-2 RCSB PDB | cryoem | resolution: 3.7 Å | in vitro Cryo-EM structure of SARS-CoV-2 Omicron Spike protein with human ACE2 receptor, C2 state · Spike glycoprotein (chains B,C,D) | unmapped |
| EV-PDB-7WVQ-1 RCSB PDB | cryoem | resolution: 4.04 Å | in vitro Cryo-EM structure of SARS-CoV-2 Omicron Spike protein with human ACE2 receptor, C3 state · Spike glycoprotein (chains B,C,D) | unmapped |
| EV-PDB-7WWI-1 RCSB PDB | cryoem | resolution: 3.5 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 BA.1 Spike trimer in complex with 55A8 Fab in the class 1 conformation · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7WWJ-1 RCSB PDB | cryoem | resolution: 3.5 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 BA.1 Spike trimer in complex with 55A8 Fab in the class 2 conformation · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7WWK-1 RCSB PDB | cryoem | resolution: 3.4 Å | in vitro Local refinement of the SARS-CoV-2 BA.1 Spike trimer in complex with 55A8 Fab · Spike glycoprotein (chains B,C) | unmapped |
| EV-PDB-7WWL-1 RCSB PDB | cryoem | resolution: 3 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose S protein of Delta variant in complex with ZWD12 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7WWM-1 RCSB PDB | cryoem | resolution: 2.8 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose S protein of Delta variant in complex with ZWC6 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7WXZ-1 RCSB PDB | xray | resolution: 2.41 Å | in vitro · -173.15 °C Crystal structure of the recombinant protein HR121 from the S2 protein of SARS-CoV-2 · Spike protein S2' (chains A,B,C,D) | unmapped |
| EV-PDB-7WZ1-1 RCSB PDB | cryoem | resolution: 3.4 Å | in vitro · ligands NAG SARS-CoV-2 Omicron Spike trimer · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7WZ2-1 RCSB PDB | cryoem | resolution: 2.7 Å | in vitro · ligands NAG SARS-CoV-2 (D614G) Spike trimer · Spike glycoprotein (chains A,C,E) | unmapped |
| EV-PDB-7X08-1 RCSB PDB | cryoem | resolution: 2.7 Å | in vitro · ligands EIC, NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose S protein of SARS-CoV-2 in complex with 2G1 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7WTF-3 RCSB PDB | cryoem | resolution: 3 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 Omicron variant spike in complex with Fab XGv051 · Spike glycoprotein (chains B,C,D) | unmapped |
| EV-PDB-7WSH-2 RCSB PDB | cryoem | resolution: 2.89 Å | in vitro · ligands NAG, ZN Cryo-EM structure of SARS-CoV-2 spike receptor-binding domain in complex with sea lion ACE2 · Spike protein S1 (chains B) | unmapped |
| EV-PDB-7WRV-1 RCSB PDB | cryoem | resolution: 2.47 Å | in vitro The interface of JMB2002 Fab binds to SARS-CoV-2 Omicron Variant S · Spike glycoprotein (chains C) | unmapped |
| EV-PDB-7WR8-1 RCSB PDB | cryoem | resolution: 3.5 Å | in vitro · ligands branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose Local CryoEM structure of the SARS-CoV-2 S6P(B.1.1.529) in complex with BD55-3152 Fab · Spike protein S1 (chains R) | unmapped |
| EV-PDB-7X2H-3 RCSB PDB | xray | resolution: 2.1 Å | in vitro · -173.15 °C · ligands NAG Crystal structure of SARS-CoV-2 spike receptor-binding domain bound with 6-2C Fab · Spike protein S1 (chains E,F) | unmapped |
| EV-PDB-7X2K-1 RCSB PDB | xray | resolution: 2.4 Å | in vitro · -173.15 °C · ligands NAG Crystal structure of nanobody Nb70 with antibody 1F11 fab and SARS-CoV-2 RBD · Spike protein S1 (chains E) | unmapped |
| EV-PDB-7X66-3 RCSB PDB | xray | resolution: 2.4 Å | in vitro · -193.15 °C SARS-CoV-2-Omicron-RBD and BD-236-GWP/P-VK antibody complex · Spike protein S1 (chains R) | unmapped |
| EV-PDB-7X6A-1 RCSB PDB | cryoem | resolution: 3.5 Å | in vitro SARS-CoV-2 BA.2 variant spike protein in complex with Fab BD55-5840 · Spike glycoprotein (chains A,B,D) | unmapped |
| EV-PDB-7X7D-1 RCSB PDB | xray | resolution: 2.92 Å | in vitro · -173.15 °C · pH 7 SARS-CoV-2 Delta RBD and Nb22 · Spike protein S1 (chains A,D,E) | unmapped |
| EV-PDB-7X7E-1 RCSB PDB | xray | resolution: 2.67 Å | in vitro · -173.15 °C · pH 7 · ligands PG4 SARS-CoV-2 RBD and Nb22 · Spike protein S1 (chains C,D,F) | unmapped |
| EV-PDB-7X7O-1 RCSB PDB | xray | resolution: 3.75 Å | in vitro · -173.15 °C SARS-CoV-2 spike RBD in complex with neutralizing antibody UT28K · Spike protein S1 (chains A,B,C,D) | unmapped |
| EV-PDB-7X8W-1 RCSB PDB | cryoem | resolution: 3.1 Å | in vitro · ligands branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab354 · Spike glycoprotein (chains A) | unmapped |
| EV-PDB-7X8Y-1 RCSB PDB | cryoem | resolution: 4.1 Å | in vitro · ligands NAG The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab159 · Spike glycoprotein (chains A) | unmapped |
| EV-PDB-7X8Z-1 RCSB PDB | cryoem | resolution: 4.1 Å | in vitro · ligands NAG The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab188 · Spike glycoprotein (chains A) | unmapped |
| EV-PDB-7X90-3 RCSB PDB | cryoem | resolution: 4.2 Å | in vitro · ligands branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab326 · Spike glycoprotein (chains G) | unmapped |
| EV-PDB-7X92-1 RCSB PDB | cryoem | resolution: 4.1 Å | in vitro · ligands branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab445 · Spike glycoprotein (chains A) | unmapped |
| EV-PDB-7X9E-3 RCSB PDB | xray | resolution: 2.6 Å | in vitro · -173.15 °C · pH 4.5 Crystal structure of the 76E1 Fab in complex with a SARS-CoV-2 spike peptide · Spike peptide (chains E,F) | unmapped |
| EV-PDB-7XB0-2 RCSB PDB | xray | resolution: 2.9 Å | in vitro · -173.15 °C · pH 5.5 · ligands NAG, ZN, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Crystal structure of Omicron BA.2 RBD complexed with hACE2 · Spike protein S1 (chains B) | unmapped |
| EV-PDB-7XB1-2 RCSB PDB | xray | resolution: 2.7 Å | in vitro · -173.15 °C · pH 7 · ligands NAG, ZN, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose Crystal structure of Omicron BA.3 RBD complexed with hACE2 · Spike protein S1 (chains B) | unmapped |
| EV-PDB-7XBY-2 RCSB PDB | xray | resolution: 2.85 Å | in vitro · -173.15 °C · ligands BR, NAG, ZN The crystal structure of SARS-CoV-2 Omicron BA.1 variant RBD in complex with equine ACE2 · Spike protein S1 (chains B) | unmapped |
| EV-PDB-7XCI-2 RCSB PDB | cryoem | resolution: 3.2 Å | in vitro · ligands NAG, ZN, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 Omicron RBD in complex with human ACE2 ectodomain (local refinement) · Spike glycoprotein (chains B) | unmapped |
| EV-PDB-7XCK-3 RCSB PDB | cryoem | resolution: 2.5 Å | in vitro · ligands branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 Omicron RBD in complex with S309 fab (local refinement) · Spike protein S1 (chains M) | unmapped |
| EV-PDB-7XCO-1 RCSB PDB | cryoem | resolution: 2.5 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 Omicron spike protein (S-6P-RRAR) in complex with S309 fab · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7XCP-2 RCSB PDB | cryoem | resolution: 3.05 Å | in vitro · ligands NAG, ZN, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of Omicron RBD complexed with ACE2 and 304 Fab · Spike protein S1 (chains B) | unmapped |
| EV-PDB-7XCZ-1 RCSB PDB | cryoem | resolution: 3.2 Å | in vitro Cryo-EM structure of SARS-CoV-2 Delta RBD in complex with BA7054 and BA7125 fab (local refinement) · Spike glycoprotein (chains A) | unmapped |
| EV-PDB-7XDA-3 RCSB PDB | cryoem | resolution: 2.98 Å | in vitro Cryo-EM structure of SARS-CoV-2 Delta RBD in complex with BA7208 and BA7125 fab (local refinement) · Spike glycoprotein (chains A) | unmapped |
| EV-PDB-7XDK-1 RCSB PDB | cryoem | resolution: 3.2 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 Delta Spike protein in complex with BA7054 and BA7125 fab · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7XDL-1 RCSB PDB | cryoem | resolution: 3.08 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 Delta Spike protein in complex with BA7208 and BA7125 fab · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7XIC-1 RCSB PDB | cryoem | resolution: 3.3 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose S-ECD (Omicron) in complex with STS165 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7XIX-1 RCSB PDB | cryoem | resolution: 3.25 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 Omicron BA.2 variant spike (state 2) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7XIW-1 RCSB PDB | cryoem | resolution: 3.62 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 Omicron BA.2 variant spike (state 1) · Spike glycoprotein (chains A,B,D) | unmapped |
| EV-PDB-7XIL-1 RCSB PDB | xray | resolution: 2.91 Å | in vitro · -193.15 °C · ligands NAG SARS-CoV-2-Beta-RBD and B38-GWP/P-VK antibody complex · Spike protein S1 (chains A) | unmapped |
| EV-PDB-7XIK-1 RCSB PDB | xray | resolution: 2.89 Å | in vitro · -193.15 °C SARS-CoV-2-Omicron-RBD and B38-GWP/P-VK antibody complex · Spike protein S1 (chains A) | unmapped |
| EV-PDB-7XID-1 RCSB PDB | cryoem | resolution: 3.3 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose S-ECD (Omicron) in complex with PD of ACE2 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7XH8-1 RCSB PDB | cryoem | resolution: 2.99 Å | in vitro The structure of ZCB11 Fab against SARS-CoV-2 Omicron Spike · Spike glycoprotein (chains A) | unmapped |
| EV-PDB-7XEI-1 RCSB PDB | xray | resolution: 2.76 Å | in vitro · -173.15 °C SARS-CoV-2-prototyped-RBD and CB6-092-Fab complex · Spike protein S1 (chains A,B) | unmapped |
| EV-PDB-7XEG-1 RCSB PDB | xray | resolution: 2.69 Å | in vitro · -173.15 °C SARS-CoV-2-Beta-RBD and CB6-092-Fab complex · Spike protein S1 (chains A,B) | unmapped |
| EV-PDB-7XDB-2 RCSB PDB | cryoem | resolution: 2.62 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 Omicron Spike protein in complex with BA7208 fab · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7XD2-1 RCSB PDB | cryoem | resolution: 3.3 Å | in vitro SARS-CoV-2 S ectodomain trimer in complex with neutralizing antibody 10-5B · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7XCH-1 RCSB PDB | cryoem | resolution: 3.4 Å | in vitro · ligands NAG, ZN, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 Omicron spike protein (S-6P-RRAR) in complex with human ACE2 ectodomain (two-RBD-up state) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7XAZ-2 RCSB PDB | xray | resolution: 3 Å | in vitro · -173.15 °C · pH 7 · ligands NAG, ZN, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Crystal structure of Omicron BA.1.1 RBD complexed with hACE2 · Spike protein S1 (chains B,D) | unmapped |
| EV-PDB-7XA7-2 RCSB PDB | xray | resolution: 3.31 Å | in vitro · -173.15 °C · ligands NAG, ZN Crystal structure of SARS-CoV-2 receptor-binding domain in complex with intermediate horseshoe bat ACE2 · Spike protein S1 (chains B,D,F,H) | unmapped |
| EV-PDB-7X96-1 RCSB PDB | cryoem | resolution: 3.4 Å | in vitro · ligands branched: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab847 · Spike glycoprotein (chains G) | unmapped |
| EV-PDB-7X95-1 RCSB PDB | cryoem | resolution: 3.9 Å | in vitro · ligands branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab709 · Spike glycoprotein (chains A) | unmapped |
| EV-PDB-7X94-1 RCSB PDB | cryoem | resolution: 4 Å | in vitro · ligands branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab712 · Spike glycoprotein (chains A) | unmapped |
| EV-PDB-7X93-1 RCSB PDB | cryoem | resolution: 3.3 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab765 · Spike glycoprotein (chains A,D,G) | unmapped |
| EV-PDB-7X91-1 RCSB PDB | cryoem | resolution: 4.3 Å | in vitro · ligands branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose The SARS-CoV-2 receptor binding domain bound with an Fv-clasp form of a human neutralizing antibody Ab496 · Spike glycoprotein (chains A) | unmapped |
| EV-PDB-7X7U-1 RCSB PDB | cryoem | resolution: 3.77 Å | in vitro · ligands NAG Cryo-EM structure of SARS-CoV-2 Delta variant spike protein in complex with three nAbs X01, X10 and X17 · Spike protein S1 (chains G) | unmapped |
| EV-PDB-7X7T-1 RCSB PDB | cryoem | resolution: 3.48 Å | in vitro · ligands NAG Cryo-EM structure of SARS-CoV-2 spike protein in complex with three nAbs X01, X10 and X17 · Spike protein S1 (chains G) | unmapped |
| EV-PDB-7X7N-1 RCSB PDB | cryoem | resolution: 4.47 Å | in vitro · ligands NAG 3D model of the 3-RBD up single trimeric spike protein of SARS-CoV2 in the presence of synthetic peptide SIH-5. · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7X63-3 RCSB PDB | xray | resolution: 2.24 Å | in vitro · -193.15 °C SARS-CoV-2-Beta-RBD and BD-236-GWP/P-VK antibody complex · Spike protein S1 (chains R) | unmapped |
| EV-PDB-7X2M-1 RCSB PDB | xray | resolution: 1.8 Å | in vitro · -173.15 °C · ligands branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-D-mannopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose Crystal structure of nanobody 1-2C7 with SARS-CoV-2 RBD · Spike protein S1 (chains E) | unmapped |
| EV-PDB-7X2L-1 RCSB PDB | xray | resolution: 2.4 Å | in vitro · -173.15 °C · ligands branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose Crystal structure of nanobody 3-2A2-4 with SARS-CoV-2 RBD · Spike protein S1 (chains E) | unmapped |
| EV-PDB-7X1M-7 RCSB PDB | cryoem | resolution: 2.74 Å | in vitro · ligands branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose The complex structure of Omicron BA.1 RBD with BD604, S309,and S304 · Spike protein S1 (chains M) | unmapped |
| EV-PDB-7XIY-1 RCSB PDB | cryoem | resolution: 3.07 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 Omicron BA.3 variant spike · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7XIZ-1 RCSB PDB | cryoem | resolution: 3.74 Å | in vitro · ligands NAG SARS-CoV-2 Omicron BA.3 variant spike (local) · Spike protein S1 (chains B) | unmapped |
| EV-PDB-7XJ6-1 RCSB PDB | cryoem | resolution: 3.29 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 BA.1 Spike trimer in complex with 55A8 Fab and 58G6 Fab in the class 1 conformation · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7XJ8-1 RCSB PDB | cryoem | resolution: 3.3 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 BA.1 Spike trimer in complex with 55A8 Fab and 58G6 Fab in the class 2 conformation · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7XJ9-1 RCSB PDB | cryoem | resolution: 3.27 Å | in vitro Local refinement of the SARS-CoV-2 BA.1 Spike trimer in complex with 55A8 Fab and 58G6 Fab · Spike glycoprotein (chains B,C) | unmapped |
| EV-PDB-7XMZ-1 RCSB PDB | cryoem | resolution: 3.25 Å | in vitro · ligands NAG Cryo-EM structure of SARS-CoV-2 spike glycoprotein in complex with three D2 Fab · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7XNQ-1 RCSB PDB | cryoem | resolution: 3.52 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 Omicron BA.4 variant spike · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7XNR-1 RCSB PDB | cryoem | resolution: 3.49 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 Omicron BA.2.13 variant spike · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7XNS-1 RCSB PDB | cryoem | resolution: 3.48 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 Omicron BA.2.12.1 variant spike · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7XO4-1 RCSB PDB | cryoem | resolution: 3.24 Å | in vitro · ligands NAG, ZN SARS-CoV-2 Omicron BA.1 Variant Spike Trimer with two mouse ACE2 Bound · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7XO5-1 RCSB PDB | cryoem | resolution: 3.13 Å | in vitro · ligands NAG, ZN SARS-CoV-2 Omicron BA.1 Variant Spike Trimer with one mouse ACE2 Bound · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7XO7-1 RCSB PDB | cryoem | resolution: 3.38 Å | in vitro · ligands CL, NAG, ZN SARS-CoV-2 Omicron BA.2 Variant Spike Trimer with two human ACE2 Bound · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7XO8-1 RCSB PDB | cryoem | resolution: 3.48 Å | in vitro · ligands CL, NAG, ZN SARS-CoV-2 Omicron BA.2 Variant Spike Trimer with three human ACE2 Bound · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7XO9-1 RCSB PDB | cryoem | resolution: 3 Å | in vitro · ligands CL, NAG, ZN SARS-CoV-2 Omicron BA.2 Variant RBD complexed with human ACE2 · Spike glycoprotein (chains A) | unmapped |
| EV-PDB-7XOA-1 RCSB PDB | cryoem | resolution: 3.2 Å | in vitro · ligands NAG, ZN SARS-CoV-2 Omicron BA.2 Variant Spike Trimer with one mouse ACE2 Bound · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7XOB-1 RCSB PDB | cryoem | resolution: 3.3 Å | in vitro · ligands NAG, ZN SARS-CoV-2 Omicron BA.2 Variant Spike Trimer with two mouse ACE2 Bound · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7XOC-2 RCSB PDB | cryoem | resolution: 3 Å | in vitro · ligands NAG, ZN, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 Omicron BA.2 Variant RBD complexed with mouse ACE2 · Spike glycoprotein (chains A) | unmapped |
| EV-PDB-7XOD-1 RCSB PDB | cryoem | resolution: 3.27 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 Omicron BA.2 Variant Spike Trimer with three JMB2002 Fab Bound · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7XOG-1 RCSB PDB | cryoem | resolution: 3.5 Å | in vitro · ligands MAN, NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-3)-alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of S glycoprotein encoded by the Covid-19 mRNA vaccine candidate RQ3013 (Postfusion state) · Spike glycoprotein,peptide (chains A,B,C) | unmapped |
| EV-PDB-7XQS-3 RCSB PDB | xray | resolution: 2.69 Å | in vitro · -173.15 °C · pH 7 The structure of FLA-K*00701/KP-CoV-9 · peptide from Spike glycoprotein (chains C) | unmapped |
| EV-PDB-7XRP-3 RCSB PDB | cryoem | resolution: 3.88 Å | in vitro · ligands NAG Cryo-EM structure of SARS-CoV-2 spike protein in complex with nanobody C5G2 (localized refinement) · Spike protein S1 (chains F) | unmapped |
| EV-PDB-7XRP-1 RCSB PDB | cryoem | resolution: 3.88 Å | in vitro · ligands NAG Cryo-EM structure of SARS-CoV-2 spike protein in complex with nanobody C5G2 (localized refinement) · Spike protein S1 (chains A) | unmapped |
| EV-PDB-7XST-1 RCSB PDB | cryoem | resolution: 3.04 Å | in vitro · ligands NAG Cryo-EM structure of SARS-CoV-2 Omicron spike glycoprotein in complex with three F61 Fab and three D2 Fab · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7XTZ-1 RCSB PDB | cryoem | resolution: 2.8 Å | in vitro · ligands BLA, EIC, NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Structure of SARS-CoV-2 Spike Protein with Engineered x3 Disulfide (x3(D427C, V987C) and single Arg S1/S2 cleavage site), Locked-1 Conformation · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7XU1-1 RCSB PDB | cryoem | resolution: 3 Å | in vitro · ligands BLA, EIC, NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Structure of SARS-CoV-2 Spike Protein with Engineered x3 Disulfide (x3(D427C, V987C) and single Arg S1/S2 cleavage site), Locked-122 Conformation · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7XU2-1 RCSB PDB | cryoem | resolution: 3.2 Å | in vitro · ligands BLA, EIC, NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Structure of SARS-CoV-2 Spike Protein with Engineered x3 Disulfide (x3(D427C, V987C) and single Arg S1/S2 cleavage site), Locked-2 Conformation · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7XU3-1 RCSB PDB | cryoem | resolution: 3 Å | in vitro · ligands BLA, NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Structure of SARS-CoV-2 Spike Protein with Engineered x3 Disulfide (x3(D427C, V987C) and single Arg S1/S2 cleavage site), Closed Conformation · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7XU5-1 RCSB PDB | cryoem | resolution: 3.1 Å | in vitro · ligands BLA, NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Structure of SARS-CoV-2 D614G Spike Protein with Engineered x3 Disulfide (x3(D427C, V987C) and single Arg S1/S2 cleavage site), Closed Conformation · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7XU6-1 RCSB PDB | cryoem | resolution: 2.9 Å | in vitro · ligands BLA, NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Structure of SARS-CoV-2 Spike Protein with Engineered x3 Disulfide (x3(D427C, V987C) and single Arg S1/S2 cleavage site), incubated in Low pH after 40-Day Storage in PBS, Locked-2 Conformation · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7XWA-2 RCSB PDB | xray | resolution: 3.36 Å | in vitro · -173.15 °C · ligands NAG, ZN, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Crystal structure of the receptor binding domain of SARS-CoV-2 Omicron BA.4/5 variant spike protein in complex with its receptor ACE2 · Spike protein S1 (chains B,D) | unmapped |
| EV-PDB-7XXL-3 RCSB PDB | cryoem | resolution: 7.3 Å | in vitro · ligands NAG RBD in complex with Fab14 · Spike protein S1 (chains B) | unmapped |
| EV-PDB-7XY3-1 RCSB PDB | cryoem | resolution: 4.6 Å | in vitro · ligands NAG Cryo-EM structure of SARS-CoV-2 spike in complex with VHH14 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7XY4-1 RCSB PDB | cryoem | resolution: 3.3 Å | in vitro · ligands NAG Cryo-EM structure of SARS-CoV-2 spike in complex with VHH21 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7Y0C-3 RCSB PDB | xray | resolution: 2.94 Å | in vitro · 17.85 °C · pH 5 · ligands branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose Crystal structure of BD55-1403 and SARS-CoV-2 Omicron RBD · Spike protein S1 (chains E,R) | unmapped |
| EV-PDB-7Y0N-1 RCSB PDB | cryoem | resolution: 3.8 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 WT Spike in complex with R15 Fab and P14 Nanobody · Spike glycoprotein (chains A,B,D) | unmapped |
| EV-PDB-7Y0O-1 RCSB PDB | cryoem | resolution: 4.4 Å | in vitro Interface of SARS-CoV-2 WT Spike in complex with R15 Fab and P14 Nanobody · Spike protein S1 (chains A) | unmapped |
| EV-PDB-7Y0W-5 RCSB PDB | cryoem | resolution: 3.42 Å | in vitro · ligands branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose Local structure of BD55-5514 and BD55-5840 Fab and Omicron BA.1 RBD complex · Spike protein S1 (chains R) | unmapped |
| EV-PDB-7Y1Z-1 RCSB PDB | cryoem | resolution: 3.4 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose S-ECD (Omicron BA.3) in complex with three PD of ACE2 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7Y20-1 RCSB PDB | cryoem | resolution: 3.8 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose S-ECD (Omicron BA.3) in complex with two PD of ACE2 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7Y21-1 RCSB PDB | cryoem | resolution: 2.8 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose S-ECD (Omicron BA.5) in complex with PD of ACE2 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7Y1Y-1 RCSB PDB | cryoem | resolution: 3.3 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose S-ECD (Omicron BA.2) in complex with PD of ACE2 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7Y0V-3 RCSB PDB | xray | resolution: 2.48 Å | in vitro · 19.85 °C · pH 7.25 · ligands branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose The co-crystal structure of BA.1-RBD with Fab-5549 · Spike protein S1 (chains R) | unmapped |
| EV-PDB-7XU4-1 RCSB PDB | cryoem | resolution: 3.2 Å | in vitro · ligands BLA, EIC, NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Structure of SARS-CoV-2 D614G Spike Protein with Engineered x3 Disulfide (x3(D427C, V987C) and single Arg S1/S2 cleavage site), Locked-2 Conformation · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7XU0-1 RCSB PDB | cryoem | resolution: 2.9 Å | in vitro · ligands BLA, EIC, NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Structure of SARS-CoV-2 Spike Protein with Engineered x3 Disulfide (x3(D427C, V987C) and single Arg S1/S2 cleavage site), Locked-211 Conformation · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7XSC-2 RCSB PDB | xray | resolution: 2.88 Å | in vitro · -173.15 °C Crystal structure of SARS-CoV-2 spike receptor binding domain bound with P5S-2B10 · Spike protein S1 (chains E,F) | unmapped |
| EV-PDB-7XSB-1 RCSB PDB | xray | resolution: 3.2 Å | in vitro · -173.15 °C Crystal structure of SARS-CoV-2 spike receptor binding domain bound with P5S-3B11 Fab · Spike protein S1 (chains A,B,C,E) | unmapped |
| EV-PDB-7XSA-3 RCSB PDB | xray | resolution: 2.2 Å | in vitro · -173.15 °C Crystal structure of SARS-CoV-2 spike receptor binding domain bound with P2S-2E9 Fab · Spike protein S1 (chains E,J) | unmapped |
| EV-PDB-7XS8-2 RCSB PDB | xray | resolution: 2.8 Å | in vitro · -173.15 °C · ligands NAG Crystal structure of SARS-CoV-2 spike receptor binding domain bound with P5S-1H1 Fab · Spike protein S1 (chains E) | unmapped |
| EV-PDB-7XOE-1 RCSB PDB | cryoem | resolution: 3.9 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of S glycoprotein encoded by the Covid-19 mRNA vaccine candidate RQ3013 (Prefusion state) · Spike glycoprotein,peptide (chains A,B,C) | unmapped |
| EV-PDB-7XO6-2 RCSB PDB | cryoem | resolution: 2.6 Å | in vitro · ligands NAG, ZN, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 Omicron BA.1 Variant RBD with mouse ACE2 Bound · Spike glycoprotein (chains A) | unmapped |
| EV-PDB-7XMX-1 RCSB PDB | cryoem | resolution: 3.62 Å | in vitro · ligands NAG Cryo-EM structure of SARS-CoV-2 spike glycoprotein in complex with three F61 Fab · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7Y3O-3 RCSB PDB | xray | resolution: 2.1 Å | in vitro · -173.15 °C · pH 7 · ligands NAG Crystal structure of SARS-CoV-2 receptor binding domain in complex with human antibody BIOLS56 · Spike protein S1 (chains A) | unmapped |
| EV-PDB-7Y42-1 RCSB PDB | cryoem | resolution: 3.45 Å | in vitro · ligands NAG, REA Cryo-EM structure of the SARS-CoV-2 spike glycoprotein in complex with all-trans retinoic acid · Spike glycoprotein (chains A,B,D) | unmapped |
| EV-PDB-7Y6K-1 RCSB PDB | cryoem | resolution: 3.34 Å | in vitro · ligands NAG Cryo-EM structure of SARS-CoV-2 receptor binding domain in complex with K202.B bispecific antibody · Spike glycoprotein (chains B) | unmapped |
| EV-PDB-7Y71-3 RCSB PDB | cryoem | resolution: 3.12 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 spike glycoprotein trimer complexed with Fab fragment of anti-RBD antibody E7 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7Y75-3 RCSB PDB | cryoem | resolution: 3.1 Å | in vitro · ligands 3PH, NAG, ZN, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SIT1-ACE2-BA.2 RBD · Spike protein S1 (chains E,F) | unmapped |
| EV-PDB-7Y7K-1 RCSB PDB | cryoem | resolution: 4.4 Å | in vitro SARS-CoV-2 RBD in complex with 1F Fab · Spike protein S1 (chains A) | unmapped |
| EV-PDB-7Y8J-2 RCSB PDB | xray | resolution: 1.03 Å | in vitro · -196.15 °C 3D1 in complex with 6-mer HR1 peptide from SARS-CoV-2 · Spike protein S2' (chains A) | unmapped |
| EV-PDB-7Y9N-2 RCSB PDB | xray | resolution: 1.885 Å | in vitro · -173.15 °C an engineered 5-helix bundle derived from SARS-CoV-2 S2 in complex with HR2P · SARS-coV-2 S2 subunit (chains B) | unmapped |
| EV-PDB-7Y9N-1 RCSB PDB | xray | resolution: 1.885 Å | in vitro · -173.15 °C an engineered 5-helix bundle derived from SARS-CoV-2 S2 in complex with HR2P · Spike protein S2',5HB-H2 (chains A) | unmapped |
| EV-PDB-7Y9Z-1 RCSB PDB | cryoem | resolution: 2.85 Å | in vitro · ligands NAG, ZN, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 Omicron spike protein (S-6P-RRAR) in complex with human ACE2 ectodomain (one-RBD-up state) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7YA0-1 RCSB PDB | cryoem | resolution: 3.1 Å | in vitro · ligands NAG, ZN, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of hACE2-bound SARS-CoV-2 Omicron spike protein with L371S, P373S and F375S mutations (S-6P-RRAR) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7YA1-2 RCSB PDB | cryoem | resolution: 3.11 Å | in vitro · ligands NAG, ZN, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of hACE2-bound SARS-CoV-2 Omicron spike protein with L371S, P373S and F375S mutations (local refinement) · Spike protein S1 (chains B) | unmapped |
| EV-PDB-7YBH-1 RCSB PDB | cryoem | resolution: 3.5 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 lambda variant spike · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7YBI-1 RCSB PDB | cryoem | resolution: 4.1 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 Mu variant spike (open state) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7YBJ-1 RCSB PDB | cryoem | resolution: 3.73 Å | in vitro SARS-CoV-2 Mu variant spike(close state) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7YBK-1 RCSB PDB | cryoem | resolution: 3.9 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 B.1.620 variant spike (open state) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7YBM-1 RCSB PDB | cryoem | resolution: 3.45 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 C.1.2 variant spike (Close state) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7YC5-1 RCSB PDB | cryoem | resolution: 3.1 Å | in vitro · ligands NAG Cryo-EM structure of SARS-CoV-2 spike in complex with K202.B bispecific antibody · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7YCN-1 RCSB PDB | xray | resolution: 2.85 Å | in vitro · -173.15 °C · pH 7 · ligands NAG Crystal structure of SARS-CoV-2 Spike RBD in complex with IY-2A Fab · Spike protein S1 (chains A,B,G,J) | unmapped |
| EV-PDB-7YCO-1 RCSB PDB | xray | resolution: 1.96 Å | in vitro · -173.15 °C · ligands NAG Crystal structure of SARS-CoV-2 Receptor Binding Domain bound to A6 repebody · Spike protein S1 (chains A) | unmapped |
| EV-PDB-7YD0-1 RCSB PDB | cryoem | resolution: 3.58 Å | in vitro SARS-CoV-2 Omicron 1-RBD up spike trimer complexed with two XG005 Fab · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7YD1-1 RCSB PDB | cryoem | resolution: 2.99 Å | in vitro Local refinement of SARS-CoV-2 Omicron S trimer complexed with XG005 · Spike protein S1 (chains C) | unmapped |
| EV-PDB-7YDY-1 RCSB PDB | cryoem | resolution: 4.75 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 Spike (6P) in complex with 1 R1-32 Fab · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7YE5-1 RCSB PDB | cryoem | resolution: 6.75 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 Spike (6P) in complex with 2 R1-32 Fabs · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7YEG-1 RCSB PDB | cryoem | resolution: 3.73 Å | in vitro · ligands NAG, ZN, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 Spike (6P) in complex with 3 R1-32 Fabs and 3 ACE2 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7YH6-3 RCSB PDB | cryoem | resolution: 3.4 Å | in vitro · ligands NAG Structure of SARS-CoV-2 spike RBD in complex with neutralizing antibody NIV-8 · Spike protein S1 (chains A) | unmapped |
| EV-PDB-7YHW-2 RCSB PDB | cryoem | resolution: 3.09 Å | in vitro · ligands NAG, ZN, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 Omicron BA.2.12.1 RBD in complex with human ACE2 (local refinement) · Spike protein S1 (chains B) | unmapped |
| EV-PDB-7YJ3-2 RCSB PDB | cryoem | resolution: 3.14 Å | in vitro · ligands NAG, ZN Cryo-EM structure of SARS-CoV-2 Omicron BA.2 RBD in complex with human ACE2 (local refinement) · Spike protein S1 (chains B) | unmapped |
| EV-PDB-7YOW-3 RCSB PDB | xray | resolution: 3.3 Å | in vitro · -173.15 °C · pH 5.5 · ligands SO4 Crystal structure of SARS-CoV-2 omicron variant spike receptor-binding domain (RBD) in complex with NCV2SG48 Fab · Spike protein S1 (chains C,R) | unmapped |
| EV-PDB-7YQT-1 RCSB PDB | cryoem | resolution: 3.45 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 BA.2.75 S Trimer (1 RBD Up) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7YQU-1 RCSB PDB | cryoem | resolution: 3.19 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 BA.2.75 S Trimer (3 RBD Down) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7YQV-1 RCSB PDB | cryoem | resolution: 3.58 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose pH 5.5 SARS-CoV-2 BA.2.75 S Trimer (1 RBD Up) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7YQW-1 RCSB PDB | cryoem | resolution: 3.51 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 BA.2.75 S Trimer (3 RBD Down) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7YKJ-1 RCSB PDB | cryoem | resolution: 3.5 Å | in vitro Omicron RBDs bound with P3E6 Fab (one up and one down) · Spike glycoprotein (chains B,C) | unmapped |
| EV-PDB-7YH7-1 RCSB PDB | cryoem | resolution: 3.3 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 spike in complex with neutralizing antibody NIV-8 (state 2) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7YE9-1 RCSB PDB | cryoem | resolution: 4.17 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 Spike (6P) in complex with 3 R1-32 Fabs · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7YDI-2 RCSB PDB | cryoem | resolution: 3.98 Å | in vitro · ligands NAG, ZN SARS-CoV-2 Spike (6P) in complex with 3 R1-32 Fabs and 3 ACE2, focused refinement of RBD region · Spike protein S1 (chains E) | unmapped |
| EV-PDB-7YCZ-1 RCSB PDB | cryoem | resolution: 3.24 Å | in vitro SARS-CoV-2 Omicron 2-RBD up Spike trimer complexed with three XG005 molecules · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7YCY-1 RCSB PDB | cryoem | resolution: 3.74 Å | in vitro SARS-CoV-2 Omicron 1-RBD up Spike trimer complexed with three XG005 molecules · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7YCL-3 RCSB PDB | xray | resolution: 2.13 Å | in vitro · -173.15 °C · pH 8 · ligands branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose Crystal structure of SARS-CoV-2 Spike RBD in complex with IS-9A Fab · Spike protein S1 (chains D,R) | unmapped |
| EV-PDB-7YCK-1 RCSB PDB | xray | resolution: 2.6 Å | in vitro · -173.15 °C · pH 9 · ligands branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose Crystal structure of SARS-CoV-2 Spike RBD in complex with FP-12A Fab · Spike protein S1 (chains A,B) | unmapped |
| EV-PDB-7YBN-1 RCSB PDB | cryoem | resolution: 3.82 Å | in vitro SARS-CoV-2 C.1.2 variant spike (Open state) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7YBL-1 RCSB PDB | cryoem | resolution: 3.6 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 B.1.620 variant spike (close state) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7YAD-3 RCSB PDB | cryoem | resolution: 2.66 Å | in vitro · ligands branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of S309-RBD-RBD-S309 in the S309-bound Omicron spike protein (local refinement) · Spike protein S1 (chains E,M) | unmapped |
| EV-PDB-7Y9S-1 RCSB PDB | cryoem | resolution: 3 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of apo SARS-CoV-2 Omicron spike protein (S-2P-GSAS) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7Y7J-1 RCSB PDB | cryoem | resolution: 3.8 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 S trimer in complex with 1F Fab · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7Y76-3 RCSB PDB | cryoem | resolution: 3.2 Å | in vitro · ligands 3PH, NAG, ZN, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SIT1-ACE2-BA.5 RBD · Spike protein S1 (chains E,F) | unmapped |
| EV-PDB-7Y72-1 RCSB PDB | cryoem | resolution: 4.03 Å | in vitro SARS-CoV-2 spike glycoprotein trimer complexed with Fab fragment of anti-RBD antibody E7 (focused refinement on Fab-RBD interface) · Spike glycoprotein (chains A,C) | unmapped |
| EV-PDB-7Y6N-1 RCSB PDB | cryoem | resolution: 4.4 Å | in vitro · ligands NAG The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab803 · Spike glycoprotein (chains A) | unmapped |
| EV-PDB-7Y6L-1 RCSB PDB | cryoem | resolution: 3.5 Å | in vitro · ligands NAG The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab816 · Spike glycoprotein (chains A) | unmapped |
| EV-PDB-7Y6D-1 RCSB PDB | cryoem | resolution: 4.39 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 Delta variant spike proteins on intact virions: 3 Closed RBD · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7YR3-1 RCSB PDB | cryoem | resolution: 3.52 Å | in vitro · ligands CL, NAG, ZN, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 BA.2.75 S Trimer in complex with ACE2(state2) · Spike glycoprotein (chains B,C,F) | unmapped |
| EV-PDB-7Z1A-1 RCSB PDB | xray | resolution: 2.59 Å | in vitro · -173.15 °C · ligands NAG Nanobody H11 and F2 bound to RBD · Spike protein S1 (chains A,C) | unmapped |
| EV-PDB-7ZF3-5 RCSB PDB | xray | resolution: 3.15 Å | in vitro · -173.15 °C · ligands GOL, IPA SARS-CoV-2 Omicron RBD in complex with Omi-3 and EY6A Fabs · Spike protein S1 (chains E) | unmapped |
| EV-PDB-7ZF8-3 RCSB PDB | xray | resolution: 2.95 Å | in vitro · -173.15 °C SARS-CoV-2 Omicron BA.2 RBD in complex with COVOX-150 Fab · Spike protein S1 (chains E) | unmapped |
| EV-PDB-7ZF9-3 RCSB PDB | xray | resolution: 3.25 Å | in vitro · -173.15 °C · ligands NAG SARS-CoV-2 Omicron BA.2 RBD in complex with COVOX-150 Fab (P21) · Spike protein S1 (chains C,E) | unmapped |
| EV-PDB-7ZFA-1 RCSB PDB | xray | resolution: 4.24 Å | in vitro · -173.15 °C SARS-CoV-2 Omicron RBD in complex with Omi-6 and COVOX-150 Fabs · Spike protein S1 (chains A,B,C,D) | unmapped |
| EV-PDB-7ZF7-2 RCSB PDB | xray | resolution: 3.46 Å | in vitro · -173.15 °C · ligands NAG, ZN SARS-CoV-2 Omicron BA.2 RBD in complex with ACE2 · Spike protein S1 (chains B) | unmapped |
| EV-PDB-7ZF5-3 RCSB PDB | xray | resolution: 5.32 Å | in vitro · -173.15 °C SARS-CoV-2 Omicron RBD in complex with Omi-12 and Beta-54 Fabs · Spike protein S1 (chains A,E) | unmapped |
| EV-PDB-7ZF4-4 RCSB PDB | xray | resolution: 4.18 Å | in vitro · -173.15 °C SARS-CoV-2 Omicron RBD in complex with Omi-9 Fab and nanobody F2 · Spike protein S1 (chains E) | unmapped |
| EV-PDB-7ZDQ-2 RCSB PDB | cryoem | resolution: 3.2 Å | in vitro · ligands NAG Cryo-EM structure of Human ACE2 bound to a high-affinity SARS CoV-2 mutant · Spike protein S1 (chains B) | unmapped |
| EV-PDB-7ZCF-1 RCSB PDB | cryoem | resolution: 4 Å | in vitro · ligands NAG SARS-CoV-2 Spike RBD in complex with the single chain fragment scFv76 (Focused Refinement) · Spike glycoprotein,Fibritin (chains C) | unmapped |
| EV-PDB-7ZCE-1 RCSB PDB | cryoem | resolution: 3.5 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 Spike protein in complex with the single chain fragment scFv76 · Spike glycoprotein,Fibritin (chains A,B,C) | unmapped |
| EV-PDB-7ZBU-1 RCSB PDB | cryoem | resolution: 4.31 Å | in vitro · ligands 3Q9, NAG CryoEM structure of SARS-CoV-2 spike monomer in complex with neutralising antibody P008_60 · Spike glycoprotein (chains A) | unmapped |
| EV-PDB-7Z9R-1 RCSB PDB | cryoem | resolution: 4.2 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE : H11-H4 Q98R H100E nanobody complex in 2Up1Down conformation · Spike glycoprotein,Fibritin (chains A,B,C) | unmapped |
| EV-PDB-7Z9Q-1 RCSB PDB | cryoem | resolution: 3.6 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE : H11-A10 nanobody complex · Spike glycoprotein,Fibritin (chains A,B,C) | unmapped |
| EV-PDB-7Z8O-1 RCSB PDB | xray | resolution: 0.96 Å | in vitro · -173.15 °C · ligands GOL, KZ0 Crystal structure of SARS-CoV-2 S RBD in complex with a stapled peptide · Spike protein S1 (chains A) | unmapped |
| EV-PDB-7Z86-1 RCSB PDB | cryoem | resolution: 3.4 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE : H11-H4 Q98R H100E nanobody complex in 1Up2Down conformation · Spike glycoprotein,Fibritin (chains A,B,C) | unmapped |
| EV-PDB-7Z85-1 RCSB PDB | cryoem | resolution: 3.1 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE : H11-B5 nanobody complex · Spike glycoprotein,Fibritin (chains A,B,C) | unmapped |
| EV-PDB-7Z7X-1 RCSB PDB | cryoem | resolution: 3.3 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE : H11-H6 nanobody complex · Spike glycoprotein,Fibritin (chains A,B,C) | unmapped |
| EV-PDB-7Z6V-1 RCSB PDB | cryoem | resolution: 3.1 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE : H11 nanobody complex · Spike glycoprotein,Fibritin (chains A,B,C) | unmapped |
| EV-PDB-7Z3Z-1 RCSB PDB | cryoem | resolution: 3.1 Å | in vitro · ligands NAG, STE, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Locked Wuhan SARS-CoV2 Prefusion Spike ectodomain with lipid bound · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7Z1E-1 RCSB PDB | xray | resolution: 1.59 Å | in vitro · -173.15 °C · ligands GOL, NAG, NO3 Nanobody H11-H4 Q98R H100E bound to RBD · Spike protein S1 (chains EEE) | unmapped |
| EV-PDB-7Z1D-1 RCSB PDB | xray | resolution: 1.55 Å | in vitro · -173.15 °C · ligands GOL, NAG Nanobody H11-H6 bound to RBD · Spike protein S1 (chains EEE) | unmapped |
| EV-PDB-7Z1C-1 RCSB PDB | xray | resolution: 1.9 Å | in vitro · -173.15 °C · ligands NAG, PEG Nanobody H11-B5 and H11-F2 bound to RBD · Spike protein S1 (chains A,C) | unmapped |
| EV-PDB-7Z1B-1 RCSB PDB | xray | resolution: 2.3 Å | in vitro · -173.15 °C · ligands NAG Nanobody H11-A10 and F2 bound to RBD · Spike protein S1 (chains A,C) | unmapped |
| EV-PDB-7Z0Y-3 RCSB PDB | xray | resolution: 2.95 Å | in vitro · -173.15 °C · pH 6.5 · ligands SO4, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose THSC20.HVTR04 Fab bound to SARS-CoV-2 Receptor Binding Domain · Spike protein S1 (chains R) | unmapped |
| EV-PDB-7Z0X-3 RCSB PDB | xray | resolution: 1.8 Å | in vitro · -173.15 °C · pH 7 · ligands EPE, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose THSC20.HVTR26 Fab bound to SARS-CoV-2 Receptor Binding Domain · Spike protein S1 (chains R) | unmapped |
| EV-PDB-7YVU-2 RCSB PDB | cryoem | resolution: 3.2 Å | in vitro · ligands NAG, ZN Cryo-EM structure of SARS-CoV-2 Omicron BA.2 RBD in complex with mouse ACE2 (local refinement) · Spike protein S1 (chains B) | unmapped |
| EV-PDB-7YVP-5 RCSB PDB | cryoem | resolution: 3.8 Å | in vitro · ligands NAG Omicron BA.4/5 SARS-CoV-2 S in complex with TH272/281 Fab · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7YVO-1 RCSB PDB | cryoem | resolution: 3.3 Å | in vitro · ligands NAG Omicron BA.4/5 SARS-CoV-2 S in complex with TH027/132 Fab · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7YVN-1 RCSB PDB | cryoem | resolution: 3.4 Å | in vitro · ligands NAG Omicron BA.4/5 SARS-CoV-2 S in complex with TH281 Fab · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7YVM-3 RCSB PDB | cryoem | resolution: 3.5 Å | in vitro Omicron BA.4/5 SARS-CoV-2 S RBD in complex with TH272 Fab · Spike glycoprotein (chains B) | unmapped |
| EV-PDB-7YVL-3 RCSB PDB | cryoem | resolution: 3.3 Å | in vitro Omicron BA.4/5 SARS-CoV-2 S RBD in complex with TH272 Fab · Spike glycoprotein (chains B) | unmapped |
| EV-PDB-7YVK-1 RCSB PDB | cryoem | resolution: 3.2 Å | in vitro · ligands NAG Omicron BA.4/5 SARS-CoV-2 S in complex with TH272 Fab · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7YVJ-3 RCSB PDB | cryoem | resolution: 3.6 Å | in vitro Omicron BA.4/5 SARS-CoV-2 S RBD in complex with TH236 Fab · Spike glycoprotein (chains B) | unmapped |
| EV-PDB-7YVI-1 RCSB PDB | cryoem | resolution: 3.7 Å | in vitro · ligands NAG Omicron BA.4/5 SARS-CoV-2 S in complex with TH236 Fab · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7YVH-3 RCSB PDB | cryoem | resolution: 3.6 Å | in vitro Omicron BA.4/5 SARS-CoV-2 S RBD in complex with TH132 Fab · Spike glycoprotein (chains B) | unmapped |
| EV-PDB-7YVG-1 RCSB PDB | cryoem | resolution: 3.4 Å | in vitro · ligands NAG Omicron BA.4/5 SARS-CoV-2 S in complex with TH132 Fab · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7YVF-3 RCSB PDB | cryoem | resolution: 3.4 Å | in vitro Omicron BA.4/5 SARS-CoV-2 S RBD in complex with TH027 Fab · Spike glycoprotein (chains B) | unmapped |
| EV-PDB-7YVE-1 RCSB PDB | cryoem | resolution: 3.4 Å | in vitro · ligands NAG Omicron BA.4/5 SARS-CoV-2 S in complex with TH027 Fab · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7YV8-2 RCSB PDB | cryoem | resolution: 2.94 Å | in vitro · ligands NAG, ZN Cryo-EM structure of SARS-CoV-2 Omicron BA.2 RBD in complex with golden hamster ACE2 (local refinement) · Spike glycoprotein (chains B) | unmapped |
| EV-PDB-7YUE-2 RCSB PDB | xray | resolution: 2.35 Å | in vitro · -173.15 °C · pH 5.9 Epitope-directed anti-SARS CoV 2 scFv engineered against the key spike protein region. · Spike protein S2 (chains C) | unmapped |
| EV-PDB-7YTN-3 RCSB PDB | xray | resolution: 3.51 Å | in vitro · -173.15 °C · pH 7 Crystal structure of SARS-CoV-2 Alpha RBD in complex with the D27LEY neutralizing antibody Fab fragment · Spike protein S1 (chains C) | unmapped |
| EV-PDB-7YR4-2 RCSB PDB | cryoem | resolution: 4.12 Å | in vitro SARS-CoV-2 BA.2.75 S Trimer in complex with ACE2(interface) · Spike glycoprotein (chains D) | unmapped |
| EV-PDB-7YR2-2 RCSB PDB | cryoem | resolution: 3.3 Å | in vitro · ligands CL, NAG, ZN, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 BA.2.75 S Trimer in complex with ACE2(state1) · Spike glycoprotein (chains C,D,E) | unmapped |
| EV-PDB-7YR1-1 RCSB PDB | cryoem | resolution: 3.62 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 BA.2.75 S Trimer in complex with XG2v024 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7YR0-1 RCSB PDB | cryoem | resolution: 3.98 Å | in vitro · ligands branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 BA.2.75 S Trimer in complex with S309 (interface) · Spike protein S1 (chains A) | unmapped |
| EV-PDB-7YQZ-1 RCSB PDB | cryoem | resolution: 3.84 Å | in vitro · ligands NAG, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 BA.2.75 S Trimer in complex with S309 (state3) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7YQY-1 RCSB PDB | cryoem | resolution: 3.74 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 BA.2.75 S Trimer in complex with S309 (state2) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7YQX-1 RCSB PDB | cryoem | resolution: 3.72 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 BA.2.75 S Trimer in complex with S309 (state1) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8A94-1 RCSB PDB | cryoem | resolution: 2.4 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS CoV2 Spike in the 2-up state in complex with Fab47. · SARS-CoV2 Spike in 2-up conformation in complex with Fab47 (chains A,B,C) | unmapped |
| EV-PDB-8BBN-3 RCSB PDB | xray | resolution: 3.58 Å | in vitro · -173.15 °C SARS-CoV-2 Delta-RBD complexed with BA.2-10 and EY6A Fabs · Spike protein S1 (chains R,X,Y) | unmapped |
| EV-PDB-8C8P-2 RCSB PDB | cryoem | resolution: 4.1 Å | in vitro Structure of the SARS-CoV-2 spike glycoprotein in complex with the 10D12 heavy-chain-only antibody (local refinement) · Spike glycoprotein,SARS-CoV-2 spike glycoprotein (chains A) | unmapped |
| EV-PDB-8C89-1 RCSB PDB | cryoem | resolution: 4.41 Å | in vitro · ligands branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 spike in complex with the 17T2 neutralizing antibody Fab fragment (local refinement of RBD and Fab) · Spike protein S2' (chains C) | unmapped |
| EV-PDB-8C5R-1 RCSB PDB | cryoem | resolution: 3.7 Å | in vitro Omicron B.1.1.529 2 RBD up conformation · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8C3V-3 RCSB PDB | xray | resolution: 2.74 Å | in vitro · -173.15 °C · ligands GOL, PG0, PG4, branched: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 Delta-RBD complexed with BA.2-13 Fab and C1 nanobody · Spike protein S1 (chains R,X,Y) | unmapped |
| EV-PDB-8C2R-1 RCSB PDB | cryoem | resolution: 2.56 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV2 Omicron BA.1 spike in complex with CAB-A17 antibody · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8C1V-1 RCSB PDB | cryoem | resolution: 2.9 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 S-trimer (3 RBDs up) bound to TriSb92, fitted into cryo-EM map · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8C0Y-1 RCSB PDB | cryoem | resolution: 2.68 Å | in vitro SARS-CoV2 Omicron BA.1 RBD in complex with CAB-A17 antibody · Spike protein S2' (chains A) | unmapped |
| EV-PDB-8BSF-1 RCSB PDB | xray | resolution: 2.2 Å | in vitro · -173.15 °C · ligands GOL, NAG CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN (RBD-beta variant) in complex with 3D2 Fab · Spike protein S1 (chains A) | unmapped |
| EV-PDB-8BSE-1 RCSB PDB | xray | resolution: 1.9 Å | in vitro · -173.15 °C · ligands GOL, NAG, TRS CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN (RBD) in complex with 1D1 Fab · Spike glycoprotein (chains A) | unmapped |
| EV-PDB-8BON-1 RCSB PDB | cryoem | resolution: 3.2 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Structure of the SARS-CoV-2 spike glycoprotein in complex with the macrocyclic peptide S1B3inL1 · Spike glycoprotein,Fibritin (chains A,B,C) | unmapped |
| EV-PDB-8BH5-3 RCSB PDB | xray | resolution: 2.38 Å | in vitro · -173.15 °C · ligands GOL, PO4, branched: alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 BA.2.12.1 RBD in complex with Beta-27 Fab and C1 nanobody · Spike protein S1 (chains E) | unmapped |
| EV-PDB-8BGG-1 RCSB PDB | cryoem | resolution: 6.04 Å | in vitro · ligands NAG, branched: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 spike (Omicron BA.1 variant) in complex with nanobody W25 (map 5, focus refinement on RBD, W25 and adjacent NTD) · Spike glycoprotein (chains B,C) | unmapped |
| EV-PDB-8BG8-1 RCSB PDB | cryoem | resolution: 3.64 Å | in vitro · ligands branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 S protein in complex with pT1696 Fab · Spike glycoprotein (chains A) | unmapped |
| EV-PDB-8BG6-3 RCSB PDB | cryoem | resolution: 4.11 Å | in vitro · ligands NAG SARS-CoV-2 S protein in complex with pT1644 Fab · Spike glycoprotein (chains E) | unmapped |
| EV-PDB-8BG5-2 RCSB PDB | xray | resolution: 2.05 Å | in vitro · -173.15 °C · ligands NAG Crystal structure of the SARS-CoV-2 S RBD in complex with pT1631 scFV · Spike protein S1 (chains B,D) | unmapped |
| EV-PDB-8BG4-2 RCSB PDB | xray | resolution: 1.6 Å | in vitro · -173.15 °C · ligands NAG Crystal structure of the SARS-CoV-2 S RBD in complex with pT1611 scFV · Spike protein S1 (chains B,D) | unmapped |
| EV-PDB-8BG3-2 RCSB PDB | xray | resolution: 1.9 Å | in vitro · -173.15 °C · pH 6 · ligands NAG Crystal structure of the SARS-CoV-2 S RBD in complex with pT1610 scFV · Spike protein S1 (chains B,D) | unmapped |
| EV-PDB-8BG2-2 RCSB PDB | xray | resolution: 2.1 Å | in vitro · -173.15 °C · ligands NAG Crystal structure of the SARS-CoV-2 S RBD in complex with pT1580 scFV · Spike protein S1 (chains B,D) | unmapped |
| EV-PDB-8BG1-3 RCSB PDB | xray | resolution: 2.88 Å | in vitro · -173.15 °C · pH 7.5 · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose Crystal structure of the SARS-CoV-2 S RBD in complex with pT1511 scFV · Spike protein S1 (chains C,F,I,L) | unmapped |
| EV-PDB-8BEV-1 RCSB PDB | cryoem | resolution: 5.92 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 spike (HexaPro variant) in complex with nanobody W25 (map 3, focus refinement on RBD, W25 and adjacent NTD) · Spike glycoprotein (chains A,C) | unmapped |
| EV-PDB-8BEC-2 RCSB PDB | xray | resolution: 1.7 Å | in vitro · -173.15 °C · pH 8.5 · ligands SO4, branched: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Crystal structure of the SARS-CoV-2 S RBD in complex with pT1375 scFV · Spike protein S1 (chains B,D) | unmapped |
| EV-PDB-8BE1-3 RCSB PDB | xray | resolution: 1.98 Å | in vitro · -173.15 °C · pH 6.5 · ligands SO4 SARS-CoV-2 RBD in complex with a Fab fragment of a neutralising antibody mRBD2 · Spike protein S1 (chains C,F) | unmapped |
| EV-PDB-8BCZ-1 RCSB PDB | cryoem | resolution: 2.9 Å | in vitro SARS-CoV-2 Delta-RBD complexed with Fabs BA.2-36, BA.2-23, EY6A and COVOX-45 · Spike protein S1 (chains R) | unmapped |
| EV-PDB-8ASY-2 RCSB PDB | xray | resolution: 2.85 Å | in vitro · -173.15 °C · ligands CL, GOL, NAG, PGE SARS-CoV-2 Omicron BA.2.75 RBD in complex with ACE2 · Spike protein S1 (chains B) | unmapped |
| EV-PDB-8AQW-1 RCSB PDB | cryoem | resolution: 3.3 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose BA.4/5 SARS-CoV-2 Spike bound to mouse ACE2 (local) · Spike glycoprotein,Fibritin (chains B) | unmapped |
| EV-PDB-8AQV-2 RCSB PDB | cryoem | resolution: 2.96 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose BA.2.12.1 SARS-CoV-2 Spike bound to mouse ACE2 (local) · Spike glycoprotein,Fibritin (chains B) | unmapped |
| EV-PDB-8AQU-2 RCSB PDB | cryoem | resolution: 3.22 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose BA.1 SARS-CoV-2 Spike bound to mouse ACE2 (local) · Spike glycoprotein,Fibritin (chains B) | unmapped |
| EV-PDB-8AQT-2 RCSB PDB | cryoem | resolution: 4.4 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Beta SARS-CoV-2 Spike bound to mouse ACE2 (local) · Spike glycoprotein,Fibritin (chains B) | unmapped |
| EV-PDB-8AJL-1 RCSB PDB | cryoem | resolution: 2.77 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Structure of the Ancestral Scaffold Antigen-6 of Coronavirus Spike protein · Spike glycoprotein,Fibritin (chains A,B,C) | unmapped |
| EV-PDB-8AJA-1 RCSB PDB | cryoem | resolution: 2.59 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Structure of the Ancestral Scaffold Antigen-5 of Coronavirus Spike protein · Spike glycoprotein,Fibritin (chains A,B,C) | unmapped |
| EV-PDB-8AAA-1 RCSB PDB | xray | resolution: 1.9 Å | in vitro · -173.15 °C · ligands 29N Crystal structure of SARS-CoV-2 S RBD in complex with a stapled peptide · Spike protein S1 (chains A) | unmapped |
| EV-PDB-8A99-1 RCSB PDB | cryoem | resolution: 2.5 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS Cov2 Spike in 1-up conformation complex with Fab47 · SARS-CoV2 spike 1-up conformation in complex with Fab47 (chains A,B,C) | unmapped |
| EV-PDB-8A96-1 RCSB PDB | cryoem | resolution: 2.7 Å | in vitro SARS Cov2 Spike RBD in complex with Fab47 · Spike protein S1 (chains C) | unmapped |
| EV-PDB-8A95-1 RCSB PDB | cryoem | resolution: 2.64 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS Cov2 Spike RBD in complex with Fab47 · SARS-CoV2 Trimeric Spike in 1-up conformation in complex with three Fab47 (chains A,B,C) | unmapped |
| EV-PDB-7ZXU-1 RCSB PDB | xray | resolution: 1.89 Å | in vitro · -173.15 °C · ligands GOL, IPA, NAG, PG4 SARS-CoV-2 Omicron BA.4/5 RBD in complex with Beta-27 Fab and C1 nanobody · Spike protein S1 (chains E) | unmapped |
| EV-PDB-7ZSS-1 RCSB PDB | cryoem | resolution: 2.63 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose cryo-EM structure of D614 spike in complex with de novo designed binder · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7ZSD-1 RCSB PDB | cryoem | resolution: 3.29 Å | in vitro · ligands branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose cryo-EM structure of omicron spike in complex with de novo designed binder, local · Spike glycoprotein (chains M) | unmapped |
| EV-PDB-7ZRV-1 RCSB PDB | cryoem | resolution: 2.8 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose cryo-EM structure of omicron spike in complex with de novo designed binder, full map · Spike glycoprotein,Envelope glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7ZRC-1 RCSB PDB | cryoem | resolution: 3.5 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose OMI-38 FAB IN COMPLEX WITH SARS-COV-2 BETA SPIKE · Spike glycoprotein,Fibritin (chains A,B,C) | unmapped |
| EV-PDB-7ZR9-1 RCSB PDB | cryoem | resolution: 4 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose OMI-2 FAB IN COMPLEX WITH SARS-COV-2 BETA SPIKE GLYCOPROTEIN · Spike glycoprotein,Fibritin (chains A,B,C) | unmapped |
| EV-PDB-7ZR8-1 RCSB PDB | cryoem | resolution: 3.7 Å | in vitro · ligands NAG OMI-38 FAB IN COMPLEX WITH SARS-COV-2 BETA SPIKE RBD (local refinement) · Spike glycoprotein,Fibritin (chains A) | unmapped |
| EV-PDB-7ZR7-1 RCSB PDB | cryoem | resolution: 3.7 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose OMI-42 FAB IN COMPLEX WITH SARS-COV-2 BETA SPIKE GLYCOPROTEIN · Spike glycoprotein,Fibritin (chains A,B,C) | unmapped |
| EV-PDB-7ZR2-2 RCSB PDB | xray | resolution: 1.45 Å | in vitro · -173.15 °C · pH 7.5 Crystal structure of a chimeric protein mimic of SARS-CoV-2 Spike HR1 in complex with HR2 · Spike protein S2' (chains B) | unmapped |
| EV-PDB-7ZR2-1 RCSB PDB | xray | resolution: 1.45 Å | in vitro · -173.15 °C · pH 7.5 Crystal structure of a chimeric protein mimic of SARS-CoV-2 Spike HR1 in complex with HR2 · Spike protein S2',Chimeric protein mimic of SARS-CoV-2 Spike HR1 (chains A) | unmapped |
| EV-PDB-7ZJL-1 RCSB PDB | cryoem | resolution: 2.6 Å | in vitro Delta SARS-CoV-2 spike protein in complex with REGN10987 Fab homologue. · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-7ZFE-2 RCSB PDB | xray | resolution: 3.25 Å | in vitro · -173.15 °C SARS-CoV-2 Omicron RBD in complex with Omi-32 Fab and nanobody C1 · Spike protein S1 (chains A,B,C,E) | unmapped |
| EV-PDB-7ZFD-2 RCSB PDB | xray | resolution: 3.39 Å | in vitro · -173.15 °C SARS-CoV-2 Omicron RBD in complex with Omi-25 Fab · Spike protein S1 (chains E,F) | unmapped |
| EV-PDB-7ZFC-6 RCSB PDB | xray | resolution: 3.24 Å | in vitro · -173.15 °C · ligands branched: alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 Beta RBD in complex with nanobody C1, Omi-18 and Omi-31 Fabs · Spike protein S1 (chains E) | unmapped |
| EV-PDB-7ZFB-2 RCSB PDB | xray | resolution: 3.08 Å | in vitro · -173.15 °C · ligands NAG SARS-CoV-2 Omicron RBD in complex with nanobody C1, Omi-18 and Omi-31 Fabs · Spike protein S1 (chains E,F) | unmapped |
| EV-PDB-8CBD-1 RCSB PDB | xray | resolution: 3.52 Å | in vitro · -173.15 °C · ligands NAG SARS-CoV-2 Delta-RBD complexed with BA.4/5-1 and EY6A Fabs · Spike protein S1 (chains R,X,Y) | unmapped |
| EV-PDB-8CBE-3 RCSB PDB | xray | resolution: 3.16 Å | in vitro · -173.15 °C · ligands branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 Delta-RBD complexed with BA.4/5-2 and Beta-49 Fabs · Spike protein S1 (chains E) | unmapped |
| EV-PDB-8CBF-1 RCSB PDB | xray | resolution: 2.33 Å | in vitro · -173.15 °C · ligands CL, GOL, SO4, branched: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 Delta-RBD complexed with Omi-42 and Beta-49 Fabs · Spike protein S1 (chains E) | unmapped |
| EV-PDB-8CII-1 RCSB PDB | cryoem | resolution: 2.7 Å | in vitro · ligands branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose Delta-RBD complex with BA.2-07 fab, SARS1-34 fab and C1 nanobody · Spike protein S2' (chains E) | unmapped |
| EV-PDB-8CIM-1 RCSB PDB | cryoem | resolution: 3 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose BA.2-07 FAB IN COMPLEX WITH SARS-COV-2 BA.2.12.1 SPIKE GLYCOPROTEIN · Spike glycoprotein,Fibritin (chains A,B,C) | unmapped |
| EV-PDB-8CIN-1 RCSB PDB | cryoem | resolution: 2.7 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose BA.4/5-5 FAB IN COMPLEX WITH SARS-COV-2 BA.4 SPIKE GLYCOPROTEIN · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8CMB-3 RCSB PDB | xray | resolution: 1.84 Å | in vitro · -173.15 °C · pH 6 · ligands DHL, EDO Human Leukocyte Antigen class II allotype DR1 presenting SARS-CoV-2 Spike peptide S486-505 · Spike protein S2' (chains C) | unmapped |
| EV-PDB-8CMD-3 RCSB PDB | xray | resolution: 2.54 Å | in vitro · -173.15 °C · pH 5 · ligands EDO Human Leukocyte Antigen class II allotype DR1 presenting SARS-CoV-2 Spike peptide S761-775 · Spike protein S2' (chains C,F,I) | unmapped |
| EV-PDB-8CMH-3 RCSB PDB | xray | resolution: 1.64 Å | in vitro · -173.15 °C · pH 6 · ligands DHL, EDO, SO4 Human Leukocyte Antigen class II allotype DR1 presenting SARS-CoV-2 Omicron (BA.1) Spike peptide S486-505 · Spike protein S2' (chains C) | unmapped |
| EV-PDB-8CMI-3 RCSB PDB | xray | resolution: 2.6 Å | in vitro · -173.15 °C · pH 7 · ligands EDO, SO4 Human Leukocyte Antigen class II allotype DR1 presenting SARS-CoV-2 Omicron (BA.1) Spike peptide S761-775 · Spike protein S2' (chains C,F,I) | unmapped |
| EV-PDB-8CSA-1 RCSB PDB | cryoem | resolution: 3.84 Å | in vitro Triple mutant (K417N-E484K-N501Y) SARS-CoV-2 spike protein in the 3-RBD-Down conformation (S-GSAS-D614G-K417N-E484K-N501Y) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8CWI-1 RCSB PDB | xray | resolution: 1.873 Å | in vitro · -173.15 °C · pH 5 · ligands CL, MG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose Fab arm of antibody 10G4 bound to CoV-2 receptor binding domain (RBD) · Spike protein S1 (chains A) | unmapped |
| EV-PDB-8CWJ-3 RCSB PDB | xray | resolution: 2.449 Å | in vitro · -173.15 °C · ligands CL, GOL, NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose Fab arms of antibodies 4C12-B12 and CR3022 bound to pangolin receptor binding domain (pRBD) · Spike glycoprotein (chains G,I) | unmapped |
| EV-PDB-8CWK-5 RCSB PDB | xray | resolution: 2.368 Å | in vitro · -173.15 °C · ligands GOL, NAG Fab arm of antibodies 4G1-C2 and 10G4 bound to CoV-2 receptor binding domain (RBD) · Spike protein S1 (chains C) | unmapped |
| EV-PDB-8CWU-1 RCSB PDB | xray | resolution: 1.71 Å | in vitro · -173.15 °C · pH 10.5 · ligands branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose Crystal structure of SARS-CoV-2 spike protein receptor-binding domain in complex with a cross-neutralizing nanobody 1-21 · Spike protein S1 (chains A) | unmapped |
| EV-PDB-8CXN-1 RCSB PDB | cryoem | resolution: 2.9 Å | in vitro · ligands NAG SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 2-57 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8CXQ-1 RCSB PDB | cryoem | resolution: 2.3 Å | in vitro SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 1-22 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8CY9-1 RCSB PDB | cryoem | resolution: 2.9 Å | in vitro SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 1-23 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8CYA-1 RCSB PDB | cryoem | resolution: 2.7 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 2-67 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8CYB-1 RCSB PDB | cryoem | resolution: 2.7 Å | in vitro · ligands AH2, NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-L-fucopyranose-(1-2)-beta-D-galactopyranose-(1-4)-alpha-L-fucopyranose-(1-6)-[beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)]2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-L-fucopyranose-(1-3)-[2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)]2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-3)]2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 1-8 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8CYC-1 RCSB PDB | cryoem | resolution: 2.9 Å | in vitro SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 2-34 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8CYD-1 RCSB PDB | cryoem | resolution: 2.6 Å | in vitro SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 2-45 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8CZI-2 RCSB PDB | cryoem | resolution: 2.22 Å | in vitro Cryo-EM structure of the SARS-CoV-2 HR1HR2 fusion core complex with extended HR2 · Spike protein S2' HR2 (chains D,E,F) | unmapped |
| EV-PDB-8CZI-1 RCSB PDB | cryoem | resolution: 2.22 Å | in vitro Cryo-EM structure of the SARS-CoV-2 HR1HR2 fusion core complex with extended HR2 · Scaffolded Spike protein S2' HR1 (chains A,B,C) | unmapped |
| EV-PDB-8D0Z-1 RCSB PDB | cryoem | resolution: 3.7 Å | in vitro · ligands NAG S728-1157 IgG in complex with SARS-CoV-2-6P-Mut7 Spike protein (focused refinement) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8D36-3 RCSB PDB | xray | resolution: 1.45 Å | in vitro · -173.15 °C · pH 4 Crystal structure of SARS-CoV-2 fusion peptide in complex with neutralizing antibody COV44-62 · Spike protein S2 fusion peptide (chains F) | unmapped |
| EV-PDB-8D48-1 RCSB PDB | cryoem | resolution: 3.7 Å | in vitro · ligands branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose sd1.040 Fab in complex with SARS-CoV-2 Spike 2P glycoprotein · Spike glycoprotein (chains A) | unmapped |
| EV-PDB-8D55-1 RCSB PDB | cryoem | resolution: 2.8 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Closed state of SARS-CoV-2 BA.2 variant spike protein · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8D56-1 RCSB PDB | cryoem | resolution: 3 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose One RBD-up state of SARS-CoV-2 BA.2 variant spike protein · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8D5A-1 RCSB PDB | cryoem | resolution: 3.1 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Middle state of SARS-CoV-2 BA.2 variant spike protein · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8D8Q-3 RCSB PDB | cryoem | resolution: 4.2 Å | in vitro · ligands NAG SARS-CoV-2 Spike RBD in complex with DMAbs 2130 and 2196 · Spike glycoprotein (chains A) | unmapped |
| EV-PDB-8D8R-3 RCSB PDB | cryoem | resolution: 4.1 Å | in vitro · ligands NAG SARS-CoV-2 Spike RBD in complex with DMAb 2196 · Spike glycoprotein (chains A) | unmapped |
| EV-PDB-8DAD-3 RCSB PDB | cryoem | resolution: 3.85 Å | in vitro · ligands branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 receptor binding domain in complex with AZ090 Fab · Spike glycoprotein (chains B) | unmapped |
| EV-PDB-8DAO-5 RCSB PDB | xray | resolution: 2.8 Å | in vitro · -173.15 °C · pH 8.5 Crystal structure of SARS-CoV-2 spike stem fusion peptide in complex with neutralizing antibody COV44-79 · Spike protein S2 fusion peptide (chains I,J) | unmapped |
| EV-PDB-8DCC-1 RCSB PDB | xray | resolution: 2.6 Å | in vitro · -173.15 °C · pH 7.4 · ligands NAG SARS-CoV-2 Receptor-Binding Domain SPEEDesign Immunogen 3 Bound to P2B-2F6 Fab · Spike protein S1 (chains E) | unmapped |
| EV-PDB-8DF5-6 RCSB PDB | xray | resolution: 2.7 Å | in vitro · -173.15 °C · ligands CL, EDO, NAG, ZN, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 Beta RBD in complex with human ACE2 and S304 Fab and S309 Fab · Spike protein S1 (chains R,S) | unmapped |
| EV-PDB-8DGU-1 RCSB PDB | xray | resolution: 1.89 Å | in vitro · -173.15 °C · pH 5.6 · ligands GOL Crystal structure of SARS-CoV-2 spike stem helix peptide in complex with Fab of broadly neutralizing antibody CC25.106 isolated from a vaccinated COVID-19 convalescent · Spike protein S2' (chains A) | unmapped |
| EV-PDB-8DI5-1 RCSB PDB | cryoem | resolution: 3.04 Å | in vitro · ligands NAG Cryo-EM structure of SARS-CoV-2 Beta (B.1.351) spike protein in complex with VH domain F6 (focused refinement of RBD and VH F6) · Spike glycoprotein (chains C) | unmapped |
| EV-PDB-8DLI-1 RCSB PDB | cryoem | resolution: 2.56 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 Alpha (B.1.1.7) spike protein · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8DLK-1 RCSB PDB | cryoem | resolution: 3.04 Å | in vitro · ligands NAG Cryo-EM structure of SARS-CoV-2 Alpha (B.1.1.7) spike protein in complex with human ACE2 (focused refinement of RBD and ACE2) · Spike glycoprotein (chains B) | unmapped |
| EV-PDB-8DLJ-1 RCSB PDB | cryoem | resolution: 2.91 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 Alpha (B.1.1.7) spike protein in complex with human ACE2 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8DCE-2 RCSB PDB | xray | resolution: 2 Å | in vitro · -173.15 °C SARS-CoV-2 Receptor-Binding Domain SPEEDesign Immunogen 1 Bound to C144 scFv · Spike protein S1 (chains A) | unmapped |
| EV-PDB-8D6Z-3 RCSB PDB | xray | resolution: 2.3 Å | in vitro · -173.15 °C · pH 7.5 Crystal structure of SARS-CoV-2 spike stem fusion peptide in complex with neutralizing antibody COV91-27 · Spike protein S2 fusion peptide (chains H,J,K,L) | unmapped |
| EV-PDB-8D47-3 RCSB PDB | xray | resolution: 2 Å | in vitro · -173.15 °C · pH 4.8 · ligands EDO, PEG, PO4 fp.006 Fab in complex with SARS-CoV-2 Fusion Peptide · SARS-CoV-2 fusion peptide (chains C,D) | unmapped |
| EV-PDB-8CYJ-5 RCSB PDB | cryoem | resolution: 3.6 Å | in vitro RBD of SARS-CoV-2 Spike protein in complex with pan-sarbecovirus nanobodies 2-10, 2-67, 2-62 and 1-25 · Spike glycoprotein (chains R) | unmapped |
| EV-PDB-8CY7-1 RCSB PDB | cryoem | resolution: 2.9 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 2-34 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8CY6-1 RCSB PDB | cryoem | resolution: 3.2 Å | in vitro SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 2-65 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8CWV-1 RCSB PDB | xray | resolution: 2.51 Å | in vitro · -173.15 °C · pH 7 · ligands branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose Crystal structure of SARS-CoV-2 spike protein receptor-binding domain in complex with a cross-neutralizing nanobody 2-31 and a human antibody CC12.1 Fab · Spike protein S1 (chains A) | unmapped |
| EV-PDB-8CSJ-1 RCSB PDB | cryoem | resolution: 3.53 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(2-3)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of NTD-directed non-neutralizing antibody 4-33 in complex with prefusion SARS-CoV-2 spike glycoprotein · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8CMC-3 RCSB PDB | xray | resolution: 1.42 Å | in vitro · -173.15 °C · pH 7 · ligands EDO, MES, SO4 Human Leukocyte Antigen class II allotype DR1 presenting SARS-CoV-2 Spike peptide S511-530 · Spike protein S2' (chains C) | unmapped |
| EV-PDB-8CMA-2 RCSB PDB | xray | resolution: 3.29 Å | in vitro · -173.15 °C · ligands NAG SARS-CoV-2 Delta-RBD complexed with BA.4/5-35 Fab · Spike protein S1 (chains E) | unmapped |
| EV-PDB-8DNN-1 RCSB PDB | xray | resolution: 3.12 Å | in vitro · -193.15 °C · ligands NAG Crystal structure of neutralizing antibody 80 in complex with SARS-CoV-2 receptor binding domain · Spike protein S1 (chains A,D) | unmapped |
| EV-PDB-8DTR-3 RCSB PDB | xray | resolution: 1.5 Å | in vitro · -173.15 °C · pH 6.5 Crystal structure of SARS-CoV-2 spike stem helix peptide in complex with neutralizing antibody COV30-14 · Spike protein S2' stem helix peptide (chains G,J) | unmapped |
| EV-PDB-8DXS-1 RCSB PDB | cryoem | resolution: 3.76 Å | in vitro · ligands NAG Cryo-EM structure of RBD-directed neutralizing antibody P2B4 in complex with prefusion SARS-CoV-2 spike glycoprotein · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8EL2-3 RCSB PDB | xray | resolution: 2.89 Å | in vitro · -173.15 °C · pH 5.5 · ligands GOL, NAG, ZN SARS-CoV-2 RBD bound to neutralizing antibody Fab ICO-hu23 · Spike protein S1 (chains A,B) | unmapped |
| EV-PDB-8EKD-3 RCSB PDB | cryoem | resolution: 3.6 Å | in vitro · ligands NAG Cryo-EM map of SARS-CoV-2 Omicron BA.2 spike in complex with 2130-1-0114-112 · Spike protein S2' (chains G) | unmapped |
| EV-PDB-8EDF-3 RCSB PDB | xray | resolution: 3.4 Å | in vitro · -173.15 °C · pH 4.2 · ligands NAG Bovine Fab SKD in complex with Sars COV-2 receptor binding domain · Spike protein S1 (chains A) | unmapped |
| EV-PDB-8E1G-3 RCSB PDB | xray | resolution: 2.57 Å | in vitro · -173.15 °C · ligands NAG SARS-CoV-2 RBD in complex with Omicron-neutralizing antibody 2A10 · Spike protein S1 (chains A,B) | unmapped |
| EV-PDB-8DZI-1 RCSB PDB | cryoem | resolution: 3.5 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Structure of SARS-CoV-2 Omicron BA.1.1.529 Spike trimer with one RBD down in complex with the Fab fragment of human neutralizing antibody MB.02 · Spike glycoprotein (chains A,C,E) | unmapped |
| EV-PDB-8DZH-1 RCSB PDB | cryoem | resolution: 3.2 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Structure of SARS-CoV-2 Omicron BA.1.1.529 Spike trimer with two RBDs down in complex with the Fab fragment of human neutralizing antibody MB.02 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8DYA-1 RCSB PDB | cryoem | resolution: 3.67 Å | in vitro · ligands NAG Structure of the SARS-CoV-2 spike glycoprotein S2 subunit · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8DXU-1 RCSB PDB | xray | resolution: 2.728 Å | in vitro · -173.15 °C · pH 6 · ligands CL, NAG Fab arms of antibodies GAR03 and 10G4 bound to the receptor binding domain of SARS-CoV-2 in a 1:1:1 complex. · Spike protein S1 (chains R) | unmapped |
| EV-PDB-8DXT-3 RCSB PDB | xray | resolution: 2.25 Å | in vitro · -173.15 °C · pH 5.5 · ligands branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose Fab arm of antibody GAR12 bound to the receptor binding domain of SARS-CoV-2. · Spike protein S1 (chains R) | unmapped |
| EV-PDB-8DWA-1 RCSB PDB | xray | resolution: 3.2 Å | in vitro · -173.15 °C · ligands NAG Crystal structure of neutralizing antibody P1D9 Fab in complex with SARS-CoV-2 spike receptor binding domain (RBD) · Spike protein S1 (chains A) | unmapped |
| EV-PDB-8DW9-1 RCSB PDB | xray | resolution: 4 Å | in vitro · -173.15 °C Crystal structure of neutralizing antibody D29 Fab in complex with SARS-CoV-2 spike receptor binding domain (RBD) · Spike protein S1 (chains A,B) | unmapped |
| EV-PDB-8DW3-2 RCSB PDB | cryoem | resolution: 4.26 Å | in vitro · ligands branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 RBD in complex with anti-SARS-CoV-2 DARPin,SR16m, and two antibody Fabs, S309 and CR3022 · Spike protein S1 (chains B) | unmapped |
| EV-PDB-8DW2-2 RCSB PDB | cryoem | resolution: 4.11 Å | in vitro · ligands branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 RBD in complex with anti-SARS-CoV-2 DARPin,SR22, and two antibody Fabs, S309 and CR3022 · Spike protein S1 (chains B) | unmapped |
| EV-PDB-8DV2-1 RCSB PDB | cryoem | resolution: 3.5 Å | in vitro · ligands NAG SARS-CoV-2 Wuhan-hu-1-Spike-RBD bound to computationally engineered ACE2 mimetic CVD293 · Spike glycoprotein (chains A) | unmapped |
| EV-PDB-8DV1-1 RCSB PDB | cryoem | resolution: 3.4 Å | in vitro · ligands NAG SARS-CoV-2 Wuhan-hu-1-Spike-RBD bound to linker variant of affinity matured ACE2 mimetic CVD432 · Spike glycoprotein (chains A) | unmapped |
| EV-PDB-8DTX-3 RCSB PDB | xray | resolution: 1.6 Å | in vitro · -173.15 °C · pH 5.6 Crystal structure of SARS-CoV-2 spike stem helix peptide in complex with neutralizing antibody COV89-22 · Spike protein S2' stem helix peptide (chains G,I) | unmapped |
| EV-PDB-8DTT-3 RCSB PDB | xray | resolution: 1.75 Å | in vitro · -173.15 °C · pH 7 Crystal structure of SARS-CoV-2 spike stem helix peptide in complex with neutralizing antibody COV93-03 · Spike protein S2' stem helix peptide (chains G,J) | unmapped |
| EV-PDB-8DTK-1 RCSB PDB | cryoem | resolution: 3.77 Å | in vitro · ligands NAG Structure of RBD directed antibody DH1047 in complex with SARS-CoV-2 spike: Local refinement of RBD-Fab interace · Spike protein S1 (chains A) | unmapped |
| EV-PDB-8DT8-1 RCSB PDB | cryoem | resolution: 3.34 Å | in vitro · ligands NAG LM18/Nb136 bispecific tetra-nanobody immunoglobulin in complex with SARS-CoV-2-6P-Mut7 S protein (focused refinement) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8DT3-1 RCSB PDB | cryoem | resolution: 3.3 Å | in vitro · ligands branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of spike binding to Fab of neutralizing antibody (locally refined) · Spike glycoprotein (chains C) | unmapped |
| EV-PDB-8DPZ-1 RCSB PDB | cryoem | resolution: 3.38 Å | in vitro · ligands branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Local refinement of SARS-CoV-2 vaccine induced antibody DH1338 bound to SARS-CoV-2 HexaPro RBD Spike ectodomain · Spike protein S1 (chains B) | unmapped |
| EV-PDB-8DMA-1 RCSB PDB | cryoem | resolution: 2.79 Å | in vitro · ligands NAG Cryo-EM structure of SARS-CoV-2 Omicron BA.1 spike protein in complex with mouse ACE2 (focused refinement of RBD and ACE2) · Spike glycoprotein (chains A) | unmapped |
| EV-PDB-8DM9-1 RCSB PDB | cryoem | resolution: 2.56 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 Omicron BA.1 spike protein in complex with mouse ACE2 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8DM8-1 RCSB PDB | cryoem | resolution: 2.68 Å | in vitro · ligands NAG Cryo-EM structure of SARS-CoV-2 Omicron BA.2 spike protein in complex with mouse ACE2 (focused refinement of RBD and ACE2) · Spike glycoprotein (chains A) | unmapped |
| EV-PDB-8DM7-1 RCSB PDB | cryoem | resolution: 2.49 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 Omicron BA.2 spike protein in complex with mouse ACE2 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8DM6-1 RCSB PDB | cryoem | resolution: 2.77 Å | in vitro · ligands NAG Cryo-EM structure of SARS-CoV-2 Omicron BA.2 spike protein in complex with human ACE2 (focused refinement of RBD and ACE2) · Spike glycoprotein (chains A) | unmapped |
| EV-PDB-8DM5-1 RCSB PDB | cryoem | resolution: 2.51 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 Omicron BA.2 spike protein in complex with human ACE2 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8DM4-1 RCSB PDB | cryoem | resolution: 2.45 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 Omicron BA.2 spike protein in complex with Fab 4A8 (focused refinement of NTD and 4A8) · Spike glycoprotein (chains A) | unmapped |
| EV-PDB-8DM3-1 RCSB PDB | cryoem | resolution: 2.37 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 Omicron BA.2 spike protein in complex with Fab 4A8 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8DM2-1 RCSB PDB | cryoem | resolution: 2.91 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 Omicron BA.2 spike protein (focused refinement of NTD) · Spike glycoprotein (chains A) | unmapped |
| EV-PDB-8DM1-1 RCSB PDB | cryoem | resolution: 3.04 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 Omicron BA.2 spike protein · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8DM0-1 RCSB PDB | cryoem | resolution: 3.21 Å | in vitro · ligands NAG Cryo-EM structure of SARS-CoV-2 D614G spike protein in complex with VH ab6 (focused refinement of NTD and VH ab6) · Spike glycoprotein (chains C) | unmapped |
| EV-PDB-8DLZ-1 RCSB PDB | cryoem | resolution: 2.57 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 D614G spike protein in complex with VH ab6 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8DLY-1 RCSB PDB | cryoem | resolution: 3 Å | in vitro · ligands NAG Cryo-EM structure of SARS-CoV-2 Epsilon (B.1.429) spike protein in complex with VH ab6 (focused refinement of NTD and VH ab6) · Spike glycoprotein (chains C) | unmapped |
| EV-PDB-8DLX-1 RCSB PDB | cryoem | resolution: 2.45 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 Epsilon (B.1.429) spike protein in complex with VH ab6 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8DLW-1 RCSB PDB | cryoem | resolution: 2.16 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 Epsilon (B.1.429) spike protein in complex with Fab S2M11 · Spike glycoprotein (chains A,B,E) | unmapped |
| EV-PDB-8DLV-1 RCSB PDB | cryoem | resolution: 3.11 Å | in vitro · ligands NAG Cryo-EM structure of SARS-CoV-2 Epsilon (B.1.429) spike protein in complex with human ACE2 (focused refinement of RBD and ACE2) · Spike glycoprotein (chains B) | unmapped |
| EV-PDB-8DLU-1 RCSB PDB | cryoem | resolution: 3.14 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 Epsilon (B.1.429) spike protein in complex with human ACE2 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8DLT-1 RCSB PDB | cryoem | resolution: 2.4 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 Epsilon (B.1.429) spike protein · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8DLS-1 RCSB PDB | cryoem | resolution: 2.66 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 Gamma (P.1) spike protein in complex with Fab 4A8 (focused refinement of NTD and 4A8) · Spike glycoprotein (chains A) | unmapped |
| EV-PDB-8DLR-1 RCSB PDB | cryoem | resolution: 2.51 Å | in vitro · ligands NAG Cryo-EM structure of SARS-CoV-2 Gamma (P.1) spike protein in complex with Fab 4-8 (focused refinement of NTD and 4-8) · Spike glycoprotein (chains A) | unmapped |
| EV-PDB-8DLQ-1 RCSB PDB | cryoem | resolution: 2.77 Å | in vitro · ligands NAG Cryo-EM structure of SARS-CoV-2 Gamma (P.1) spike protein in complex with human ACE2 (focused refinement of RBD and ACE2) · Spike glycoprotein (chains B) | unmapped |
| EV-PDB-8DLP-1 RCSB PDB | cryoem | resolution: 2.64 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 Gamma (P.1) spike protein in complex with human ACE2 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8DLO-1 RCSB PDB | cryoem | resolution: 2.25 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 Gamma (P.1) spike protein · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8DLN-1 RCSB PDB | cryoem | resolution: 3.04 Å | in vitro · ligands NAG Cryo-EM structure of SARS-CoV-2 Beta (B.1.351) spike protein in complex with human ACE2 (focused refinement of RBD and ACE2) · Spike glycoprotein (chains B) | unmapped |
| EV-PDB-8DLM-1 RCSB PDB | cryoem | resolution: 2.89 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 Beta (B.1.351) spike protein in complex with human ACE2 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8DLL-1 RCSB PDB | cryoem | resolution: 2.56 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 Beta (B.1.351) spike protein · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8EPN-1 RCSB PDB | cryoem | resolution: 2.8 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 Spike trimer S2D14 in the 3-RBD Down conformation · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8F2J-3 RCSB PDB | xray | resolution: 3.16 Å | in vitro · -173.15 °C · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Crystal structure of antibody WRAIR-2134 in complex with SARS-CoV-2 receptor binding domain · Spike protein S1 (chains C,E,G,K) | unmapped |
| EV-PDB-8FXB-4 RCSB PDB | cryoem | resolution: 3.1 Å | in vitro · ligands NAG, branched: alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 XBB.1 spike RBD bound to the human ACE2 ectodomain and the S309 neutralizing antibody Fab fragment · Spike protein S1 (chains E) | unmapped |
| EV-PDB-8FXC-4 RCSB PDB | cryoem | resolution: 3.2 Å | in vitro · ligands NAG, ZN, branched: alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 BQ.1.1 spike RBD bound to the human ACE2 ectodomain and the S309 neutralizing antibody Fab fragment · Spike protein S1 (chains E) | unmapped |
| EV-PDB-8GB5-1 RCSB PDB | xray | resolution: 3.35 Å | in vitro · -173.15 °C · ligands BCN, GOL, SO4, branched: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody 25F9 · Spike protein S1 (chains A,D,G,J) | unmapped |
| EV-PDB-8GB0-1 RCSB PDB | cryoem | resolution: 4.1 Å | in vitro SARS-CoV-2 Spike H655Y variant, One RBD Open · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8G7C-1 RCSB PDB | cryoem | resolution: 4.1 Å | in vitro · ligands NAG local refinement of SARS-CoV-2 spike/Nb4 complex with 2 RBDs up and 3 Nb4 bound · Spike glycoprotein (chains A,B,D) | unmapped |
| EV-PDB-8G7B-2 RCSB PDB | cryoem | resolution: 3.2 Å | in vitro · ligands NAG SARS-CoV-2 spike/Nb3 complex with 1 RBD up and 2 Nb3 (local refinement) · Spike glycoprotein (chains A,B,D) | unmapped |
| EV-PDB-8G7A-2 RCSB PDB | cryoem | resolution: 3.3 Å | in vitro · ligands NAG SARS-CoV-2 spike/Nb3 complex with 2 RBDs up and 3 Nb3 (local refinement) · Spike glycoprotein (chains A,B,D) | unmapped |
| EV-PDB-8G79-1 RCSB PDB | cryoem | resolution: 6.1 Å | in vitro Local refinement of SARS-CoV-2 spike/nanobody mixture complex around RBD · Spike glycoprotein (chains A,B,D) | unmapped |
| EV-PDB-8G78-1 RCSB PDB | cryoem | resolution: 3.4 Å | in vitro · ligands NAG Local refinement of SARS-CoV-2 spike/nanobody mixture complex around NTD · Spike glycoprotein (chains A,B,D) | unmapped |
| EV-PDB-8G77-1 RCSB PDB | cryoem | resolution: 2.8 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 spike/Nb6 complex · Spike glycoprotein (chains A,B,D) | unmapped |
| EV-PDB-8G76-1 RCSB PDB | cryoem | resolution: 3.8 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 spike/Nb5 complex · Spike glycoprotein (chains A,B,D) | unmapped |
| EV-PDB-8G75-1 RCSB PDB | cryoem | resolution: 3.4 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 spike/Nb4 complex with 2 RBDs up and 3 Nb4 bound · Spike glycoprotein (chains A,B,D) | unmapped |
| EV-PDB-8G74-2 RCSB PDB | cryoem | resolution: 2.5 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 spike/Nb3 complex with 1 RBD up and 2 Nb3 · Spike glycoprotein (chains A,B,D) | unmapped |
| EV-PDB-8G73-2 RCSB PDB | cryoem | resolution: 2.5 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 spike/Nb3 complex with 2 RBDs up and 3 Nb3 bound at 2.5 A · Spike glycoprotein (chains A,B,D) | unmapped |
| EV-PDB-8G72-2 RCSB PDB | cryoem | resolution: 5.6 Å | in vitro SARS-CoV-2 spike/Nb2 complex with 1 RBD up (local refinement at 5.6 A) · Spike glycoprotein (chains B) | unmapped |
| EV-PDB-8G71-1 RCSB PDB | cryoem | resolution: 2.1 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Spike/Nb2 complex with 1 RBD up · Spike glycoprotein (chains A,B,D) | unmapped |
| EV-PDB-8G70-1 RCSB PDB | cryoem | resolution: 3.4 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 spike/nanobody mixture complex · Spike glycoprotein (chains A,B,D) | unmapped |
| EV-PDB-8FU9-1 RCSB PDB | cryoem | resolution: 3.52 Å | in vitro · ligands NAG Structure of Covid Spike variant deltaN25 with one erect RBD · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8FU8-1 RCSB PDB | cryoem | resolution: 3.08 Å | in vitro · ligands NAG Structure of Covid Spike variant deltaN135 with one erect RBD · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8FU7-1 RCSB PDB | cryoem | resolution: 3.21 Å | in vitro · ligands NAG Structure of Covid Spike variant deltaN135 in fully closed form · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8FI9-1 RCSB PDB | xray | resolution: 4.2 Å | in vitro · -173.15 °C · ligands GOL, NAG Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody WRAIR-5001 · Spike protein S1 (chains A,C,K,O) | unmapped |
| EV-PDB-8FHY-1 RCSB PDB | xray | resolution: 2.53 Å | in vitro · -173.15 °C · ligands GOL, MLI, NAG Crystal structure of the SARS-CoV-2 receptor binding domain in complex with neutralizing antibody WRAIR-5021 · Spike protein S1 (chains A,D,I) | unmapped |
| EV-PDB-8FEZ-1 RCSB PDB | cryoem | resolution: 3.72 Å | in vitro Prefusion-stabilized SARS-CoV-2 spike protein · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8FDW-1 RCSB PDB | cryoem | resolution: 2.9 Å | in vitro · ligands MAN, NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-3)-alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 postfusion spike in membrane · Spike protein S2 (chains A,B,C) | unmapped |
| EV-PDB-8FAH-3 RCSB PDB | xray | resolution: 4.22 Å | in vitro · -173.15 °C · ligands branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Crystal structure of SARS-CoV-2 receptor binding domain in complex with SARS-CoV-2 reactive human antibody CR3022 · Spike protein S1 (chains A) | unmapped |
| EV-PDB-8FA2-2 RCSB PDB | cryoem | resolution: 2.82 Å | in vitro Cryo-EM structure of the SARS-CoV-2 Omicron HR1-42G complex · Spike protein S2' 42G (chains D,E,F) | unmapped |
| EV-PDB-8FA2-1 RCSB PDB | cryoem | resolution: 2.82 Å | in vitro Cryo-EM structure of the SARS-CoV-2 Omicron HR1-42G complex · Scaffolded Spike protein S2' HR1 (chains A,B,C) | unmapped |
| EV-PDB-8FA1-2 RCSB PDB | cryoem | resolution: 2.51 Å | in vitro Cryo-EM structure of the SARS-CoV-2 HR1HR2 fusion core complex with N969K mutation · Spike protein S2' HR2 (chains D,E,F) | unmapped |
| EV-PDB-8F4P-1 RCSB PDB | cryoem | resolution: 3.7 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 spike protein trimer (down conformation) bound with a nanobody · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8F2X-1 RCSB PDB | xray | resolution: 3.501 Å | in vitro · -173.15 °C · pH 8.5 · ligands branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Crystal structure of antibody WRAIR-2123 in complex with SARS-CoV-2 receptor binding domain · Spike protein S1 (chains A) | unmapped |
| EV-PDB-8F0I-1 RCSB PDB | xray | resolution: 3.7 Å | in vitro · -173.15 °C · pH 6.5 · ligands NAG Crystal structure of SARS-CoV-2 receptor binding domain in complex with human antibody COVA309-22 · Spike protein S1 (chains A,B,G) | unmapped |
| EV-PDB-8F0H-2 RCSB PDB | cryoem | resolution: 3.18 Å | in vitro · ligands branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose Structure of SARS-CoV-2 spike with antibody Fabs 2A10 and 1H2 (Local refinement of the RBD and Fabs 1H2 and 2A10) · Spike glycoprotein (chains C) | unmapped |
| EV-PDB-8F0G-3 RCSB PDB | cryoem | resolution: 3.35 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Structure of SARS-CoV-2 Omicron BA.1 spike in complex with antibody Fab 1C3 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8EYH-2 RCSB PDB | cryoem | resolution: 3.75 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 spike protein bound with a nanobody · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8EYG-1 RCSB PDB | cryoem | resolution: 3.73 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 spike protein complexed with two nanobodies · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8ERR-1 RCSB PDB | cryoem | resolution: 3.1 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 Omicron BA.1 spike ectodomain trimer in complex with the S2X324 neutralizing antibody Fab fragment · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8ERQ-3 RCSB PDB | cryoem | resolution: 3.3 Å | in vitro · ligands NAG SARS-CoV-2 BA.1 spike ectodomain trimer in complex with the S2X324 neutralizing antibody Fab fragment (local refinement of the RBD and S2X324) · Spike glycoprotein (chains A) | unmapped |
| EV-PDB-8EQF-1 RCSB PDB | cryoem | resolution: 3.16 Å | in vitro · ligands branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose cryoEM structure of a broadly neutralizing anti-SARS-CoV-2 antibody STI-9167 · Spike protein S1 (chains A) | unmapped |
| EV-PDB-8EPQ-1 RCSB PDB | cryoem | resolution: 3.3 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 Spike trimer S2D14 with two RBDs exposed · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8EPP-1 RCSB PDB | cryoem | resolution: 3.1 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 Spike trimer S2D14 with two RBDs in the open conformation · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8EOO-3 RCSB PDB | xray | resolution: 2.77 Å | in vitro · -173.15 °C · ligands GOL, NAG Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing human antibodies WRAIR-2063 and WRAIR-2151 · Spike protein S1 (chains C,D) | unmapped |
| EV-PDB-8ENX-2 RCSB PDB | xray | resolution: 1.8 Å | in vitro · -173.15 °C · pH 6.2 Crystal structure of beta'-COPI-WD40 domain Y33A mutant in complex with SARS-CoV-2 clientized spike tail heptapeptide. · Clientized spike tail heptapeptide (chains C) | unmapped |
| EV-PDB-8ENW-2 RCSB PDB | xray | resolution: 1.45 Å | in vitro · -173.15 °C · ligands EDO Crystal structure of beta'-COPI-WD40 domain in complex with SARS-CoV-2 clientized spike tail heptapeptide. · Clientized spike tail peptide (chains C,D) | unmapped |
| EV-PDB-8ENS-2 RCSB PDB | xray | resolution: 1.45 Å | in vitro · -173.15 °C Crystal structure of beta'-COPI-WD40 domain in complex with SARS-CoV-2 spike tail hepta-peptide · spike tail hepta-peptide (chains C) | unmapped |
| EV-PDB-8ELQ-1 RCSB PDB | xray | resolution: 2.21 Å | in vitro · -163.15 °C · pH 4.6 · ligands NAG Crystal structure of SARS-CoV-2 spike protein receptor-binding domain in complex with antibody CC12.1 Fab and nanobody Nb-C4-255 · Spike protein S1 (chains A) | unmapped |
| EV-PDB-8ELP-1 RCSB PDB | xray | resolution: 2.83 Å | in vitro · -173.15 °C · pH 4.6 · ligands NAG Crystal structure of SARS-CoV-2 spike protein receptor-binding domain in complex with antibody CC12.1 Fab and nanobody Nb-C4-240 · Spike protein S1 (chains A) | unmapped |
| EV-PDB-8ELO-1 RCSB PDB | xray | resolution: 2.72 Å | in vitro · -173.15 °C · ligands NAG Crystal structure of SARS-CoV-2 spike protein receptor-binding domain in complex with antibody CC12.1 Fab and nanobody Nb-C4-225 · Spike protein S1 (chains A) | unmapped |
| EV-PDB-8ELJ-1 RCSB PDB | cryoem | resolution: 3.6 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 spike glycoprotein in complex with the ICO-hu23 neutralizing antibody Fab fragment · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8ELH-3 RCSB PDB | xray | resolution: 1.85 Å | in vitro · -173.15 °C · pH 8 · ligands ACT, PEG Crystal Structure of HLA-B*15:01 in complex with spike derived peptide NQKLIANQF from SARS-CoV-2 virus · Spike protein S2' (chains C) | unmapped |
| EV-PDB-8GJM-1 RCSB PDB | cryoem | resolution: 2.8 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose 17b10 fab in complex with full-length SARS-CoV-2 Spike G614 trimer · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8GJN-3 RCSB PDB | cryoem | resolution: 3.6 Å | in vitro · ligands NAG 17B10 fab in complex with up-RBD of SARS-CoV-2 Spike G614 trimer · Spike protein S2' (chains C) | unmapped |
| EV-PDB-8GOU-1 RCSB PDB | cryoem | resolution: 3.7 Å | in vitro · ligands NAG Omicron BA.4/5 SARS-CoV-2 S in complex with TH003 Fab · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8GS9-1 RCSB PDB | cryoem | resolution: 2.66 Å | in vitro SARS-CoV-2 BA.2 spike RBD in complex bound with VacBB-551 · Spike glycoprotein (chains A) | unmapped |
| EV-PDB-8GX9-1 RCSB PDB | xray | resolution: 4.01 Å | in vitro · -173.15 °C · ligands NAG Crystal structure of SARS-CoV-2 RBD with P2C-1F11 and P2B-1G5 · Spike protein S1 (chains A,E) | unmapped |
| EV-PDB-8H91-1 RCSB PDB | xray | resolution: 3.07 Å | in vitro · -173.15 °C Crystal structure of SARS-CoV-2 spike receptor-binding domain in complex with nanobody N19 · Spike protein S1 (chains A,B) | unmapped |
| EV-PDB-8HEC-1 RCSB PDB | cryoem | resolution: 3.5 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 Spike trimer in complex with RmAb 9H1 Fab in the class 2 conformation · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8HEB-1 RCSB PDB | cryoem | resolution: 3.53 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 Spike trimer in complex with RmAb 9H1 Fab in the class 1 conformation · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8HCB-1 RCSB PDB | cryoem | resolution: 4.18 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 Omicron BA.1 spike trimer (6P) in complex with 3 YB13-292 Fabs (2 RBD up) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8HCA-1 RCSB PDB | cryoem | resolution: 4.35 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 Omicron BA.1 spike trimer (6P) in complex with 3 YB13-292 Fabs (1 RBD up) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8HC9-1 RCSB PDB | cryoem | resolution: 6.03 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 Omicron BA.1 spike trimer (6P) in complex with 3 YB13-292 Fabs (3 RBD down) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8HC8-1 RCSB PDB | cryoem | resolution: 3.95 Å | in vitro · ligands NAG SARS-CoV-2 Omicron BA.1 spike trimer (6P) in complex with YB13-292 Fab, focused refinement of Fab region · Spike protein S1 (chains C) | unmapped |
| EV-PDB-8HC7-2 RCSB PDB | cryoem | resolution: 4.54 Å | in vitro · ligands NAG SARS-CoV-2 Omicron BA.1 spike trimer (6P) complex with YB9-258 Fab, focused refinement of RBD-dimer region · Spike protein S1 (chains A) | unmapped |
| EV-PDB-8HC7-1 RCSB PDB | cryoem | resolution: 4.54 Å | in vitro · ligands NAG SARS-CoV-2 Omicron BA.1 spike trimer (6P) complex with YB9-258 Fab, focused refinement of RBD-dimer region · Spike protein S1 (chains C) | unmapped |
| EV-PDB-8HC6-4 RCSB PDB | cryoem | resolution: 4.69 Å | in vitro · ligands NAG SARS-CoV-2 Omicron BA.1 spike trimer (6P) in complex with YB9-258 Fab, focused refinement of Fab region · Spike protein S1 (chains B) | unmapped |
| EV-PDB-8HC6-1 RCSB PDB | cryoem | resolution: 4.69 Å | in vitro · ligands NAG SARS-CoV-2 Omicron BA.1 spike trimer (6P) in complex with YB9-258 Fab, focused refinement of Fab region · Spike protein S1 (chains C) | unmapped |
| EV-PDB-8HC5-1 RCSB PDB | cryoem | resolution: 3.43 Å | in vitro · ligands NAG SARS-CoV-2 wildtype S1 in complex with YB9-258 Fab and R1-32 Fab · Spike glycoprotein (chains C) | unmapped |
| EV-PDB-8HC4-1 RCSB PDB | cryoem | resolution: 3.54 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 wildtype spike trimer (6P) in complex with 3 YB9-258 Fabs and 3 R1-32 Fabs (3 RBD up) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8HC3-1 RCSB PDB | cryoem | resolution: 4.35 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 Omicron BA.1 spike trimer (6P) in complex with 2 YB9-258 Fabs (2 RBD up) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8HC2-1 RCSB PDB | cryoem | resolution: 6.21 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 Omicron BA.1 spike trimer (6P) in complex with 1 YB9-258 Fab (1 RBD up) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8H7Z-1 RCSB PDB | cryoem | resolution: 3.07 Å | in vitro Cryo-EM structure of SARS-CoV-2 BA.2 RBD in complex with BA7535 fab (local refinement) · Spike glycoprotein (chains A) | unmapped |
| EV-PDB-8H7L-1 RCSB PDB | cryoem | resolution: 2.44 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM Structure of SARS-CoV-2 BA.2 Spike protein in complex with BA7535 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8H6F-1 RCSB PDB | cryoem | resolution: 3.3 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 Spike protein in complex with A6 repebody · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8H5U-1 RCSB PDB | xray | resolution: 2.401 Å | in vitro · -173.15 °C · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Crystal structure of SARS-CoV-2 spike receptor-binding domain in complex with neutralizing nanobody Nb-021 · Spike protein S1 (chains A,C) | unmapped |
| EV-PDB-8H5T-1 RCSB PDB | xray | resolution: 2 Å | in vitro · -173.15 °C · ligands NAG Crystal structure of SARS-CoV-2 spike receptor-binding domain in complex with neutralizing nanobody Nb-015 · Spike protein S1 (chains A) | unmapped |
| EV-PDB-8H5C-2 RCSB PDB | xray | resolution: 2.9 Å | in vitro · -173.15 °C · pH 7 · ligands NAG, ZN, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose Structure of SARS-CoV-2 Omicron BA.2.75 RBD in complex with human ACE2 · Spike protein S1 (chains B) | unmapped |
| EV-PDB-8H3N-1 RCSB PDB | cryoem | resolution: 2.73 Å | in vitro · ligands NAG Conformation 2 of SARS-CoV-2 Omicron BA.1 Variant Spike protein complexed with MO1 Fab · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8H3M-1 RCSB PDB | cryoem | resolution: 2.48 Å | in vitro · ligands NAG Conformation 1 of SARS-CoV-2 Omicron BA.1 Variant Spike protein complexed with MO1 Fab · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8H3E-1 RCSB PDB | cryoem | resolution: 3.06 Å | in vitro · ligands NAG, Q83 Complex structure of a small molecule (SPC-14) bound SARS-CoV-2 spike protein, closed state · Spike glycoprotein,Fibritin (chains A,B,C) | unmapped |
| EV-PDB-8H3D-1 RCSB PDB | cryoem | resolution: 3.27 Å | in vitro · ligands NAG Structure of apo SARS-CoV-2 spike protein with one RBD up · Spike glycoprotein,Fibritin (chains A,B,C) | unmapped |
| EV-PDB-8H08-1 RCSB PDB | cryoem | resolution: 3.2 Å | in vitro · ligands NAG SARS-CoV-2 BA.1 variants S ectodomain trimer in complex with neutralizing antibody 10-5B and 6-2C · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8H07-1 RCSB PDB | cryoem | resolution: 2.9 Å | in vitro · ligands NAG SARS-CoV-2 BA.4 variants S ectodomain trimer in complex with neutralizing antibody 10-5B and 6-2C · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8H06-2 RCSB PDB | cryoem | resolution: 2.66 Å | in vitro · ligands NAG, ZN, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 Omicron BA.4/5 RBD in complex with human ACE2 (local refinement) · Spike protein S1 (chains B) | unmapped |
| EV-PDB-8H01-1 RCSB PDB | cryoem | resolution: 3.7 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 Omicron BA.1 Spike glycoprotein in complex with rabbit monoclonal antibody 1H1 Fab in class 2 conformation · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8H00-1 RCSB PDB | cryoem | resolution: 3.41 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 Omicron BA.1 Spike glycoprotein in complex with rabbit monoclonal antibody 1H1 Fab in the class 1 conformation · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8GZZ-1 RCSB PDB | cryoem | resolution: 3.52 Å | in vitro Local refinement of SARS-CoV-2 Omicron BA.1 Spike glycoprotein in complex with rabbit monoclonal antibody 1H1 Fab · Spike protein S1 (chains A,B) | unmapped |
| EV-PDB-8GZ5-1 RCSB PDB | xray | resolution: 1.7 Å | in vitro · -173.15 °C · pH 7 · ligands EDO, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose Crystal structure of neutralizing VHH P17 in complex with SARS-CoV-2 Alpha variant spike receptor-binding domain · Spike protein S1 (chains A) | unmapped |
| EV-PDB-8GTQ-1 RCSB PDB | cryoem | resolution: 3.1 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose cryo-EM structure of Omicron BA.5 S protein in complex with S2L20 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8GTP-1 RCSB PDB | cryoem | resolution: 3.1 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose cryo-EM structure of Omicron BA.5 S protein in complex with XGv289 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8GTO-1 RCSB PDB | cryoem | resolution: 3.2 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose cryo-EM structure of Omicron BA.5 S protein in complex with XGv282 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8GSB-1 RCSB PDB | cryoem | resolution: 3.99 Å | in vitro SARS-COV-2 BA.1 Spike incomplex with VacBB-665 · Spike protein S1 (chains A) | unmapped |
| EV-PDB-8GS6-1 RCSB PDB | cryoem | resolution: 2.86 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Structure of the SARS-CoV-2 BA.2.75 spike glycoprotein (closed state 1) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8GRY-2 RCSB PDB | cryoem | resolution: 3.29 Å | in vitro · ligands NAG, ZN Cryo-EM structure of SARS-CoV-2 Omicron BA.2 RBD in complex with rat ACE2 (local refinement) · Spike protein S1 (chains B) | unmapped |
| EV-PDB-8GPY-1 RCSB PDB | xray | resolution: 2.51 Å | in vitro · -173.15 °C Crystal structure of Omicron BA.4/5 RBD in complex with a neutralizing antibody scFv · Spike protein S1 (chains A,B) | unmapped |
| EV-PDB-8GON-3 RCSB PDB | xray | resolution: 2.601 Å | in vitro · -173.15 °C · pH 8.5 · ligands PG4 SARS-CoV-2 specific private TCR RLQ7 in complex with RLQ-T1006I-HLA-A2 · Spike protein S2 (chains C) | unmapped |
| EV-PDB-8GOM-3 RCSB PDB | xray | resolution: 2.783 Å | in vitro · -173.15 °C · pH 8.5 · ligands PG4 SARS-CoV-2 specific private TCR RLQ7 in complex with RLQ-HLA-A2 · Spike protein S2 (chains C) | unmapped |
| EV-PDB-8GNH-1 RCSB PDB | cryoem | resolution: 3.74 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Complex structure of BD-218 and Spike protein · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8GF2-1 RCSB PDB | xray | resolution: 2.851 Å | in vitro · -173.15 °C · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Crystal structure of SARS-CoV-2 receptor binding domain in complex with antibodies eCR3022.20 and CC12.3 · Spike protein S1 (chains A,B) | unmapped |
| EV-PDB-8GDR-1 RCSB PDB | cryoem | resolution: 3.6 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-Cov2 S protein structure in complex with neutralizing monoclonal antibody 002-S21B10 · Spike glycoprotein (chains A,E,F) | unmapped |
| EV-PDB-8GB8-1 RCSB PDB | xray | resolution: 2.3 Å | in vitro · -173.15 °C · ligands EDO, GLY, GOL, NAG, PEG Crystal structure of SARS-CoV-2 BA.2 receptor binding domain in complex with neutralizing antibody 20A7 · Spike protein S1 (chains E) | unmapped |
| EV-PDB-8GB7-3 RCSB PDB | xray | resolution: 2.57 Å | in vitro · -173.15 °C · ligands branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody 20A7 · Spike protein S1 (chains A) | unmapped |
| EV-PDB-8GB6-1 RCSB PDB | xray | resolution: 1.75 Å | in vitro · -173.15 °C · pH 3.3 · ligands SO4, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody 21B6 · Spike protein S1 (chains A) | unmapped |
| EV-PDB-8HED-1 RCSB PDB | cryoem | resolution: 3.59 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Local refinement of the SARS-CoV-2 Spike trimer in complex with RmAb 9H1 Fab · Spike protein S1 (chains B) | unmapped |
| EV-PDB-8HES-2 RCSB PDB | xray | resolution: 2.2 Å | in vitro · -173.15 °C · ligands NAG Crystal structure of SARS-CoV-2 RBD and NIV-10 complex · Spike protein S1 (chains C) | unmapped |
| EV-PDB-8HFY-1 RCSB PDB | cryoem | resolution: 3.21 Å | in vitro · ligands NAG, ZN, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 Omicron BA.1 spike protein receptor-binding domain in complex with white-tailed deer ACE2 · Spike protein S1 (chains B) | unmapped |
| EV-PDB-8HG0-2 RCSB PDB | cryoem | resolution: 3.51 Å | in vitro · ligands NAG, ZN Cryo-EM structure of SARS-CoV-2 prototype spike protein receptor-binding domain in complex with white-tailed deer ACE2 · Spike protein S1 (chains B) | unmapped |
| EV-PDB-8HGL-1 RCSB PDB | cryoem | resolution: 2.9 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 spike in complex with neutralizing antibody NIV-11 · Spike glycoprotein (chains A,B,E) | unmapped |
| EV-PDB-8HGM-1 RCSB PDB | cryoem | resolution: 3.4 Å | in vitro · ligands branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Structure of SARS-CoV-2 spike RBD in complex with neutralizing antibody NIV-11 · Spike glycoprotein (chains B) | unmapped |
| EV-PDB-8HHX-1 RCSB PDB | cryoem | resolution: 3.62 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 Delta Spike in complex with FP-12A · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8HLC-1 RCSB PDB | cryoem | resolution: 2.8 Å | in vitro · ligands EIC, NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose S protein of SARS-CoV-2 in complex with 3711 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8HLD-1 RCSB PDB | cryoem | resolution: 2.8 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose S protein of SARS-CoV-2 in complex with 26434 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8HN4-3 RCSB PDB | xray | resolution: 2.853 Å | in vitro · -173.15 °C · pH 8.5 Complex structure of HLA2402 with recognizing SARS-CoV-2 epitope QYIKWPWYI · SARS-CoV-2 T-cell epitope QYIKWPWYI (chains E) | unmapped |
| EV-PDB-8HN6-3 RCSB PDB | xray | resolution: 2.07 Å | in vitro · -173.15 °C · pH 7.5 Crystal structure of monoclonal antibody complexed with SARS-CoV-2 RBD · Spike protein S1 (chains E,F) | unmapped |
| EV-PDB-8HN7-3 RCSB PDB | xray | resolution: 3 Å | in vitro · -173.15 °C · pH 7.5 · ligands NAG Crystal structure of monoclonal antibody complexed with SARS-CoV-2 RBD · Spike protein S1 (chains E,F) | unmapped |
| EV-PDB-8HPF-1 RCSB PDB | cryoem | resolution: 2.34 Å | in vitro · ligands NAG Cryo-EM structure of SARS-CoV-2 Omicron BA.2 RBD in complex with fab L4.65 and L5.34 · Spike protein S2' (chains A) | unmapped |
| EV-PDB-8HPU-1 RCSB PDB | cryoem | resolution: 2.56 Å | in vitro · ligands NAG Cryo-EM structure of SARS-CoV-2 Omicron BA.4 RBD in complex with fab L4.65 and L5.34 · Spike protein S2' (chains A) | unmapped |
| EV-PDB-8HPV-1 RCSB PDB | cryoem | resolution: 2.65 Å | in vitro · ligands branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 Omicron Prototype S-trimer in complex with fab L4.65 and L5.34 · Spike protein S2' (chains A,B,C) | unmapped |
| EV-PDB-8HR2-1 RCSB PDB | xray | resolution: 1.94 Å | in vitro · -173.15 °C · pH 7 Ternary Crystal Complex Structure of RBD with NB1B5 and NB1C6 · Spike protein S1 (chains A) | unmapped |
| EV-PDB-8HRD-1 RCSB PDB | xray | resolution: 2.86 Å | in vitro · -173.15 °C · ligands NAG Crystal structure of the receptor binding domain of SARS-CoV-2 Delta variant in complex with IMCAS74 Fab and W14 Fab · Spike protein S1 (chains A,B,K,T) | unmapped |
| EV-PDB-8HSW-3 RCSB PDB | xray | resolution: 2.03 Å | in vitro · -173.15 °C · pH 8 CRYSTAL STRUCTURE OF BAT MHC CLASS I MYLU-B-67 FOR 2.1 ANGSTROM · THR-PRO-GLN-SER-ALA-PRO-HIS-GLY-VAL (chains C) | unmapped |
| EV-PDB-8HT1-3 RCSB PDB | xray | resolution: 2.4 Å | in vitro · -173.15 °C · pH 5.5 CRYSTAL STRUCTURE OF A MUTANT MYLU-B-67 FOR 2.4 ANGSTROM, 52M 53Q 54Q 55P 56W DELETED · THR-PRO-GLN-SER-ALA-PRO-HIS-GLY-VAL (chains C) | unmapped |
| EV-PDB-8HT9-3 RCSB PDB | xray | resolution: 2.2 Å | in vitro · -173.15 °C · pH 8.5 CRYSTAL STRUCTURE OF BAT MHC CLASS I MYLU-B-67 FOR 2.2 ANGSTROM · GLU-PRO-GLN-SER-ALA-PRO-HIS-GLY-VAL (chains C) | unmapped |
| EV-PDB-8HWS-1 RCSB PDB | cryoem | resolution: 2.36 Å | in vitro · ligands branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose The complex structure of Omicron BA.4 RBD with BD604, S309, and S304 · Spike protein S2' (chains A) | unmapped |
| EV-PDB-8HWT-1 RCSB PDB | cryoem | resolution: 2.91 Å | in vitro SARS-CoV-2 Omicron BA.2 RBD complexed with BD-604 and S304 Fab · Spike protein S2' (chains A) | unmapped |
| EV-PDB-8I3S-1 RCSB PDB | cryoem | resolution: 3.9 Å | in vitro · ligands NAG Local CryoEM structure of the SARS-CoV-2 S6P in complex with 7B3 Fab · Spike glycoprotein (chains A) | unmapped |
| EV-PDB-8I3U-1 RCSB PDB | cryoem | resolution: 3.6 Å | in vitro · ligands NAG Local CryoEM structure of the SARS-CoV-2 S6P in complex with 14B1 Fab · Spike glycoprotein (chains A) | unmapped |
| EV-PDB-8I4E-1 RCSB PDB | cryoem | resolution: 3.98 Å | in vitro Omicron spike variant XBB with Bn03 · Spike glycoprotein (chains A) | unmapped |
| EV-PDB-8I4F-1 RCSB PDB | cryoem | resolution: 3.44 Å | in vitro Omicron spike variant XBB with n3130v-Fc · Spike glycoprotein (chains A) | unmapped |
| EV-PDB-8I5H-1 RCSB PDB | xray | resolution: 2.38 Å | in vitro · -173.15 °C · ligands NAG Crystal structure of SARS-CoV-2 delta variant spike receptor-binding domain (RBD) in complex with NCV2SG48 Fab · Spike protein S1 (chains A,D,R) | unmapped |
| EV-PDB-8I5I-1 RCSB PDB | xray | resolution: 3.06 Å | in vitro · -173.15 °C Crystal structure of SARS-CoV-2 delta variant spike receptor-binding domain (RBD) in complex with NCV2SG53 Fab · Spike protein S1 (chains R) | unmapped |
| EV-PDB-8I9E-2 RCSB PDB | cryoem | resolution: 3.2 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose S-RBD(Omicron BA.3) in complex with PD of ACE2 · Spike protein S1 (chains E) | unmapped |
| EV-PDB-8I9G-2 RCSB PDB | cryoem | resolution: 3.2 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose S-RBD (Omicron BF.7) in complex with PD of ACE2 · Spike protein S2' (chains A) | unmapped |
| EV-PDB-8I9F-2 RCSB PDB | cryoem | resolution: 2.9 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose S-RBD (Omicron BA.2.75) in complex with PD of ACE2 · Spike protein S2' (chains E) | unmapped |
| EV-PDB-8I9D-1 RCSB PDB | cryoem | resolution: 3.95 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose S-ECD (Omicron XBB.1) in complex with PD of ACE2 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8I9C-1 RCSB PDB | cryoem | resolution: 3.85 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose S-ECD (Omicron BF.7) in complex with PD of ACE2 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8I9B-1 RCSB PDB | cryoem | resolution: 3.5 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose S-ECD (Omicron BA.2.75) in complex with PD of ACE2 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8I4H-1 RCSB PDB | cryoem | resolution: 3.81 Å | in vitro Omicron spike variant BA.1 with Bn03 · Spike glycoprotein (chains A) | unmapped |
| EV-PDB-8I4G-2 RCSB PDB | cryoem | resolution: 3.68 Å | in vitro Omicron spike variant BQ.1.1 with n3130v-Fc · Spike glycoprotein (chains A) | unmapped |
| EV-PDB-8HXJ-1 RCSB PDB | cryoem | resolution: 3.5 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose BANAL-20-52 Spike trimer · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8HSO-3 RCSB PDB | xray | resolution: 2.1 Å | in vitro · -173.15 °C · pH 5 CRYSTAL STRUCTURE OF A MUTANT MYLU-B-67 FOR 2.2 ANGSTROM, 52M 53Q 54Q 55P 56W DELETED · PHE-PRO-GLN-SER-ALA-PRO-HIS-GLY-VAL (chains C) | unmapped |
| EV-PDB-8HSM-3 RCSB PDB | xray | resolution: 2.2 Å | in vitro · -173.15 °C · pH 7.3 CRYSTAL STRUCTURE OF BAT MHC CLASS I MYLU-B-67 · PHE-PRO-GLN-SER-ALA-PRO-HIS-GLY-VAL (chains C) | unmapped |
| EV-PDB-8HRL-2 RCSB PDB | cryoem | resolution: 2.8 Å | in vitro SARS-CoV-2 Delta S-RBD-ACE2 · Spike protein S1 (chains E) | unmapped |
| EV-PDB-8HRK-2 RCSB PDB | cryoem | resolution: 3.3 Å | in vitro SARS-CoV-2 Delta S-RBD-ACE2 complex · Spike protein S1 (chains E) | unmapped |
| EV-PDB-8HRJ-1 RCSB PDB | cryoem | resolution: 3.1 Å | in vitro SARS-CoV-2 Delta variant spike protein · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8HRI-1 RCSB PDB | cryoem | resolution: 2.9 Å | in vitro SARS-CoV-2 Delta variant spike protein · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8HQT-2 RCSB PDB | xray | resolution: 1.8 Å | in vitro · -173.15 °C The complex structure of COPI cargo sorting module with SARS-CoV-2 Spike KxHxx sorting motif · SARS-CoV-2 Spike KxHxx motif (chains B) | unmapped |
| EV-PDB-8HQ7-1 RCSB PDB | cryoem | resolution: 2.7 Å | in vitro · ligands branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 Omicron Prototype RBD in complex with fab L4.65 and L5.34 · Spike protein S1 (chains A) | unmapped |
| EV-PDB-8HPQ-1 RCSB PDB | cryoem | resolution: 2.85 Å | in vitro · ligands NAG Cryo-EM structure of SARS-CoV-2 Omicron BA.4 S-trimer in complex with fab L4.65 and L5.34 · Spike protein S2' (chains A,B,C) | unmapped |
| EV-PDB-8HP9-1 RCSB PDB | cryoem | resolution: 2.75 Å | in vitro · ligands NAG Cryo-EM structure of SARS-CoV-2 Omicron BA.2 S-trimer in complex with fab L4.65 and L5.34 · Spike protein S2' (chains A,B,C) | unmapped |
| EV-PDB-8HHZ-1 RCSB PDB | cryoem | resolution: 4.28 Å | in vitro SARS-CoV-2 Omicron BA.1 Spike in complex with IY-2A · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8HHY-1 RCSB PDB | cryoem | resolution: 2.77 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 Delta Spike in complex with IS-9A · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8HFZ-1 RCSB PDB | cryoem | resolution: 2.71 Å | in vitro · ligands NAG, ZN, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 prototype spike protein in complex with white-tailed deer ACE2 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8IF2-2 RCSB PDB | xray | resolution: 2.78 Å | in vitro · -173.15 °C · ligands NAG, ZN, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]alpha-D-mannopyranose-(1-6)-[alpha-D-mannopyranose-(1-3)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Crystal structure of the receptor binding domain of SARS-CoV-2 Omicron BQ.1.1 variant spike protein in complex with its receptor ACE2 · Spike protein S1 (chains B) | unmapped |
| EV-PDB-8IFZ-1 RCSB PDB | cryoem | resolution: 2.85 Å | in vitro · ligands NAG, ZN Cryo-EM structure of SARS-CoV-2 Omicron BA.4/5 spike protein receptor-binding domain in complex with white-tailed deer ACE2 · Spike protein S1 (chains B) | unmapped |
| EV-PDB-8IOS-1 RCSB PDB | cryoem | resolution: 2.5 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Structure of the SARS-CoV-2 XBB.1 spike glycoprotein (closed-1 state) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8IOU-1 RCSB PDB | cryoem | resolution: 3.18 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Structure of SARS-CoV-2 XBB.1 spike glycoprotein in complex with ACE2 (1-up state) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8IOV-2 RCSB PDB | cryoem | resolution: 3.29 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Structure of SARS-CoV-2 XBB.1 spike RBD in complex with ACE2 · Spike glycoprotein (chains B) | unmapped |
| EV-PDB-8IV4-5 RCSB PDB | cryoem | resolution: 3.59 Å | in vitro · ligands branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 spike protein in complex with double nAbs 8H12 and 3E2 (local refinement) · Spike protein S1 (chains G) | unmapped |
| EV-PDB-8IV5-1 RCSB PDB | cryoem | resolution: 3.77 Å | in vitro · ligands branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 spike protein in complex with double nAbs 8H12 and 1C4 (local refinement) · Spike protein S1 (chains G) | unmapped |
| EV-PDB-8IX3-3 RCSB PDB | cryoem | resolution: 3.98 Å | in vitro Cryo-EM structure of SARS-CoV-2 BA.4/5 spike protein in complex with 1G11 (local refinement) · BA.4/5 variant spike protein (chains G) | unmapped |
| EV-PDB-8J1Q-5 RCSB PDB | cryoem | resolution: 3.3 Å | in vitro · ligands NAG CryoEM structure of SARS CoV-2 RBD and Aptamer complex · Spike protein S1 (chains C) | unmapped |
| EV-PDB-8J1T-3 RCSB PDB | cryoem | resolution: 3.3 Å | in vitro Local refined cryo-EM structure of Omicron BA.5 RBD in complex with 8-9D Fab · Spike protein (chains F) | unmapped |
| EV-PDB-8J1V-1 RCSB PDB | cryoem | resolution: 3.01 Å | in vitro · ligands NAG Cryo-EM structure of SARS-CoV2 Omicron BA.5 spike in complex with 8-9D Fabs · Spike protein S2' (chains A,B,E) | unmapped |
| EV-PDB-8J26-4 RCSB PDB | cryoem | resolution: 3.4 Å | in vitro · ligands NAG CryoEM structure of SARS CoV-2 RBD and Aptamer complex · Spike protein S1 (chains C) | unmapped |
| EV-PDB-8JAP-1 RCSB PDB | cryoem | resolution: 3.81 Å | in vitro · ligands NAG Cryo-EM structure of SARS-CoV-2 WT RBD in complex with W328-6H2 (local refinement) · Spike glycoprotein (chains A) | unmapped |
| EV-PDB-8JIO-1 RCSB PDB | cryoem | resolution: 3.3 Å | in vitro XBB spike protein (S) in complex with monoclonal antibody 6I18 · Spike glycoprotein (chains A) | unmapped |
| EV-PDB-8JJE-2 RCSB PDB | cryoem | resolution: 3.4 Å | in vitro · ligands NAG, SO4, ZN, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-3)-alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose RBD of SARS-CoV2 spike protein with ACE2 decoy · Spike glycoprotein (chains B) | unmapped |
| EV-PDB-8JMM-1 RCSB PDB | cryoem | resolution: 3.75 Å | in vitro Structure of XBB spike protein (S) dimer-trimer in complex with bispecific antibody G7-Fc at 3.75 Angstroms resolution. · Spike glycoprotein (chains A,B,C,D,E,F) | unmapped |
| EV-PDB-8JVA-4 RCSB PDB | cryoem | resolution: 2.81 Å | in vitro · ligands NAG Cryo-EM structure of the N-terminal domain of Omicron BA.1 in complex with nanobody N235 and S2L20 Fab · Spike protein S2' (chains F) | unmapped |
| EV-PDB-8JYM-1 RCSB PDB | cryoem | resolution: 2.79 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Structure of the SARS-CoV-2 XBB.1.5 spike glycoprotein (closed state 2) · Spike glycoprotein (chains A) | unmapped |
| EV-PDB-8JYN-1 RCSB PDB | cryoem | resolution: 3.04 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Structure of SARS-CoV-2 XBB.1.5 spike glycoprotein in complex with ACE2 (1-up state) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8JYO-1 RCSB PDB | cryoem | resolution: 3.2 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Structure of SARS-CoV-2 XBB.1.5 spike glycoprotein in complex with ACE2 (2-up state) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8JYP-1 RCSB PDB | cryoem | resolution: 3.38 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Structure of SARS-CoV-2 XBB.1.5 spike RBD in complex with ACE2 · Spike glycoprotein (chains A) | unmapped |
| EV-PDB-8JYS-2 RCSB PDB | cryoem | resolution: 4.5 Å | in vitro SARS-CoV-2 Spike RBD (dimer) in complex with two 2S-1244 nanobodies · Spike protein S1 (chains B,D) | unmapped |
| EV-PDB-8K18-1 RCSB PDB | cryoem | resolution: 3.68 Å | in vitro Neutralization antibody ZCP4C9 bound with SARS-CoV-2 Omicron BA.5 RBD · Spike protein S1 (chains E) | unmapped |
| EV-PDB-8K3K-1 RCSB PDB | xray | resolution: 2.43 Å | in vitro · -196 °C The crystal structure of nanobody Nb4 in complex with receptor binding domain (RBD) of BA.1 Spike protein · Spike protein S1 (chains E) | unmapped |
| EV-PDB-8K47-2 RCSB PDB | cryoem | resolution: 3.54 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose A potent and broad-spectrum neutralizing nanobody for SARS-CoV-2 viruses including all major Omicron strains · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8K5G-3 RCSB PDB | cryoem | resolution: 3.41 Å | in vitro Structure of the SARS-CoV-2 BA.1 RBD with UT28-RD · Spike protein S1 (chains A) | unmapped |
| EV-PDB-8K5H-1 RCSB PDB | cryoem | resolution: 3.22 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Structure of the SARS-CoV-2 BA.1 spike with UT28-RD · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8K9B-1 RCSB PDB | cryoem | resolution: 4.5 Å | in vitro · ligands NAG SARS-CoV-2 spike protein in complex with one S2H5 Fab · Spike glycoprotein (chains C,D,E) | unmapped |
| EV-PDB-8K9J-1 RCSB PDB | cryoem | resolution: 6.6 Å | in vitro · ligands NAG SARS-CoV-2 spike protein in complex with two S2H5 Fabs on NTD-1 and NTD-2 · Spike glycoprotein (chains C,D,E) | unmapped |
| EV-PDB-8K9M-1 RCSB PDB | cryoem | resolution: 6.8 Å | in vitro · ligands NAG SARS-CoV-2 spike protein in complex with two S2H5 Fabs on NTD-1 and NTD-3 · Spike glycoprotein (chains C,D,E) | unmapped |
| EV-PDB-8KA8-2 RCSB PDB | cryoem | resolution: 2.96 Å | in vitro · ligands NAG, ZN, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 Delta RBD in complex with golden hamster ACE2 (local refinement) · Spike protein S1 (chains E) | unmapped |
| EV-PDB-8KC2-2 RCSB PDB | cryoem | resolution: 2.6 Å | in vitro · ligands NAG, ZN, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 BA.3 RBD in complex with golden hamster ACE2 (local refinement) · Spike protein S1 (chains E) | unmapped |
| EV-PDB-8KDR-3 RCSB PDB | cryoem | resolution: 3.4 Å | in vitro The local refined map of SARS-CoV-2 XBB Variant Spike protein complexed with antibody PW5-535 · Spike glycoprotein (chains A) | unmapped |
| EV-PDB-8KEH-1 RCSB PDB | cryoem | resolution: 3.21 Å | in vitro State 2 of SARS-CoV-2 XBB Variant Spike protein trimer complexed with antibody PW5-5 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8KEJ-3 RCSB PDB | cryoem | resolution: 3.73 Å | in vitro Monomer state of SARS-CoV-2 XBB Variant Spike protein trimer complexed with antibody PW5-5 · Spike glycoprotein (chains A) | unmapped |
| EV-PDB-8KEO-1 RCSB PDB | cryoem | resolution: 2.78 Å | in vitro Structure of SARS-CoV-2 Omicron BA.1 Spike complexed with antibody PW5-570 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8KEP-3 RCSB PDB | cryoem | resolution: 2.93 Å | in vitro The local refined map of SARS-CoV-2 Omicron BA.1 Spike complexed with antibody PW5-570 · Spike glycoprotein (chains A) | unmapped |
| EV-PDB-8KEQ-1 RCSB PDB | cryoem | resolution: 3.14 Å | in vitro State 1 of SARS-CoV-2 XBB Variant Spike protein trimer complexed with antibody PW5-5 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8K46-2 RCSB PDB | cryoem | resolution: 3.37 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose A potent and broad-spectrum neutralizing nanobody for SARS-CoV-2 viruses including all major Omicron strains · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8K45-1 RCSB PDB | cryoem | resolution: 3.66 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose A potent and broad-spectrum neutralizing nanobody for SARS-CoV-2 viruses including all major Omicron strains · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8K19-3 RCSB PDB | cryoem | resolution: 3.88 Å | in vitro Neutralization antibody ZCP3B4 bound with SARS-CoV-2 Omicron BA.5 RBD · Spike protein S1 (chains E) | unmapped |
| EV-PDB-8JYK-1 RCSB PDB | cryoem | resolution: 2.59 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Structure of the SARS-CoV-2 XBB.1.5 spike glycoprotein (closed state 1) · Spike glycoprotein (chains A) | unmapped |
| EV-PDB-8JIN-3 RCSB PDB | cryoem | resolution: 2.45 Å | in vitro The local refined map of XBB spike protein (S) in complex with bispecific antibody G7-Fc · Spike glycoprotein (chains A) | unmapped |
| EV-PDB-8IVA-3 RCSB PDB | cryoem | resolution: 3.95 Å | in vitro · ligands branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 spike protein in complex with double nAbs XMA01 and 3E2 (local refinement) · Spike protein S1 (chains G) | unmapped |
| EV-PDB-8IV8-3 RCSB PDB | cryoem | resolution: 3.92 Å | in vitro · ligands branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 spike protein in complex with double nAbs 3E2 and 1C4 (local refinement) · Spike protein S1 (chains G) | unmapped |
| EV-PDB-8ITU-1 RCSB PDB | cryoem | resolution: 3.68 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 Omicron BA.1 Spike glycoprotein in complex with rabbit monoclonal antibody 1H1 IgG. · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8IOT-1 RCSB PDB | cryoem | resolution: 2.51 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Structure of the SARS-CoV-2 XBB.1 spike glycoprotein (closed-2 state) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8IFY-1 RCSB PDB | cryoem | resolution: 2.55 Å | in vitro · ligands NAG, ZN, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 Omicron BA.4/5 spike protein in complex with white-tailed deer ACE2 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8IDN-1 RCSB PDB | cryoem | resolution: 3.35 Å | in vitro · ligands branched: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of RBD/E77-Fab complex · Spike protein S1 (chains A) | unmapped |
| EV-PDB-8I9H-2 RCSB PDB | cryoem | resolution: 3.6 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose S-RBD (Omicron XBB.1) in complex with PD of ACE2 · Spike protein S2' (chains E) | unmapped |
| EV-PDB-8SIQ-1 RCSB PDB | xray | resolution: 2.5 Å | in vitro · -173.15 °C · ligands branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose Crystal structure of SARS-CoV-2 spike receptor-binding domain in complex with broadly neutralizing antibodies CC25.36 and CV38-142 Fab · Spike protein S1 (chains A) | unmapped |
| EV-PDB-8SGU-1 RCSB PDB | xray | resolution: 1.95 Å | in vitro · -173.15 °C · ligands FUC, GOL, NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose Crystal structure of the SARS-CoV-2 receptor binding domain · Spike protein S1 (chains A) | unmapped |
| EV-PDB-8SDH-1 RCSB PDB | xray | resolution: 2.84 Å | in vitro · -173.15 °C · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody CC25.56 · Spike protein S1 (chains A,B) | unmapped |
| EV-PDB-8SDG-3 RCSB PDB | xray | resolution: 2.71 Å | in vitro · -173.15 °C · ligands NAG Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody CC25.43 · Spike protein S1 (chains C,D) | unmapped |
| EV-PDB-8SDF-1 RCSB PDB | xray | resolution: 1.79 Å | in vitro · -173.15 °C · ligands MPD, NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody CC25.4 · Spike protein S1 (chains A,Z) | unmapped |
| EV-PDB-8S9G-2 RCSB PDB | cryoem | resolution: 3 Å | in vitro · ligands NAG, branched: alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 BN.1 spike RBD bound to the human ACE2 ectodomain and the S309 neutralizing antibody Fab fragment · Spike glycoprotein (chains E) | unmapped |
| EV-PDB-8S6M-2 RCSB PDB | xray | resolution: 1.67 Å | in vitro · 19.85 °C · ligands EDO, NAG, NI, TRS SARS-CoV-2 BQ.1.1 RBD bound to the S2V29 and the S2H97 Fab fragments · Spike protein S1 (chains R) | unmapped |
| EV-PDB-8RRN-1 RCSB PDB | xray | resolution: 3.11 Å | in vitro · -173.15 °C · pH 7 Crystal structure of the SARS-CoV-2 S RBD in complex with pT1616 Fab · Spike protein S1 (chains A,B) | unmapped |
| EV-PDB-8RJI-3 RCSB PDB | xray | resolution: 2.3 Å | in vitro · -173.15 °C HLA A*2402-NF9_5R pMHC complex · Spike glycoprotein (chains C,F,I,L) | unmapped |
| EV-PDB-8RJH-3 RCSB PDB | xray | resolution: 2.6 Å | in vitro · -173.15 °C HLA A*2402-NF9_6F pMHC complex · ASN-TYR-ASN-TYR-LEU-PHE-ARG-LEU-PHE (chains C,F,I,L,O,R) | unmapped |
| EV-PDB-8RJ7-1 RCSB PDB | xray | resolution: 2.1 Å | in vitro · -173.15 °C · ligands LYS, NAG, SO4 The crystal structure of the SARS-CoV-2 receptor binding domain in complex with the neutralizing nanobody 1.29 · Spike protein S1 (chains A,C,E,G,I) | unmapped |
| EV-PDB-8RJ5-3 RCSB PDB | xray | resolution: 3.02 Å | in vitro · -173.15 °C P1-15 T-cell Receptor bound to HLA A*2402-NF9 pMHC complex · Spike protein S1 (chains C,H) | unmapped |
| EV-PDB-8RHQ-3 RCSB PDB | xray | resolution: 2 Å | in vitro · -173.15 °C · ligands CL, EDO, MG, NA, PEG Crystal structure of HLA-A*11:01 in complex with SVLNDIFSRL, an 10-mer epitope from SARS-CoV-2 Spike (S975-984) · Spike protein S2' (chains G,H,I) | unmapped |
| EV-PDB-8RH6-3 RCSB PDB | xray | resolution: 3.32 Å | in vitro · -173.15 °C · ligands EDO, PEG Crystal structure of HLA-A*11:01 in complex with SVLNDILSRL, an 10-mer epitope from SARS-CoV-2 Spike (S975-984) · Spike protein S2' (chains G,H,I) | unmapped |
| EV-PDB-8REF-3 RCSB PDB | xray | resolution: 1.9 Å | in vitro · -173.15 °C · ligands EDO, NA, PEG Crystal structure of HLA B*13:01 in complex with SVLNDILARL, an 10-mer epitope from SARS-CoV-2 Spike (S975-984) · Spike protein S2' (chains C) | unmapped |
| EV-PDB-8RCV-3 RCSB PDB | xray | resolution: 1.65 Å | in vitro · -173.15 °C · ligands EDO, NA Crystal structure of HLA B*13:01 in complex with SVLNDIFSRL, an 10-mer epitope from SARS-CoV-2 Spike (S975-984) · Spike protein S2' (chains C) | unmapped |
| EV-PDB-8RBY-1 RCSB PDB | xray | resolution: 1.9 Å | in vitro · -173.15 °C · pH 7 · ligands MPO, NAG The crystal structure of the SARS-CoV-2 receptor binding domain in complex with the neutralizing nanobody 1.26 · Spike protein S1 (chains A) | unmapped |
| EV-PDB-8RBV-3 RCSB PDB | xray | resolution: 1.8 Å | in vitro · -173.15 °C · ligands ACT, CD, EDO, PEG SARS-CoV-2 Spike-derived peptide S976-984 S982A mutant (VLNDILARL) presented by HLA-A*02:01 · SARS-CoV-2 Spike-derived peptide S976-984 S982A mutant (chains C) | unmapped |
| EV-PDB-8RBU-3 RCSB PDB | xray | resolution: 2.7 Å | in vitro · -173.15 °C · ligands CL, EDO, NA, PEG, SO4 Crystal structure of HLA-A*11:01 in complex with SVLNDILARL, an 10-mer epitope from SARS-CoV-2 Spike (S975-984) · Spike protein S2' (chains C) | unmapped |
| EV-PDB-8R8K-1 RCSB PDB | cryoem | resolution: 3.41 Å | in vitro XBB-4 Fab in complex with SARS-CoV-2 BA.2.12.1 Spike Glycoprotein · Spike glycoprotein,Fibritin (chains A) | unmapped |
| EV-PDB-8R87-1 RCSB PDB | cryoem | resolution: 3 Å | in vitro Cryo-EM structure of the Sars-Cov2 S trimer without RBDs · Spike glycoprotein,Fibritin (chains A,B,C) | unmapped |
| EV-PDB-8R80-3 RCSB PDB | xray | resolution: 4.03 Å | in vitro · -173.15 °C SARS-CoV-2 Delta RBD in complex with XBB-9 Fab and an anti-Fab nanobody · Spike protein S1 (chains E,R) | unmapped |
| EV-PDB-8R1D-3 RCSB PDB | cryoem | resolution: 2.37 Å | in vitro · ligands NAG SD1-3 Fab in complex with SARS-CoV-2 BA.2.12.1 Spike Glycoprotein · Spike glycoprotein,Fibritin (chains A,B,C) | unmapped |
| EV-PDB-8R1C-1 RCSB PDB | cryoem | resolution: 2.2 Å | in vitro · ligands NAG SD1-2 Fab in complex with SARS-CoV-2 BA.2.12.1 Spike Glycoprotein · Spike glycoprotein,Fibritin (chains A,B,C) | unmapped |
| EV-PDB-8QZR-3 RCSB PDB | xray | resolution: 3.77 Å | in vitro · -173.15 °C · ligands NAG, SO4 SARS-CoV-2 delta RBD complexed with BA.4/5-9 Fab · Spike protein S1 (chains C,E) | unmapped |
| EV-PDB-8QTD-1 RCSB PDB | cryoem | resolution: 3.6 Å | in vitro Local refinement of SARS-CoV-2 BA.2.86 Spike and XBB-7 Fab · Spike glycoprotein,Fibritin (chains A) | unmapped |
| EV-PDB-8QSQ-1 RCSB PDB | cryoem | resolution: 3.7 Å | in vitro · ligands NAG Locally refined SARS-CoV-2 BA-2.86 Spike receptor binding domain (RBD) complexed with angiotensin converting enzyme 2 (ACE2) · Spike protein S2' (chains A) | unmapped |
| EV-PDB-8QRG-1 RCSB PDB | xray | resolution: 2.3 Å | in vitro · -173.15 °C · ligands GOL, NAG SARS-CoV-2 delta RBD complexed with XBB-2 Fab and NbC1 · Spike protein S1 (chains E) | unmapped |
| EV-PDB-8QRF-1 RCSB PDB | xray | resolution: 3.7 Å | in vitro · -173.15 °C · ligands branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 delta RBD complexed with XBB-6 and beta-49 Fabs · Spike protein S1 (chains E) | unmapped |
| EV-PDB-8QQ0-1 RCSB PDB | cryoem | resolution: 3.5 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 S protein bound to neutralising antibody UZGENT_A3 · Spike glycoprotein,Fibritin (chains A) | unmapped |
| EV-PDB-8QPR-1 RCSB PDB | cryoem | resolution: 3.8 Å | in vitro · ligands branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 S protein bound to human neutralising antibody UZGENT_G5 · Spike glycoprotein,Fibritin (chains A) | unmapped |
| EV-PDB-8QH0-1 RCSB PDB | xray | resolution: 1.87 Å | in vitro · -173.15 °C · pH 8 · ligands GOL, PRO, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Crystal structure of the SARS-CoV-2 RBD with the antibody Cv2.3194 · Spike protein S1 (chains A) | unmapped |
| EV-PDB-8Q95-1 RCSB PDB | xray | resolution: 1.6 Å | in vitro · -173.15 °C · pH 7.8 Crystal structure of the SARS-CoV-2 BA.1 RBD with neutralizing-VHHs Ma16B06 and Ma3F05 · Spike protein S1 (chains A) | unmapped |
| EV-PDB-8Q94-1 RCSB PDB | xray | resolution: 2.5 Å | in vitro · -173.15 °C · pH 7 Crystal structure of The SARS-COV-2 BA.2.75 RBD with neutralizing-VHHs Re32D03 and Ma3B12 · Spike protein S1 (chains A) | unmapped |
| EV-PDB-8Q93-1 RCSB PDB | xray | resolution: 3.1 Å | in vitro · -173.15 °C Crystal structure of the SARS-COV-2 RBD with neutralizing-VHHs Re30H02 and Re21D01 · Spike protein S1 (chains A) | unmapped |
| EV-PDB-8Q7S-1 RCSB PDB | xray | resolution: 2.7 Å | in vitro · -173.15 °C · pH 4.5 · ligands EDO, GOL, P4G Crystal structure of the SARS-CoV-2 RBD (Wuhan) with neutralizing VHHs Ma6F06 and Re21H01 · Spike protein S1 (chains A,D,G,J,M) | unmapped |
| EV-PDB-8Q5Y-3 RCSB PDB | cryoem | resolution: 2.6 Å | in vitro cryoEM structure of SARS-CoV2 Spike trimer in complex with Fab23 · Spike glycoprotein (chains C,D,E) | unmapped |
| EV-PDB-8PSD-1 RCSB PDB | cryoem | resolution: 2.9 Å | in vitro · ligands NAG SARS-CoV-2 XBB 1.0 closed conformation. · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8PQ2-3 RCSB PDB | cryoem | resolution: 3.85 Å | in vitro · ligands NAG XBB 1.0 RBD bound to P4J15 (Local) · Spike protein S2' (chains C) | unmapped |
| EV-PDB-8P9Y-1 RCSB PDB | cryoem | resolution: 4.3 Å | in vitro · ligands NA, NAG, XIO, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 S protein S:D614G mutant in 3-down with binding site of an entry inhibitor · Spike protein S1,Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8P99-1 RCSB PDB | cryoem | resolution: 3.4 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 S-protein:D614G mutant in 1-up conformation · Spike protein S1,Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8P5M-1 RCSB PDB | cryoem | resolution: 2.8 Å | in vitro SARS-CoV-2 Spike RBD in complex with Mab-23 (Fab) · Spike protein S1 (chains I) | unmapped |
| EV-PDB-8OYU-1 RCSB PDB | cryoem | resolution: 4 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Stabilised BA.1 SARS-CoV-2 spike with H6 nanobodies in '2 up 1 down' RBD conformation · Spike glycoprotein,Fibritin (chains A,B,C) | unmapped |
| EV-PDB-8OYT-1 RCSB PDB | cryoem | resolution: 3.8 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Stabilised BA.1 SARS-CoV-2 spike with H6 nanobodies in '3 up' RBD conformation · Spike glycoprotein,Fibritin (chains A,B,C) | unmapped |
| EV-PDB-8OWW-1 RCSB PDB | xray | resolution: 1.969 Å | in vitro · -173.15 °C · ligands EDO, GOL, NAG, NO3 B5-5 nanobody bound to SARS-CoV-2 spike RBD (Wuhan) · Spike protein S2' (chains A) | unmapped |
| EV-PDB-8OWV-1 RCSB PDB | xray | resolution: 1.73 Å | in vitro · -173.15 °C · ligands GOL, NAG H6 and F2 nanobodies bound to SARS-CoV-2 spike RBD · Spike protein S1 (chains EEE) | unmapped |
| EV-PDB-8OWT-2 RCSB PDB | xray | resolution: 2.37 Å | in vitro · -173.15 °C · ligands MES, NAG SARS-CoV-2 spike RBD with A8 and H3 nanobodies bound · Spike protein S1 (chains BBB,EEE) | unmapped |
| EV-PDB-8KHD-3 RCSB PDB | cryoem | resolution: 3.5 Å | in vitro · ligands NAG The interface structure of Omicron RBD binding to 5817 Fab · Spike protein S1 (chains C) | unmapped |
| EV-PDB-8KHC-1 RCSB PDB | cryoem | resolution: 3 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 Omicron spike in complex with 5817 Fab · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8KER-1 RCSB PDB | cryoem | resolution: 2.95 Å | in vitro Structure of SARS-CoV-2 XBB Variant Spike protein complexed with broadly neutralizing antibody PW5-535 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8SIT-1 RCSB PDB | xray | resolution: 2.91 Å | in vitro · -173.15 °C · ligands NAG Crystal structure of SARS-CoV-2 spike receptor-binding domain in complex with broadly neutralizing antibody CC84.24 Fab · Spike protein S1 (chains A,B,C,D) | unmapped |
| EV-PDB-8SK5-1 RCSB PDB | xray | resolution: 2.011 Å | in vitro · -173.15 °C · pH 6 · ligands branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose Crystal structure of the SARS-CoV-2 neutralizing VHH 7A9 bound to the spike receptor binding domain · Spike protein S1 (chains A) | unmapped |
| EV-PDB-8SMI-1 RCSB PDB | xray | resolution: 3.5 Å | in vitro · -173.15 °C · ligands branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Crystal structure of antibody WRAIR-2123 in complex with SARS-CoV-2 receptor binding domain · Spike protein S1 (chains A) | unmapped |
| EV-PDB-8SMT-3 RCSB PDB | xray | resolution: 3.16 Å | in vitro · -173.15 °C · ligands NAG, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Crystal structure of antibody WRAIR-2134 in complex with SARS-CoV-2 receptor binding domain · Spike protein S1 (chains C,E,G,K) | unmapped |
| EV-PDB-8SUO-5 RCSB PDB | xray | resolution: 3.3 Å | in vitro · -173.15 °C BA.2/AZD1061/AZD3152 structure analysis · Spike protein S1 (chains A) | unmapped |
| EV-PDB-8SWH-1 RCSB PDB | cryoem | resolution: 3.88 Å | in vitro · ligands NAG, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Local refinement of SARS-CoV-2 (HP-GSAS-Mut7) spike NTD in complex with TXG-0078 Fab · Spike glycoprotein (chains A) | unmapped |
| EV-PDB-8T20-1 RCSB PDB | cryoem | resolution: 3.36 Å | in vitro Cryo-EM structure of mink variant Y453F trimeric spike protein bound to two mink ACE2 receptors · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8T22-1 RCSB PDB | cryoem | resolution: 3.83 Å | in vitro Cryo-EM structure of mink variant Y453F trimeric spike protein bound to one mink ACE2 receptors at downRBD conformation · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8THF-1 RCSB PDB | cryoem | resolution: 2.83 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 BA.1 S-6P-no-RBD · Spike protein S1,Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8TM1-1 RCSB PDB | cryoem | resolution: 2.79 Å | in vitro Antibody N3-1 bound to RBDs in the up and down conformations · Spike glycoprotein (chains A,B) | unmapped |
| EV-PDB-8TYL-1 RCSB PDB | cryoem | resolution: 2.85 Å | in vitro · ligands NAG Structural and biochemical rationale for Beta variant protein booster vaccine broad cross-neutralization of SARS-CoV-2 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8TYO-1 RCSB PDB | cryoem | resolution: 2.75 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Structural and biochemical rationale for Beta variant protein booster vaccine broad cross-neutralization of SARS-CoV-2 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8U28-1 RCSB PDB | cryoem | resolution: 3.1 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Gaussian mixture model based single particle refinement - SARS (SARS-CoV-2 Spike Proteins on intact virions from EMPIAR-10492) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8UG9-2 RCSB PDB | cryoem | resolution: 3.49 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose XBB.1.5 spike/Nb5 complex · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8UKD-1 RCSB PDB | cryoem | resolution: 2.9 Å | in vitro · ligands NAG SARS-CoV-2 Omicron-XBB.1.5 3-RBD down Spike Protein Trimer consensus (S-GSAS-Omicron-XBB.1.5) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8USZ-1 RCSB PDB | cryoem | resolution: 2.98 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM Structure of Full-Length Spike Protein of Omicron XBB.1.5 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8UUL-1 RCSB PDB | cryoem | resolution: 3.2 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Prototypic SARS-CoV-2 spike (containing K417) in the closed conformation · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8UUM-1 RCSB PDB | cryoem | resolution: 3.9 Å | in vitro · ligands MAN, NAG, branched: alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Prototypic SARS-CoV-2 spike (containing K417) in the open conformation · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8UUN-1 RCSB PDB | cryoem | resolution: 3.8 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Prototypic SARS-CoV-2 spike (containing V417) in the closed conformation · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8V0L-1 RCSB PDB | cryoem | resolution: 3 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 Omicron-XBB.1.16 3-RBD-down Spike Protein Trimer 1 (S-RRAR-Omicron-XBB.1.16) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8V0M-1 RCSB PDB | cryoem | resolution: 3.2 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 Omicron-XBB.1.16 3-RBD-down Spike Protein Trimer 2 (S-RRAR-Omicron-XBB.1.16) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8V0N-1 RCSB PDB | cryoem | resolution: 3.4 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 Omicron-XBB.1.16 3-RBD-down Spike Protein Trimer 3 (S-RRAR-Omicron-XBB.1.16) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8V0O-1 RCSB PDB | cryoem | resolution: 3.3 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 Omicron-XBB.1.16 3-RBD down Spike Protein Trimer 1 (S-GSAS-Omicron-XBB.1.16) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8V0P-1 RCSB PDB | cryoem | resolution: 3.3 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 Omicron-XBB.1.16 3-RBD down Spike Protein Trimer 2 (S-GSAS-Omicron-XBB.1.16) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8V0Q-1 RCSB PDB | cryoem | resolution: 3.9 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 Omicron-XBB.1.16 3-RBD down Spike Protein Trimer 3 (S-GSAS-Omicron-XBB.1.16) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8V0R-1 RCSB PDB | cryoem | resolution: 3 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 Omicron-XBB.1.5 3-RBD down Spike Protein Trimer 1 (S-GSAS-Omicron-XBB.1.5) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8V0S-1 RCSB PDB | cryoem | resolution: 3.3 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 Omicron-XBB.1.5 3-RBD down Spike Protein Trimer 2 (S-GSAS-Omicron-XBB.1.5) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8V0T-1 RCSB PDB | cryoem | resolution: 3.1 Å | in vitro · ligands NAG SARS-CoV-2 Omicron-XBB.1.5 3-RBD down Spike Protein Trimer 3 (S-GSAS-Omicron-XBB.1.5) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8V0U-1 RCSB PDB | cryoem | resolution: 3.3 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 Omicron-XBB.1.5 3-RBD down Spike Protein Trimer 4 (S-GSAS-Omicron-XBB.1.5) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8V0W-1 RCSB PDB | cryoem | resolution: 3.3 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 Omicron-EG.5 3-RBD down Spike Protein Trimer 2 (S-GSAS-Omicron-EG.5) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8V0X-1 RCSB PDB | cryoem | resolution: 3.3 Å | in vitro · ligands NAG SARS-CoV-2 Omicron-EG.5 3-RBD down Spike Protein Trimer 3 (S-GSAS-Omicron-EG.5) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8V4F-3 RCSB PDB | cryoem | resolution: 2.68 Å | in vitro Model and map from local refinement of a CAB-A17 - Omicron Ba.1 spike complex · Spike protein S1 (chains A) | unmapped |
| EV-PDB-8V5V-1 RCSB PDB | cryoem | resolution: 2.93 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Structure of a SARS-CoV-2 spike S2 subunit in a pre-fusion, open conformation · Spike protein S2,Fibritin (chains E,F,G) | unmapped |
| EV-PDB-8VCR-1 RCSB PDB | cryoem | resolution: 3 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 Spike S2 bound to Fab 54043-5 · Spike protein S2 (chains A,B,C) | unmapped |
| EV-PDB-8VIA-2 RCSB PDB | cryoem | resolution: 3.6 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Protective effect of human non-neutralizing cross-reactive spike antibodies elicited by SARS-CoV-2 mRNA vaccination · Spike protein S2 (chains C) | unmapped |
| EV-PDB-8VIA-1 RCSB PDB | cryoem | resolution: 3.6 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Protective effect of human non-neutralizing cross-reactive spike antibodies elicited by SARS-CoV-2 mRNA vaccination · Spike protein S1 (chains D) | unmapped |
| EV-PDB-8VIF-3 RCSB PDB | cryoem | resolution: 3.1 Å | in vitro · ligands NAG SARS-CoV-2 spike omicron (BA.1) ectodomain trimer in complex with SC27 Fab, local refinement · Spike glycoprotein (chains R) | unmapped |
| EV-PDB-8VAO-1 RCSB PDB | cryoem | resolution: 2.8 Å | in vitro · ligands NAG Simulation-driven design of prefusion stabilized SARS-CoV-2 spike S2 antigen · Spike protein S2 (chains A,B,C) | unmapped |
| EV-PDB-8V0V-1 RCSB PDB | cryoem | resolution: 3.1 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 Omicron-EG.5 3-RBD down Spike Protein Trimer 1 (S-GSAS-Omicron-EG.5) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8UUO-1 RCSB PDB | cryoem | resolution: 3.9 Å | in vitro · ligands MAN, NAG, branched: alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Prototypic SARS-CoV-2 spike (containing V417) in the open conformation · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8UKF-1 RCSB PDB | cryoem | resolution: 3.1 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 Omicron-EG.5 3-RBD down Spike Protein Trimer consensus (S-GSAS-Omicron-EG.5) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8UK1-1 RCSB PDB | cryoem | resolution: 3 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 Omicron-XBB.1.16 3-RBD-down Spike Protein Trimer consensus (S-RRAR-Omicron-XBB.1.16) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8UIR-1 RCSB PDB | cryoem | resolution: 3.2 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 Omicron-XBB.1.16 3-RBD down Spike Protein Trimer consensus (S-GSAS-Omicron-XBB.1.16) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8U1G-1 RCSB PDB | xray | resolution: 3.2 Å | in vitro · -173.15 °C · pH 7.5 · ligands NAG Prefusion-stabilized SARS-CoV-2 S2 subunit · Spike protein S2 (chains A,B) | unmapped |
| EV-PDB-8TMY-1 RCSB PDB | xray | resolution: 3.07 Å | in vitro · -173.15 °C · ligands FLC Crystal structure of SARS-CoV-2 spike stem helix peptide in complex with neutralizing antibody CHM-16 · Stem helix peptide of Spike protein S2' (chains M,N,S) | unmapped |
| EV-PDB-8TMA-1 RCSB PDB | cryoem | resolution: 3.2 Å | in vitro Antibody N3-1 bound to RBD in the up conformation · Spike glycoprotein (chains A) | unmapped |
| EV-PDB-8TAZ-1 RCSB PDB | cryoem | resolution: 3.75 Å | in vitro Cryo-EM structure of mink variant Y453F trimeric spike protein bound to one mink ACE2 receptors · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8T25-2 RCSB PDB | cryoem | resolution: 3.62 Å | in vitro Cryo-EM structure of the RBD-ACE2 interface of the SARS-CoV-2 trimeric spike protein bound to ACE2 receptor after local refinement at downRBD conformation. · Spike glycoprotein (chains B) | unmapped |
| EV-PDB-8T23-2 RCSB PDB | cryoem | resolution: 3.87 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of the RBD-ACE2 interface of the SARS-CoV-2 trimeric spike protein bound to ACE2 receptor after local refinement at upRBD conformation · Spike glycoprotein (chains B) | unmapped |
| EV-PDB-8SIS-1 RCSB PDB | xray | resolution: 3.08 Å | in vitro · -173.15 °C · ligands NAG Crystal structure of SARS-CoV-2 spike receptor-binding domain in complex with broadly neutralizing antibody CC84.2 Fab · Spike protein S1 (chains A) | unmapped |
| EV-PDB-8SIR-1 RCSB PDB | xray | resolution: 3.3 Å | in vitro · -173.15 °C · ligands NAG Crystal structure of SARS-CoV-2 spike receptor-binding domain in complex with broadly neutralizing antibody CC25.54 Fab · Spike protein S1 (chains A) | unmapped |
| EV-PDB-8VKE-3 RCSB PDB | cryoem | resolution: 3.1 Å | in vitro · ligands NAG SARS-CoV-2 spike omicron (BA.1) RBD ectodomain dimer-of-trimers in complex with SC27 Fabs · Spike glycoprotein (chains C,R) | unmapped |
| EV-PDB-8VKM-1 RCSB PDB | cryoem | resolution: 2.83 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 XBB.1.5 spike protein in complex with mouse ACE2 (conformation 1) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8VKN-1 RCSB PDB | cryoem | resolution: 2.93 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 XBB.1.5 spike protein in complex with mouse ACE2 (focused refinement of RBD and mouse ACE2) · Spike protein S1 (chains A) | unmapped |
| EV-PDB-8VKO-1 RCSB PDB | cryoem | resolution: 2.68 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 XBB.1.5 spike protein in complex with human ACE2 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8VKP-1 RCSB PDB | cryoem | resolution: 2.77 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 XBB.1.5 spike protein in complex with human ACE2 (focused refinement of RBD and ACE2) · Spike protein S1 (chains A) | unmapped |
| EV-PDB-8VQ9-1 RCSB PDB | cryoem | resolution: 2.7 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Prefusion stabilized structure of the SARS-CoV-2 fusion machinery · Spike protein S2 (chains A,B,C) | unmapped |
| EV-PDB-8VQB-1 RCSB PDB | cryoem | resolution: 3 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Prefusion stabilized structure of the SARS-CoV-2 fusion machinery · Spike protein S2 (chains A,B,C) | unmapped |
| EV-PDB-8VQR-2 RCSB PDB | xray | resolution: 2.565 Å | in vitro · -173.15 °C · ligands CL, EDO, NAG, ZN, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose Crystal structure of chimeric SARS-CoV-2 RBD complexed with chimeric raccoon dog ACE2 · Spike protein S1 (chains E,F) | unmapped |
| EV-PDB-8VYA-2 RCSB PDB | xray | resolution: 2.12 Å | in vitro · -173.15 °C · pH 6.5 SARS-CoV-2 Omicron Variant Spike Glycoprotein Fusion Core (Q954H) · SARS-CoV-2 Omicron variant spike glycoprotein C-terminal heptad repeat domain (chains D,E,F) | unmapped |
| EV-PDB-8VYA-1 RCSB PDB | xray | resolution: 2.12 Å | in vitro · -173.15 °C · pH 6.5 SARS-CoV-2 Omicron Variant Spike Glycoprotein Fusion Core (Q954H) · SARS-CoV-2 Omicron variant spike glycoprotein N-terminal heptad repeat domain (Q954H) (chains A,B,C) | unmapped |
| EV-PDB-8VYE-1 RCSB PDB | cryoem | resolution: 2.7 Å | in vitro · ligands NAG SARS-CoV-2 S (C.37 Lambda variant) plus S309, S2L20, and S2X303 Fabs · Spike glycoprotein (chains E,K,O) | unmapped |
| EV-PDB-8VYG-3 RCSB PDB | cryoem | resolution: 3.1 Å | in vitro · ligands NAG SARS-CoV-2 S RBD (C.37 Lambda variant) plus S309 Fab, local refinement · Spike glycoprotein (chains R) | unmapped |
| EV-PDB-8W4F-1 RCSB PDB | cryoem | resolution: 4.2 Å | in vitro SARS-CoV-2 spike protein in complex with a trivalent nanobody · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8WDR-2 RCSB PDB | xray | resolution: 3.47 Å | in vitro · -173.15 °C · ligands NAG, ZN, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Crystal structure of BQ.1.1 RBD complexed with human ACE2 · Spike protein S1 (chains B,D) | unmapped |
| EV-PDB-8WDS-2 RCSB PDB | xray | resolution: 3.4 Å | in vitro · 17.85 °C · ligands NAG, ZN, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Crystal structure of BF.7 RBD complexed with human ACE2 · Spike protein S1 (chains B,D) | unmapped |
| EV-PDB-8WDY-2 RCSB PDB | cryoem | resolution: 2.69 Å | in vitro · ligands NAG, ZN, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 Omicron BQ.1.1 RBD complexed with human ACE2 · Spike protein S1 (chains B) | unmapped |
| EV-PDB-8WE0-2 RCSB PDB | cryoem | resolution: 2.8 Å | in vitro · ligands NAG, ZN, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 Omicron XBB RBD complexed with human ACE2 · Spike protein S2' (chains B) | unmapped |
| EV-PDB-8WE1-2 RCSB PDB | cryoem | resolution: 2.47 Å | in vitro · ligands NAG, ZN, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 Omicron BF.7 RBD complexed with human ACE2 · Spike protein S2' (chains B) | unmapped |
| EV-PDB-8WE4-2 RCSB PDB | cryoem | resolution: 2.91 Å | in vitro · ligands NAG, ZN, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 Omicron XBB.1.5 RBD complexed with human ACE2 and S304 · Spike protein S1 (chains B) | unmapped |
| EV-PDB-8WFH-1 RCSB PDB | xray | resolution: 2.72 Å | in vitro · -193.15 °C Crystal structure of Omicron BA.4/5 in complex with a neutralizing antibody scFv D1 · Spike protein S1 (chains A) | unmapped |
| EV-PDB-8WFM-2 RCSB PDB | xray | resolution: 2.99 Å | in vitro · -193.15 °C Crystal structure of Omicron BA.1 in complex with a neutralizing antibody scFv T11 · Spike protein S1 (chains B,D,F,H) | unmapped |
| EV-PDB-8WGV-1 RCSB PDB | cryoem | resolution: 2.92 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose BA.2(S375) Spike (S6P)/hACE2 complex · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8WGW-1 RCSB PDB | cryoem | resolution: 2.9 Å | in vitro · ligands NAG, ZN, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Local refinement of RBD-ACE2 · Spike glycoprotein (chains A) | unmapped |
| EV-PDB-8WHU-1 RCSB PDB | cryoem | resolution: 3.3 Å | in vitro · ligands CL, NAG, ZN, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Spike Trimer of BA.2.86 in complex with two hACE2s · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8WHV-1 RCSB PDB | cryoem | resolution: 3.32 Å | in vitro · ligands NAG, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Spike Trimer of BA.2.86 with three RBDs down · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8WOX-1 RCSB PDB | cryoem | resolution: 2.75 Å | in vitro · ligands NAG, ZN Cryo-EM structure of SARS-CoV-2 prototype RBD in complex with rabbit ACE2 (local refinement) · Spike protein S1 (chains B) | unmapped |
| EV-PDB-8WOY-2 RCSB PDB | cryoem | resolution: 3.14 Å | in vitro · ligands NAG, ZN Cryo-EM structure of SARS-CoV-2 Omicron BA.4/5 RBD in complex with rabbit ACE2 (local refinement) · Spike protein S1 (chains B) | unmapped |
| EV-PDB-8WPW-7 RCSB PDB | cryoem | resolution: 2.49 Å | in vitro · ligands branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 XBB.1.5 receptor-binding domain (RBD) complexed with CB6 mutant,S309, and S304 antibodies · Spike protein S1 (chains R) | unmapped |
| EV-PDB-8WPY-7 RCSB PDB | cryoem | resolution: 3.02 Å | in vitro · ligands branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 receptor-binding domain (RBD) complexed with CB6 mutant,S309, and S304 antibodies · Spike protein S1 (chains R) | unmapped |
| EV-PDB-8WRH-2 RCSB PDB | cryoem | resolution: 3.08 Å | in vitro · ligands NAG SARS-CoV-2 XBB.1.5.70 in complex with ACE2 · Spike protein S2' (chains B) | unmapped |
| EV-PDB-8WRL-2 RCSB PDB | cryoem | resolution: 3.36 Å | in vitro · ligands NAG XBB.1.5 RBD in complex with ACE2 · Spike protein S1 (chains B) | unmapped |
| EV-PDB-8WRO-1 RCSB PDB | cryoem | resolution: 3.9 Å | in vitro XBB.1.5.10 spike protein in complex with ACE2 · Spike glycoprotein,Spike glycoprotein,Spike glycoprotein,Fusion protein (chains A,B,C) | unmapped |
| EV-PDB-8WTD-2 RCSB PDB | cryoem | resolution: 3.06 Å | in vitro · ligands NAG XBB.1.5.10 RBD in complex with ACE2 · Spike protein S2' (chains B) | unmapped |
| EV-PDB-8WTJ-1 RCSB PDB | cryoem | resolution: 4.64 Å | in vitro XBB.1.5.70 spike protein in complex with ACE2 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8WXL-1 RCSB PDB | cryoem | resolution: 2.59 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Structure of the SARS-CoV-2 BA.2.86 spike glycoprotein (closed state) · Spike glycoprotein (chains A) | unmapped |
| EV-PDB-8WYH-1 RCSB PDB | cryoem | resolution: 3 Å | in vitro The global map of Omicron Subvariants Spike with ACE2 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8WYJ-1 RCSB PDB | cryoem | resolution: 3.1 Å | in vitro · ligands branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose The global map of Omicron Subvariants Spike with two antibodies · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8WRM-1 RCSB PDB | cryoem | resolution: 4.34 Å | in vitro XBB.1.5 spike protein in complex with ACE2 · Spike glycoprotein (chains C,F,G) | unmapped |
| EV-PDB-8WP8-2 RCSB PDB | cryoem | resolution: 2.89 Å | in vitro · ligands NAG, ZN, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 Omicron BA.2.86 RBD in complex with human ACE2 · Spike protein S1 (chains B) | unmapped |
| EV-PDB-8WMF-1 RCSB PDB | cryoem | resolution: 2.51 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Structure of the SARS-CoV-2 EG.5.1 spike glycoprotein (closed-1 state) · Spike glycoprotein (chains A) | unmapped |
| EV-PDB-8WMD-1 RCSB PDB | cryoem | resolution: 2.71 Å | in vitro · ligands NAG Structure of the SARS-CoV-2 EG.5.1 spike glycoprotein (closed-2 state) · Spike glycoprotein (chains A) | unmapped |
| EV-PDB-8WLR-2 RCSB PDB | cryoem | resolution: 3.12 Å | in vitro · ligands NAG, ZN Cryo-EM structure of SARS-CoV-2 prototype spike protein receptor-binding domain in complex with hippopotamus ACE2 · Spike glycoprotein (chains B) | unmapped |
| EV-PDB-8WLO-1 RCSB PDB | cryoem | resolution: 2.62 Å | in vitro · ligands NAG, ZN, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 prototype spike protein in complex with hippopotamus ACE2 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8WHZ-2 RCSB PDB | cryoem | resolution: 3.93 Å | in vitro · ligands CL, NAG, ZN BA.2.86 RBD in complex with hACE2 (local refinement) · Spike protein S1 (chains B) | unmapped |
| EV-PDB-8WHW-1 RCSB PDB | cryoem | resolution: 3.85 Å | in vitro · ligands NAG, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Spike Trimer of BA.2.86 with single RBD up · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8WHS-1 RCSB PDB | cryoem | resolution: 3.33 Å | in vitro · ligands CL, NAG, ZN, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Spike Trimer of BA.2.86 in complex with one hACE2 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8WDZ-2 RCSB PDB | cryoem | resolution: 2.71 Å | in vitro · ligands NAG, ZN, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 Omicron BQ.1 RBD complexed with human ACE2 · Spike protein S1 (chains B) | unmapped |
| EV-PDB-8VYF-1 RCSB PDB | cryoem | resolution: 3.2 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 S NTD (C.37 Lambda variant) plus S2L20 and S2X303 Fabs, local refinement · Spike glycoprotein (chains A) | unmapped |
| EV-PDB-8VQA-1 RCSB PDB | cryoem | resolution: 3.5 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Prefusion stabilized structure of the SARS-CoV-2 fusion machinery · Spike protein S2 (chains A,B,C) | unmapped |
| EV-PDB-8VKL-1 RCSB PDB | cryoem | resolution: 2.91 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 XBB.1.5 spike protein in complex with mouse ACE2 (conformation 2) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8VKK-1 RCSB PDB | cryoem | resolution: 2.81 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 XBB.1.5 spike protein · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8WZI-1 RCSB PDB | cryoem | resolution: 3 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose One RBD up state of Spike glycoprotein, SARS-CoV-2 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8X55-1 RCSB PDB | cryoem | resolution: 3.75 Å | in vitro · ligands NAG, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose BA.2.86 Spike Trimer with T356K mutation (3 RBD down) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8X56-1 RCSB PDB | cryoem | resolution: 3.93 Å | in vitro · ligands NAG, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose BA.2.86 Spike Trimer with T356K mutation (1 RBD up) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8X5R-1 RCSB PDB | cryoem | resolution: 3.72 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 BA.2.75 Spike with K356T mutation (1 RBD up) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8XAL-1 RCSB PDB | cryoem | resolution: 3.2 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 S-BQ.1 in complex with ACE2 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8XBF-1 RCSB PDB | cryoem | resolution: 3.6 Å | in vitro · ligands NAG Cryo-EM structure of SARS-CoV-2 S-BQ.1 in complex with antibody O5C2 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8XE9-3 RCSB PDB | cryoem | resolution: 3.3 Å | in vitro XBB.1.5 RBD in complex with BD55-1205 · Spike protein S2' (chains C) | unmapped |
| EV-PDB-8XG2-3 RCSB PDB | xray | resolution: 1.84 Å | in vitro · -173.15 °C · pH 6.5 The structure of HLA-A/Pep14 · Spike protein S1 (chains C) | unmapped |
| EV-PDB-8XI6-1 RCSB PDB | cryoem | resolution: 2.3 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 Omicron BQ.1.1 Variant Spike Protein Complexed with MO11 Fab · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8XK2-1 RCSB PDB | xray | resolution: 3.4 Å | in vitro · -173.15 °C A neutralizing nanobody VHH60 against wt SARS-CoV-2 · Spike protein S1 (chains A,C,E,G) | unmapped |
| EV-PDB-8XKC-3 RCSB PDB | xray | resolution: 2.18 Å | in vitro · -173.15 °C · pH 7 The structure of HLA-A/Pep16 · Spike protein S1 (chains C) | unmapped |
| EV-PDB-8XKE-3 RCSB PDB | xray | resolution: 1.92 Å | in vitro · -173.15 °C The structure of HLA-A/14-3-D · GLU-VAL-ASP-ASN-ALA-THR-ARG-PHE-ALA-SER-VAL-TYR (chains M) | unmapped |
| EV-PDB-8XKI-2 RCSB PDB | cryoem | resolution: 3.2 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose A neutralizing nanobody VHH60 against wt SARS-CoV-2 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8XLM-1 RCSB PDB | cryoem | resolution: 3.22 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Structure of the SARS-CoV-2 EG.5.1 spike glycoprotein in complex with ACE2 (1-up state) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8XLN-2 RCSB PDB | cryoem | resolution: 3.78 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Structure of the SARS-CoV-2 EG.5.1 spike RBD in complex with ACE2 · Spike glycoprotein (chains A) | unmapped |
| EV-PDB-8XLV-1 RCSB PDB | cryoem | resolution: 3.07 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 Omicron BA.2.86 spike protein(6P), 1-RBD-up state · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8XMG-1 RCSB PDB | cryoem | resolution: 2.9 Å | in vitro · ligands NAG Cryo-EM structure of SARS-CoV-2 Omicron HV.1 spike protein(6P), RBD-closed state · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8XMT-1 RCSB PDB | cryoem | resolution: 3.31 Å | in vitro · ligands NAG Cryo-EM structure of SARS-CoV-2 Omicron EG.5.1 spike protein(6P), RBD-closed state · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8XN2-2 RCSB PDB | cryoem | resolution: 2.79 Å | in vitro · ligands NAG, ZN, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 Omicron EG.5.1 RBD in complex with human ACE2 (local refined from the spike protein) · Spike protein S1 (chains B) | unmapped |
| EV-PDB-8XN5-2 RCSB PDB | cryoem | resolution: 2.87 Å | in vitro · ligands NAG, ZN Cryo-EM structure of SARS-CoV-2 Omicron EG.5.1 spike protein(6P) in complex with human ACE2 · Spike glycoprotein (chains B,C,D) | unmapped |
| EV-PDB-8XNF-2 RCSB PDB | cryoem | resolution: 3.26 Å | in vitro · ligands NAG, ZN, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 Omicron BA.2.86 spike protein(6P) in complex with human ACE2 · Spike glycoprotein (chains B,C,D) | unmapped |
| EV-PDB-8XRQ-1 RCSB PDB | cryoem | resolution: 4.19 Å | in vitro SARS-CoV-2 BA.1 spike RBD in complex bound with VacBB-639 · Spike protein S1 (chains A) | unmapped |
| EV-PDB-8XSD-1 RCSB PDB | cryoem | resolution: 3.55 Å | in vitro BA.5 Spike complex with CR9 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8XSE-1 RCSB PDB | cryoem | resolution: 2.5 Å | in vitro · ligands NAG SARS-CoV-2 RBD + IMCAS-123 + IMCAS-72 Fab · Spike protein S1 (chains A) | unmapped |
| EV-PDB-8XSF-2 RCSB PDB | cryoem | resolution: 2.16 Å | in vitro · ligands NAG, ZN SARS-CoV-2 RBD + IMCAS-364 + hACE2 · Spike protein S1 (chains B) | unmapped |
| EV-PDB-8XSI-1 RCSB PDB | cryoem | resolution: 2.1 Å | in vitro · ligands NAG SARS-CoV-2 RBD + IMCAS-364 (Local Refinement) · Spike protein S1 (chains B) | unmapped |
| EV-PDB-8XSJ-2 RCSB PDB | cryoem | resolution: 2.61 Å | in vitro · ligands NAG, ZN, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 Omicron BA.4 RBD + IMCAS-316 + ACE2 · Spike protein S1 (chains B) | unmapped |
| EV-PDB-8XSL-1 RCSB PDB | cryoem | resolution: 3.2 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 spike + IMCAS-123 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8XUR-1 RCSB PDB | cryoem | resolution: 3.85 Å | in vitro · ligands IDU, NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose BA.2.86 Spike Trimer in complex with heparan sulfate · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8XUS-1 RCSB PDB | cryoem | resolution: 3.18 Å | in vitro · ligands IDU, NAG JN.1 Spike Trimer in complex with heparan sulfate · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8XUT-1 RCSB PDB | cryoem | resolution: 3.2 Å | in vitro · ligands IDU, NAG XBB.1.5 Spike Trimer in complex with heparan sulfate · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8XUX-1 RCSB PDB | cryoem | resolution: 3.22 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Structure of the SARS-CoV-2 BA.2.86 spike protein (1-up state) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8XUY-1 RCSB PDB | cryoem | resolution: 3.14 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Structure of SARS-CoV-2 BA.2.86 spike glycoprotein in complex with ACE2 (2-up state) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8XUZ-1 RCSB PDB | cryoem | resolution: 3.05 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Structure of SARS-CoV-2 BA.2.86 spike glycoprotein in complex with ACE2 (2-up and 1-down state) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8XV0-2 RCSB PDB | cryoem | resolution: 3 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Structure of SARS-CoV-2 BA.2.86 spike RBD in complex with ACE2 (up state) · Spike glycoprotein (chains B) | unmapped |
| EV-PDB-8XV1-1 RCSB PDB | cryoem | resolution: 3.05 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Structure of SARS-CoV-2 BA.2.86 spike RBD in complex with ACE2 (down state) · Spike glycoprotein (chains A) | unmapped |
| EV-PDB-8XVM-1 RCSB PDB | cryoem | resolution: 2.77 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Structure of SARS-CoV-2 BA.2.86 spike glycoprotein in complex with ACE2 (3-up state) · Spike glycoprotein (chains A) | unmapped |
| EV-PDB-8XXW-2 RCSB PDB | cryoem | resolution: 3.03 Å | in vitro · ligands NAG, ZN Fab M2-7 complexed with SARS-Cov2 RBD and human ACE2 · Spike protein S1 (chains E) | unmapped |
| EV-PDB-8XUU-1 RCSB PDB | cryoem | resolution: 3.69 Å | in vitro · ligands IDU, NAG, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose BA.2.86-T356K Spike Trimer in complex with heparan sulfate (Local refinement) · Spike glycoprotein (chains A) | unmapped |
| EV-PDB-8XNK-2 RCSB PDB | cryoem | resolution: 2.78 Å | in vitro · ligands NAG, ZN Cryo-EM structure of SARS-CoV-2 Omicron HV.1 spike protein(6P) in complex with human ACE2 · Spike glycoprotein (chains B,C,D) | unmapped |
| EV-PDB-8XN3-2 RCSB PDB | cryoem | resolution: 2.64 Å | in vitro · ligands NAG, ZN SARS-CoV-2 Omicron HV.1 RBD in complex with human ACE2 (local refinement from the spike protein) · Spike protein S1 (chains B) | unmapped |
| EV-PDB-8XM5-1 RCSB PDB | cryoem | resolution: 2.61 Å | in vitro · ligands NAG Cryo-EM structure of SARS-CoV-2 Omicron EG.5 spike protein(6P), RBD-closed state · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8XEF-1 RCSB PDB | cryoem | resolution: 4.41 Å | in vitro Cocktail GC2050-GC2225 · Spike protein S2' (chains A) | unmapped |
| EV-PDB-8XEA-3 RCSB PDB | cryoem | resolution: 3.42 Å | in vitro XBB.1.5 spike protein in complex with BD55-1205 · Spike glycoprotein (chains D,E,F) | unmapped |
| EV-PDB-8X5Q-1 RCSB PDB | cryoem | resolution: 3.47 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 BA.2.75 Spike with K356T mutation (3 RBD down) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8X50-1 RCSB PDB | cryoem | resolution: 3.82 Å | in vitro · ligands NAG, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose BA.2.86 Spike Trimer with ins483V mutation (1 RBD up) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8X4Z-1 RCSB PDB | cryoem | resolution: 3.49 Å | in vitro · ligands NAG, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose BA.2.86 Spike Trimer with ins483V mutation (3 RBD down) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8X4H-1 RCSB PDB | cryoem | resolution: 3.65 Å | in vitro · ligands NAG, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 JN.1 Spike · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8X0Y-1 RCSB PDB | xray | resolution: 1.94 Å | in vitro · -173.15 °C · pH 4 · ligands CL, PO4, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose Crystal structure of JM-1A in complex with SARS-CoV-2 RBD · Spike protein S1 (chains A,B) | unmapped |
| EV-PDB-8X0X-1 RCSB PDB | xray | resolution: 3.45 Å | in vitro · -173.15 °C · ligands NAG, SO4 Crystal structure of JE-5C in complex with SARS-CoV-2 RBD · Spike protein S1 (chains A,E) | unmapped |
| EV-PDB-8XZ9-2 RCSB PDB | cryoem | resolution: 3.37 Å | in vitro · ligands branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose BA.2.86 Spike in complex with bovine ACE2 (bound 2 ACE2) · Spike glycoprotein (chains B,C,D) | unmapped |
| EV-PDB-8YZ6-1 RCSB PDB | cryoem | resolution: 4.55 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 Spike (BA.1) in complex with Fab of JH-8B · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8YZ5-1 RCSB PDB | cryoem | resolution: 3.93 Å | in vitro SARS-CoV-2 Delta Spike in complex with Fab of JE-5C · Spike glycoprotein (chains A,C,D) | unmapped |
| EV-PDB-8YWX-3 RCSB PDB | cryoem | resolution: 3.4 Å | in vitro the complex structure of the H4B6 Fab with the RBD of Omicron BA.5 S protein · Spike protein S2' (chains A) | unmapped |
| EV-PDB-8YWW-1 RCSB PDB | cryoem | resolution: 2.7 Å | in vitro The structure of HKU1-B S protein with bsAb1 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8YWE-1 RCSB PDB | cryoem | resolution: 2.69 Å | in vitro Local refinement of SARS-CoV-2 Omicron BA.2.86 S complexed with Abs G7-Fc · Spike protein S1 (chains A) | unmapped |
| EV-PDB-8YUC-1 RCSB PDB | xray | resolution: 4.51 Å | in vitro · -173.15 °C Crystal structure of SARS-CoV-2 ConSp RBD in complex with antibodies PDI222 Fab and COVA1-16 Fab · Spike protein S2' (chains G) | unmapped |
| EV-PDB-8YUB-3 RCSB PDB | xray | resolution: 2.49 Å | in vitro · -173.15 °C · ligands EDO, branched: alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-beta-D-glucopyranose Crystal structure of SARS-CoV-2 ConSp RBD in complex with neutralizing antibody CC25.4 Fab · Spike protein S2' (chains C,F) | unmapped |
| EV-PDB-8YRP-1 RCSB PDB | cryoem | resolution: 3.64 Å | in vitro SARS-CoV-2 Delta Spike in complex with JM-1A · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8YRO-1 RCSB PDB | cryoem | resolution: 3.27 Å | in vitro SARS-CoV-2 Delta Spike in complex with JL-8C · Spike glycoprotein (chains A,D,P) | unmapped |
| EV-PDB-8YKH-2 RCSB PDB | cryoem | resolution: 3.27 Å | in vitro · ligands branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Structure of SARS-CoV-2 spike RBD in complex with NT-108 scFv · Spike glycoprotein (chains B) | unmapped |
| EV-PDB-8YKG-1 RCSB PDB | cryoem | resolution: 3.28 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Structure of SARS-CoV-2 spike glycoprotein in complex with NT-108 scFv (1-up state) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8YFT-2 RCSB PDB | cryoem | resolution: 3.16 Å | in vitro · ligands NAG, ZN, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 alpha variant spike protein in complex with raccoon dog ACE2 (local refinement) · Spike protein S1 (chains B) | unmapped |
| EV-PDB-8YF2-1 RCSB PDB | cryoem | resolution: 2.64 Å | in vitro · ligands NAG, ZN, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 prototype RBD in complex with raccoon dog ACE2 (local refinement) · Spike protein S1 (chains B) | unmapped |
| EV-PDB-8YE4-3 RCSB PDB | xray | resolution: 3.2 Å | in vitro · -173.15 °C · pH 7 The complex of TCR NYN-I and HLA-A24 bound to SARS-CoV-2 Spike448-456 peptide NYNYLYRLF · Spike protein S1 (chains E,F) | unmapped |
| EV-PDB-8YDZ-1 RCSB PDB | cryoem | resolution: 5.2 Å | in vitro · ligands NAG Cryo-EM structure of SARS-CoV-2 spike ectodomain (HexaPro, Omicron BA.5 variant) in complex with CeSPIACE, class 2 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8YDY-1 RCSB PDB | cryoem | resolution: 8 Å | in vitro · ligands NAG Cryo-EM structure of SARS-CoV-2 spike ectodomain (HexaPro, Omicron BA.5 variant) in complex with CeSPIACE, class 1 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8YDX-2 RCSB PDB | cryoem | resolution: 4.9 Å | in vitro · ligands NAG Cryo-EM structure of SARS-CoV-2 spike ectodomain (HexaPro, Omicron BA.2 variant) in complex with CeSPIACE · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8YDW-2 RCSB PDB | xray | resolution: 2 Å | in vitro · -173.15 °C · ligands GOL, NA Crystal structure of the receptor binding domain of SARS-CoV-2 Omicron XBB.1.5 variant spike protein in complex with CeSPIACE · Spike protein S1 (chains B) | unmapped |
| EV-PDB-8YDV-2 RCSB PDB | xray | resolution: 2.2 Å | in vitro · -173.15 °C · ligands GOL Crystal structure of the receptor binding domain of SARS-CoV-2 Omicron BA.5 variant spike protein in complex with CeSPIACE · Spike protein S1 (chains B,D) | unmapped |
| EV-PDB-8YDU-2 RCSB PDB | xray | resolution: 1.7 Å | in vitro · -173.15 °C · ligands GOL Crystal structure of the receptor binding domain of SARS-CoV-2 Omicron BA.2 variant spike protein in complex with CeSPIACE · Spike protein S1 (chains B) | unmapped |
| EV-PDB-8YDT-2 RCSB PDB | xray | resolution: 2.5 Å | in vitro · -173.15 °C · ligands NAG Crystal structure of the receptor binding domain of SARS-CoV-2 Alpha variant spike protein in complex with Ce41 · Spike protein S1 (chains B,D) | unmapped |
| EV-PDB-8YDS-2 RCSB PDB | xray | resolution: 1.9 Å | in vitro · -173.15 °C · ligands GOL, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Crystal structure of the receptor binding domain of SARS-CoV-2 Delta variant spike protein in complex with Ce59 · Spike protein S1 (chains B) | unmapped |
| EV-PDB-8YDR-2 RCSB PDB | xray | resolution: 2.3 Å | in vitro · -173.15 °C · ligands NAG Crystal structure of the receptor binding domain of SARS-CoV-2 Alpha variant spike protein in complex with Ce59 · Spike protein S1 (chains B) | unmapped |
| EV-PDB-8YDQ-2 RCSB PDB | xray | resolution: 1.9 Å | in vitro · -173.15 °C · ligands GOL Crystal structure of the receptor binding domain of SARS-CoV-2 Omicron BA.2 variant spike protein in complex with Ce149 · Spike protein S1 (chains B) | unmapped |
| EV-PDB-8YDP-2 RCSB PDB | xray | resolution: 2.3 Å | in vitro · -173.15 °C · ligands GOL, NAG Crystal structure of the receptor binding domain of SARS-CoV-2 spike protein in complex with Ce9 · Spike protein S1 (chains B,D) | unmapped |
| EV-PDB-8YBZ-1 RCSB PDB | cryoem | resolution: 4.8 Å | in vitro State - II: Spike 3-up RBD with THSC20.HVTR26 (Fab26) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8YBY-1 RCSB PDB | cryoem | resolution: 4.4 Å | in vitro State - I: Spike 2-up RBD with THSC20.HVTR26 (Fab26) - single Fab masked · Spike glycoprotein (chains B,D,E) | unmapped |
| EV-PDB-8YBS-1 RCSB PDB | cryoem | resolution: 4.54 Å | in vitro · ligands NAG State - I: Spike 2-up RBD with THSC20.HVTR04 (Fab4) · Spike glycoprotein (chains B) | unmapped |
| EV-PDB-8Y6A-2 RCSB PDB | cryoem | resolution: 2.72 Å | in vitro · ligands NAG, ZN, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 Omicron BA.2.86 RBD in complex with human ACE2 and S309 Fab · Spike protein S1 (chains B) | unmapped |
| EV-PDB-8Y5J-1 RCSB PDB | cryoem | resolution: 2.94 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 Omicron JN.1 spike protein · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8Y4C-1 RCSB PDB | cryoem | resolution: 3.75 Å | in vitro · ligands NAG BA.2.86 S-trimer in complex with Nab XGv280 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8Y4A-1 RCSB PDB | cryoem | resolution: 3.4 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(8-4)-2-acetamido-2-deoxy-beta-D-glucopyranose BA.2.86 S-trimer in complex with Nab XG2v046 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8Y32-2 RCSB PDB | cryoem | resolution: 4.13 Å | in vitro · ligands CL, NAG BA.2.86-V483 RBD in complex with bACE2 · Spike protein S1 RBD (chains B) | unmapped |
| EV-PDB-8Y18-2 RCSB PDB | cryoem | resolution: 3.04 Å | in vitro · ligands NAG, ZN, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 Omicron JN.1 RBD in complex with human ACE2 (local refinement from the spike protein) · Spike glycoprotein (chains B) | unmapped |
| EV-PDB-8Y16-2 RCSB PDB | cryoem | resolution: 2.98 Å | in vitro · ligands NAG, ZN, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 Omicron JN.1 spike protein in complex with human ACE2 · Spike glycoprotein (chains B,C,D) | unmapped |
| EV-PDB-8Y0Y-2 RCSB PDB | cryoem | resolution: 2.86 Å | in vitro · ligands NAG Cryo-EM structure of the 123-316 scDb/PT-RBD complex · Spike glycoprotein (chains A) | unmapped |
| EV-PDB-8XZD-1 RCSB PDB | cryoem | resolution: 3.47 Å | in vitro · ligands ZN The structure of fox ACE2 and Omicron BF.7 RBD complex · Spike protein S1 (chains B) | unmapped |
| EV-PDB-8XZA-1 RCSB PDB | cryoem | resolution: 4.07 Å | in vitro · ligands CL, NAG, ZN BA.2.86 Spike in complex with bovine ACE2 (Local refinement) · Spike glycoprotein (chains B) | unmapped |
| EV-PDB-8XZ8-2 RCSB PDB | cryoem | resolution: 3.65 Å | in vitro · ligands CL, NAG, ZN, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose BA.2.86 Spike in complex with bovine ACE2 (bound 1 ACE2) · Spike glycoprotein (chains B,C,D) | unmapped |
| EV-PDB-8XZ5-2 RCSB PDB | xray | resolution: 1.8 Å | in vitro · -173.15 °C SARS-CoV-2 S and moesin complex structure · Spike protein S2' (chains B) | unmapped |
| EV-PDB-8XZ4-2 RCSB PDB | xray | resolution: 2.129 Å | in vitro · -173.15 °C SARS-CoV-2 S and radixin complex structure · Spike protein S2' (chains B) | unmapped |
| EV-PDB-8XZ0-2 RCSB PDB | xray | resolution: 2.035 Å | in vitro · -173.15 °C · pH 7.4 Crystal complex structure of SARS-CoV-2 S bound to human ezrin · Spike protein S2' (chains B) | unmapped |
| EV-PDB-8XYZ-1 RCSB PDB | cryoem | resolution: 2.96 Å | in vitro · ligands ZN The structure of fox ACE2 and PT RBD complex · Signal peptide, Spike protein S1 (chains B) | unmapped |
| EV-PDB-8XYO-2 RCSB PDB | cryoem | resolution: 3.04 Å | in vitro · ligands NAG, ZN Cryo-EM structure of CX1 receptor binding domain in complex with human ACE2 · Spike glycoprotein (chains B) | unmapped |
| EV-PDB-8XYM-1 RCSB PDB | cryoem | resolution: 2.74 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of CX1 spike protein (6P) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8XYH-1 RCSB PDB | cryoem | resolution: 2.5 Å | in vitro · ligands EIC, NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of BANAL-20-52 spike protein (6P) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8XYG-2 RCSB PDB | xray | resolution: 3.64 Å | in vitro · -173.15 °C Crystal structure of SARS-CoV-2 BQ.1.1 RBD and human ACE2 · Spike protein S1 (chains B,D) | unmapped |
| EV-PDB-8XYE-2 RCSB PDB | xray | resolution: 3.32 Å | in vitro · -173.15 °C · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Crystal structure of SARS-CoV-2 BA.4 RBD and human ACE2 · Spike protein S1 (chains C,D) | unmapped |
| EV-PDB-8XY9-2 RCSB PDB | xray | resolution: 3.64 Å | in vitro · -173.15 °C · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Crystal structure of SARS-CoV-2 BF.7 RBD and human ACE2 complex · Spike protein S1 (chains B,D) | unmapped |
| EV-PDB-8YZB-1 RCSB PDB | cryoem | resolution: 3.29 Å | in vitro BA.2.86 RBD protein in complex with ACE2. · Spike glycoprotein,Fibritin,fusion protein (chains A) | unmapped |
| EV-PDB-8YZC-1 RCSB PDB | cryoem | resolution: 2.7 Å | in vitro Structure of BA.2.86 spike protein in complex with ACE2. · Spike glycoprotein,Fibritin,Expression Tag (chains A,B,C) | unmapped |
| EV-PDB-8YZD-1 RCSB PDB | cryoem | resolution: 3.07 Å | in vitro Structure of JN.1 RBD protein in complex with ACE2. · Spike glycoprotein,Fibritin,fusion protein (chains A) | unmapped |
| EV-PDB-8YZE-1 RCSB PDB | cryoem | resolution: 3.06 Å | in vitro The JN.1 spike protein (S) in complex with ACE2. · Spike glycoprotein,Fibritin,Expression Tag (chains A,B,C) | unmapped |
| EV-PDB-8YZJ-2 RCSB PDB | cryoem | resolution: 2.95 Å | in vitro The structure of Banal-52 RBD and hACE2 complex · Spike protein S1 (chains B) | unmapped |
| EV-PDB-8YZR-3 RCSB PDB | xray | resolution: 1.8 Å | in vitro · -173.15 °C The structure of HLA-A*2402 complex with peptide from SARS-CoV-2 S448-456 NYNYLYRLL(EG.5.1) · Spike protein S1 (chains E) | unmapped |
| EV-PDB-8YZW-3 RCSB PDB | xray | resolution: 2.36 Å | in vitro · -173.15 °C · pH 5.5 The structure of HLA-A*2402 complex with peptide from SARS-CoV-2 S448-456 NYDYWYRLF(BA.2.86) · Spike protein S2' (chains C,F) | unmapped |
| EV-PDB-8YZZ-3 RCSB PDB | xray | resolution: 1.88 Å | in vitro · -173.15 °C · pH 5.5 The structure of HLA-A*2402 complex with peptide from SARS-CoV-2 S448-456 NYNYLYRLF(Prototype) · Spike protein S1 (chains E) | unmapped |
| EV-PDB-8Z05-3 RCSB PDB | xray | resolution: 1.96 Å | in vitro · -173.15 °C The structure of HLA-A*0201 complex with peptide from SARS-CoV-2 N222-230 LLLDRLNKL(BA.2.86/JN.1) · Spike protein S2' (chains C) | unmapped |
| EV-PDB-8Z06-3 RCSB PDB | xray | resolution: 2.39 Å | in vitro · -173.15 °C · pH 6.5 The structure of HLA-A*2402 complex with peptide from SARS-CoV-2 S448-456 NYDYWYRSF(JN.1) · Spike protein S2' (chains E) | unmapped |
| EV-PDB-8Z07-3 RCSB PDB | xray | resolution: 2.7 Å | in vitro · -173.15 °C · pH 6.5 The structure of HLA-A*2402 complex with peptide from SARS-CoV-2 S448-456 NYNYRYRLF(Delta/BA.5.2) · Spike protein S2' (chains C) | unmapped |
| EV-PDB-8Z08-3 RCSB PDB | xray | resolution: 2.01 Å | in vitro · -173.15 °C The structure of HLA-A*2402 complex with peptide from SARS-CoV-2 S448-456 NYNYQYRLF(BA.2.12.1) · ASN-TYR-ASN-TYR-GLN-TYR-ARG-LEU-PHE (chains F) | unmapped |
| EV-PDB-8Z2E-2 RCSB PDB | xray | resolution: 2.3 Å | in vitro · -173.15 °C · ligands branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Crystal structure of nanobody Tnb04-1 with antibody 1F11 fab and SARS-CoV-2 RBD · Spike protein S1 (chains E) | unmapped |
| EV-PDB-8Z3W-1 RCSB PDB | cryoem | resolution: 3.45 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 D614G S with one ACE2 receptor binding (RB1) in prefusion conformation · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8Z4X-1 RCSB PDB | cryoem | resolution: 3.4 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 D614G S with two ACE2 receptors binding (RB2) in prefusion conformation · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8Z64-1 RCSB PDB | cryoem | resolution: 3.53 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 D614G S with three ACE2 receptors binding (RB3) in prefusion conformation (focused refinement of NTD-SD1-RBD-ACE2) · Spike glycoprotein (chains A,C) | unmapped |
| EV-PDB-8Z6A-1 RCSB PDB | cryoem | resolution: 2.99 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 D614G S with three ACE2 receptors binding (RB3) in prefusion conformation · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8Z6Q-1 RCSB PDB | cryoem | resolution: 5.41 Å | in vitro SARS-CoV-2 XBB.1.16 Spike in complex with CYFN1006-1(S-CYFN1006-1 dimer trimer). · Spike glycoprotein,Fibritin,Expression Tag (chains A,B,C,J,K,L) | unmapped |
| EV-PDB-8Z6R-1 RCSB PDB | cryoem | resolution: 2.87 Å | in vitro Structure of XBB.1.16 S trimer with 3 down-RBDs complex with antibody CYFN1006-1. · Spike glycoprotein,Fibritin,Spike glycoprotein,Fibritin,Spike glycoprotein,Fibritin,Expression Tag (chains A,B,C) | unmapped |
| EV-PDB-8Z6S-3 RCSB PDB | cryoem | resolution: 2.84 Å | in vitro Structure of XBB.1.16 S trimer with 2 down-RBDs complex with antibody CYFN1006-1. · Spike glycoprotein,Fibritin,Expression Tag (chains A,B,C) | unmapped |
| EV-PDB-8Z6U-1 RCSB PDB | cryoem | resolution: 3.83 Å | in vitro SARS-CoV-2 EG.5.1 Spike in complex with CYFN1006-2(S-CYFN1006-2 dimer trimer). · Spike glycoprotein,Fibritin,Expression Tag (chains A,B,C,D,E,F) | unmapped |
| EV-PDB-8Z6W-1 RCSB PDB | cryoem | resolution: 3.04 Å | in vitro Structure of EG.5.1 S trimer with 3 down-RBDs complex with antibody CYFN1006-2. · Spike glycoprotein,Fibritin,Expression Tag (chains A,B,C) | unmapped |
| EV-PDB-8Z6X-1 RCSB PDB | cryoem | resolution: 2.96 Å | in vitro Structure of EG.5.1 RBD in complex with antibody CYFN1006-2. · Spike glycoprotein,Fibritin,Expression Tag (chains A) | unmapped |
| EV-PDB-8Z7B-2 RCSB PDB | cryoem | resolution: 3.3 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 S trimer in the early fusion intermediate conformation (E-FIC) (focused refinement of NTD-SD1-RBD-ACE2) · Spike glycoprotein (chains A,C) | unmapped |
| EV-PDB-8Z7G-1 RCSB PDB | cryoem | resolution: 3.06 Å | in vitro · ligands NAG Cryo-EM structure of SARS-CoV-2 S trimer in the early fusion intermediate conformation (E-FIC) (focused refinement of intact S2) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8Z7L-1 RCSB PDB | cryoem | resolution: 3.42 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 S trimer in the early fusion intermediate conformation (E-FIC) (focused refinement of S-bottom) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8Z7P-2 RCSB PDB | cryoem | resolution: 3.45 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 S trimer in the early fusion intermediate conformation (E-FIC) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8Z86-1 RCSB PDB | cryoem | resolution: 3.87 Å | in vitro BA.5 RBD in complex with CR9 · Spike protein S1 (chains A) | unmapped |
| EV-PDB-8Z9L-2 RCSB PDB | xray | resolution: 3.598 Å | in vitro · -173.15 °C · ligands NAG, branched: alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-beta-D-glucopyranose Crystal structure of SARS-CoV-2 RBD bound to Rhinolophus affinis ACE2 · Spike protein S1 (chains F,L,R,X) | unmapped |
| EV-PDB-8ZBQ-2 RCSB PDB | cryoem | resolution: 3.03 Å | in vitro Local map of Omicron Subvariant JN.1 RBD with ACE2 · Spike protein S2' (chains F) | unmapped |
| EV-PDB-8ZBY-1 RCSB PDB | cryoem | resolution: 3.67 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 Omicron BA.1 spike trimer (x2-4P) in complex with 3 D1F6 Fabs (0 RBD up) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8ZBZ-1 RCSB PDB | cryoem | resolution: 4.71 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 Omicron BA.2 spike trimer (6P) in complex with 3 D1F6 Fabs (1 RBD up) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8ZC0-1 RCSB PDB | cryoem | resolution: 4.17 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 Omicron BA.2 spike trimer (6P) in complex with 3 D1F6 Fabs (2 RBD up) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8ZC1-1 RCSB PDB | cryoem | resolution: 4.17 Å | in vitro SARS-CoV-2 Omicron BA.2 spike trimer (6P) in complex with D1F6 Fab, focused refinement of RBD region · Spike protein S1 (chains B) | unmapped |
| EV-PDB-8ZC2-1 RCSB PDB | cryoem | resolution: 7.82 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 Omicron BA.2 spike trimer (6P) in complex with D1F6 Fab, head-to-head aggregate · Spike glycoprotein (chains A,B,C,D,E,F) | unmapped |
| EV-PDB-8ZC3-1 RCSB PDB | cryoem | resolution: 4.69 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 Omicron BA.4 spike trimer (6P) in complex with 3 D1F6 Fabs (1 RBD up) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8ZC4-1 RCSB PDB | cryoem | resolution: 3.95 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 Omicron BA.4 spike trimer (6P) in complex with 3 D1F6 Fabs (2 RBD up) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8ZC5-1 RCSB PDB | cryoem | resolution: 3.91 Å | in vitro · ligands NAG SARS-CoV-2 Omicron BA.4 spike trimer (6P) in complex with D1F6 Fab, focused refinement of RBD region · Spike protein S1 (chains A,B) | unmapped |
| EV-PDB-8ZC6-1 RCSB PDB | cryoem | resolution: 6.85 Å | in vitro · ligands NAG SARS-CoV-2 Omicron BA.4 spike trimer (6P) in complex with D1F6 Fab, head-to-head aggregate · Spike glycoprotein (chains A,B,C,D,E,F) | unmapped |
| EV-PDB-8ZER-1 RCSB PDB | xray | resolution: 3.1 Å | in vitro · -173.15 °C · ligands branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-galactopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-beta-D-mannopyranose-(1-4)-[beta-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Crystal structure of the complex of Wuhan SARS-CoV-2 RBD (319-541) with P2C5 nanobody · Spike protein S1 (chains B,C,E,G,I) | unmapped |
| EV-PDB-8ZES-1 RCSB PDB | xray | resolution: 3.7 Å | in vitro · -173.15 °C · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Crystal structure of the Wuhan SARS-CoV-2 RBD (333-541) complexed with P2C5 nanobody · Spike protein S1 (chains A,C,D,G,I) | unmapped |
| EV-PDB-8ZHD-1 RCSB PDB | cryoem | resolution: 3.41 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 spike trimer (6P) in complex with two R1-26 Fabs · Spike glycoprotein,Fibritin,Expression Tag (chains A,B,C) | unmapped |
| EV-PDB-8ZHE-1 RCSB PDB | cryoem | resolution: 3.16 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 spike trimer (6P) in complex with three R1-26 Fabs · Spike glycoprotein,Fibritin,Expression Tag (chains A,B,C) | unmapped |
| EV-PDB-8ZHF-1 RCSB PDB | cryoem | resolution: 5.26 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 spike trimer (6P) in complex with R1-26 Fab, head-to-head aggregate · Spike glycoprotein,Fibritin,Expression Tag (chains A,B,C,D,E,I) | unmapped |
| EV-PDB-8ZHG-1 RCSB PDB | cryoem | resolution: 3.51 Å | in vitro · ligands branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 spike trimer (6P) in complex with R1-26 Fab, focused refinement of RBD-Fab region · Spike glycoprotein,Fibritin,Expression Tag (chains C) | unmapped |
| EV-PDB-8ZHH-1 RCSB PDB | cryoem | resolution: 5.55 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 spike trimer (6P) in complex with two H18 Fabs · Spike glycoprotein,Fibritin,Expression Tag (chains A,B,C) | unmapped |
| EV-PDB-8ZHI-1 RCSB PDB | cryoem | resolution: 6.05 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 spike trimer (6P) in complex with three H18 Fabs · Spike glycoprotein,Fibritin,Expression Tag (chains A,B,C) | unmapped |
| EV-PDB-8ZHJ-1 RCSB PDB | cryoem | resolution: 8.45 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 spike trimer (6P) in complex with three H18 Fabs, head-to-head aggregate (C1 symmetry) · Spike glycoprotein,Fibritin,Expression Tag (chains A,B,C,G,H,I) | unmapped |
| EV-PDB-8ZHK-1 RCSB PDB | cryoem | resolution: 6.3 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 spike trimer (6P) in complex with three H18 Fabs, head-to-head aggregate (C3 symmetry) · Spike glycoprotein,Fibritin,Expression Tag (chains A,B,C,G,H,I) | unmapped |
| EV-PDB-8Z6T-1 RCSB PDB | cryoem | resolution: 2.92 Å | in vitro Structure of XBB.1.16 RBD in complex with antibody CYFN1006-1. · Spike glycoprotein,Fibritin,Expression Tag (chains A) | unmapped |
| EV-PDB-8ZHL-1 RCSB PDB | cryoem | resolution: 3.96 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 spike trimer (6P) in complex with two H18 and two R1-32 Fabs · Spike glycoprotein,Fibritin,Expression Tag (chains A,B,C) | unmapped |
| EV-PDB-8ZHM-1 RCSB PDB | cryoem | resolution: 3.39 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 spike trimer (6P) in complex with three H18 and three R1-32 Fabs · Spike glycoprotein,Fibritin,Expression Tag (chains A,B,C) | unmapped |
| EV-PDB-8ZHO-1 RCSB PDB | cryoem | resolution: 3.54 Å | in vitro · ligands NAG SARS-CoV-2 S1 in complex with H18 and R1-32 Fab · Spike glycoprotein (chains C) | unmapped |
| EV-PDB-8ZHP-1 RCSB PDB | cryoem | resolution: 3.66 Å | in vitro · ligands NAG Dimer of SARS-CoV-2 S1 in complex with H18 and R1-32 Fabs · Spike glycoprotein (chains A,C) | unmapped |
| EV-PDB-8ZPP-1 RCSB PDB | cryoem | resolution: 3.6 Å | in vitro Local CryoEM structure of the SARS-CoV-2 BA.5 in complex with ORB10 Fab · Spike glycoprotein,Fibritin (chains A) | unmapped |
| EV-PDB-8ZPQ-3 RCSB PDB | xray | resolution: 2.75 Å | in vitro · -173.15 °C Crystal structure of SARS-Cov-2-BQ1.1-RBD and 70fab · Spike protein S1 (chains E,F) | unmapped |
| EV-PDB-8ZV9-3 RCSB PDB | xray | resolution: 2.6 Å | in vitro · -173.15 °C · pH 7.5 · ligands EDO Complex structure of HLA2402 with recognizing SARS-CoV-2 Y453F epitope NYNYLFRLF · Spike protein S1 (chains C,F,I) | unmapped |
| EV-PDB-8ZYF-1 RCSB PDB | xray | resolution: 2.6 Å | in vitro · -173.15 °C · ligands NAG Crystal structure of ZW2G10 Fab in complex with omicron RBD · Spike protein S1 (chains A,B) | unmapped |
| EV-PDB-9ARU-1 RCSB PDB | cryoem | resolution: 3.9 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose COVA2-15 fragment antigen binding in complex with SARS-CoV-2 6P-mut7 S protein · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-9ASD-3 RCSB PDB | cryoem | resolution: 3.3 Å | in vitro · ligands NAG VIR-7229 Fab fragment bound the SARS-CoV-2 BA.2.86 spike trimer (local refinement of the BA 2.86 RBD/VIR-7229 VHVL) · Spike glycoprotein (chains R) | unmapped |
| EV-PDB-9ATO-1 RCSB PDB | cryoem | resolution: 3.2 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose XBB.1.5 spike/Nanosota-3C complex · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-9ATP-1 RCSB PDB | cryoem | resolution: 3.5 Å | in vitro local refinement of XBB.1.5 spike/Nanosota-3C complex · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-9ATQ-1 RCSB PDB | cryoem | resolution: 3.7 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose XBB.1.5 spike/Nanosota-8 complex · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-9AU2-3 RCSB PDB | cryoem | resolution: 3.1 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose VIR-7229 Fab fragment bound the BA.2.86 spike trimer (global refinement) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-9AYW-1 RCSB PDB | cryoem | resolution: 3 Å | in vitro · ligands NAG SARS-CoV-2 Omicron-EG.5.1 3-RBD down Spike Protein Trimer 1 (S-GSAS-Omicron-EG.5.1) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-9AYX-1 RCSB PDB | cryoem | resolution: 3 Å | in vitro · ligands NAG SARS-CoV-2 Omicron-EG.5.1 3-RBD down Spike Protein Trimer 2 (S-GSAS-Omicron-EG.5.1) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-9AYY-1 RCSB PDB | cryoem | resolution: 3.1 Å | in vitro · ligands NAG SARS-CoV-2 Omicron-EG.5.1 3-RBD down Spike Protein Trimer 3 (S-GSAS-Omicron-EG.5.1) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-9B0Y-1 RCSB PDB | cryoem | resolution: 2.32 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS CoV-2 Spike protein Ectodomain with internal tag, all RBD-down conformation · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-9B2V-1 RCSB PDB | cryoem | resolution: 2.55 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-6)-alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS CoV-2 Spike protein Ectodomain with internal tag, 1RBD-up conformation · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-9B4X-1 RCSB PDB | cryoem | resolution: 3.33 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-3)-[2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS CoV-2 full-length spike protein with Lys1269Ala and His1271Ala substitutions in the coatomer binding motif, 1RBD-up conformation (SPIKE-AXA) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-9B82-1 RCSB PDB | xray | resolution: 3.38 Å | in vitro · -173.15 °C · ligands NAG Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody COVA2-15 · Spike protein S1 (chains A,B,C,D,E,F) | unmapped |
| EV-PDB-9B8F-1 RCSB PDB | cryoem | resolution: 4.15 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-6)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-3)]2-acetamido-2-deoxy-beta-D-glucopyranose SARS CoV-2 full-length spike protein with Lys1269Ala and His1271Ala substitutions in the coatomer binding motif, 2RBD-up conformation (SPIKE-AXA) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-9BD9-1 RCSB PDB | cryoem | resolution: 2.95 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS CoV-2 full-length WT spike protein, 1RBD-up conformation (SPIKE-WT) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-9BJ2-1 RCSB PDB | cryoem | resolution: 2.8 Å | in vitro · ligands NAG Structure of the SARS-CoV-2 S 6P trimer complex with the human neutralizing antibody Fab fragment, C1533 (local refinement of NTD and C1533) · Spike glycoprotein (chains A) | unmapped |
| EV-PDB-9BJ3-1 RCSB PDB | cryoem | resolution: 3.04 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Structure of the SARS-CoV-2 S 6P trimer complex with the human neutralizing antibody Fab fragment, C1596 · Spike glycoprotein (chains A,B,S) | unmapped |
| EV-PDB-9BJ4-1 RCSB PDB | cryoem | resolution: 3.4 Å | in vitro · ligands branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Structure of the SARS-CoV-2 S 6P trimer complex with the human neutralizing antibody Fab fragment, C952 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-9BND-2 RCSB PDB | cryoem | resolution: 3.19 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 spike HexaPro protein in complex with T0A trimeric antagonist · Spike glycoprotein (chains B,D,F) | unmapped |
| EV-PDB-9BNE-2 RCSB PDB | cryoem | resolution: 3.43 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 spike HexaPro protein in complex with T3A trimeric antagonist · Spike glycoprotein (chains B,D,F) | unmapped |
| EV-PDB-9BNF-2 RCSB PDB | cryoem | resolution: 3.33 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 spike HexaPro protein in complex with T5A trimeric antagonist · Spike glycoprotein (chains B,D,F) | unmapped |
| EV-PDB-9BNG-2 RCSB PDB | cryoem | resolution: 3.73 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 spike HexaPro protein in complex with T18A trimeric antagonist · Spike glycoprotein (chains B,D,F) | unmapped |
| EV-PDB-9C44-1 RCSB PDB | cryoem | resolution: 2.6 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 S + S2L20 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-9C45-3 RCSB PDB | cryoem | resolution: 3.2 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 S + S2L20 (local refinement of NTD and S2L20 Fab variable region) · Spike glycoprotein (chains A) | unmapped |
| EV-PDB-9C6Y-3 RCSB PDB | xray | resolution: 2.68 Å | in vitro · -173.15 °C · ligands A2G, CL, NAG, SO4, branched: alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose Crystal structure of SARS-CoV-2 XBB.1.5 RBD bound to COV2-3906 Fab · Spike protein S2' (chains E,F) | unmapped |
| EV-PDB-9C7X-3 RCSB PDB | xray | resolution: 1.96 Å | in vitro · -173.15 °C Crystal structure of SARS-CoV-2 antibody 1H06 in complex with a HR2 peptide · Spike protein S2' (chains C) | unmapped |
| EV-PDB-9CCI-2 RCSB PDB | cryoem | resolution: 2.65 Å | in vitro · ligands NAG Dissecting human monoclonal antibody responses from mRNA and protein-based booster vaccinations against XBB1.5 SARS-CoV-2 · Spike glycoprotein (chains A) | unmapped |
| EV-PDB-9CCJ-3 RCSB PDB | cryoem | resolution: 2.37 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Dissecting human monoclonal antibody responses from mRNA and protein-based booster vaccinations against XBB1.5 SARS-CoV-2 · Spike glycoprotein (chains A) | unmapped |
| EV-PDB-9CFE-3 RCSB PDB | cryoem | resolution: 3.03 Å | in vitro Cryo-EM Local Refinement of Antibody 19-77 in complex with prefusion SARS-CoV-2 Spike glycoprotein RBD · Spike protein S1 (chains C) | unmapped |
| EV-PDB-9CFF-3 RCSB PDB | cryoem | resolution: 3 Å | in vitro Cryo-EM Refinement of Antibody 19-77 in complex with SARS-CoV-2 HK.3 RBD · Spike protein S1 (chains A) | unmapped |
| EV-PDB-9CFG-3 RCSB PDB | cryoem | resolution: 2.9 Å | in vitro Cryo-EM Refinement of Antibody 19-77 R71V in complex with SARS-CoV-2 HK.3 RBD · Spike protein S1 (chains A) | unmapped |
| EV-PDB-9CB0-1 RCSB PDB | cryoem | resolution: 3.1 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-6)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 S protein - Accum modified · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-9C7S-1 RCSB PDB | cryoem | resolution: 4 Å | in vitro · ligands NAG Cryo EM structure of SARS-COV-2 (BQ 1.1) RBD in complex with Fab COV2-3891 (local refine) · Spike protein S2' (chains C) | unmapped |
| EV-PDB-9BLL-3 RCSB PDB | cryoem | resolution: 4.1 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM of RBD(EG5.1)/1301B7 Fab Complex · Spike glycoprotein (chains T) | unmapped |
| EV-PDB-9BEA-1 RCSB PDB | cryoem | resolution: 3.85 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-3)-alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-6)-alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Structure of SARS-CoV-2 full-length WT spike protein with internal tag, 2RBD-up conformation (SPIKE-WT) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-9BBK-1 RCSB PDB | cryoem | resolution: 2.95 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 full-length spike protein with His1271Lys substitution in the coatomer binding motif, 2RBD-up conformation (SPIKE-KxK) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-9B9U-1 RCSB PDB | cryoem | resolution: 2.86 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 full-length spike protein with His1271Lys substitution in the coatomer binding motif, 1RBD-up conformation (SPIKE-KXK) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-9ATR-1 RCSB PDB | cryoem | resolution: 3.7 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose local refinement of XBB.1.5 spike/Nanosota-8 complex · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8ZY3-1 RCSB PDB | cryoem | resolution: 3.3 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Sarbecovirus BANAL-20-236 Spike Trimer in a Locked Conformation · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8ZY2-1 RCSB PDB | cryoem | resolution: 2.9 Å | in vitro · ligands BLA, EIC, NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Sarbecovirus BANAL-20-52 Spike Trimer in a Locked Conformation · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-8ZRD-1 RCSB PDB | xray | resolution: 2.715 Å | in vitro · -173.15 °C · ligands NAG The complex structure of SARS-CoV-2 RBD and llama single-domain antibody S4 · Spike protein S1 (chains A,E) | unmapped |
| EV-PDB-8ZHN-1 RCSB PDB | cryoem | resolution: 4.12 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 spike trimer (6P) in complex with three H18 and three R1-32 Fabs (one RBD rotated) · Spike glycoprotein,Fibritin,Expression Tag (chains A,B,C) | unmapped |
| EV-PDB-9FGU-1 RCSB PDB | cryoem | resolution: 4.3 Å | in vitro · ligands NAG SARS-CoV-2 (B.1.1.529/Omicron variant) Spike protein in complex with the single chain fragment scFv76-77 (focused refinement) · Spike glycoprotein,Fibritin (chains C) | unmapped |
| EV-PDB-9FGT-1 RCSB PDB | cryoem | resolution: 3.8 Å | in vitro · ligands NAG SARS-CoV-2 (B.1.1.529/Omicron variant) Spike protein in complex with the single chain fragment scFv76 (focused refinement) · Spike glycoprotein,Fibritin (chains C) | unmapped |
| EV-PDB-9FGS-1 RCSB PDB | cryoem | resolution: 4 Å | in vitro · ligands NAG SARS-CoV-2 (wuhan variant) Spike protein in complex with the single chain fragment scFv41N (focused refinement) · Spike glycoprotein,Fibritin (chains C) | unmapped |
| EV-PDB-9FGR-1 RCSB PDB | cryoem | resolution: 4 Å | in vitro · ligands NAG SARS-CoV-2 (wuhan variant) Spike protein in complex with the single chain fragment scFv76-77 (focused refinement) · Spike glycoprotein (chains C) | unmapped |
| EV-PDB-9FCM-2 RCSB PDB | xray | resolution: 1.94 Å | in vitro · -173.15 °C · ligands CL Single-domain antibody binding the SARS-COV2 S2 · Spike protein S2' (chains D,E,F) | unmapped |
| EV-PDB-9FC2-1 RCSB PDB | xray | resolution: 1.21 Å | in vitro · -173.15 °C · pH 4.5 · ligands ACT, EDO, NAG The crystal structure of the SARS-CoV-2 receptor binding domain in complex with the neutralizing nanobody 4. · Spike protein S1 (chains A) | unmapped |
| EV-PDB-9F9Y-1 RCSB PDB | cryoem | resolution: 2.8 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 BA-2.87.1 Spike ectodomain · Spike glycoprotein,Fibritin (chains A,B,C) | unmapped |
| EV-PDB-9ELQ-1 RCSB PDB | cryoem | resolution: 2.64 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 Omicron JN.1.11.1+S31 deletion spike protein (closed state) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-9ELP-1 RCSB PDB | cryoem | resolution: 2.94 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 Omicron JN.1.11.1+S31 deletion spike protein (one RBD up state) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-9ELO-1 RCSB PDB | cryoem | resolution: 2.74 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 Omicron JN.1.11+S31 deletion spike protein (closed state) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-9ELN-1 RCSB PDB | cryoem | resolution: 2.93 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 Omicron JN.1.11+S31 deletion spike protein (one RBD up state) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-9ELI-1 RCSB PDB | cryoem | resolution: 2.82 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 Omicron KP.3.1.1 spike protein (closed state) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-9ELH-1 RCSB PDB | cryoem | resolution: 2.98 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 Omicron KP.3.1.1 spike protein (one RBD up state) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-9ELG-2 RCSB PDB | cryoem | resolution: 3.71 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 Omicron KP.3.1.1 spike RBD and NTD (local refinement of RBD and NTD) · Spike protein S1 (chains C) | unmapped |
| EV-PDB-9ELG-1 RCSB PDB | cryoem | resolution: 3.71 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 Omicron KP.3.1.1 spike RBD and NTD (local refinement of RBD and NTD) · Spike protein S1 (chains A) | unmapped |
| EV-PDB-9ELF-2 RCSB PDB | cryoem | resolution: 2.88 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 Omicron KP.3.1.1 spike protein in complex with human ACE2 · Spike glycoprotein (chains E,F,G) | unmapped |
| EV-PDB-9ELE-2 RCSB PDB | cryoem | resolution: 3.16 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 Omicron KP.3.1.1 RBD in complex with human ACE2 (local refinement of RBD and hACE2) · Spike protein S1 (chains B) | unmapped |
| EV-PDB-9ECZ-1 RCSB PDB | cryoem | resolution: 3.89 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 spike protein in complex with human neutralizing antibody WRAIR-2008 (focused refinement of NTD and WRAIR-2008) · Spike glycoprotein (chains A) | unmapped |
| EV-PDB-9DSL-1 RCSB PDB | cryoem | resolution: 3.6 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Structure of the SARS-CoV-2 S 6P trimer in complex with the cow antibody 99 Fab · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-9DSG-1 RCSB PDB | xray | resolution: 2.4 Å | in vitro · -173.15 °C · ligands CIT, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Crystal structure of the SARS-CoV-2 RBD in complex with the cow antibody P2 · Spike protein S1 (chains A) | unmapped |
| EV-PDB-9DHY-3 RCSB PDB | cryoem | resolution: 2.7 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Structure of SARS-CoV-2 spike in complex with antibody Fab COVIC-154 · Spike glycoprotein (chains C,F,K) | unmapped |
| EV-PDB-9D8L-1 RCSB PDB | cryoem | resolution: 3.3 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose KP.2 SARS-COV-2 Spike 2-up conformation · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-9D8K-1 RCSB PDB | cryoem | resolution: 3.2 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose KP.2 SARS-COV-2 Spike 1-up conformation · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-9D8I-1 RCSB PDB | cryoem | resolution: 2.9 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose JN.1 SARS-COV-2 Spike 1-up conformation · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-9D8H-1 RCSB PDB | cryoem | resolution: 2.7 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose JN.1 SARS-COV-2 Spike 3-down conformation · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-9CXE-1 RCSB PDB | cryoem | resolution: 2.48 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS CoV-2 Spike protein Ectodomain with internal tag, all RBD-down conformation -C1 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-9CVH-1 RCSB PDB | cryoem | resolution: 2.76 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(5-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 spike protein Ecto-domain with internal tag, 1RBD UP, State-2 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-9CT2-1 RCSB PDB | cryoem | resolution: 2.7 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 spike protein Ecto-domain with internal tag, All RBD down conformation, State-3 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-9CSS-1 RCSB PDB | cryoem | resolution: 2.72 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 spike protein Ecto-domain with internal tag, 1UP RBD conformation · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-9CRI-1 RCSB PDB | cryoem | resolution: 2.8 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 Spike Proteins on intact virions: Mu (B.1.621) variant 3 closed RBDs · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-9CRH-1 RCSB PDB | cryoem | resolution: 3.4 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 Spike Proteins on intact virions: Delta (B.1.617.2) variant 3 closed RBDs · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-9CRG-1 RCSB PDB | cryoem | resolution: 3.3 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 Spike Proteins on intact virions: Gamma (P.1) variant 3 closed RBDs · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-9CRF-1 RCSB PDB | cryoem | resolution: 4 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 Spike Proteins on intact virions: Alpha (B.1.1.7) variant 1 open RBD · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-9CRE-1 RCSB PDB | cryoem | resolution: 3.2 Å | in vitro · ligands NAG, ZN, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 Spike Proteins on intact virions: Alpha (B.1.1.7) variant 3 closed RBDs · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-9CRD-1 RCSB PDB | cryoem | resolution: 3.5 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 Spike Proteins on intact virions: B.1 variant 1 open RBD · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-9CRC-1 RCSB PDB | cryoem | resolution: 2.9 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 Spike Proteins on intact virions: B.1 variant 3 closed RBDs · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-9CPY-5 RCSB PDB | xray | resolution: 3.1 Å | in vitro · -173.15 °C · ligands NAG Crystal structure of SARS-CoV-2 receptor binding domain in complex with antibodies C11-0860 and CC12.3 · Spike protein S1 (chains A) | unmapped |
| EV-PDB-9CPX-5 RCSB PDB | xray | resolution: 2.7 Å | in vitro · -173.15 °C · ligands branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Crystal structure of SARS-CoV-2 receptor binding domain in complex with antibodies C03-0138 and CC12.3 · Spike protein S1 (chains A) | unmapped |
| EV-PDB-9CPW-5 RCSB PDB | xray | resolution: 3.1 Å | in vitro · -173.15 °C · ligands branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Crystal structure of SARS-CoV-2 receptor binding domain in complex with antibodies C11-1036 and CC12.3 · Spike protein S1 (chains A) | unmapped |
| EV-PDB-9CPV-5 RCSB PDB | xray | resolution: 3 Å | in vitro · -173.15 °C · ligands branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Crystal structure of SARS-CoV-2 receptor binding domain in complex with antibodies C03-0614 and CC12.3 · Spike protein S1 (chains A) | unmapped |
| EV-PDB-9CPU-1 RCSB PDB | xray | resolution: 2.6 Å | in vitro · -173.15 °C · ligands branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Crystal structure of SARS-CoV-2 receptor binding domain in complex with antibodies C03-0304 and CC12.3 · Spike protein S1 (chains A) | unmapped |
| EV-PDB-9CPT-1 RCSB PDB | xray | resolution: 3.51 Å | in vitro · -173.15 °C · ligands CIT, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Crystal structure of SARS-CoV-2 receptor binding domain in complex with antibodies M22-92 and CC12.3 · Spike protein S1 (chains A) | unmapped |
| EV-PDB-9CPS-1 RCSB PDB | xray | resolution: 3.03 Å | in vitro · -173.15 °C · ligands CIT, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Crystal structure of SARS-CoV-2 receptor binding domain in complex with antibodies M22-91 and CC12.3 · Spike protein S1 (chains A) | unmapped |
| EV-PDB-9CPR-1 RCSB PDB | xray | resolution: 3.1 Å | in vitro · -173.15 °C · ligands CIT, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-6)-2-acetamido-2-deoxy-beta-D-glucopyranose Crystal structure of SARS-CoV-2 receptor binding domain in complex with antibodies M22-90 and CC12.3 · Spike protein S1 (chains A) | unmapped |
| EV-PDB-9CPQ-1 RCSB PDB | xray | resolution: 2.88 Å | in vitro · -173.15 °C · ligands CIT, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Crystal structure of SARS-CoV-2 receptor binding domain in complex with antibodies M22-44 and CC12.3 · Spike protein S1 (chains A) | unmapped |
| EV-PDB-9CPP-1 RCSB PDB | xray | resolution: 3.19 Å | in vitro · -173.15 °C · ligands CIT, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Crystal structure of SARS-CoV-2 receptor binding domain in complex with antibodies M22-17 and CC12.3 · Spike protein S1 (chains A) | unmapped |
| EV-PDB-9CO9-1 RCSB PDB | cryoem | resolution: 3.44 Å | in vitro Local refinement of JN.1 spike/Nanosota-9 complex · Spike glycoprotein (chains A,B) | unmapped |
| EV-PDB-9CO8-1 RCSB PDB | cryoem | resolution: 2.99 Å | in vitro · ligands branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose JN.1 spike/Nanosota-9 complex · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-9CO7-1 RCSB PDB | cryoem | resolution: 3.32 Å | in vitro Local refinement of BA.5 spike/Nanosota-9 complex · Spike glycoprotein (chains A,B) | unmapped |
| EV-PDB-9CO6-1 RCSB PDB | cryoem | resolution: 3.01 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose BA.5 spike/Nanosota-9 complex · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-9CFH-1 RCSB PDB | cryoem | resolution: 3.1 Å | in vitro Cryo-EM Refinement of Antibody 19-77 R71V in complex with SARS-CoV-2 JD.1.1 RBD · Spike protein S1 (chains A) | unmapped |
| EV-PDB-9FR4-1 RCSB PDB | cryoem | resolution: 3.1 Å | in vitro Structure of the SARS-CoV-2 spike glycoprotein in complex with nanobody 7F (local refinement) · Spike glycoprotein (chains B,D) | unmapped |
| EV-PDB-9GDY-1 RCSB PDB | cryoem | resolution: 2.8 Å | in vitro SARS-CoV-2 Spike protein Beta Variant at 37C structural flexibility / heterogeneity analyses · Spike glycoprotein,Fibritin (chains A,B,C) | unmapped |
| EV-PDB-9IU1-2 RCSB PDB | cryoem | resolution: 4.3 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Structure of SARS-CoV-2 JN.1 spike RBD in complex with ACE2 (up state) · Spike glycoprotein (chains B) | unmapped |
| EV-PDB-9J66-3 RCSB PDB | cryoem | resolution: 3.55 Å | in vitro Cryo-EM structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragment CAV-C65 (local refinement) · Spike protein S1 (chains A,D) | unmapped |
| EV-PDB-9JTD-2 RCSB PDB | xray | resolution: 3.59 Å | in vitro · -173.15 °C · ligands NAG, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Crystal structure of PCoV-GD receptor binding domain complexed with fox ACE2 · Spike glycoprotein (chains E) | unmapped |
| EV-PDB-9JTE-2 RCSB PDB | xray | resolution: 3.66 Å | in vitro · -173.15 °C · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Crystal structure of SARS-CoV-2 receptor binding domain complexed with fox ACE2 · Spike protein S1 (chains C,E) | unmapped |
| EV-PDB-9KT3-1 RCSB PDB | cryoem | resolution: 3.63 Å | in vitro Structure of EG.5.1 S trimer with 2 down-RBDs complex with antibody CYFN1006-2. · Spike glycoprotein,Fibritin,Expression Tag (chains A,B,C) | unmapped |
| EV-PDB-9KVF-2 RCSB PDB | cryoem | resolution: 3 Å | in vitro Cryo-EM structure of SARS-CoV-2 EG.1 spike protein in complex with triple-nAb 4A5, 4C1 and 2E10 · Spike protein S1 (chains G) | unmapped |
| EV-PDB-9KZD-3 RCSB PDB | cryoem | resolution: 3.65 Å | in vitro The local refined map of SARS-CoV-2 EG.5.1 Variant Spike protein complexed with antibody XGi-171 · Spike glycoprotein (chains A) | unmapped |
| EV-PDB-9KZE-3 RCSB PDB | cryoem | resolution: 3.4 Å | in vitro · ligands branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose The local refined map of SARS-CoV-2 EG.5.1 Variant Spike protein complexed with antibody XGi-183 · Spike glycoprotein (chains A) | unmapped |
| EV-PDB-9KZZ-3 RCSB PDB | cryoem | resolution: 3.18 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Structure of SARS-CoV-2 EG.5.1 Variant Spike protein complexed with antibody XGi-171 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-9L05-3 RCSB PDB | cryoem | resolution: 3.24 Å | in vitro The local refined map of SARS-CoV-2 EG.5.1 Variant Spike protein complexed with antibody XGi-198 · Spike glycoprotein (chains A) | unmapped |
| EV-PDB-9L07-1 RCSB PDB | cryoem | resolution: 3.28 Å | in vitro The local refined map of SARS-CoV-2 EG.5.1 Variant Spike protein complexed with antibody XGi-203 · Spike glycoprotein (chains A) | unmapped |
| EV-PDB-9L15-3 RCSB PDB | cryoem | resolution: 2.95 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Structure of SARS-CoV-2 EG.5.1 Variant Spike protein complexed with antibody XGi-203 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-9L3I-1 RCSB PDB | cryoem | resolution: 3.1 Å | in vitro · ligands branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 BA.2.75 Spike Protein complex with a potent broad-spectrum macrocyclic peptide inhibitor 6L3-3P11K · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-9L3Q-1 RCSB PDB | cryoem | resolution: 2.7 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 PT Spike Protein complex with a potent broad-spectrum macrocyclic peptide inhibitor 6L3-3P11K · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-9LBS-6 RCSB PDB | cryoem | resolution: 3.41 Å | in vitro · ligands branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of Omicron BA.1 RBD complexed with ConBA-998,S309 and S304Fabs · Spike protein S1 (chains F) | unmapped |
| EV-PDB-9LAE-1 RCSB PDB | cryoem | resolution: 3.46 Å | in vitro · ligands NAG Locally refined region of SARS-CoV-2 spike in complex with antibodies 9G11 and 3E2. · Spike protein S1 (chains G) | unmapped |
| EV-PDB-9L6C-2 RCSB PDB | cryoem | resolution: 3.33 Å | in vitro · ligands branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of Delta RBD complexed with ConD-852, P2C-1F11 and S304 Fabs · Spike protein S1 (chains E) | unmapped |
| EV-PDB-9L2L-1 RCSB PDB | cryoem | resolution: 2.98 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Structure of SARS-CoV-2 EG.5.1 Variant Spike protein complexed with antibody XGi-198 · Spike glycoprotein (chains A,B,C,D,E,F) | unmapped |
| EV-PDB-9KWY-2 RCSB PDB | cryoem | resolution: 2.82 Å | in vitro · ligands NAG, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 RBD in complex with ACE2 and mAb 1C4 · Spike protein S1 (chains G) | unmapped |
| EV-PDB-9KVT-5 RCSB PDB | cryoem | resolution: 3.9 Å | in vitro · ligands branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 BA.2 spike protein in complex with triple-nAb 8H12, 3E2 and 1C4 (local refinement) · Spike protein S1 (chains G) | unmapped |
| EV-PDB-9KVQ-5 RCSB PDB | cryoem | resolution: 3.95 Å | in vitro · ligands branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 BA.1 spike protein in complex with three-nAb 8H12, 3E2 and 1C4 · Spike protein S1 (chains G) | unmapped |
| EV-PDB-9KVK-5 RCSB PDB | cryoem | resolution: 3.44 Å | in vitro · ligands branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 spike protein in complex with three-nAb 8H12, 3E2 and 1C4 · Spike protein S1 (chains G) | unmapped |
| EV-PDB-9KVJ-3 RCSB PDB | cryoem | resolution: 3.82 Å | in vitro · ligands branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 BA.5 spike protein in complex with nAb 1C4 (local refinement) · Spike protein S1 (chains G) | unmapped |
| EV-PDB-9KVE-5 RCSB PDB | cryoem | resolution: 2.98 Å | in vitro Cryo-EM structure of SARS-CoV-2 prototype spike protein in complex with triple-nAb 4H1, 4A5 and 4C1 · Spike protein S1 (chains C) | unmapped |
| EV-PDB-9KUD-2 RCSB PDB | xray | resolution: 3.14 Å | in vitro · -173.15 °C · ligands NAG, ZN, branched: alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Crystal structure of SARS-CoV-2 JN.1 variant RBD complexed with squirrel ACE2 · Spike protein S1 (chains E,F) | unmapped |
| EV-PDB-9K75-1 RCSB PDB | cryoem | resolution: 3.11 Å | in vitro · ligands NAG SARS-CoV-2 related bat coronavirus BANAL-103 spike in the closed state · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-9K6Z-1 RCSB PDB | cryoem | resolution: 3.51 Å | in vitro · ligands EIC, NAG SARS-CoV-2 related bat coronavirus BANAL-52 spike in the locked state · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-9K6Y-3 RCSB PDB | cryoem | resolution: 2.67 Å | in vitro · ligands branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 prototype spike protein in complex with H4 Fab (local refinement) · Spike protein S1 (chains R) | unmapped |
| EV-PDB-9K6J-1 RCSB PDB | xray | resolution: 2.39 Å | in vitro · -173.15 °C · pH 8 · ligands NAG Crystal structure of SARS-CoV-2 WT RBD bound with P5-1C8 Fab · Spike protein S1 (chains C) | unmapped |
| EV-PDB-9JS4-3 RCSB PDB | cryoem | resolution: 3.8 Å | in vitro Cryo-EM structure of neutralizing antibody 8G3 in complex with BA.1 RBD · Spike glycoprotein (chains C) | unmapped |
| EV-PDB-9JRC-2 RCSB PDB | xray | resolution: 3.16 Å | in vitro · -173.15 °C · ligands NAG, ZN, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Crystal structure of SARS-CoV-2 receptor-binding domain complexed with squirrel ACE2 · Spike protein S1 (chains E) | unmapped |
| EV-PDB-9JR5-1 RCSB PDB | xray | resolution: 3.414 Å | in vitro · -173.15 °C · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Crystal structure of PCoV-GD receptor-binding domain complexed with squirrel ACE2 · Spike glycoprotein (chains E) | unmapped |
| EV-PDB-9JEB-2 RCSB PDB | xray | resolution: 2.3 Å | in vitro · -193.15 °C · ligands NAG Crystal structure of SARS-CoV-2 RBD in complex with a neutralizing antibody scFv N1 · Spike protein S1 (chains B,D) | unmapped |
| EV-PDB-9IUU-2 RCSB PDB | cryoem | resolution: 3.29 Å | in vitro · ligands CL, NAG, ZN JN.1 RBD with Q493E in complex with ACE2 · Spike protein S1 (chains B) | unmapped |
| EV-PDB-9IUQ-2 RCSB PDB | cryoem | resolution: 3.3 Å | in vitro · ligands NAG KP.2 RBD in complex with ACE2 · Spike protein S1 (chains B) | unmapped |
| EV-PDB-9IUP-2 RCSB PDB | cryoem | resolution: 3.3 Å | in vitro · ligands NAG KP.3 RBD in complex with ACE2 · Spike protein S1 (chains B) | unmapped |
| EV-PDB-9IQP-1 RCSB PDB | xray | resolution: 1.55 Å | in vitro · -173.15 °C · ligands NA, NAG Crystal structure of the Wuhan SARS-CoV-2 Spike RBD (319-541) complexed with 1p1B10 nanobody · Spike protein S1 (chains A) | unmapped |
| EV-PDB-9IB3-1 RCSB PDB | cryoem | resolution: 3.3 Å | in vitro · ligands NAG Cryo-EM focus map of prefusion SARS-CoV-2 spike (RBDs: 2 up & 1 down) bound to RBD-targeting MO176-117 antibody · Spike glycoprotein (chains A) | unmapped |
| EV-PDB-9IB2-1 RCSB PDB | cryoem | resolution: 2.9 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM consensus map of prefusion SARS-CoV-2 spike (RBDs: 2 up & 1 down) bound to RBD-targeting MO176-117 antibody · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-9IB1-1 RCSB PDB | cryoem | resolution: 3.2 Å | in vitro · ligands NAG Cryo-EM focus map of prefusion SARS-CoV-2 spike (RBDs: 1 up & 2 down) bound to RBD-targeting MO176-117 antibody · Spike glycoprotein (chains A) | unmapped |
| EV-PDB-9IB0-1 RCSB PDB | cryoem | resolution: 2.9 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM consensus map of prefusion SARS-CoV-2 spike (RBDs: 1 up & 2 down) bound to RBD-targeting MO176-117 antibody · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-9H6U-1 RCSB PDB | cryoem | resolution: 3.27 Å | in vitro · ligands NAG SARS-CoV-2 S protein in complex with pT1679 Fab · Spike glycoprotein,Fibritin (chains A) | unmapped |
| EV-PDB-9GXG-1 RCSB PDB | cryoem | resolution: 1.92 Å | in vitro · ligands KZ0, NAG, R06, STE, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Structure of the SARS-CoV spike glycoprotein in complex with a biparatopic Bicycle molecule · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-9GXE-1 RCSB PDB | cryoem | resolution: 2.3 Å | in vitro · ligands KZ0, NAG, STE, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Structure of the SARS-CoV spike glycoprotein in complex with a homotrimeric Bicycle molecule · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-9GDX-1 RCSB PDB | cryoem | resolution: 2.8 Å | in vitro SARS-CoV-2 Spike protein Beta Variant at 4C structural flexibility / heterogeneity analyses · Spike glycoprotein,Fibritin (chains A,B,C) | unmapped |
| EV-PDB-9FR3-2 RCSB PDB | cryoem | resolution: 3.3 Å | in vitro · ligands NAG Structure of the SARS-CoV-2 spike glycoprotein in complex with nanobody 7F · Spike glycoprotein (chains A,B,D,G,H,J) | unmapped |
| EV-PDB-9FMW-1 RCSB PDB | cryoem | resolution: 3.6 Å | in vitro Omicron BA.1 Spike protein with neutralizing NTD specific mAb K501SP6 · Spike glycoprotein,Fibritin (chains A,B,C) | unmapped |
| EV-PDB-9FJK-1 RCSB PDB | cryoem | resolution: 2.84 Å | in vitro Omicron BA.1 Spike protein with neutralizing NTD specific mAb K501SP6 · Spike glycoprotein,Fibritin (chains A,B,C) | unmapped |
| EV-PDB-9LDJ-1 RCSB PDB | cryoem | resolution: 6.21 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 wide-type S trimer in the early fusion intermediate conformation (E-FIC) complexed with ACE2 and 76E1-Fab · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-9LE9-1 RCSB PDB | xray | resolution: 3.14 Å | in vitro · -173.15 °C · ligands NAG Complex structure of THC-4447 Fab bound to SARS-CoV-2 XBB.1.5 RBD · Spike protein S1 (chains B,E) | unmapped |
| EV-PDB-9LF4-1 RCSB PDB | xray | resolution: 2.98 Å | in vitro · -173.15 °C · ligands NAG Complex structure of THC-2027 and THC-4555 Fab bound to SARS-CoV-2 XBB.1.5 RBD · Spike protein S1 (chains C) | unmapped |
| EV-PDB-9LF5-1 RCSB PDB | xray | resolution: 2.95 Å | in vitro · -173.15 °C Complex structure of THC-4677 and THC-4881 Fab bound to SARS-CoV-2 WT RBD · Spike protein S1 (chains A,B) | unmapped |
| EV-PDB-9LFP-1 RCSB PDB | xray | resolution: 3.14 Å | in vitro · -173.15 °C · ligands NAG Complex structure of THC-2030 Fab and S309 bound to SARS-CoV-2 WT RBD · Spike protein S1 (chains A,B) | unmapped |
| EV-PDB-9LH2-1 RCSB PDB | xray | resolution: 2.3 Å | in vitro · -173.15 °C · pH 8.5 · ligands NAG Crystal structure of SARS-CoV-2 spike receptor-binding domain (Delta) in complex with pH-dependent nanobody MNb-11. · Spike protein S1 (chains A,C) | unmapped |
| EV-PDB-9LOY-1 RCSB PDB | cryoem | resolution: 2.66 Å | in vitro · ligands NAG Cryo-EM structure of SARS-CoV-2 JN.1 spike glycoprotein in complex with F61R2-780 Fab · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-9LOZ-1 RCSB PDB | cryoem | resolution: 3.55 Å | in vitro · ligands NAG Cryo-EM structure of SARS-CoV-2 JN.1 RBD in complex with F61R2-780 Fab · Spike protein S1 (chains A) | unmapped |
| EV-PDB-9LP0-1 RCSB PDB | cryoem | resolution: 2.61 Å | in vitro · ligands NAG Cryo-EM structure of SARS-CoV-2 KP.3.1.1 spike glycoprotein in complex with F61R2-780 Fab · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-9LP1-3 RCSB PDB | cryoem | resolution: 3.47 Å | in vitro · ligands NAG Cryo-EM structure of SARS-CoV-2 KP.3.1.1 RBD in complex with F61R2-780 Fab · Spike protein S1 (chains C) | unmapped |
| EV-PDB-9LVI-1 RCSB PDB | cryoem | resolution: 2.86 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 spike protein · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-9LVS-1 RCSB PDB | cryoem | resolution: 2.95 Å | in vitro · ligands EZO, NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of the SARS-CoV-2 spike protein in complex with S416 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-9LYO-3 RCSB PDB | cryoem | resolution: 3.07 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Alpha SARS-CoV-2 spike protein in complex with REGN10987 Fab homologue. · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-9M3F-2 RCSB PDB | cryoem | resolution: 2.79 Å | in vitro · ligands branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of Rc-o319 RBD/R. cornutus ACE2 complex · Spike glycoprotein (chains B) | unmapped |
| EV-PDB-9MI3-1 RCSB PDB | cryoem | resolution: 3.23 Å | in vitro · ligands NAG Cryo-EM structure of SARS-CoV-2 spike protein in complex with neutralizing human antibody WRAIR-2008 · Spike glycoprotein (chains A,C,K) | unmapped |
| EV-PDB-9ML4-1 RCSB PDB | cryoem | resolution: 3.3 Å | in vitro · ligands NAG Structure of the SARS-CoV-2 Spike 6P in complex with the rabbit M8b-A10 Fab · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-9ML6-1 RCSB PDB | cryoem | resolution: 3.5 Å | in vitro · ligands NAG Structure of the SARS-CoV-2 Spike 6P in complex with the rabbit M8b-C9 Fab · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-9ML8-1 RCSB PDB | xray | resolution: 2.4 Å | in vitro · -173.15 °C · ligands SO4, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Crystal structure of the SARS-CoV-2 RBD in complex with the rabbit M8b-B1 Fab · Spike protein S1 (chains A,B,C,D) | unmapped |
| EV-PDB-9ML9-1 RCSB PDB | xray | resolution: 2.59 Å | in vitro · -173.15 °C · ligands NAG, TRS Crystal structure of the SARS-CoV-2 RBD in complex with the rabbit M8b-C9 Fab · Spike protein S1 (chains A) | unmapped |
| EV-PDB-9MR1-3 RCSB PDB | cryoem | resolution: 3.59 Å | in vitro · ligands NAG SARS-CoV-2 S2 monomer in complex with R125-61 Fab · Spike protein S2 (chains C) | unmapped |
| EV-PDB-9MR2-3 RCSB PDB | cryoem | resolution: 3.79 Å | in vitro SARS-CoV-2 S2 monomer in complex with NICA01A-1401 Fab · Spike protein S2 (chains C) | unmapped |
| EV-PDB-9NFT-1 RCSB PDB | cryoem | resolution: 3 Å | in vitro · ligands NAG PRO-37587 bound to SARS-CoV-2 Spike protein · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-9NHP-3 RCSB PDB | xray | resolution: 1.93 Å | in vitro · -173.15 °C GB-0669 Fab: S2 stem helix peptide · Spike protein S2 (chains P) | unmapped |
| EV-PDB-9NVG-1 RCSB PDB | cryoem | resolution: 3 Å | in vitro · ligands branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Structure of SARS-CoV-2 BA.1 spike RBD bound to COV2-3835 Fab · Spike glycoprotein (chains A) | unmapped |
| EV-PDB-9NXY-1 RCSB PDB | cryoem | resolution: 3.08 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-3)-alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 spike S2' trimer · Spike protein S2 (chains A,B,C) | unmapped |
| EV-PDB-9O5T-2 RCSB PDB | xray | resolution: 2.9 Å | in vitro · -173.15 °C · ligands CL, EDO, NA, NAG, ZN, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Crystal structure of chimeric SARS-CoV-2 RBD complexed with chimeric Rhinolophus sinicus ACE2 · Spike protein S1 (chains E,F) | unmapped |
| EV-PDB-9O5V-2 RCSB PDB | xray | resolution: 3.35 Å | in vitro · -173.15 °C · ligands CL, EDO, NA, NAG, ZN, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Crystal structure of chimeric BANAL-52 RBD complexed with chimeric Rhinolophus sinicus ACE2 · Spike protein S1 (chains E,F) | unmapped |
| EV-PDB-9OG4-1 RCSB PDB | cryoem | resolution: 3.56 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-COV-2-6P-MUT7 S PROTEIN-DY-III-281 complex closed conformation · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-9OG5-1 RCSB PDB | cryoem | resolution: 3.3 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-COV-2-6P-MUT7 S PROTEIN-DY-III-281 complex 1 RBD up conformation · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-9OG6-1 RCSB PDB | cryoem | resolution: 3.14 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-3)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Apo SARS-COV-2-6P-MUT7 S PROTEIN closed conformation · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-9PSO-1 RCSB PDB | xray | resolution: 2.62 Å | in vitro · -173.15 °C · ligands EDO, GOL, PEG, PGE, SO4, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Crystal structure of SARS-CoV-2 receptor binding domain in complex with antibodies BoWLB-622 and CC12.3 · Spike protein S1 receptor binding domain (chains E) | unmapped |
| EV-PDB-9PSP-1 RCSB PDB | xray | resolution: 2.81 Å | in vitro · -173.15 °C · ligands 1PE, EDO, NAG, PEG, PGE, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Crystal structure of SARS-CoV-2 receptor binding domain in complex with antibodies BoWLB-1173 and CC12.3 · Spike protein S1 receptor binding domain (chains T,U) | unmapped |
| EV-PDB-9PW4-1 RCSB PDB | cryoem | resolution: 2.85 Å | in vitro · ligands branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose Structure of V30V4 in complex with SARS-CoV-2 spike · Spike protein S1 (chains A) | unmapped |
| EV-PDB-9SAT-3 RCSB PDB | xray | resolution: 2.56 Å | in vitro · -173.15 °C · pH 5.5 · ligands ZN Monoclonal Antibodies from COVID-19 Convalescent Patients Target Cryptic Epitopes for Universal SARS-CoV-2 Neutralization · Spike protein S1 (chains R) | unmapped |
| EV-PDB-9SBB-3 RCSB PDB | xray | resolution: 2.12 Å | in vitro · -173.15 °C · ligands GOL, LI, NAG, PEG Monoclonal Antibodies from COVID-19 Convalescent Patients Target Cryptic Epitopes for Universal SARS-CoV-2 Neutralization · Spike protein S1 (chains R) | unmapped |
| EV-PDB-9T74-2 RCSB PDB | cryoem | resolution: 3.46 Å | in vitro · ligands MG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose 2'-fluoro-modified pyrimidine (FY) RNA aptamer binding to the receptor binding domain (RBD) of the SARS-CoV-2 spike protein. (focus map: RBD-aptamer) · Spike glycoprotein (chains B) | unmapped |
| EV-PDB-9TVT-1 RCSB PDB | xray | resolution: 2.85 Å | in vitro · -173.15 °C · pH 8.5 · ligands GOL, NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN (RBD-beta variant) in complex with 3D2 Fab and 1D1 Fab · Spike protein S1 (chains A,B) | unmapped |
| EV-PDB-9UE6-1 RCSB PDB | cryoem | resolution: 2.9 Å | in vitro Cryo-EM structure of SARS-CoV-2 KP.2 spike RBD in complex with ACE2 · Spike protein S1 (chains A) | unmapped |
| EV-PDB-9RN6-1 RCSB PDB | xray | resolution: 2.4 Å | in vitro · -173.15 °C · pH 7.5 Crystal structure of a protein mimic of SARS-CoV-2 spike's HR1 domain in complex with two nanobodies bound to different epitopes · Spike protein S2',Chimeric protein mimic of SARS-CoV-2 Spike HR1 (chains A) | unmapped |
| EV-PDB-9PSN-1 RCSB PDB | xray | resolution: 2.54 Å | in vitro · -173.15 °C · ligands EDO, NAG, PEG, PG4, PGE, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Crystal structure of SARS-CoV-2 receptor binding domain in complex with antibodies BoWLB-105 and CC12.3 · Spike protein S1 receptor binding domain (chains E,T) | unmapped |
| EV-PDB-9OG7-1 RCSB PDB | cryoem | resolution: 3.09 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-3)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose APO SARS-COV-2-6P-MUT7 S PROTEIN 1 RBD UP CONFORMATION · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-9N2L-1 RCSB PDB | cryoem | resolution: 2.99 Å | in vitro Cryo-EM structure of locally refined up conformation of SARS-CoV-2 spike protein Receptor Binding Domain · Spike protein S1 (chains F) | unmapped |
| EV-PDB-9MPW-1 RCSB PDB | cryoem | resolution: 3.37 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV2 Spike S2 Subunit in complex with M15 Antibody Fragment · Spike protein S2 (chains S) | unmapped |
| EV-PDB-9ML7-1 RCSB PDB | cryoem | resolution: 3.2 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Structure of the SARS-CoV-2 Spike 6P in complex with the rabbit M8b-C10 Fab · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-9ML5-1 RCSB PDB | cryoem | resolution: 3.4 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Structure of the SARS-CoV-2 Spike 6P in complex with the rabbit M8b-B8 Fab · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-9MAO-1 RCSB PDB | cryoem | resolution: 3.09 Å | in vitro · ligands NAG SARS-CoV-2 spike-Crp5 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-9LS3-1 RCSB PDB | cryoem | resolution: 3.4 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose S-ECD of SARS-CoV-2 Delta variant in complex with Fab854 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-9LFO-1 RCSB PDB | xray | resolution: 2.91 Å | in vitro · -173.15 °C Complex structure of THC-2199 Fab bound to SARS-CoV-2 XBB.1.5 RBD · Spike protein S1 (chains C,F) | unmapped |
| EV-PDB-9LDS-2 RCSB PDB | xray | resolution: 1.6 Å | in vitro · -173.15 °C Crystal structure of nanobody H145 bound to SARS-CoV-2 spike stem-helix · Spike protein S2' (chains B,D) | unmapped |
| EV-PDB-9LD2-1 RCSB PDB | cryoem | resolution: 3.73 Å | in vitro · ligands NAG Cryo-EM structure of SARS-CoV-2 wide-type S trimer in the early fusion intermediate conformation (E-FIC) complexed with ACE2 and 76E1-Fab (focused refinement of the S2-76E1) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-9UG3-1 RCSB PDB | cryoem | resolution: 3.75 Å | in vitro Structure of SARS-CoV-2 spike-CD147 complex at 3.75 Angstroms resolution · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-9UHF-1 RCSB PDB | cryoem | resolution: 4.18 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose JN.1 RBD in complex with antibody BA5-12 · Spike protein S1 (chains A) | unmapped |
| EV-PDB-9UHG-1 RCSB PDB | cryoem | resolution: 3.91 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose JN.1 RBD in complex with antibody BA5-12-CDR1 · Spike protein S1 (chains A) | unmapped |
| EV-PDB-9UHH-3 RCSB PDB | cryoem | resolution: 4.05 Å | in vitro · ligands NAG WT RBD in complex with antibody BA5-12-GR · Spike protein S1 (chains C) | unmapped |
| EV-PDB-9UHQ-1 RCSB PDB | cryoem | resolution: 4.62 Å | in vitro Local refinement of JN.1 spike in complex with antibody BA5-39 · Spike protein S1 (chains A) | unmapped |
| EV-PDB-9UXD-1 RCSB PDB | cryoem | resolution: 3.03 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV2 Spike protein with Fab fragment antibody KXD355,state1 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-9UXS-2 RCSB PDB | cryoem | resolution: 3.4 Å | in vitro The local refine of 3D reconstruction of the complex formed by SARS-CoV2 BA.1 spike glycoprotein and a single-domain antibody · Spike glycoprotein (chains B) | unmapped |
| EV-PDB-9UYD-1 RCSB PDB | cryoem | resolution: 2.7 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 Ancestral strain spike S-cred · Spike glycoprotein (chains A,B,F) | unmapped |
| EV-PDB-9VFX-2 RCSB PDB | cryoem | resolution: 2.8 Å | in vitro · ligands NAG SARS-CoV-2 spike di-trimer of RBD and NTD · Spike protein S1 (chains B,D) | unmapped |
| EV-PDB-9VFX-1 RCSB PDB | cryoem | resolution: 2.8 Å | in vitro · ligands NAG SARS-CoV-2 spike di-trimer of RBD and NTD · Spike protein S1 (chains A,C) | unmapped |
| EV-PDB-9VG7-1 RCSB PDB | cryoem | resolution: 2.55 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM Structure of Rc-o319 Ectodomain trimer · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-9VLS-1 RCSB PDB | cryoem | resolution: 4.14 Å | in vitro · ligands NAG Cryo-EM structure of SARS-CoV-2 XBB.1.5 S trimer in the early fusion intermediate conformation (E-FIC) complexed with ACE2 and 76E1-Fab (focused refinement of the S2-76E1) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-9WIG-7 RCSB PDB | cryoem | resolution: 3.93 Å | in vitro · ligands NAG Structure of the PT NTD-C1536-CoV2-3434-BLN8 complex · Spike protein S1 (chains G) | unmapped |
| EV-PDB-9WLA-3 RCSB PDB | cryoem | resolution: 3.6 Å | in vitro · ligands CL Local refinement region of SARS-CoV-2 spike RBD in complex with antibodies CT1-5. · Spike protein S1 (chains R) | unmapped |
| EV-PDB-9WLB-4 RCSB PDB | cryoem | resolution: 3.74 Å | in vitro · ligands CL Local refinement region of SARS-CoV-2 spike RBD in complex with antibodies S309 and CT1-1. · Spike protein S1 (chains R) | unmapped |
| EV-PDB-9WPP-1 RCSB PDB | xray | resolution: 3.1 Å | in vitro · -173.15 °C Crystal structure of the SARS-CoV-2 spike protein HR1 in complex with a designed peptide inhibitor dP-S2FI-0087 at 3.1 angstrom resolution · Spike protein S2' (chains A,C) | unmapped |
| EV-PDB-9WSP-1 RCSB PDB | cryoem | resolution: 4.55 Å | in vitro Cryo-EM structure of SARS CoV2 S protein with stabilising mutations · Spike glycoprotein (chains B) | unmapped |
| EV-PDB-9X9Z-1 RCSB PDB | xray | resolution: 2.55 Å | in vitro · -173.15 °C · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose Structure of the Omicron BA.2.86 variant Spike N-terminal domain(NTD)in complex with the antibody Fab fragment, C1717 · Spike protein S1 (chains A) | unmapped |
| EV-PDB-9XA4-3 RCSB PDB | xray | resolution: 2.52 Å | in vitro · -173.15 °C · ligands EDO, NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Structure of the Omicron BA.4/5 Spike N-terminal domain(NTD) in complex with the AC2 Fab · Spike protein S1 (chains A) | unmapped |
| EV-PDB-9XAR-1 RCSB PDB | xray | resolution: 2.77 Å | in vitro · -173.15 °C · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose Structure of the SARS-CoV-2 Spike N-terminal domain(NTD) in complex with the C1624 Fab · Spike protein S1 (chains A,D) | unmapped |
| EV-PDB-9XGO-3 RCSB PDB | cryoem | resolution: 3.77 Å | in vitro · ligands NAG Omicron-specific ultra-potent SARS-CoV-2 neutralizing antibodies targeting the N1/N2 loop of Spike N-terminal domain · Spike protein S1 (chains N) | unmapped |
| EV-PDB-9XGO-4 RCSB PDB | cryoem | resolution: 3.77 Å | in vitro · ligands NAG Omicron-specific ultra-potent SARS-CoV-2 neutralizing antibodies targeting the N1/N2 loop of Spike N-terminal domain · Spike glycoprotein (chains R) | unmapped |
| EV-PDB-9XGX-3 RCSB PDB | cryoem | resolution: 2.8 Å | in vitro · ligands NAG Cryo-EM structure of SARS-CoV-2 receptor binding domain in complex with SR-23 Fab (local refinement of RBD and Fv) · Spike protein S1 (chains E) | unmapped |
| EV-PDB-9XHZ-1 RCSB PDB | cryoem | resolution: 5.28 Å | in vitro · ligands NAG, ZN, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 Omicron BA.4/5 spike trimer in complex with C092 Fab and ACE2 (2 RBD up) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-9XI0-1 RCSB PDB | cryoem | resolution: 3.98 Å | in vitro · ligands NAG, ZN, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 Omicron BA.4/5 spike trimer in complex with C092 Fab and ACE2 (3 RBD up) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-9XI1-2 RCSB PDB | cryoem | resolution: 2.58 Å | in vitro · ligands NAG, ZN SARS-CoV-2 Omicron BA.4/5 spike RBD in complex with C092 Fab and ACE2 · Spike protein S1 (chains E) | unmapped |
| EV-PDB-9XI2-2 RCSB PDB | cryoem | resolution: 2.83 Å | in vitro · ligands NAG, ZN SARS-CoV-2 Omicron BA.4/5 spike RBD in complex with C807 Fab and ACE2 · Spike protein S1 (chains E) | unmapped |
| EV-PDB-9XI3-4 RCSB PDB | cryoem | resolution: 4.74 Å | in vitro · ligands NAG, ZN, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 Omicron BA.4/5 spike trimer in complex with C807 Fab and ACE2 (3 RBD up) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-9XI4-2 RCSB PDB | cryoem | resolution: 2.83 Å | in vitro · ligands NAG, ZN SARS-CoV-2 Omicron BA.4/5 spike RBD in complex with BD56-104 Fab and ACE2 · Spike protein S1 (chains E) | unmapped |
| EV-PDB-9XI6-2 RCSB PDB | cryoem | resolution: 2.6 Å | in vitro · ligands NAG, ZN SARS-CoV-2 Omicron BA.4/5 spike RBD in complex with BD56-597 Fab and ACE2 · Spike protein S1 (chains E) | unmapped |
| EV-PDB-9XI7-1 RCSB PDB | cryoem | resolution: 3.22 Å | in vitro · ligands NAG, ZN, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 Omicron BA.4/5 spike trimer in complex with BD56-597 Fab and ACE2 (3 RBD up) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-9XI9-4 RCSB PDB | cryoem | resolution: 2.93 Å | in vitro · ligands branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 Omicron LP.8.1 spike trimer (S-6P) in complex with 3 ZL58 Fabs and 3 ZL525 Fabs, focused refinement of RBD and Fab region · Spike protein S1 (chains C) | unmapped |
| EV-PDB-9XID-3 RCSB PDB | cryoem | resolution: 2.97 Å | in vitro SARS-CoV-2 Omicron JD.1.1 spike trimer (S-6P) in complex with 3 R102-9 Fabs and 3 C092 Fabs, focused refinement of RBD and Fab region · Spike protein S1 (chains A) | unmapped |
| EV-PDB-9YJI-3 RCSB PDB | xray | resolution: 2.05 Å | in vitro · -173.15 °C Crystal structure of SARS-CoV-2 spike stem helix peptide in complex with monoclonal antibody CC65.1 · Stem helix peptide of Spike protein S2' (chains C,D) | unmapped |
| EV-PDB-9YOK-1 RCSB PDB | cryoem | resolution: 3.56 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Fab-14/SARS-CoV-2 D614G spike complex, Mode I conformation · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-9YNX-1 RCSB PDB | cryoem | resolution: 4.1 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Local refinement of Fab-14/SARS-CoV-2 D614G spike complex, Mode IV, Subgroup I conformation · Spike protein S1 (chains A,B) | unmapped |
| EV-PDB-9Y5Y-1 RCSB PDB | cryoem | resolution: 3.16 Å | in vitro Structure of the Omicron Spike RBD bound by the monobody s19382 (local refinement from dimerized Spike protein ECDs) · Spike protein S1 (chains A,C,E,G) | unmapped |
| EV-PDB-9XIC-1 RCSB PDB | cryoem | resolution: 2.76 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 Omicron JD.1.1 spike trimer (S-6P) in complex with 3 R102-9 Fabs and 3 C092 Fabs (3 RBD up) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-9XI5-4 RCSB PDB | cryoem | resolution: 3.06 Å | in vitro · ligands NAG, ZN, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 Omicron BA.4/5 spike trimer in complex with BD56-104 Fab and ACE2 (3 RBD up) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-9XHY-2 RCSB PDB | cryoem | resolution: 3.84 Å | in vitro · ligands NAG, ZN SARS-CoV-2 Omicron BA.4/5 spike RBD in complex with C092 Fab and ACE2 · Spike protein S1 (chains E) | unmapped |
| EV-PDB-9XGW-3 RCSB PDB | cryoem | resolution: 3.2 Å | in vitro · ligands NAG Cryo-EM structure of SARS-CoV-2 receptor binding domain in complex with CS-42 Fab (local refinement of RBD and Fv) · Spike protein S1 (chains E) | unmapped |
| EV-PDB-9XAW-2 RCSB PDB | xray | resolution: 3.13 Å | in vitro · -173.15 °C · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose Structure of the SARS-CoV-2 Spike N-terminal domain(NTD) in complex with the BLN8 Fab · Spike protein S1 (chains I,J,K,L) | unmapped |
| EV-PDB-9XA5-1 RCSB PDB | xray | resolution: 3.32 Å | in vitro · -173.15 °C · ligands EDO, NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose Structure of the Omicron BA.4/5 Spike N-terminal domain(NTD) in complex with the AC8 Fab · Spike protein S1 (chains A) | unmapped |
| EV-PDB-9XA0-1 RCSB PDB | xray | resolution: 3.51 Å | in vitro · -173.15 °C · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose, branched: alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-beta-D-glucopyranose Structure of the Omicron KP.3.1.1 variant Spike N-terminal domain(NTD)in complex with the C1717 Fab and S2L20 Fab · Spike glycoprotein (chains C) | unmapped |
| EV-PDB-9X9T-5 RCSB PDB | cryoem | resolution: 3.45 Å | in vitro · ligands NAG Local refinement of SARS-CoV-2 KP.3.1.1 RBD with BD57-2704 and AB2-122 Fab · Spike protein S1 (chains R) | unmapped |
| EV-PDB-9WP8-1 RCSB PDB | xray | resolution: 3.1 Å | in vitro · -173.15 °C Crystal structure of the SARS-CoV-2 spike protein HR1 in complex with a designed peptide inhibitor dP-S2FI-0089 at 3.1 angstrom resolution · dP-S2FI-0089,Spike protein S2' (chains A,C,E,G,I,K) | unmapped |
| EV-PDB-9W6U-1 RCSB PDB | cryoem | resolution: 2.81 Å | in vitro · ligands NAG Structure of the PT NTD-C1554-C1540 complex · Spike protein S1 (chains A) | unmapped |
| EV-PDB-9W14-1 RCSB PDB | cryoem | resolution: 2.33 Å | in vitro · ligands branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 WT spike protein in complex with nAb 1C4 · Spike protein S1 (chains G) | unmapped |
| EV-PDB-9VLT-1 RCSB PDB | cryoem | resolution: 5.65 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 XBB.1.5 S trimer in the early fusion intermediate conformation (E-FIC) complexed with ACE2 and 76E1-Fab · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-9UXE-1 RCSB PDB | cryoem | resolution: 3.17 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, branched: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV2 Spike protein with Fab fragment antibody KXD355,state2 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-9UTF-2 RCSB PDB | xray | resolution: 2.95 Å | in vitro · -173.15 °C · pH 3.5 · ligands NAG Crystal Structure of SARS-CoV-2 S receptor-binding domain (RBD) in complex XG83 Fab · Spike protein S1 (chains A) | unmapped |
| EV-PDB-9UPR-4 RCSB PDB | cryoem | resolution: 2.77 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of the N-terminal domain of Omicron BA.1 in complex with nanobody N103 and S2L20 Fab · Spike glycoprotein (chains F) | unmapped |
| EV-PDB-9Z18-3 RCSB PDB | cryoem | resolution: 2.9 Å | in vitro · ligands NAG SARS-CoV-2 spike S2 in complex with antibody N6-2 · Spike protein S2 (chains A) | unmapped |
| EV-PDB-9ZT8-1 RCSB PDB | cryoem | resolution: 2.75 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Stabilized SARS-CoV-2 S2 apo · Spike protein S2 (chains A,B,C) | unmapped |
| EV-PDB-9ZT7-3 RCSB PDB | cryoem | resolution: 3.11 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 S2 in complex with COV2-2509 · Spike protein S2 (chains C,D,E) | unmapped |
| EV-PDB-9ZT6-3 RCSB PDB | cryoem | resolution: 2.83 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 S2 in complex with polyclonal Fab-B_Donor8 · Spike protein S2 (chains C,D,E) | unmapped |
| EV-PDB-9ZT5-3 RCSB PDB | cryoem | resolution: 3.21 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 S2 in complex with polyclonal Fab-B_Donor3 · Spike protein S2 (chains C,D,E) | unmapped |
| EV-PDB-9ZDU-1 RCSB PDB | xray | resolution: 2.6 Å | in vitro · -173.15 °C · ligands NAG, PEG, PO4 Crystal structure of SARS-CoV-2 RBD in complex with human Ab401 Fab · Spike protein S1 (chains A) | unmapped |
| EV-PDB-9ZBY-5 RCSB PDB | xray | resolution: 2.73 Å | in vitro · -173.15 °C · ligands EDO, PO4 Crystal structure of SARS-CoV-2 Omicron BA.1 receptor binding domain in complex with antibodies HB148-M4 and LY-CoV1404 · Spike protein S1 (chains C) | unmapped |
| EV-PDB-9ZBX-1 RCSB PDB | xray | resolution: 2.6 Å | in vitro · -173.15 °C · ligands EDO, NAG, PO4, TRS Crystal structure of SARS-CoV-2 receptor binding domain in complex with antibodies HB148-M4 and LY-CoV1404 · Spike protein S1 (chains C) | unmapped |
| EV-PDB-9ZBW-4 RCSB PDB | xray | resolution: 3.1 Å | in vitro · -173.15 °C · ligands NAG, PO4 Crystal structure of SARS-CoV-2 receptor binding domain in complex with antibodies HB148 and LY-CoV1404 · Spike protein S1 (chains C,I) | unmapped |
| EV-PDB-9Z80-3 RCSB PDB | cryoem | resolution: 3.17 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose SARS-CoV-2 S2 in complex with polyclonal Fab_Donor1 · Spike protein S2 (chains C,D,E) | unmapped |
| EV-PDB-9Z3K-1 RCSB PDB | cryoem | resolution: 3.3 Å | in vitro · ligands NAG SARS-CoV-2 S2 trimer stabilized in the early fusion intermediate conformation by circular permutation and clamping by gp41 (E-FICs-v1) · SPIKE PROTEIN (chains A,B,C) | unmapped |
| EV-PDB-9Z12-3 RCSB PDB | cryoem | resolution: 3.2 Å | in vitro · ligands NAG SARS-CoV-2 spike S2 in complex with antibody B3-1 · Spike protein S2 (chains A) | unmapped |
| EV-PDB-9YYV-1 RCSB PDB | cryoem | resolution: 3.3 Å | in vitro · ligands NAG SARS-CoV-2 spike trimer in the early fusion intermediate conformation bound to the VN01H1 Fab (S2 local refinement) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-9YYU-1 RCSB PDB | cryoem | resolution: 3.3 Å | in vitro · ligands NAG SARS-CoV-2 spike trimer in the early fusion intermediate conformation bound to the VN01H1 Fab (Fab local refinement) · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-9YVI-1 RCSB PDB | cryoem | resolution: 2.66 Å | in vitro · ligands A1CZB, NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of BA.5 spike in complex with S22 · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-9YTC-1 RCSB PDB | cryoem | resolution: 2.68 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 Omicron neutralizing antibody S212 with BA.5 RBD and SP1-77 Fab complex · Spike glycoprotein (chains A) | unmapped |
| EV-PDB-9YTA-1 RCSB PDB | cryoem | resolution: 3.27 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 Omicron neutralizing antibody L52 with BA.5 RBD and SP1-77 Fab complex · Spike glycoprotein (chains A) | unmapped |
| EV-PDB-9YSG-1 RCSB PDB | cryoem | resolution: 3 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose Cryo-EM structure of SARS-CoV-2 Omicron neutralizing antibody AB2-122 with BA.5 RBD and SP1-77 Fab complex · Spike glycoprotein (chains A) | unmapped |
| EV-PDB-9YPR-1 RCSB PDB | cryoem | resolution: 3.46 Å | in vitro · ligands NAG, branched: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Fab-14/SARS-CoV-2 D614G spike complex, Mode IV, subgroup I conformation · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-PDB-9YPB-3 RCSB PDB | cryoem | resolution: 3.5 Å | in vitro · ligands NAG Fab-14/SARS-CoV-2 D614G spike complex, Mode IV, subgroup II conformation · Spike glycoprotein (chains A,B,C) | unmapped |
| EV-BMRB-30842 BMRB | nmr_shifts | chemical_shift | in vitro · 29.85 °C · pH 6.8 SARS-CoV-2 spike Protein TM domain · BMRB data: 13C chemical shifts, 15N chemical shifts, 1H chemical shifts | unmapped |
| EV-BMRB-30909 BMRB | nmr_shifts | chemical_shift | in vitro · 31.85 °C · pH 5 Fusion Peptide of SARS-CoV-2 Spike Rearranges into a Wedge Inserted in Bilayered Micelles · BMRB data: 13C chemical shifts, 15N chemical shifts, 1H chemical shifts | unmapped |
| EV-BMRB-30931 BMRB | nmr_shifts | chemical_shift | in vitro · 34.85 °C · pH 6 Membrane bound structure of HR1 domain of SARS-CoV-2 spike protein · BMRB data: 13C chemical shifts, 15N chemical shifts, 1H chemical shifts | unmapped |
| EV-BMRB-34651 BMRB | nmr_shifts | chemical_shift | in vitro · 24.85 °C · pH 2.5 NMR structure of a peptide deriving from SARS-CoV-2 S RBD 482-506 fragment in HFIP/H2O · BMRB data: 13C chemical shifts, 1H chemical shifts | unmapped |
| EV-BMRB-34652 BMRB | nmr_shifts | chemical_shift | in vitro · 24.85 °C · pH 2.5 NMR structure of a peptide deriving from SARS-CoV-2 Lineage B.1.1.7 S RBD 482-506 fragment in HFIP/H2O · BMRB data: 13C chemical shifts, 1H chemical shifts | unmapped |
| EV-BMRB-34653 BMRB | nmr_shifts | chemical_shift | in vitro · 24.85 °C · pH 2.5 NMR structure of a peptide deriving from SARS-CoV-2 Lineages P.1 and B.1.351 S RBD 482-506 fragment in HFIP/H2O · BMRB data: 13C chemical shifts, 1H chemical shifts | unmapped |
| EV-SASBDB-SASDJG4 SASBDB | saxs_sans | radius_of_gyration: 2.97 nm ± 0.02 | in vitro · 20 °C · pH 7.5 Selection, biophysical and structural analysis of synthetic nanobodies that effectively neutralize SARS-CoV-2 · Spike glycoprotein (ACE2 receptor binding domain) | unmapped |
| EV-SASBDB-SASDJH4 SASBDB | saxs_sans | radius_of_gyration: 3.53 nm ± 0.01 | in vitro · 20 °C · pH 7.5 · ligands partner: Synthetic nanobody Sybody 23 Selection, biophysical and structural analysis of synthetic nanobodies that effectively neutralize SARS-CoV-2 · Spike glycoprotein (ACE2 receptor binding domain) with Synthetic nanobody Sybody 23 | unmapped |
| EV-SASBDB-SASDQ39 SASBDB | saxs_sans | radius_of_gyration: 3.011 nm ± 0.006 | in vitro · pH 7.4 Form factor determination of biological molecules with X-ray free electron laser small-angle scattering (XFEL-SAS). · Spike glycoprotein (ACE2 receptor binding domain) | unmapped |
| EV-SASBDB-SASDXX6 SASBDB | saxs_sans | radius_of_gyration: 6.709 nm ± 0.562 | in vitro · 10 °C · pH 8 · ligands partner: Angiotensin converting Enzyme 2 ACE2 RBD Complex · Receptor Binding Domain with Angiotensin converting Enzyme 2 | unmapped |
| EV-SASBDB-SASDXZ6 SASBDB | saxs_sans | radius_of_gyration: 2.942 nm ± 0.15 | in vitro · 10 °C · pH 8 Receptor Binding Domain of SARS CoV-2 · Receptor Binding Domain of SARS CoV-2 | unmapped |
| EV-SASBDB-SASDYG7 SASBDB | saxs_sans | radius_of_gyration: 4.393 nm ± 0.896 | in vitro · 10 °C · pH 8 · ligands partner: Angiotensin-converting enzyme 2 ACE 2 RBD with Umifenovir · Spike glycoprotein with Angiotensin-converting enzyme 2 | unmapped |
| EV-DISPROT-DP02772r001 DisProt | cryoem | disorder_region: 10 residues | in vitro DisProt DP02772: disorder, residues 70-79 · residues 70-79; evidence: cryogenic electron microscopy-based structural model with missing residue coordinates used in manual assertion | unmapped |
| EV-DISPROT-DP02772r002 DisProt | cryoem | disorder_region: 21 residues | in vitro DisProt DP02772: disorder, residues 144-164 · residues 144-164; evidence: cryogenic electron microscopy-based structural model with missing residue coordinates used in manual assertion | unmapped |
| EV-DISPROT-DP02772r003 DisProt | cryoem | disorder_region: 13 residues | in vitro DisProt DP02772: disorder, residues 173-185 · residues 173-185; evidence: cryogenic electron microscopy-based structural model with missing residue coordinates used in manual assertion | unmapped |
| EV-DISPROT-DP02772r004 DisProt | cryoem | disorder_region: 17 residues | in vitro DisProt DP02772: disorder, residues 246-262 · residues 246-262; evidence: cryogenic electron microscopy-based structural model with missing residue coordinates used in manual assertion | unmapped |
| EV-DISPROT-DP02772r005 DisProt | cryoem | disorder_region: 20 residues | in vitro DisProt DP02772: disorder, residues 469-488 · residues 469-488; evidence: cryogenic electron microscopy-based structural model with missing residue coordinates used in manual assertion | unmapped |
| EV-DISPROT-DP02772r006 DisProt | cryoem | disorder_region: 20 residues | in vitro DisProt DP02772: disorder, residues 621-640 · residues 621-640; evidence: cryogenic electron microscopy-based structural model with missing residue coordinates used in manual assertion | unmapped |
| EV-DISPROT-DP02772r007 DisProt | cryoem | disorder_region: 11 residues | in vitro DisProt DP02772: disorder, residues 677-687 · residues 677-687; evidence: cryogenic electron microscopy-based structural model with missing residue coordinates used in manual assertion | unmapped |
| EV-DISPROT-DP02772r008 DisProt | cryoem | disorder_region: 26 residues | in vitro DisProt DP02772: disorder, residues 828-853 · residues 828-853; evidence: cryogenic electron microscopy-based structural model with missing residue coordinates used in manual assertion | unmapped |
| EV-DISPROT-DP02772r009 DisProt | cryoem | disorder_region: 126 residues | in vitro DisProt DP02772: disorder, residues 1148-1273 · residues 1148-1273; evidence: cryogenic electron microscopy-based structural model with missing residue coordinates used in manual assertion | unmapped |
| EV-DISPROT-DP02772r010 DisProt | cryoem | disorder_region: 26 residues | in vitro DisProt DP02772: disorder, residues 1-26 · residues 1-26; evidence: cryogenic electron microscopy-based structural model with missing residue coordinates used in manual assertion | unmapped |
| EV-DISPROT-DP02772r011 DisProt | cryoem | disorder_region: 14 residues | in vitro DisProt DP02772: disorder, residues 67-80 · residues 67-80; evidence: cryogenic electron microscopy-based structural model with missing residue coordinates used in manual assertion | unmapped |
| EV-DISPROT-DP02772r012 DisProt | cryoem | disorder_region: 13 residues | in vitro DisProt DP02772: disorder, residues 142-154 · residues 142-154; evidence: cryogenic electron microscopy-based structural model with missing residue coordinates used in manual assertion | unmapped |
| EV-DISPROT-DP02772r013 DisProt | cryoem | disorder_region: 17 residues | in vitro DisProt DP02772: disorder, residues 246-262 · residues 246-262; evidence: cryogenic electron microscopy-based structural model with missing residue coordinates used in manual assertion | unmapped |
| EV-DISPROT-DP02772r014 DisProt | cryoem | disorder_region: 36 residues | in vitro DisProt DP02772: disorder, residues 455-490 · residues 455-490; evidence: cryogenic electron microscopy-based structural model with missing residue coordinates used in manual assertion | unmapped |
| EV-DISPROT-DP02772r015 DisProt | cryoem | disorder_region: 17 residues | in vitro DisProt DP02772: disorder, residues 621-637 · residues 621-637; evidence: cryogenic electron microscopy-based structural model with missing residue coordinates used in manual assertion | unmapped |
| EV-DISPROT-DP02772r016 DisProt | cryoem | disorder_region: 14 residues | in vitro DisProt DP02772: disorder, residues 673-686 · residues 673-686; evidence: cryogenic electron microscopy-based structural model with missing residue coordinates used in manual assertion | unmapped |
| EV-DISPROT-DP02772r017 DisProt | cryoem | disorder_region: 24 residues | in vitro DisProt DP02772: disorder, residues 829-852 · residues 829-852; evidence: cryogenic electron microscopy-based structural model with missing residue coordinates used in manual assertion | unmapped |
| EV-DISPROT-DP02772r018 DisProt | cryoem | disorder_region: 62 residues | in vitro DisProt DP02772: disorder, residues 1147-1208 · residues 1147-1208; evidence: cryogenic electron microscopy-based structural model with missing residue coordinates used in manual assertion | unmapped |
| EV-DISPROT-DP02772r019 DisProt | xray | disorder_region: 14 residues | in vitro DisProt DP02772: disorder, residues 319-332 · residues 319-332; evidence: X-ray crystallography-based structural model with missing residue coordinates used in manual assertion | unmapped |
| EV-DISPROT-DP02772r020 DisProt | xray | disorder_region: 15 residues | in vitro DisProt DP02772: disorder, residues 527-541 · residues 527-541; evidence: X-ray crystallography-based structural model with missing residue coordinates used in manual assertion | unmapped |
| EV-DISPROT-DP02772r021 DisProt | cryoem | disorder_region: 14 residues | in vitro DisProt DP02772: disorder, residues 319-332 · residues 319-332; evidence: cryogenic electron microscopy-based structural model with missing residue coordinates used in manual assertion | unmapped |
| EV-DISPROT-DP02772r022 DisProt | cryoem | disorder_region: 15 residues | in vitro DisProt DP02772: disorder, residues 527-541 · residues 527-541; evidence: cryogenic electron microscopy-based structural model with missing residue coordinates used in manual assertion | unmapped |
| EV-DISPROT-DP02772r029 DisProt | cryoem | disorder_region: 17 residues | in vitro DisProt DP02772: disorder, residues 319-335 · residues 319-335; evidence: cryogenic electron microscopy-based structural model with missing residue coordinates used in manual assertion | unmapped |
| EV-DISPROT-DP02772r030 DisProt | cryoem | disorder_region: 23 residues | in vitro DisProt DP02772: disorder, residues 519-541 · residues 519-541; evidence: cryogenic electron microscopy-based structural model with missing residue coordinates used in manual assertion | unmapped |
| EV-DISPROT-DP02772r043 DisProt | cryoem | disorder_region: 223 residues | in vitro DisProt DP02772: disorder to order, residues 319-541 · residues 319-541; evidence: cryogenic electron microscopy evidence used in manual assertion | unmapped |
| EV-AFDB-AF-0000000365840314 AlphaFold DB | af_prediction | plddt: 67.14 pLDDT | in silico AlphaFold DB prediction AF-0000000365840314 · ColabFold v1.5.2, residues 1-1273 | unmapped |
| EV-MDDB-MCV1900002 MDDB | md | trajectory: 200 ns | in silico · 36.85 °C SARS spike receptor binding domain bound with FERR ACE2 · start 6VW1; force field not stated | unmapped |
| EV-MDDB-MCV1900003 MDDB | md | trajectory: 200 ns | in silico · 36.85 °C Bat-SARSr-CoV RATG13 spike receptor binding domain · start 6VW1; force field not stated | unmapped |
| EV-MDDB-MCV1900005 MDDB | md | trajectory: 200 ns | in silico · 36.85 °C SARS spike receptor binding domain · start 6VW1; force field not stated | unmapped |
| EV-MDDB-MCV1900006 MDDB | md | trajectory: 200 ns | in silico · 36.85 °C SARS-CoV-2 spike receptor binding domain · start 6VW1; force field not stated | unmapped |
| EV-MDDB-MCV1900013 MDDB | md | trajectory: 200 ns | in silico · 36.85 °C Bat-SARSr-CoV RATG13 spike receptor binding domain bound with Rhinolophus Affinis ACE2 · start 6VW1; force field not stated | unmapped |
| EV-MDDB-MCV1900014 MDDB | md | trajectory: 200 ns | in silico · 36.85 °C Bat-SARSr-CoV RATG13 spike receptor binding domain bound with FERR ACE2 · start 6VW1; force field not stated | unmapped |
| EV-MDDB-MCV1900015 MDDB | md | trajectory: 200 ns | in silico · 36.85 °C Bat-SARSr-CoV RATG13 spike receptor binding domain bound with MACR ACE2 · start 6VW1; force field not stated | unmapped |
| EV-MDDB-MCV1900016 MDDB | md | trajectory: 200 ns | in silico · 36.85 °C Bat-SARSr-CoV RATG13 spike receptor binding domain bound with Pangolin ACE2 · start 6VW1; force field not stated | unmapped |
| EV-MDDB-MCV1900017 MDDB | md | trajectory: 200 ns | in silico · 36.85 °C Bat-SARSr-CoV RATG13 spike receptor binding domain bound with PUS ACE2 · start 6VW1; force field not stated | unmapped |
| EV-MDDB-MCV1900018 MDDB | md | trajectory: 196.94 ns | in silico · 36.85 °C Bat-SARSr-CoV RATG13 spike receptor binding domain bound with SIN1 ACE2 · start 6VW1; force field not stated | unmapped |
| EV-MDDB-MCV1900019 MDDB | md | trajectory: 200 ns | in silico · 36.85 °C Bat-SARSr-CoV RATG13 spike receptor binding domain bound with SIN2 ACE2 · start 6VW1; force field not stated | unmapped |
| EV-MDDB-MCV1900020 MDDB | md | trajectory: 200 ns | in silico · 36.85 °C Bat-SARSr-CoV RATG13 spike receptor binding domain bound with SIN3 ACE2 · start 6VW1; force field not stated | unmapped |
| EV-MDDB-MCV1900021 MDDB | md | trajectory: 200 ns | in silico · 36.85 °C Bat-SARSr-CoV RATG13 spike receptor binding domain bound with ZIBB ACE2 · start 6VW1; force field not stated | unmapped |
| EV-MDDB-MCV1900022 MDDB | md | trajectory: 200 ns | in silico · 36.85 °C SARS spike receptor binding domain bound with human ACE2 · start 6VW1; force field not stated | unmapped |
| EV-MDDB-MCV1900023 MDDB | md | trajectory: 200 ns | in silico · 36.85 °C SARS spike receptor binding domain bound with MACR ACE2 · start 6VW1; force field not stated | unmapped |
| EV-MDDB-MCV1900024 MDDB | md | trajectory: 200 ns | in silico · 36.85 °C SARS spike receptor binding domain bound with Pangolin ACE2 · start 6VW1; force field not stated | unmapped |
| EV-MDDB-MCV1900025 MDDB | md | trajectory: 200 ns | in silico · 36.85 °C SARS spike receptor binding domain bound with PUS ACE2 · start 6VW1; force field not stated | unmapped |
| EV-MDDB-MCV1900026 MDDB | md | trajectory: 199.56 ns | in silico · 36.85 °C SARS spike receptor binding domain bound with SIN1 ACE2 · start 6VW1; force field not stated | unmapped |
| EV-MDDB-MCV1900027 MDDB | md | trajectory: 200 ns | in silico · 36.85 °C SARS spike receptor binding domain bound with SIN2 ACE2 · start 6VW1; force field not stated | unmapped |
| EV-MDDB-MCV1900028 MDDB | md | trajectory: 200 ns | in silico · 36.85 °C SARS spike receptor binding domain bound with SIN3 ACE2 · start 6VW1; force field not stated | unmapped |
| EV-MDDB-MCV1900029 MDDB | md | trajectory: 200 ns | in silico · 36.85 °C SARS spike receptor binding domain bound with ZIBB ACE2 · start 6VW1; force field not stated | unmapped |
| EV-MDDB-MCV1900030 MDDB | md | trajectory: 192.05 ns | in silico · 36.85 °C SARS-CoV-2 spike receptor binding domain bound with human ACE2 (REAL) · start 6VW1; force field not stated | unmapped |
| EV-MDDB-MCV1900031 MDDB | md | trajectory: 189.97 ns | in silico · 36.85 °C SARS-CoV-2 spike receptor binding domain bound with FERR ACE2 (REAL) · start 6VW1; force field not stated | unmapped |
| EV-MDDB-MCV1900032 MDDB | md | trajectory: 200 ns | in silico · 36.85 °C SARS-CoV-2 spike receptor binding domain bound with MACR ACE2 (REAL) · start 6VW1; force field not stated | unmapped |
| EV-MDDB-MCV1900033 MDDB | md | trajectory: 200 ns | in silico · 36.85 °C SARS-CoV-2 spike receptor binding domain bound with Pangolin ACE2 (REAL) · start 6VW1; force field not stated | unmapped |
| EV-MDDB-MCV1900034 MDDB | md | trajectory: 190.9 ns | in silico · 36.85 °C SARS-CoV-2 spike receptor binding domain bound with PUS ACE2 (REAL) · start 6VW1; force field not stated | unmapped |
| EV-MDDB-MCV1900035 MDDB | md | trajectory: 195.72 ns | in silico · 36.85 °C SARS-CoV-2 spike receptor binding domain bound with SIN1 ACE2 (REAL) · start 6VW1; force field not stated | unmapped |
| EV-MDDB-MCV1900036 MDDB | md | trajectory: 200 ns | in silico · 36.85 °C SARS-CoV-2 spike receptor binding domain bound with SIN2 ACE2 (REAL) · start 6VW1; force field not stated | unmapped |
| EV-MDDB-MCV1900037 MDDB | md | trajectory: 195.56 ns | in silico · 36.85 °C SARS-CoV-2 spike receptor binding domain bound with SIN3 ACE2 (REAL) · start 6VW1; force field not stated | unmapped |
| EV-MDDB-MCV1900038 MDDB | md | trajectory: 196.16 ns | in silico · 36.85 °C SARS-CoV-2 spike receptor binding domain bound with ZIBB ACE2 (REAL) · start 6VW1; force field not stated | unmapped |
| EV-MDDB-MCV1900039 MDDB | md | trajectory: 178.97 ns | in silico · 36.85 °C SARS-CoV-2 spike receptor binding domain bound with AFFINIS ACE2 (REAL) · start 6VW1; force field not stated | unmapped |
| EV-MDDB-MCV1900040 MDDB | md | trajectory: 200 ns | in silico · 36.85 °C SARS-CoV-2 spike receptor binding domain bound with human ACE2 · start 6VW1; force field not stated | unmapped |
| EV-MDDB-MCV1900041 MDDB | md | trajectory: 200 ns | in silico · 36.85 °C SARS-CoV-2 spike receptor binding domain bound with FERR ACE2 · start 6VW1; force field not stated | unmapped |
| EV-MDDB-MCV1900042 MDDB | md | trajectory: 198.55 ns | in silico · 36.85 °C SARS-CoV-2 spike receptor binding domain bound with MACR ACE2 · start 6VW1; force field not stated | unmapped |
| EV-MDDB-MCV1900043 MDDB | md | trajectory: 200 ns | in silico · 36.85 °C SARS-CoV-2 spike receptor binding domain bound with Pangolin ACE2 · start 6VW1; force field not stated | unmapped |
| EV-MDDB-MCV1900044 MDDB | md | trajectory: 200 ns | in silico · 36.85 °C SARS-CoV-2 spike receptor binding domain bound with PUS ACE2 · start 6VW1; force field not stated | unmapped |
| EV-MDDB-MCV1900045 MDDB | md | trajectory: 200 ns | in silico · 36.85 °C SARS-CoV-2 spike receptor binding domain bound with SIN1 ACE2 · start 6VW1; force field not stated | unmapped |
| EV-MDDB-MCV1900046 MDDB | md | trajectory: 200 ns | in silico · 36.85 °C SARS-CoV-2 spike receptor binding domain bound with SIN2 ACE2 · start 6VW1; force field not stated | unmapped |
| EV-MDDB-MCV1900047 MDDB | md | trajectory: 200 ns | in silico · 36.85 °C SARS-CoV-2 spike receptor binding domain bound with SIN3 ACE2 · start 6VW1; force field not stated | unmapped |
| EV-MDDB-MCV1900048 MDDB | md | trajectory: 200 ns | in silico · 36.85 °C SARS-CoV-2 spike receptor binding domain bound with ZIBB ACE2 · start 6VW1; force field not stated | unmapped |
| EV-MDDB-MCV1900064 MDDB | md | trajectory: 57.76 ns | in silico · 26.85 °C Gromacs 60 ns MD of SARS-CoV-2 spike trimer, All Atom model (60 ns) · start 6VXX; CHARMM27 | unmapped |
| EV-MDDB-MCV1900144 MDDB | md | trajectory: 2000 ns | in silico · 36.85 °C DESRES-ANTON-10930523 2 µs simulation of an investigational or FDA approved drug molecule binding to a construct of the SARS-CoV-2 trimeric spike protein, no water or ions (alprostadil) · start 6VXX; Amber ff99SB-ILDN | unmapped |
| EV-MDDB-MCV1900145 MDDB | md | trajectory: 2000 ns | in silico · 36.85 °C DESRES-ANTON-10940986 2 µs simulation of an investigational or FDA approved drug molecule binding to a construct of the SARS-CoV-2 trimeric spike protein, no water or ions (amcinonide) · start 6VXX; Amber ff99SB-ILDN | unmapped |
| EV-MDDB-MCV1900146 MDDB | md | trajectory: 2000 ns | in silico · 36.85 °C DESRES-ANTON-10942625 2 µs simulation of an investigational or FDA approved drug molecule binding to a construct of the SARS-CoV-2 trimeric spike protein, no water or ions (aprepitant) · start 6VXX; Amber ff99SB-ILDN | unmapped |
| EV-MDDB-MCV1900147 MDDB | md | trajectory: 2000 ns | in silico · 36.85 °C DESRES-ANTON-10921672 2 µs simulation of an investigational or FDA approved drug molecule binding to a construct of the SARS-CoV-2 trimeric spike protein, no water or ions (atazanavir) · start 6VXX; Amber ff99SB-ILDN | unmapped |
| EV-MDDB-MCV1900148 MDDB | md | trajectory: 2000 ns | in silico · 36.85 °C DESRES-ANTON-10930821 2 µs simulation of an investigational or FDA approved drug molecule binding to a construct of the SARS-CoV-2 trimeric spike protein, no water or ions (atorvastatin) · start 6VXX; Amber ff99SB-ILDN | unmapped |
| EV-MDDB-MCV1900149 MDDB | md | trajectory: 2000 ns | in silico · 36.85 °C DESRES-ANTON-10942532 2 µs simulation of an investigational or FDA approved drug molecule binding to a construct of the SARS-CoV-2 trimeric spike protein, no water or ions (atropine) · start 6VXX; Amber ff99SB-ILDN | unmapped |
| EV-MDDB-MCV1900150 MDDB | md | trajectory: 2000 ns | in silico · 36.85 °C DESRES-ANTON-10941382 2 µs simulation of an investigational or FDA approved drug molecule binding to a construct of the SARS-CoV-2 trimeric spike protein, no water or ions (azilsartan) · start 6VXX; Amber ff99SB-ILDN | unmapped |
| EV-MDDB-MCV1900151 MDDB | md | trajectory: 2000 ns | in silico · 36.85 °C DESRES-ANTON-10930748 2 µs simulation of an investigational or FDA approved drug molecule binding to a construct of the SARS-CoV-2 trimeric spike protein, no water or ions (brigatinib) · start 6VXX; Amber ff99SB-ILDN | unmapped |
| EV-MDDB-MCV1900152 MDDB | md | trajectory: 2000 ns | in silico · 36.85 °C DESRES-ANTON-10940762 2 µs simulation of an investigational or FDA approved drug molecule binding to a construct of the SARS-CoV-2 trimeric spike protein, no water or ions (captopril) · start 6VXX; Amber ff99SB-ILDN | unmapped |
| EV-MDDB-MCV1900153 MDDB | md | trajectory: 2000 ns | in silico · 36.85 °C DESRES-ANTON-10941841 2 µs simulation of an investigational or FDA approved drug molecule binding to a construct of the SARS-CoV-2 trimeric spike protein, no water or ions (calcifediol) · start 6VXX; Amber ff99SB-ILDN | unmapped |
| EV-MDDB-MCV1900154 MDDB | md | trajectory: 2000 ns | in silico · 36.85 °C DESRES-ANTON-10941424 2 µs simulation of an investigational or FDA approved drug molecule binding to a construct of the SARS-CoV-2 trimeric spike protein, no water or ions (cefamandole nafate) · start 6VXX; Amber ff99SB-ILDN | unmapped |
| EV-MDDB-MCV1900155 MDDB | md | trajectory: 2000 ns | in silico · 36.85 °C DESRES-ANTON-10918686 2 µs simulation of an investigational or FDA approved drug molecule binding to a construct of the SARS-CoV-2 trimeric spike protein, no water or ions (cefixime) · start 6VXX; Amber ff99SB-ILDN | unmapped |
| EV-MDDB-MCV1900156 MDDB | md | trajectory: 2000 ns | in silico · 36.85 °C DESRES-ANTON-10941112 2 µs simulation of an investigational or FDA approved drug molecule binding to a construct of the SARS-CoV-2 trimeric spike protein, no water or ions (clobazam) · start 6VXX; Amber ff99SB-ILDN | unmapped |
| EV-MDDB-MCV1900157 MDDB | md | trajectory: 2000 ns | in silico · 36.85 °C DESRES-ANTON-10941273 2 µs simulation of an investigational or FDA approved drug molecule binding to a construct of the SARS-CoV-2 trimeric spike protein, no water or ions (CP-195543) · start 6VXX; Amber ff99SB-ILDN | unmapped |
| EV-MDDB-MCV1900158 MDDB | md | trajectory: 2000 ns | in silico · 36.85 °C DESRES-ANTON-10918731 2 µs simulation of an investigational or FDA approved drug molecule binding to a construct of the SARS-CoV-2 trimeric spike protein, no water or ions (darunavir) · start 6VXX; Amber ff99SB-ILDN | unmapped |
| EV-MDDB-MCV1900159 MDDB | md | trajectory: 2000 ns | in silico · 36.85 °C DESRES-ANTON-10941722 2 µs simulation of an investigational or FDA approved drug molecule binding to a construct of the SARS-CoV-2 trimeric spike protein, no water or ions (deferasirox) · start 6VXX; Amber ff99SB-ILDN | unmapped |
| EV-MDDB-MCV1900160 MDDB | md | trajectory: 2000 ns | in silico · 36.85 °C DESRES-ANTON-10942525 2 µs simulation of an investigational or FDA approved drug molecule binding to a construct of the SARS-CoV-2 trimeric spike protein, no water or ions (dihydroergotamine) · start 6VXX; Amber ff99SB-ILDN | unmapped |
| EV-MDDB-MCV1900161 MDDB | md | trajectory: 2000 ns | in silico · 36.85 °C DESRES-ANTON-10931330 2 µs simulation of an investigational or FDA approved drug molecule binding to a construct of the SARS-CoV-2 trimeric spike protein, no water or ions (divalproex sodium) · start 6VXX; Amber ff99SB-ILDN | unmapped |
| EV-MDDB-MCV1900162 MDDB | md | trajectory: 2000 ns | in silico · 36.85 °C DESRES-ANTON-10918694 2 µs simulation of an investigational or FDA approved drug molecule binding to a construct of the SARS-CoV-2 trimeric spike protein, no water or ions (duloxetine) · start 6VXX; Amber ff99SB-ILDN | unmapped |
| EV-MDDB-MCV1900163 MDDB | md | trajectory: 2000 ns | in silico · 36.85 °C DESRES-ANTON-10931344 2 µs simulation of an investigational or FDA approved drug molecule binding to a construct of the SARS-CoV-2 trimeric spike protein, no water or ions (efavirenz) · start 6VXX; Amber ff99SB-ILDN | unmapped |
| EV-MDDB-MCV1900164 MDDB | md | trajectory: 2000 ns | in silico · 36.85 °C DESRES-ANTON-10930719 2 µs simulation of an investigational or FDA approved drug molecule binding to a construct of the SARS-CoV-2 trimeric spike protein, no water or ions (fluticasone propionate) · start 6VXX; Amber ff99SB-ILDN | unmapped |
| EV-MDDB-MCV1900165 MDDB | md | trajectory: 2000 ns | in silico · 36.85 °C DESRES-ANTON-10906572 2 µs simulation of an investigational or FDA approved drug molecule binding to a construct of the SARS-CoV-2 trimeric spike protein, no water or ions (iloprost) · start 6VXX; Amber ff99SB-ILDN | unmapped |
| EV-MDDB-MCV1900166 MDDB | md | trajectory: 2000 ns | in silico · 36.85 °C DESRES-ANTON-10941783 2 µs simulation of an investigational or FDA approved drug molecule binding to a construct of the SARS-CoV-2 trimeric spike protein, no water or ions (isocarboxazid) · start 6VXX; Amber ff99SB-ILDN | unmapped |
| EV-MDDB-MCV1900167 MDDB | md | trajectory: 2000 ns | in silico · 36.85 °C DESRES-ANTON-10941101 2 µs simulation of an investigational or FDA approved drug molecule binding to a construct of the SARS-CoV-2 trimeric spike protein, no water or ions (ketoconazole) · start 6VXX; Amber ff99SB-ILDN | unmapped |
| EV-MDDB-MCV1900168 MDDB | md | trajectory: 2000 ns | in silico · 36.85 °C DESRES-ANTON-10942558 2 µs simulation of an investigational or FDA approved drug molecule binding to a construct of the SARS-CoV-2 trimeric spike protein, no water or ions (lapatinib) · start 6VXX; Amber ff99SB-ILDN | unmapped |
| EV-MDDB-MCV1900169 MDDB | md | trajectory: 2000 ns | in silico · 36.85 °C DESRES-ANTON-10941419 2 µs simulation of an investigational or FDA approved drug molecule binding to a construct of the SARS-CoV-2 trimeric spike protein, no water or ions (levomefolate calcium) · start 6VXX; Amber ff99SB-ILDN | unmapped |
| EV-MDDB-MCV1900170 MDDB | md | trajectory: 2000 ns | in silico · 36.85 °C DESRES-ANTON-10941234 2 µs simulation of an investigational or FDA approved drug molecule binding to a construct of the SARS-CoV-2 trimeric spike protein, no water or ions (lometrexol) · start 6VXX; Amber ff99SB-ILDN | unmapped |
| EV-MDDB-MCV1900171 MDDB | md | trajectory: 2000 ns | in silico · 36.85 °C DESRES-ANTON-10931493 2 µs simulation of an investigational or FDA approved drug molecule binding to a construct of the SARS-CoV-2 trimeric spike protein, no water or ions (lomibuvir) · start 6VXX; Amber ff99SB-ILDN | unmapped |
| EV-MDDB-MCV1900172 MDDB | md | trajectory: 2000 ns | in silico · 36.85 °C DESRES-ANTON-10932268 2 µs simulation of an investigational or FDA approved drug molecule binding to a construct of the SARS-CoV-2 trimeric spike protein, no water or ions (megestrol acetate) · start 6VXX; Amber ff99SB-ILDN | unmapped |
| EV-MDDB-MCV1900173 MDDB | md | trajectory: 2000 ns | in silico · 36.85 °C DESRES-ANTON-10906575 2 µs simulation of an investigational or FDA approved drug molecule binding to a construct of the SARS-CoV-2 trimeric spike protein, no water or ions (methsuximide) · start 6VXX; Amber ff99SB-ILDN | unmapped |
| EV-MDDB-MCV1900174 MDDB | md | trajectory: 2000 ns | in silico · 36.85 °C DESRES-ANTON-10918707 2 µs simulation of an investigational or FDA approved drug molecule binding to a construct of the SARS-CoV-2 trimeric spike protein, no water or ions (nebivolol) · start 6VXX; Amber ff99SB-ILDN | unmapped |
| EV-MDDB-MCV1900175 MDDB | md | trajectory: 2000 ns | in silico · 36.85 °C DESRES-ANTON-10906602 2 µs simulation of an investigational or FDA approved drug molecule binding to a construct of the SARS-CoV-2 trimeric spike protein, no water or ions (naloxone) · start 6VXX; Amber ff99SB-ILDN | unmapped |
| EV-MDDB-MCV1900176 MDDB | md | trajectory: 2000 ns | in silico · 36.85 °C DESRES-ANTON-10942574 2 µs simulation of an investigational or FDA approved drug molecule binding to a construct of the SARS-CoV-2 trimeric spike protein, no water or ions (nilutamide) · start 6VXX; Amber ff99SB-ILDN | unmapped |
| EV-MDDB-MCV1900177 MDDB | md | trajectory: 2000 ns | in silico · 36.85 °C DESRES-ANTON-10930676 2 µs simulation of an investigational or FDA approved drug molecule binding to a construct of the SARS-CoV-2 trimeric spike protein, no water or ions (nitazoxanide) · start 6VXX; Amber ff99SB-ILDN | unmapped |
| EV-MDDB-MCV1900178 MDDB | md | trajectory: 2000 ns | in silico · 36.85 °C DESRES-ANTON-10941210 2 µs simulation of an investigational or FDA approved drug molecule binding to a construct of the SARS-CoV-2 trimeric spike protein, no water or ions (pelitrexol) · start 6VXX; Amber ff99SB-ILDN | unmapped |
| EV-MDDB-MCV1900179 MDDB | md | trajectory: 2000 ns | in silico · 36.85 °C DESRES-ANTON-10941177 2 µs simulation of an investigational or FDA approved drug molecule binding to a construct of the SARS-CoV-2 trimeric spike protein, no water or ions (raltitrexed) · start 6VXX; Amber ff99SB-ILDN | unmapped |
| EV-MDDB-MCV1900180 MDDB | md | trajectory: 2000 ns | in silico · 36.85 °C DESRES-ANTON-10941364 2 µs simulation of an investigational or FDA approved drug molecule binding to a construct of the SARS-CoV-2 trimeric spike protein, no water or ions (rebamipide) · start 6VXX; Amber ff99SB-ILDN | unmapped |
| EV-MDDB-MCV1900181 MDDB | md | trajectory: 2000 ns | in silico · 36.85 °C DESRES-ANTON-10941282 2 µs simulation of an investigational or FDA approved drug molecule binding to a construct of the SARS-CoV-2 trimeric spike protein, no water or ions (recoflavone) · start 6VXX; Amber ff99SB-ILDN | unmapped |
| EV-MDDB-MCV1900182 MDDB | md | trajectory: 2000 ns | in silico · 36.85 °C DESRES-ANTON-10921687 2 µs simulation of an investigational or FDA approved drug molecule binding to a construct of the SARS-CoV-2 trimeric spike protein, no water or ions (ritonavir) · start 6VXX; Amber ff99SB-ILDN | unmapped |
| EV-MDDB-MCV1900183 MDDB | md | trajectory: 2000 ns | in silico · 36.85 °C DESRES-ANTON-10940767 2 µs simulation of an investigational or FDA approved drug molecule binding to a construct of the SARS-CoV-2 trimeric spike protein, no water or ions (rivaroxaban) · start 6VXX; Amber ff99SB-ILDN | unmapped |
| EV-MDDB-MCV1900184 MDDB | md | trajectory: 2000 ns | in silico · 36.85 °C DESRES-ANTON-10942509 2 µs simulation of an investigational or FDA approved drug molecule binding to a construct of the SARS-CoV-2 trimeric spike protein, no water or ions (tadalafil) · start 6VXX; Amber ff99SB-ILDN | unmapped |
| EV-MDDB-MCV1900185 MDDB | md | trajectory: 2000 ns | in silico · 36.85 °C DESRES-ANTON-10931335 2 µs simulation of an investigational or FDA approved drug molecule binding to a construct of the SARS-CoV-2 trimeric spike protein, no water or ions (telaprevir) · start 6VXX; Amber ff99SB-ILDN | unmapped |
| EV-MDDB-MCV1900186 MDDB | md | trajectory: 2000 ns | in silico · 36.85 °C DESRES-ANTON-10931329 2 µs simulation of an investigational or FDA approved drug molecule binding to a construct of the SARS-CoV-2 trimeric spike protein, no water or ions (tenofovir) · start 6VXX; Amber ff99SB-ILDN | unmapped |
| EV-MDDB-MCV1900187 MDDB | md | trajectory: 2000 ns | in silico · 36.85 °C DESRES-ANTON-10918688 2 µs simulation of an investigational or FDA approved drug molecule binding to a construct of the SARS-CoV-2 trimeric spike protein, no water or ions (terazosin) · start 6VXX; Amber ff99SB-ILDN | unmapped |
| EV-MDDB-MCV1900188 MDDB | md | trajectory: 2000 ns | in silico · 36.85 °C DESRES-ANTON-10906555 2 µs simulation of an investigational or FDA approved drug molecule binding to a construct of the SARS-CoV-2 trimeric spike protein, no water or ions (treprostinil) · start 6VXX; Amber ff99SB-ILDN | unmapped |
| EV-MDDB-MCV1900189 MDDB | md | trajectory: 2000 ns | in silico · 36.85 °C DESRES-ANTON-10941754 2 µs simulation of an investigational or FDA approved drug molecule binding to a construct of the SARS-CoV-2 trimeric spike protein, no water or ions (triazolam) · start 6VXX; Amber ff99SB-ILDN | unmapped |
| EV-MDDB-MCV1900190 MDDB | md | trajectory: 2000 ns | in silico · 36.85 °C DESRES-ANTON-10930743 2 µs simulation of an investigational or FDA approved drug molecule binding to a construct of the SARS-CoV-2 trimeric spike protein, no water or ions (vorapaxar) · start 6VXX; Amber ff99SB-ILDN | unmapped |
| EV-MDDB-MCV1900191 MDDB | md | trajectory: 2000 ns | in silico · 36.85 °C DESRES-ANTON-10941318 2 µs simulation of an investigational or FDA approved drug molecule binding to a construct of the SARS-CoV-2 trimeric spike protein, no water or ions (AZD-8330) · start 6VXX; Amber ff99SB-ILDN | unmapped |
| EV-MDDB-MCV1900192 MDDB | md | trajectory: 2000 ns | in silico · 36.85 °C DESRES-ANTON-10941772 2 µs simulation of an investigational or FDA approved drug molecule binding to a construct of the SARS-CoV-2 trimeric spike protein, no water or ions (cobimetinib) · start 6VXX; Amber ff99SB-ILDN | unmapped |
| EV-MDDB-MCV1900193 MDDB | md | trajectory: 543.6 ns | in silico · 36.85 °C Trajectories of full-length SPIKE protein in the Closed state · start 6VXX; CHARMM36 All-atom additive | unmapped |
| EV-MDDB-MCV1900196 MDDB | md | trajectory: 1000.5 ns | in silico · 36.85 °C Trajectories of full-length SPIKE protein in the Open state · start 6VSB; CHARMM36 All-atom additive | unmapped |
| EV-MDDB-MCV1900202 MDDB | md | trajectory: 1001.3 ns | in silico · 36.85 °C Trajectories of full-length SPIKE protein in the Open state (N165A / N234A mutations) · start 6VSB; CHARMM36 All-atom additive | unmapped |
| EV-MDDB-MCV1900217 MDDB | md | trajectory: 1000 ns | in silico · 36.85 °C SARS-CoV2 spike glycoprotein homotrimeric head-in a closed conformation (1μs) · start 6ACC; Amber ff14SB, GLYCAM-06j | unmapped |
| EV-MDDB-MCV1900221 MDDB | md | trajectory: 1000 ns | in silico · 36.85 °C SARS-CoV2 spike glycoprotein homotrimeric head in a closed conformation with one 31-monosaccharides heparin chain bound (1µs) · start 6ACC; Amber ff14SB, GLYCAM-06j | unmapped |
| EV-MDDB-MCV1900225 MDDB | md | trajectory: 1000 ns | in silico · 36.85 °C SARS-CoV2 spike glycoprotein homotrimeric head- in a closed conformation with three 31-monosaccharides heparin chain bound (1µs) · start 6ACC; Amber ff14SB, GLYCAM-06j | unmapped |
| EV-MDDB-MCV1900229 MDDB | md | trajectory: 1000 ns | in silico · 36.85 °C SARS-CoV2 spike glycoprotein homotrimeric head- in an open conformation (1µs) · start 6ACD; Amber ff14SB, GLYCAM-06j | unmapped |
| EV-MDDB-MCV1900233 MDDB | md | trajectory: 1000 ns | in silico · 36.85 °C SARS-CoV2 spike glycoprotein homotrimeric head- in an open conformation with three 31-monosaccharides heparin chain bound (1µs) · start 6ACC; Amber ff14SB, GLYCAM-06j | unmapped |
| EV-MDDB-MCV1900237 MDDB | md | trajectory: 50 ns | in silico · 26.85 °C MMGB/SA Consensus Estimate of the Binding Free Energy Between the Novel Coronavirus Spike Protein to the Human ACE2 Receptor · start 6M0J; Amber ff14SB | unmapped |
| EV-MDDB-MCV1900238 MDDB | md | trajectory: 300 ns | in silico · 36.85 °C Interaction between the SARS-CoV-2 spike and the α7 nicotinic receptor · start no PDB start structure listed; Amber ff99SB-ILDN | unmapped |
| EV-SMASH-SMFS-000033 SMASH-BIO | force_spectroscopy | study_record | in vitro Beyond ACE2: unveiling the receptor-mediated endocytic dynamic mechanism of SARS-CoV-2 at the single-particle level. · SARS-CoV-2 spike (RBD); afm smfs; experiment class: receptor_ligand_adhesion | unmapped |
| EV-SMASH-SMFS-000109 SMASH-BIO | force_spectroscopy | study_record | in vitro Force-Activated Slip-Catch-Slip Bonds Stabilize Virus Interactions · SARS-CoV-2 spike (RBD); force spectroscopy unspecified; experiment class: receptor_ligand_adhesion | unmapped |
| EV-SMASH-SMFS-000124 SMASH-BIO | force_spectroscopy | study_record | in vitro Heparin Modulates SARS-CoV-2 Spike-Platelet Factor 4 Interactions through Concentration-Dependent Interface Remodeling. · SARS-CoV-2 spike (RBD); afm smfs; experiment class: receptor_ligand_adhesion, rheology_cell, unfolding_protein | unmapped |
| EV-SMASH-SMFS-000275 SMASH-BIO | force_spectroscopy | study_record | in vitro Single molecule force spectroscopy for evaluating inhibitors of SARS-CoV-2 variants of concern. · SARS-CoV-2 spike (RBD); afm smfs; experiment class: receptor_ligand_adhesion | unmapped |
| EV-SMASH-SMFS-000315 SMASH-BIO | force_spectroscopy | study_record | in vitro · pH 7.4 Switching Spike Plasticity Shapes ACE2 Engagement Across SARS-CoV-2 Variants. · SARS-CoV-2 spike (RBD); afm smfs; experiment class: nucleic_acid_protein_interaction, receptor_ligand_adhesion | unmapped |
| EV-SMASH-SMFS-000424 SMASH-BIO | force_spectroscopy | study_record | in vitro Direct measurement of SARS-CoV-2 spike RBD binding to integrin αvβ6 by single-molecule force spectroscopy. · SARS-CoV-2 spike (RBD); afm smfs; experiment class: receptor_ligand_adhesion | unmapped |
| EV-SMASH-SMFS-000452 SMASH-BIO | force_spectroscopy | study_record | in vitro From Attraction to Repulsion: Omicron-Driven Rewiring of Nanobody Interfaces on the SARS-CoV-2 RBD · SARS-CoV-2 spike (RBD); afm smfs; experiment class: receptor_ligand_adhesion, unfolding_protein | unmapped |
| EV-SMASH-SMFS-000511 SMASH-BIO | force_spectroscopy | study_record | in vitro Mechano-Locking Strategy for Broad-Spectrum SARS-CoV-2 Neutralization. · SARS-CoV-2 spike (RBD); magnetic tweezers; experiment class: receptor_ligand_adhesion | unmapped |
| EV-SMASH-SMFS-000517 SMASH-BIO | force_spectroscopy | study_record | in vitro Modulation of SARS-CoV-2 spike binding to ACE2 through conformational selection. · SARS-CoV-2 spike (RBD); magnetic tweezers; experiment class: receptor_ligand_adhesion | unmapped |
| EV-SMASH-SMFS-000520 SMASH-BIO | force_spectroscopy | study_record | in vitro · pH 7.2 Molecular Insights into the Interaction between CD147 and the SARS-CoV‑2 Spike Protein. · SARS-CoV-2 spike (RBD); afm smfs; experiment class: receptor_ligand_adhesion | unmapped |
| EV-SMASH-SMFS-000561 SMASH-BIO | force_spectroscopy | study_record | in vitro · pH 7.4 Probing SARS-CoV-2 membrane binding peptide via single-molecule AFM-based force spectroscopy. · SARS-CoV-2 spike membrane-binding peptide MBP1 (TMPRSS2-primed form, spike residues 816-855); SARS-CoV-2 spike membrane-binding peptide MBP2 (unprimed form, spike residues 806-855); SARS-CoV-2 spike S2 subunit (His-tagged, Wuhan-1); afm smfs; experiment class: receptor_ligand_adhesion, membrane_mechanics | unmapped |
| EV-SMASH-SMFS-000690 SMASH-BIO | force_spectroscopy | study_record | in vitro Biomechanics Model to Characterize Atomic Force Microscopy-Based Virus-Host Cell Adhesion Measurements. · SARS-CoV-2 spike (RBD); afm smfs; experiment class: receptor_ligand_adhesion, rheology_cell | unmapped |
| EV-SMASH-SMFS-000867 SMASH-BIO | force_spectroscopy | study_record | in vitro Nanomechanical footprint of SARS-CoV-2 variants in complex with a potent nanobody by molecular simulations. · SARS-CoV-2 spike (RBD); force spectroscopy unspecified; experiment class: receptor_ligand_adhesion, unfolding_protein | unmapped |
| EV-SMASH-SMFS-000907 SMASH-BIO | force_spectroscopy | study_record | in vitro Pulling Forces Differentially Affect Refolding Pathways Due to Entangled Misfolded States in SARS-CoV-1 and SARS-CoV-2 Receptor Binding Domain. · SARS-CoV-2 spike (RBD); afm smfs; experiment class: receptor_ligand_adhesion, unfolding_protein | unmapped |
| EV-SMASH-SMFS-000939 SMASH-BIO | force_spectroscopy | study_record | in vitro Single-Molecule Investigation of the Binding Interface Stability of SARS-CoV-2 Variants with ACE2. · SARS-CoV-2 spike (RBD); afm smfs; experiment class: receptor_ligand_adhesion | unmapped |
| EV-SMASH-SMFS-000945 SMASH-BIO | force_spectroscopy | study_record | in vitro Single-molecule force stability of the SARS-CoV-2-ACE2 interface in variants-of-concern. · SARS-CoV-2 spike (RBD); magnetic tweezers; experiment class: receptor_ligand_adhesion | unmapped |
| EV-SMASH-SMFS-001020 SMASH-BIO | force_spectroscopy | study_record | in vitro Variant-specific interactions at the plasma membrane: Heparan sulfate’s impact on SARS-CoV-2 binding kinetics · SARS-CoV-2 spike (RBD); afm smfs; experiment class: membrane_mechanics, receptor_ligand_adhesion | unmapped |
| EV-SMASH-SMFS-001281 SMASH-BIO | force_spectroscopy | study_record | in vitro Probing nanomechanical interactions of SARS-CoV-2 variants Omicron and XBB with common surfaces. · SARS-CoV-2 spike (RBD); afm smfs; experiment class: receptor_ligand_adhesion | unmapped |
| EV-SMASH-SMFS-001302 SMASH-BIO | force_spectroscopy | study_record | in vitro S373P Mutation Stabilizes the Receptor-Binding Domain of the Spike Protein in Omicron and Promotes Binding. · SARS-CoV-2 spike (RBD); afm smfs; experiment class: receptor_ligand_adhesion, unfolding_protein | unmapped |
| EV-SMASH-SMFS-001392 SMASH-BIO | force_spectroscopy | study_record | in vitro · pH 7.4 A molecularly engineered, broad-spectrum anti-coronavirus lectin inhibits SARS-CoV-2 and MERS-CoV infection in vivo. · SARS-CoV-2 spike trimer (wild type, N234Q, B.1.617.2 Delta, B.1.1.529 Omicron); afm smfs; experiment class: receptor_ligand_adhesion | unmapped |
| EV-SMASH-SMFS-001661 SMASH-BIO | force_spectroscopy | study_record | in vitro Pathogen-Host Adhesion between SARS-CoV-2 Spike Proteins from Different Variants and Human ACE2 Probed at Single-Molecule and Single-Cell Levels · SARS-CoV-2 spike (RBD); afm smfs; experiment class: receptor_ligand_adhesion | unmapped |
| EV-SMASH-SMFS-001662 SMASH-BIO | force_spectroscopy | study_record | in vitro · pH 7.4 Pathogen-host adhesion between SARS-CoV-2 spike proteins from different variants and human ACE2 studied at single-molecule and single-cell levels. · SARS-CoV-2 spike (RBD); afm smfs; experiment class: receptor_ligand_adhesion | unmapped |
| EV-SMASH-SMFS-001699 SMASH-BIO | force_spectroscopy | study_record | in vitro S373P Mutation Stabilizes the Receptor-binding Domain of Spike Protein in Omicron and Promotes Binding · SARS-CoV-2 spike (RBD); afm smfs; experiment class: receptor_ligand_adhesion, unfolding_protein | unmapped |
| EV-SMASH-SMFS-001742 SMASH-BIO | force_spectroscopy | study_record | in vitro Supported Natural Membranes on Microspheres for Protein-Protein Interaction Studies. · SARS-CoV-2 spike (RBD); optical tweezers; experiment class: membrane_mechanics, receptor_ligand_adhesion | unmapped |
| EV-SMASH-SMFS-001799 SMASH-BIO | force_spectroscopy | study_record | in vitro A Tethered Ligand Assay to Probe SARS-CoV-2:ACE2 Interactions · SARS-CoV-2 spike (RBD); magnetic tweezers; experiment class: receptor_ligand_adhesion, unfolding_protein | unmapped |
| EV-SMASH-SMFS-001803 SMASH-BIO | force_spectroscopy | study_record | in vitro A molecularly engineered, broad-spectrum anti-coronavirus lectin inhibits SARS-CoV-2 and MERS-CoV infection in vivo · SARS-CoV-2 spike (RBD); afm smfs; experiment class: receptor_ligand_adhesion, translation_transcription_replication | unmapped |
| EV-SMASH-SMFS-001832 SMASH-BIO | force_spectroscopy | study_record | in vitro · pH 7.4 Biomechanical characterization of SARS-CoV-2 spike RBD and human ACE2 protein-protein interaction. · SARS-CoV-2 spike (RBD); afm smfs; experiment class: receptor_ligand_adhesion | unmapped |
| EV-SMASH-SMFS-001909 SMASH-BIO | force_spectroscopy | study_record | in vitro Endothelial glycocalyx shields the interaction of SARS-CoV-2 spike protein with ACE2 receptors. · SARS-CoV-2 spike (RBD); afm smfs; experiment class: receptor_ligand_adhesion, rheology_cell | unmapped |
| EV-SMASH-SMFS-002035 SMASH-BIO | force_spectroscopy | study_record | in vitro · pH 7.4 N501Y mutation of spike protein in SARS-CoV-2 strengthens its binding to receptor ACE2. · SARS-CoV-2 spike (RBD); afm smfs; experiment class: receptor_ligand_adhesion | unmapped |
| EV-SMASH-SMFS-002120 SMASH-BIO | force_spectroscopy | study_record | in vitro SARS-CoV-2 spike protein-induced platelet activation: Mechanism for virus and vaccine-induced thrombotic thrombocytopenia · SARS-CoV-2 spike (RBD); force spectroscopy unspecified; experiment class: receptor_ligand_adhesion, translation_transcription_replication | unmapped |
| EV-SMASH-SMFS-002217 SMASH-BIO | force_spectroscopy | study_record | in vitro A Tethered Ligand Assay to Probe the SARS-CoV-2 ACE2 Interaction under Constant Force · SARS-CoV-2 spike (RBD); magnetic tweezers; experiment class: receptor_ligand_adhesion, unfolding_protein | unmapped |
| EV-SMASH-SMFS-002258 SMASH-BIO | force_spectroscopy | study_record | in vitro Biomechanical Characterization of SARS-CoV-2 Spike RBD and Human ACE2 Protein-Protein Interaction · SARS-CoV-2 spike (RBD); afm smfs; experiment class: receptor_ligand_adhesion | unmapped |
| EV-SMASH-SMFS-003962 SMASH-BIO | force_spectroscopy | study_record | in vitro · pH 7.4 Metformin is a novel suppressor for transforming growth factor (TGF)-β1. · SARS-CoV-2 spike (RBD); afm smfs; experiment class: receptor_ligand_adhesion | unmapped |
| EV-SMASH-SMFS-005218 SMASH-BIO | force_spectroscopy | study_record | in vitro Influenza virus binds its host cell using multiple dynamic interactions. · SARS-CoV-2 spike (RBD); optical tweezers; experiment class: receptor_ligand_adhesion | unmapped |
| EV-SMASH-SMFS-006877 SMASH-BIO | force_spectroscopy | study_record | in vitro · pH 6 Probing the interaction between vesicular stomatitis virus and phosphatidylserine. · SARS-CoV-2 spike (RBD); afm smfs; experiment class: membrane_mechanics | unmapped |
| EV-SMASH-SMFS-007372 SMASH-BIO | force_spectroscopy | study_record | in vitro Membrane recognition by vesicular stomatitis virus involves enthalpy-driven protein-lipid interactions. · SARS-CoV-2 spike (RBD); force spectroscopy unspecified; experiment class: membrane_mechanics | unmapped |
Conflicts
No conflicts found among comparable evidence.
2462 evidence items could not be compared: they lack a comparable observable type, a value, or an uncertainty. Absence of a conflict here is not agreement.